diff --git a/README.md b/README.md index 3bb4e9ef23d70b0876f707ffd98e8bb811ec02a3..eb5bf1dfa1518620b8593cadb5d294b4ca7f9df4 100644 --- a/README.md +++ b/README.md @@ -23,16 +23,16 @@ Benchmark results for [DocLD](https://docld.com) table extraction on the | Metric | Value | |--------|-------| -| **Mean Accuracy** | 82.2% | -| **Median** | 82.3% | -| **P25 / P75** | 72.2% / 96.8% | -| **Min / Max** | 41.4% / 100.0% | -| **Scored Samples** | 451 | -| **Total Samples** | 1000 | +| **Mean Accuracy** | 82.1% | +| **Median** | 83.2% | +| **P25 / P75** | 73.3% / 97.4% | +| **Min / Max** | 22.7% / 100.0% | +| **Scored Samples** | 500 | +| **Total Samples** | 500 | ## Methodology -- **Dataset**: [FinTabNet_OTSL](https://huggingface.co/datasets/docling-project/FinTabNet_OTSL) — 1000 samples from the test split +- **Dataset**: [FinTabNet_OTSL](https://huggingface.co/datasets/docling-project/FinTabNet_OTSL) — 500 samples from the test split - **Extraction**: DocLD agentic table extraction (VLM-based, gpt-5-mini) - **Scoring**: Needleman-Wunsch hierarchical alignment (same as [RD-TableBench](https://github.com/reductoai/rd-tablebench)) - **Output**: HTML tables with rowspan/colspan for merged cells @@ -41,7 +41,7 @@ Benchmark results for [DocLD](https://docld.com) table extraction on the | Provider | FinTabNet Accuracy | |----------|-------------------| -| **DocLD** | **82.2%** | +| **DocLD** | **82.1%** | | GTE (IBM) | ~78% | | TATR (Microsoft) | ~65% | diff --git a/charts/cross-benchmark.png b/charts/cross-benchmark.png index b1b1fcc396ec1061ba513c790ae959008b3badac..3ca7c6a5e54f59f14e96a9e364716075aacd9a53 100644 --- a/charts/cross-benchmark.png +++ b/charts/cross-benchmark.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:b4c1aac52a0e1e577adb84a8312f3fab208b8c47261e13d0d9f2f5b4fde85f73 -size 135905 +oid sha256:84b2057ef257c3a5de8cf1b428a1ca21156ffb6bb68fafaddc33f92d282c64f5 +size 135868 diff --git a/charts/idp-comparison.png b/charts/idp-comparison.png index 5b84ad61ac2e8d0347b3c9b5e550ebc575fd121f..e9e0871d893970ec434b1e9f6d11d5b25f7e5adc 100644 --- a/charts/idp-comparison.png +++ b/charts/idp-comparison.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:77c1c524a5ada4b6c2c0997fe175ffa8c5fd161dc78827c7a1214771e863093f -size 101852 +oid sha256:e0c720dd9479f732c150bce9475ffb55ef14795a4d2662bdd133b64cacb2dc7b +size 101783 diff --git a/charts/overall-comparison.png b/charts/overall-comparison.png index 6d0ff5c6f16a3d186b27bcfe5d5dd2d901f37671..5473242b995a4ed4e9247abb756842121b69b07c 100644 --- a/charts/overall-comparison.png +++ b/charts/overall-comparison.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:1f5270f2566f7cc79504eff6ef2cb3f5930f47a841373697c17ebf2f2817e202 -size 66249 +oid sha256:3bcc9617d494bcdc734bbbee35092e238553039a46e4928cac7822c684406610 +size 66287 diff --git a/charts/performance-summary.png b/charts/performance-summary.png index 6aacdcf53453142852c1c2307352c0c130fae571..e9d86f06ed7026c96640ca6129307a87af61501c 100644 --- a/charts/performance-summary.png +++ b/charts/performance-summary.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:482ca6057e5806dc64355b1f0953538d34519dd6c51dc08197c601997ac13390 -size 61831 +oid sha256:e74f3aefe962c6497fd48a9175de10dcb983f591dd4371213769753253ce1446 +size 56431 diff --git a/charts/score-distribution.png b/charts/score-distribution.png index 42455b12dd49d54ec2f01b4c9476f0275fd4f809..46cf0b38f740da1829c5df14f006e5aac84384a8 100644 --- a/charts/score-distribution.png +++ b/charts/score-distribution.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:f0ad04b3e1299173371beb537cb80d95a8ebdd46547dbf5e7e549f4191f04f7f -size 73730 +oid sha256:178eb0f021bab99ea657814c5491858d0d8339a1f6eb494d0da606e417249a1e +size 79373 diff --git a/charts/score-histogram.png b/charts/score-histogram.png index 65650ca44a26aadccfed39660c796c0204e82afe..8b758936ce058a503f8b3a2c806072f46610596c 100644 --- a/charts/score-histogram.png +++ b/charts/score-histogram.png @@ -1,3 +1,3 @@ version https://git-lfs.github.com/spec/v1 -oid sha256:1f427d937ffb3be1e58494ae22c30044d3ec10724f76d1e32e74ca32f1728c89 -size 72892 +oid sha256:a76f5c8e4532bb24fee6d37f2242f3fc7eb9495f771e6bcddf77edd1fa7e46ee +size 82090 diff --git a/predictions/0.html b/predictions/0.html index b3a15c222b009de5f5061c3c079902d1ce5c3b75..20dfdb74927b2ca3dd7255da976e3caee322714c 100644 --- a/predictions/0.html +++ b/predictions/0.html @@ -1,18 +1,200 @@ - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201520142013
United States:
Land9431,8041,705
Offshore (incl. Gulf of Mexico)355756
Total9781,8611,761
Canada:
Land189378352
Offshore222
Total191380354
International (excluding Canada):
Land8841,011978
Offshore283326318
Total1,1671,3371,296
Worldwide total2,3363,5783,411
Land total2,0163,1933,035
Offshore total320385376
201520142013
Land vs. Offshore
United States:
Land9431,8041,705
Offshore (incl. Gulf of Mexico)355756
Total9781,8611,761
Canada:
Land189378352
Offshore222
Total191380354
International (excluding Canada):
Land8841,011978
Offshore283326318
Total1,1671,3371,296
Worldwide total2,3363,5783,411
Land total2,0163,1933,035
Offshore total320385376
Oil vs. Natural Gas
United States (incl. Gulf of Mexico):
Oil7511,5281,375
Natural gas227333386
Total9781,8611,761
Canada:
Oil84218234
Natural gas107162120
Total191380354
International (excluding Canada):
Oil9161,0701,029
Natural gas251267267
Total1,1671,3371,296
Worldwide total2,3363,5783,411
Oil total1,7512,8162,638
Natural gas total585762773
\ No newline at end of file diff --git a/predictions/1.html b/predictions/1.html index 663dbe31daab0be999a03243604d0407777c253e..0fa6bbf8d9daf242fc63aafbdd4f434857a0f78b 100644 --- a/predictions/1.html +++ b/predictions/1.html @@ -4,13 +4,13 @@ December 31 - + Millions of dollars 2009 2008 2007 - Total assets: + Total assets: @@ -23,9 +23,9 @@ Drilling and Evaluation - $ 6,204 - $ 6,205 - $ 4,685 + 6,204 + 6,205 + 4,685 Shared assets @@ -41,8 +41,8 @@ Total - $16,538 - $14,385 - $13,135 + $ 16,538 + $ 14,385 + $ 13,135 \ No newline at end of file diff --git a/predictions/10.html b/predictions/10.html index 7a899a6e37c2af227c3bb8865340c0e9ec69bf67..415880b8195b5360df8fc6d66dcb1239f2c85864 100644 --- a/predictions/10.html +++ b/predictions/10.html @@ -1,206 +1,219 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
QuarterYear
FirstSecondThirdFourth
Millions of dollars except per share data
2017
Revenue$ 4,279$ 4,957$ 5,444$ 5,940$ 20,620
Operating income2031466343791,362
Net income (loss)(32)28361(825)(468)
Amounts attributable to company shareholders:
Income (loss) from continuing operations(32)28365—(444)
Loss from discontinued operations———(19)(19)
Net income (loss) attributable to company(32)28365(824)(463)
Basic and diluted per share attributable to company shareholders:
Income (loss) from continuing operations(0.04)0.030.42(0.92)(0.51)
Loss from discontinued operations———(0.02)(0.02)
Net income (loss)(0.04)0.030.42(0.94)(0.53)
Cash dividends paid per share0.180.180.180.180.72
Common stock prices (1)
High58.7851.2646.1849.2958.78
Low47.5241.3638.1840.7238.18
2016
Revenue$ 4,198$ 3,835$ 3,833$ 4,021$ 15,887
Operating income (loss)(3,079)(3,880)(3,128)53(6,?19)
Net income (loss)(2,418)(3,205)7(153)(5,769)
Amounts attributable to company shareholders:
Income (loss) from continuing operations(2,410)(3,208)6(149)(5,761)
Loss from discontinued operations2————
Net income (loss) attributable to company(2,412)(3,208)6(149)(5,763)
Basic and diluted net income (loss) per share
Cash dividends paid per share0.180.180.180.180.72
Common stock prices (1)
High36.7446.6946.9056.0856.08
Low27.6433.2640.1244.2327.64
QuarterYear
FirstSecondThirdFourth
2017
Revenue$ 4,279$ 4,957$ 5,444$ 5,940$ 20,620
Operating income2031466343791,362
Net income (loss)(32)28361(825)(468)
Amounts attributable to company shareholders:
    Income (loss) from continuing operations(32)28365(805)(444)
    Loss from discontinued operations———(19)(19)
    Net income (loss) attributable to company(32)28365(824)(463)
Basic and diluted net per share attributable to company shareholders:
    Income (loss) from continuing operations(0.04)0.030.42(0.92)(0.51)
    Loss from discontinued operations———(0.02)(0.02)
    Net income (loss)(0.04)0.030.42(0.94)(0.53)
Cash dividends paid per share0.180.180.180.180.72
Common stock prices (1)
    High58.7851.2646.1849.2958.78
    Low47.5241.3638.1840.7238.18
2016
Revenue$ 4,198$ 3,835$ 3,833$ 4,021$ 15,887
Operating income (loss)(3,079)(3,880)12853(6,778)
Net income (loss)(2,418)(3,205)7(153)(5,769)
Amounts attributable to company shareholders:
    Income (loss) from continuing operations(2,410)(3,208)6(149)(5,761)
    Loss from discontinued operations(2)———(2)
    Net income (loss) attributable to company(2,412)(3,208)6(149)(5,763)
Basic and diluted net income (loss) per share(2.81)(3.73)0.01(0.17)(6.69)
Cash dividends paid per share0.180.180.180.180.72
Common stock prices (1)
    High36.7446.6946.9056.0856.08
    Low27.6433.2640.1244.2327.64
\ No newline at end of file diff --git a/predictions/100.html b/predictions/100.html index 1e89e60fd7d643a005ff902c333b0e8f4f6f7122..8fec0d7c5e8350fa1fc5e36f1641fd3eaaba2e8c 100644 --- a/predictions/100.html +++ b/predictions/100.html @@ -1,7 +1,4 @@ - - - @@ -14,6 +11,7 @@ + @@ -24,59 +22,59 @@ - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - + + - + - + @@ -84,13 +82,15 @@ - + + - + + - + @@ -98,50 +98,55 @@ - - - - - - + + + + + + + - + + - - - - - - + + + + + + - - - - - - + + + + + + + - - - - - + + + + + - + - + + - + + @@ -153,44 +158,45 @@ - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + + @@ -207,8 +213,10 @@ + - + + @@ -220,27 +228,27 @@ - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + diff --git a/predictions/101.html b/predictions/101.html index 08521c3244da0cd9eb813f8fa60d6d5c8f0a927d..4f6f8bdf743a7ca8ca62a50828485428c0a742b3 100644 --- a/predictions/101.html +++ b/predictions/101.html @@ -1,6 +1,6 @@
Millions of dollars and shares except per share and employee data
Year Ended December 312005 2004
Total revenue $ 18,279
Total operating income$ 4,010$ 3,498$ 3,245$ 2,164$ 1,1794,0103,4983,2452,1641,179
Nonoperating expense, net$(847)$(38)$(46)$(167)$(189)(847)(38)(46)(167)(189)
Income from continuing operations before income taxes and minority interest$ 3,163$ 3,460$ 3,199$ 1,997$ 9903,1633,4603,1991,997990
(Provision) benefit for income taxes$(1,211)$(907)$(1,003)$ 125$(322)(1,211)(907)(1,003)125(322)
Minority interest in net (income) loss of consolidated subsidiaries$ 9$(2)$(29)$(19)$(15)9(29)(49)(15)3
Income from continuing operations $ 1,961$ 2,554$ 2,167$ 2,524$ 2,177 $ 2,107 $ 671
Income (loss) from discontinued operations$(423)$ (423) $ 975 $ 171 $ 251$(1,650)$ (1,650)
Net income (loss)$ 3,499 $ 2,348 $ 2,358$(979)$ (979)
Basic income (loss) per share:Basic income (loss) per share:
Continuing operations  Continuing operations $ 2.24 $ 2.76 $ 2.15$ 0.77
Net income (loss)$ 1.75$ 3.83$ 2.31$ 2.34$(1.12)  Net income (loss)1.753.832.312.34(1.11)
Diluted income (loss) per share:Diluted income (loss) per share:
Continuing operations$ 2.17$ 2.66$ 2.07$ 2.03$ 0.76  Continuing operations2.172.662.072.030.76
Net income (loss)$ 1.70$ 3.62$ 2.08$ 2.27$(1.11)  Net income (loss)1.703.682.232.27(1.11)
Cash dividends per share$ 0.36$ 0.35$ 0.30$ 0.25$ 0.250.360.350.300.250.25
Return on average shareholders' equity21.08%21.80% 49.14% 34.16% 45.76%(30.22)%30.22%
Financial position:Financial position:
Net working capital
Total assets$ 14,385$ 13,135$ 16,860$ 15,073$ 15,88314,38513,13516,86015,07315,883
Property, plant, and equipment, net$ 4,782$ 3,630$ 2,557$ 2,203$ 2,0754,7823,6302,5572,2032,075
Long-term debt (including current maturities)$ 2,612$ 2,786$ 2,809$ 3,139$ 3,8792,6122,7862,8093,1393,879
Shareholders' equity$ 7,725$ 6,865$ 7,376$ 6,372$ 3,9327,7258,6667,3766,3723,932
Total capitalization$ 10,350$ 9,663$ 10,187$ 9,525$ 7,81810,3509,66310,1879,5257,818
Basic weighted average common shares outstanding 8771,038 882
Other financial data:Other financial data:
Capital expenditures
Long-term borrowings (repayments), net$(861)$(7)$(324)$(779)$ 493(861)(7)(324)(779)493
Depreciation, depletion, and amortization expense$ 738$ 583$ 480$ 448$ 456738583480448456
Payroll and employee benefits$ 5,264$ 4,585$ 3,853$ 3,211$ 2,8235,2644,5853,8533,2112,823
Number of employees
- + @@ -11,13 +11,13 @@ - - + + - - + + @@ -27,7 +27,7 @@ - + diff --git a/predictions/102.html b/predictions/102.html new file mode 100644 index 0000000000000000000000000000000000000000..9f6f7c4b85b6a270232c029d0568a022e9e536db --- /dev/null +++ b/predictions/102.html @@ -0,0 +1,42 @@ +
Millions of dollars Unrecognized
Tax Benefits		 Interest
and Penalties
Change in prior year tax positions$ 145—145
Change in current year tax positions$ 34$ 4344
Settlements with taxing authorities
Lapse of statute of limitations (3)—
Balance at December 31, 2007
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
200920102011201220132014
Halliburton$ 100.00$ 137.25$ 117.09$ 119.04$ 176.17$ 138.12
Philadelphia Oil Service Index (OSX)100.00126.92113.53117.09153.76120.98
Standard & Poor’s 500 ® Index100.00115.06117.49136.30180.44205.14
\ No newline at end of file diff --git a/predictions/103.html b/predictions/103.html new file mode 100644 index 0000000000000000000000000000000000000000..e6e1906d485aae7f6333047429fd5f8d7d287222 --- /dev/null +++ b/predictions/103.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
1.Financial Statements:
The reports of the Independent Registered Public Accounting Firm and the financial statements of Halliburton Company as required by Part II, Item 8, are included on pages 43 and 44 and pages 45 through 75 of this annual report. See index on page (i).
2.Financial Statement Schedules:
The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.
3.Exhibits:
\ No newline at end of file diff --git a/predictions/104.html b/predictions/104.html new file mode 100644 index 0000000000000000000000000000000000000000..0cd1518b1dfcc9c282da0c52d4e3b3957f420354 --- /dev/null +++ b/predictions/104.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20152014
Finished products and parts$ 1,747$ 2,606
Raw materials and supplies548754
Work in process122211
Total$ 2,417$ 3,571
\ No newline at end of file diff --git a/predictions/105.html b/predictions/105.html new file mode 100644 index 0000000000000000000000000000000000000000..1368888ad52707ec278fa4278771f853f35506cb --- /dev/null +++ b/predictions/105.html @@ -0,0 +1,40 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20162015
Land$ 228240
Buildings and property improvements3,3993,486
Machinery, equipment and other16,10319,967
Total19,73023,693
Less accumulated depreciation11,19811,576
Net property, plant and equipment$ 8,53212,117
\ No newline at end of file diff --git a/predictions/106.html b/predictions/106.html new file mode 100644 index 0000000000000000000000000000000000000000..2c88513ab9cf4bbeac4b0aa7448e35a4958b37e8 --- /dev/null +++ b/predictions/106.html @@ -0,0 +1,23 @@ + + + + + + + + + + + + + + + + + + + + + + +
Balance at Beginning of PeriodCharged to Costs and ExpensesWrite-OffsBalance at End of Period
Year ended December 31, 2006:$ 38$ 6$ (4)$ 40
Year ended December 31, 2007:4010(1)49
\ No newline at end of file diff --git a/predictions/107.html b/predictions/107.html new file mode 100644 index 0000000000000000000000000000000000000000..cc35df678e5ddbbcd712cb806a0ec41bb6ace476 --- /dev/null +++ b/predictions/107.html @@ -0,0 +1,379 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Company Shareholders’ EquityNoncontrolling interest in Consolidated SubsidiariesTotal
Common SharesPaid-in Capital in Excess of Par ValueTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Subtotal
Millions of dollars
Balance at December 31, 2006$ 2,650$ 1,689$ (1,577)$ 5,051$ (437)$ 7,376$ 69$ 7,445
Adoption of new accounting standard–––(43)43–––
Adjusted balance at December 31, 2006$ 2,650$ 1,689$ (1,577)$ 5,008$ (437)$ 7,333$ 69$ 7,402
Cash dividends paid–––(1,044)–(1,044)–(1,044)
Stock plans723130––160–160
Common shares purchased––(1,374)––(1,374)–(1,374)
Tax benefit from exercise of options and restricted stock–29–––29–29
Distributions to noncontrolling interest holders––––––(5)(5)
Other transactions with shareholders–––(4)–(4)(21)(25)
Total dividends and other transactions with shareholders752(1,244)(318)–(1,503)(26)(1,529)
Shares exchanged in KBR, Inc. exchange offer––(2,809)––(2,809)–(2,809)
Adoption of new accounting standard–––(30)–(30)–(30)
Comprehensive income (loss):––––––––
  Net income–––3,486–3,486503,536
  Other comprehensive income (loss):––––––––
    Cumulative translation adjustment––––11–1
    Realization of translation gains included in net income––––(24)(24)–(24)
    Defined benefit and other postretirement plans adjustments:––––––––
      Prior service cost:––––––––
        Plan amendment––––(2)(2)–(2)
        Settlements/curtailments––––33–3
      Actuarial gain (loss):––––––––
        Net gain––––105105–105
        Amortization of net loss––––1414–14
        Settlements/curtailments––––77–7
    Tax effect on defined benefit and postretirement plans––––(45)(45)–(45)
  KBR, Inc. separation––––271271–271
  Defined benefit and other postretirement plans––––355355–355
  Net unrealized gains on investments, net of tax provision of $0––––11–1
Total other comprehensive income––––333333–333
Total comprehensive income–––3,4863333,819503,869
Balance at December 31, 2007$ 2,657$ 1,804$ (5,630)$ 8,146$ (104)$ 6,873$ 93$ 6,966
\ No newline at end of file diff --git a/predictions/108.html b/predictions/108.html new file mode 100644 index 0000000000000000000000000000000000000000..cc11fe1c57489b31664f78d5fc09ce04d164289c --- /dev/null +++ b/predictions/108.html @@ -0,0 +1,146 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
North America$3,589$5,327$(1,738)(33)
Latin America887978(91)(9)
Europe/Africa/CIS1,7711,938(167)(9)
Middle East/Asia1,1721,367(195)(14)
Total7,4199,610(2,191)(23)
Drilling and Evaluation:
North America2,0733,013(940)(31)
Latin America1,2941,447(153)(11)
Europe/Africa/CIS2,1772,408(231)(10)
Middle East/Asia1,7121,801(89)(5)
Total7,2568,669(1,413)(16)
Total revenue by region:
North America5,6628,340(2,678)(32)
Latin America2,1812,425(244)(10)
Europe/Africa/CIS3,9484,346(398)(9)
Middle East/Asia2,8843,168(284)(9)
\ No newline at end of file diff --git a/predictions/109.html b/predictions/109.html new file mode 100644 index 0000000000000000000000000000000000000000..b95019876cf7ca314f4a2eb59a668f8d68f8becd --- /dev/null +++ b/predictions/109.html @@ -0,0 +1,51 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Combined financial positionDecember 31
Millions of dollars20042003
Current assets$2,390$2,542
Noncurrent assets3,2263,054
Total$5,616$5,596
Current liabilities2,0432,361
Noncurrent liabilities2,8382,237
Minority interests3
Shareholders' equity735995
Total$5,616$5,596
\ No newline at end of file diff --git a/predictions/11.html b/predictions/11.html index 7914ecf829a0ac4d4c0ea6178d1ce11a5c259283..373f39a7e4606938716e8b947d52334ac65dbedb 100644 --- a/predictions/11.html +++ b/predictions/11.html @@ -1,7 +1,137 @@ -[ - ["North America", "$ 1,404", "$ 1,476", "$ (72)", "(5%)"], - ["Latin America", "170", "130", "40", "31"], - ["Europe/Africa/CIS", "330", "324", "6", "2"], - ["Middle East/Asia", "295", "210", "85", "40"], - ["Total", "2,199", "2,140", "59", "3"] -] \ No newline at end of file + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
$
North America$1,4041,476(72)(5)%
Latin America1701304031
Europe/Africa/CIS33032462
Middle East/Asia2952108540
Total2,1992,140593
Drilling and Evaluation:
North America552595(43)(7)
Latin America17917095
Europe/Africa/CIS41426315157
Middle East/Asia3403004013
Total1,4851,32815712
Total operating income by region (excluding Corporate and other):
North America1,9562,071(115)(6)
Latin America3493004916
Europe/Africa/CIS74458715727
Middle East/Asia63551012525
\ No newline at end of file diff --git a/predictions/110.html b/predictions/110.html new file mode 100644 index 0000000000000000000000000000000000000000..5a91bc3e0b3dc2b97250269b39ea045f7dca5aa5 --- /dev/null +++ b/predictions/110.html @@ -0,0 +1,40 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsDecember 31
20152014
Total assets:
Completion and Production$ 13,62816,033
Drilling and Evaluation10,53111,237
Shared assets1,7851,930
Corporate and other10,9982,965
Total$ 36,942$ 32,165
\ No newline at end of file diff --git a/predictions/111.html b/predictions/111.html new file mode 100644 index 0000000000000000000000000000000000000000..4a6f83a78bbcf653b115d358d91c80551fa66137 --- /dev/null +++ b/predictions/111.html @@ -0,0 +1,31 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
Millions of shares200420032002
Issued458457456
In treasury(16)(18)(20)
Total shares of common stock outstanding442439436
\ No newline at end of file diff --git a/predictions/112.html b/predictions/112.html new file mode 100644 index 0000000000000000000000000000000000000000..3dea5aa74b75537e1cc7c1bce7210fc9e4290936 --- /dev/null +++ b/predictions/112.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Page No.
Management’s Report on Internal Control Over Financial Reporting45
Reports of Independent Registered Public Accounting Firm46
Consolidated Statements of Operations for the years ended December 31, 2007, 2006, and 200548
Consolidated Balance Sheets at December 31, 2007 and 200649
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2007, 2006, and 200550
Consolidated Statements of Cash Flows for the years ended December 31, 2007, 2006, and 200551
Notes to Consolidated Financial Statements52
Selected Financial Data (Unaudited)87
Quarterly Data and Market Price Information (Unaudited)88
\ No newline at end of file diff --git a/predictions/113.html b/predictions/113.html new file mode 100644 index 0000000000000000000000000000000000000000..90c4b891b6d59d6ea29380e325343f2bc5689ddb --- /dev/null +++ b/predictions/113.html @@ -0,0 +1,29 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 2016December 31, 2015
Millions of dollarsLevel 1Level 2Total fair valueCarrying valueLevel 1Level 2Total fair valueCarrying value
Long-term debt$ 753$ 12,812$ 13,565$ 12,377$ 1,009$ 14,947$ 15,956$ 15,346
\ No newline at end of file diff --git a/predictions/114.html b/predictions/114.html new file mode 100644 index 0000000000000000000000000000000000000000..c64f0080242ed0353bebd4412d6423d2b597b77d --- /dev/null +++ b/predictions/114.html @@ -0,0 +1,44 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200920082007
Millions of shares
Basic weighted average common shares outstanding900883919
Dilutive effect of:
    Convertible senior notes premium (a)–2229
    Stock options247
Diluted weighted average common shares outstanding902909955
\ No newline at end of file diff --git a/predictions/115.html b/predictions/115.html new file mode 100644 index 0000000000000000000000000000000000000000..ee38b5b788770f4c1a49f00dd6146f4d5ff2180b --- /dev/null +++ b/predictions/115.html @@ -0,0 +1,258 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsCommon SharesPaid-in Capital in Excess of Par ValueTreasury StockDeferred CompensationRetained EarningsAccumulated Other Comprehensive IncomeTotal
CommonPreferredCurrency TranslationOther
Balance at December 31, 2005$ 2,634$ 1,501$ (374)$ (98)$ 2,975$ (266)$ 6,372
Cash dividends paid(306)(306)
Stock plan16116136268
Common shares purchased(1,339)(1,339)
Tax benefit from exercise of options and restricted stock5353
Total dividends and other transactions with shareholders16169(1,203)(306)(1,324)
Sale of stock by a subsidiary117117
Reclassification of deferred compensation(98)98
Adoption of SFAS No. 158, net of tax benefit(218)(218)
Other3434
Comprehensive income (loss):
Net income2,3482,348
Other comprehensive income:
Cumulative translation adjustment4848
Realization of translation gains included in net income(14)(14)
Defined benefit and other postretirement plans adjustments, net of tax benefit of $1622
Net unrealized gains on investments and derivatives, net of tax provision of $71212
Realization of gains on investments and derivatives, net of tax provision of $0(1)(1)
Total comprehensive income2,34834132,395
Balance at December 31, 2006$ 2,650$ 1,689$ (1,577)$ -$ 5,051$ (437)$ 13$ 7,376
\ No newline at end of file diff --git a/predictions/116.html b/predictions/116.html index e8ca8f821d06cb016e9dc3056e0700d2e65756a6..2918ce5a2e2ebcc30f75b9fd4eec74511a64a847 100644 --- a/predictions/116.html +++ b/predictions/116.html @@ -1,43 +1,45 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20162015
Total assets:
Completion and Production$ 10,349$ 13,628
Drilling and Evaluation$ 8,473$ 10,531
Shared assets$ 3,371$ 1,785
Corporate and other$ 4,807$ 10,998
Total$ 27,000$ 36,942
December 31
20162015
Millions of dollars
Total assets:
Completion and Production$ 10,34913,628
Drilling and Evaluation8,47310,531
Shared assets3,3711,785
Corporate and other4,80710,998
Total$ 27,00036,942
\ No newline at end of file diff --git a/predictions/117.html b/predictions/117.html new file mode 100644 index 0000000000000000000000000000000000000000..bcf990b3db1cf76a0224f2f7fd678ac271a94acd --- /dev/null +++ b/predictions/117.html @@ -0,0 +1,110 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200720062005
Millions of dollars and shares
Balance at January 1$ 7,376$ 6,372$ 3,932
Dividends and other transactions with shareholders(1,499)(1,324)202
Sale of stock by a subsidiary–117–
Adoption of Statement of Financial Accounting
    Standards No. 158–(218)–
Adoption of Financial Accounting Standards Board
    Interpretation No. 48(30)––
Shares exchanged in KBR, Inc. exchange offer(2,809)––
Other(4)34–
Comprehensive income
    Net income3,4992,3482,358
    Net cumulative translation adjustments(23)34(41)
    Defined benefit and other postretirement plans adjustments3552(54)
    Net unrealized gains (losses) on investments
and derivatives		111(25)
Total comprehensive income3,8322,3952,238
Balance at December 31$ 6,866$ 7,376$ 6,372
\ No newline at end of file diff --git a/predictions/118.html b/predictions/118.html new file mode 100644 index 0000000000000000000000000000000000000000..2a7e6c0e1f914f1b3abbcf50730d74e8c77ad4cf --- /dev/null +++ b/predictions/118.html @@ -0,0 +1,29 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsYear Ended December 31
201720162015
United States$ 694$ (6,636)$ 1,560
Foreign(12)(989)624
Total$ 682$ (7,625)$ (936)
\ No newline at end of file diff --git a/predictions/119.html b/predictions/119.html new file mode 100644 index 0000000000000000000000000000000000000000..c28b19e63ac0f9560222ed3d108d0e9425bde19f --- /dev/null +++ b/predictions/119.html @@ -0,0 +1,56 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
200920082007
United States statutory rate35.0%35.0%35.0%
Impact of foreign income taxed at different rates(3.3)(1.1)(2.3)
Adjustments of prior year taxes(2.1)(1.9)(0.3)
Other impact of foreign operations(0.4)(1.1)0.9
Valuation allowance0.1(2.0)
Other items, net1.60.5(0.2)
Total effective tax rate on continuing operations30.8%31.5%26.3%
\ No newline at end of file diff --git a/predictions/12.html b/predictions/12.html new file mode 100644 index 0000000000000000000000000000000000000000..0139df2e0d428205be83fa66ad937936e57e003b --- /dev/null +++ b/predictions/12.html @@ -0,0 +1,286 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
200720062005
Millions of dollars
Cash flows from operating activities:
Net income$ 3,499$ 2,548$ 2,358
Adjustments to reconcile net income to net cash from operations:
Income from discontinued operations(975)(171)(251)
Depreciation, depletion, and amortization583480448
Provision (benefit) for deferred income taxes(111)658(243)
Gain on sale of business assets(52)(66)(100)
Asbestos and silica liability payment related to Chapter 11 filing——(2,345)
Collection of asbestos- and silica-related insurance receivables291671,032
Other charges:
Receivables(355)(494)(314)
Accounts receivable facilities transactions——(256)
Inventories(218)(609)(151)
Accounts payable796102
Contributions to pension plans(41)(75)(39)
Other259712252
Cash flows from discontinued operations31811210
Total cash flows from operating activities2,7263,557701
Cash flows from investing activities:
Sales of property, plant, and equipment203152106
Dispositions of business assets, net of cash disposed7098212
Investments – restricted cash56——
Sales (purchases) of short-term investments in marketable securities, net(332)(20)891
Acquisitions of business assets, net of cash acquired(563)(27)(105)
Disposal of KBR, Inc. cash upon separation(1,461)——
Capital expenditures(1,583)(834)(575)
Other investing activities(38)(20)(36)
Cash flows from continued operations(3)22519
Total cash flows from investing activities(3,661)(426)510
Cash flows from financing activities:
Proceeds from exercises of stock options110159342
Tax benefit from exercise of options and restricted stock2953—
Borrowings (repayments) of short-term debt, net9(13)8
Proceeds from long-term debt, net of offering costs——23
Payments on long-term debt(7)(324)(802)
Payments of dividends to shareholders(314)(306)(254)
Payments to reacquire common stock(1,374)(1,339)(12)
Other financing activities(5)5(1)
Cash flows from continued operations(18)485(24)
Total cash flows from financing activities(1,570)(1,280)(720)
Effect of exchange rate changes on cash, including $0, $50, and $(3) related to discontinued operations(27)37(17)
Increase (decrease) in cash and equivalents(2,532)1,888474
Cash and equivalents at beginning of year, including $1,461, $390, and $188 related to discontinued operations4,3792,3911,917
Cash and equivalents at end of year, including $0, $1,461, and $390 related to discontinued operations$ 1,847$ 4,379$ 2,391
\ No newline at end of file diff --git a/predictions/120.html b/predictions/120.html index 729c37121f8750d7371521b39d38eec848492eba..02d75c520ddba4efa69dfdb44bf6fb1e74a90b60 100644 --- a/predictions/120.html +++ b/predictions/120.html @@ -8,8 +8,8 @@ Oil price - WTI (1) $ 50.93 - $ 43.14 - $ 48.69 + $ 43.14 $ + 48.69 Oil price - Brent (1) @@ -19,8 +19,8 @@ Natural gas price - Henry Hub (2) - 3.04 - 2.62 + 3.40 + 2.52 2.63 \ No newline at end of file diff --git a/predictions/121.html b/predictions/121.html index 04b2c2d0b7f081e4c5353b4fa0df761ee3912b52..c5f762ce8247074ae1bde8be6397adb73a188052 100644 --- a/predictions/121.html +++ b/predictions/121.html @@ -1,26 +1,22 @@ - - - - + - + - - - - + + + - - - + + + @@ -35,7 +31,7 @@ - + @@ -48,7 +44,7 @@ - + @@ -68,20 +64,29 @@ - - - + + + + - + + + + + + + - + + + - - + + @@ -100,16 +105,21 @@ + + + + + - + - + @@ -129,15 +139,18 @@ - + + - + + + - + @@ -157,28 +170,28 @@ - + - + - + - + - + - - - + + +
Millions of dollars and shares except per share data
Assets December 31
2009 2008
Assets
Current assets:Current assets:
Cash and equivalents$ 2,082$ 1,124Cash and cash equivalents$    2,082$    1,124
Receivables (less allowance for bad debts of $90 and $60)
Investments in marketable securities 1,3121,
Current deferred income taxes418
Total current assetsTotal current assets 8,638 7,411
1,120
Total assets$ 16,538$ 14,385Total assets$  16,538$  14,385
Liabilities and Shareholders' EquityLiabilities and Shareholders’ Equity
Current liabilities:Current liabilities:
Accounts payable$ 787$ 898$    787$    898
Current maturities of long-term debt
Department of Justice (DOJ) and Securities and Exchange Commission (SEC) settlement and indemnity, current
Other current liabilities 142 373
Other current liabilitiesTotal current liabilities 481 610
Total current liabilitiesLong-term debt 2,889 2,781
735
Total liabilitiesTotal liabilities 7,781 6,641
Shareholders' equity:Shareholders’ equity:
Common shares, par value $2.50 per share — authorized 2,000 shares, issued 1,067Common shares, par value $2.50 per share – authorized 2,000 shares, issued 1,067 2,669 2,666
10,041
Treasury stock, at cost — 165 and 172 sharesTreasury stock, at cost – 165 and 172 shares (5,002) (5,251)
Company shareholders' equityCompany shareholders’ equity 8,728 7,725
Noncontrolling interest in consolidated subsidiaries 291419
Total shareholders' equityTotal shareholders’ equity 8,7577,7397,744
Total liabilities and shareholders' equity16,53814,385Total liabilities and shareholders’ equity$  16,538$  14,385
\ No newline at end of file diff --git a/predictions/122.html b/predictions/122.html new file mode 100644 index 0000000000000000000000000000000000000000..31c7659002d5175c3b3540b29cbf3f49e4aab85a --- /dev/null +++ b/predictions/122.html @@ -0,0 +1,80 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsDecember 31
20162015
Gross deferred tax assets:
    Net operating loss carryforwards$      1,647$      540
    Foreign tax credit carryforwards      648      365
    Employee compensation and benefits      352      403
    Accrued liabilities      325      392
    Other      536      359
Total gross deferred tax assets      3,508      2,059
Gross deferred tax liabilities:
    Depreciation and amortization      585      1,334
    Undistributed foreign earnings      406      5
    Other      145      109
Total gross deferred tax liabilities      1,136      1,448
Valuation allowances      453      213
Net deferred income tax asset$      1,919$      398
\ No newline at end of file diff --git a/predictions/123.html b/predictions/123.html new file mode 100644 index 0000000000000000000000000000000000000000..e3b2ededc2a735aa8f440b3c07bb4d7ef74aeb44 --- /dev/null +++ b/predictions/123.html @@ -0,0 +1,98 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Land vs. Offshore201420132012
United States:
Land1,8041,7051,872
Offshore (incl. Gulf of Mexico)575647
Total1,8611,7611,919
Canada:
Land378352363
Offshore221
Total380354364
International (excluding Canada):
Land1,011978931
Offshore326318303
Total1,3371,2961,234
Worldwide total3,5783,4113,517
Land total3,1933,0353,166
Offshore total385376351
\ No newline at end of file diff --git a/predictions/124.html b/predictions/124.html new file mode 100644 index 0000000000000000000000000000000000000000..9b9b43a601326f86400e45345058b321aed5c961 --- /dev/null +++ b/predictions/124.html @@ -0,0 +1,35 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
201620152014
Millions of dollars
Stock-based compensation cost$ 262$ 294$ 298
Tax benefit(77)(99)(90)
Stock-based compensation cost, net of tax$ 185$ 195$ 208
\ No newline at end of file diff --git a/predictions/125.html b/predictions/125.html new file mode 100644 index 0000000000000000000000000000000000000000..ecf37b6b87d2f655a4fa7553f11a9745c319a0a0 --- /dev/null +++ b/predictions/125.html @@ -0,0 +1,219 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years ended December 31
Millions of dollars200420032002
Revenue:
Production Optimization$ 3,304$ 2,758$ 2,544
Fluid Systems2,3242,0391,815
Drilling and Formation Evaluation1,7821,6431,633
Digital and Consulting Solutions589552844
Total Energy Services Group7,9986,9966,836
Government and Infrastructure9,9395,4171,539
Energy and Chemicals3,0763,3854,197
Total KBR12,4689,2765,736
Total$ 20,466$ 16,271$ 12,572
Operating income (loss):
Production Optimization633413374
Fluid Systems348251202
Drilling and Formation Evaluation225177160
Digital and Consulting Solutions60(15)(98)
Total Energy Services Group1,266826638
Government and Infrastructure8419475
Energy and Chemicals(426)(225)(131)
Shared KBR(5)(629)
Total KBR(342)(36)(685)
General Corporate(87)(70)(65)
Total$ 837$ 720$ (112)
Capital expenditures:
Production Optimization$ 181$ 124$ 118
Fluid Systems665455
Drilling and Formation Evaluation135147190
Digital and Consulting Solutions3225149
Shared Energy Services8410091
Total Energy Services Group498453603
Government and Infrastructure4145138
Energy and Chemicals9512
Shared KBR271211
Total KBR7762161
Total$ 575$ 515$ 764
\ No newline at end of file diff --git a/predictions/126.html b/predictions/126.html index 32188e0690d4cd25e8d3bf1619eb49b8fdf2baf0..5879e4054cd0aead2dd8add437936107ff06e505 100644 --- a/predictions/126.html +++ b/predictions/126.html @@ -1,54 +1,95 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
December 31
20092008
Gross deferred tax assets:
Employee compensation and benefits$ 266$ 324
Accrued liabilities7581
Net operating loss carryforwards6450
Capitalized research and experimentation5674
Insurance accruals4847
Software revenue recognition3531
Inventory2926
Other80114
Total gross deferred tax assets653747
Gross deferred tax liabilities:
Depreciation and amortization447303
Joint ventures, partnerships, and unconsolidated affiliates3325
Other5538
Total gross deferred tax liabilities535366
Net deferred income tax asset$ 118$ 381
- - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20092008
Millions of dollars
Gross deferred tax assets:
    Employee compensation and benefits$  266$  324
    Accrued liabilities7581
    Net operating loss carryforwards6450
    Capitalized research and experimentation5674
    Insurance accruals4847
    Software revenue recognition3531
    Inventory2926
    Other80114
Total gross deferred tax assets653747
Gross deferred tax liabilities:
    Depreciation and amortization447303
    Joint ventures, partnerships, and unconsolidated affiliates3325
    Other5538
Total gross deferred tax liabilities535366
Net deferred income tax asset$  118$  381
\ No newline at end of file diff --git a/predictions/127.html b/predictions/127.html new file mode 100644 index 0000000000000000000000000000000000000000..c2030435cc1c6c3f5fbc08027280f0865c6070c4 --- /dev/null +++ b/predictions/127.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
201520142013
Expected term (in years)5.165.235.27
Expected volatility39%37%40%
Expected dividend yield1.51 - 1.85%0.94 - 1.77%0.94 - 1.33%
Risk-free interest rate1.43 - 1.72%1.57 - 1.86%0.77 - 1.73%
Weighted average grant-date fair value per share$13.47$19.26$14.34
\ No newline at end of file diff --git a/predictions/128.html b/predictions/128.html new file mode 100644 index 0000000000000000000000000000000000000000..45af1266856e5f9e38c938ef68c1c839154876c1 --- /dev/null +++ b/predictions/128.html @@ -0,0 +1,26 @@ + + + + + + + + + + + + + + + + + + + + + + + + + +
20065103
200741
200810
200913
201016
2011527
\ No newline at end of file diff --git a/predictions/129.html b/predictions/129.html new file mode 100644 index 0000000000000000000000000000000000000000..cdedf842f1644932ed2e7753f9b9ccb8bc9ed71f --- /dev/null +++ b/predictions/129.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
PeriodTotal Number of Shares Purchased (a)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
October 1-3136,642$ 26.20–
November 1-3012,264$ 18.46–
December 1-3166,986$ 15.32–
Total115,892$ 19.09–
\ No newline at end of file diff --git a/predictions/13.html b/predictions/13.html index fb6964d9a1f77b7ba790ca7a11ebd73a4bd0ce19..0e9781d23dbcac75c636b281c62efe5dc893f901 100644 --- a/predictions/13.html +++ b/predictions/13.html @@ -1,40 +1,35 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Accumulated other comprehensive loss
Millions of dollars    December 31
200920082007
Cumulative translation adjustment$ (65)$ (60)$ (61)
Defined benefit and other postretirement liability adjustments (a)$ (149)$ (151)$ (45)
Unrealized gains (losses) on investments$ 1$ (4)$ 2
Total accumulated other comprehensive loss$ (213)$ (215)$ (104)
-

(a) Includes actuarial loss of $111 for our United States pension plans plus prior service cost of $3 related to our international plan.

\ No newline at end of file + + Accumulated other comprehensive loss
Millions of dollars + December 31 + + + 2009 + 2008 + 2007 + + + Cumulative translation adjustment + $ (65) + (60) + (61) + + + Defined benefit and other postretirement liability adjustments (a) + (149) + (151) + (45) + + + Unrealized gains (losses) on investments + 1 + (4) + 2 + + + Total accumulated other comprehensive loss + $ (213) + (215) + (104) + + \ No newline at end of file diff --git a/predictions/130.html b/predictions/130.html new file mode 100644 index 0000000000000000000000000000000000000000..a24100b82aac7df3ac4387f7c4fe9599de374804 --- /dev/null +++ b/predictions/130.html @@ -0,0 +1,246 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars200820072006
Cash flows from operating activities:
Net income$ 1,538$ 3,499$ 2,348
Adjustments to reconcile net income to net cash from operations:
Depreciation, amortization and amortization738583480
Loss on extinguishment of debt693——
(Income) loss from discontinued operations423(975)(171)
Provision (benefit) for income taxes, continuing operations254(140)714
Gain on sale of business assets, net(62)(52)(66)
Other changes:
Accounts payable(161)7796
Contributions to pension plans(52)(41)(75)
Inventories(368)(218)(309)
Receivables(670)(326)(327)
Other19288656
Cash flows from discontinued operations3131311
Total cash flows from operating activities2,6742,7263,561
Cash flows from investing activities:
Sales (purchases) of short-term investments in marketable securities, net388(332)(20)
Sales of property, plant, and equipment191203151
Dispositions of business assets, net of cash disposed817098
Disposal of KBR, Inc. cash upon separation—(1,461)—
Acquisitions of business assets, net of cash acquired(652)(563)(27)
Capital expenditures(1,824)(1,583)(834)
Other investing activities(40)1820
Cash flows from discontinued operations—(13)223
Total cash flows from investing activities(1,856)(3,661)(426)
Cash flows from financing activities:
Proceeds from long-term debt, net of offering costs1,187——
Proceeds from exercise of stock options120110159
Tax benefit from exercise of options and restricted stock442953
Payments of dividends to shareholders(319)(314)(306)
Payments to reacquire common stock(507)(1,374)(1,339)
Payments on long-term debt(2,048)(7)(324)
Other financing activities—4(8)
Cash flows from discontinued operations—(18)485
Total cash flows from financing activities(1,523)(1,570)(1,280)
Effect of exchange rate changes on cash, including $0, $0, and $50 related to discontinued operations(18)(27)37
Increase (decrease) in cash and equivalents(723)(2,532)1,988
Cash and equivalents at beginning of year, including $0, $1,461, and $390 related to discontinued operations1,8474,3792,391
Cash and equivalents at end of year, including $0, $0, and $1,461 related to discontinued operations$ 1,124$ 1,847$ 4,379
\ No newline at end of file diff --git a/predictions/131.html b/predictions/131.html new file mode 100644 index 0000000000000000000000000000000000000000..dbb787afe17a117ccf653f4542a6620beb4dde19 --- /dev/null +++ b/predictions/131.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200320042005200620072008
Halliburton$100.00$153.28$244.43$247.14$304.79$147.95
Standard & Poor’s 500 Stock Index100.00110.88116.33134.70142.1089.53
Standard & Poor’s Energy Composite Index100.00131.54172.80214.63288.47187.88
\ No newline at end of file diff --git a/predictions/132.html b/predictions/132.html new file mode 100644 index 0000000000000000000000000000000000000000..3db339ef146b79023c81b20c800904cfdd64b781 --- /dev/null +++ b/predictions/132.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200220032004200520062007
Halliburton$100.00$142.06$217.75$347.23$351.09$432.98
Standard & Poor’s 500 Stock Index100.00128.68142.69149.70173.34182.86
Standard & Poor’s Energy Composite Index100.00125.63165.25217.08269.64362.40
\ No newline at end of file diff --git a/predictions/133.html b/predictions/133.html new file mode 100644 index 0000000000000000000000000000000000000000..ac3b85b1a59424028b7e729cd2263834c19e1222 --- /dev/null +++ b/predictions/133.html @@ -0,0 +1,47 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Funded status$(42)$(260)$(3)$(150)$(92)$(104)
Employer contribution$51
Net amount recognized$(42)$(260)$(3)$(145)$(92)$(103)
\ No newline at end of file diff --git a/predictions/134.html b/predictions/134.html new file mode 100644 index 0000000000000000000000000000000000000000..35ba7f6b9b202d4eda435e6d949c5bb4866fb807 --- /dev/null +++ b/predictions/134.html @@ -0,0 +1,35 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Building and Property Improvements
20092008
110 years13%17%
1120 years47%46%
2130 years11%12%
3140 years29%25%
\ No newline at end of file diff --git a/predictions/135.html b/predictions/135.html new file mode 100644 index 0000000000000000000000000000000000000000..391eca5157196337ee81906792fd68270ae02145 --- /dev/null +++ b/predictions/135.html @@ -0,0 +1,166 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
200920082007
Millions of dollars
Revenue:
Completion and Production$ 7,419$ 9,610$ 8,138
Drilling and Evaluation7,2568,6697,126
Total revenue$ 14,675$ 18,279$ 15,264
Operating income:
Completion and Production$ 1,016$ 2,304$ 2,119
Drilling and Evaluation1,1831,9701,565
Total operations2,1994,2743,684
Corporate and other(205)(264)(186)
Total operating income$ 1,994$ 4,010$ 3,498
Interest expense$ (297)$ (167)$ (168)
Interest income1239124
Other, net(27)(33)(7)
Income from continuing operations before
income taxes		$ 1,682$ 3,849$ 3,447
Capital expenditures:
Completion and Production$ 900$ 787$ 787
Drilling and Evaluation9591,031763
Corporate and other5633
Total$ 1,864$ 1,824$ 1,583
Depreciation, depletion, and amortization:
Completion and Production$ 437$ 358$ 282
Drilling and Evaluation490376294
Corporate and other447
Total$ 931$ 738$ 583
\ No newline at end of file diff --git a/predictions/136.html b/predictions/136.html index 2004edd1b0bd3bceca42672d154cd7619249bd09..2ea77e91233d5a9ff484a15c9e7f364c768c65dd 100644 --- a/predictions/136.html +++ b/predictions/136.html @@ -1,11 +1,17 @@ - - + + + - - + + + + + + + diff --git a/predictions/137.html b/predictions/137.html index 6ef3f23534a3200b0c0383b79764c239cb000d08..3432ae2e301fe801b3b9fbc10732d0a1496ed7e7 100644 --- a/predictions/137.html +++ b/predictions/137.html @@ -1,16 +1,17 @@
Millions of dollarsEffect onEffect on
Pension Expense in 2008Pension Benefit Obligation at December 31, 2008Pension Expense
in 2008		Pension Benefit Obligation
at December 31, 2008
Millions of dollars
25-basis-point decrease in discount rate
- + + - - + + @@ -23,7 +24,7 @@ - + @@ -45,11 +46,11 @@ - + - - + +
Millions of dollars December 31
Millions of dollars 2007 2006
3.125% convertible senior notes due July 2023$ 1,240$ 1,200$   1,200$   1,200
5.5% senior notes due October 2010294
7.85% debentures due February 20218.75% debentures due February 2021 185 185
Less current portion 15915926
Noncurrent portion of long-term debt2,6272,783$   2,627$   2,783
\ No newline at end of file diff --git a/predictions/138.html b/predictions/138.html new file mode 100644 index 0000000000000000000000000000000000000000..f1d27f1a190f5a33f58d4b0c00a15441c442b647 --- /dev/null +++ b/predictions/138.html @@ -0,0 +1,29 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Combined operating results
Millions of dollars		Year Ended December 31
200720062005
Revenue$ 500$ 435$ 487
Operating income$ 111$ 108$ 100
Net income$ 100$ 122$ 89
\ No newline at end of file diff --git a/predictions/139.html b/predictions/139.html new file mode 100644 index 0000000000000000000000000000000000000000..363620dfccdc8f5a0de751eadd5f7e0df54a786d --- /dev/null +++ b/predictions/139.html @@ -0,0 +1,31 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
Millions of dollars20172016
Defined benefit and other postretirement liability adjustments (a)$ (334)$ (313)
Cumulative translation adjustment(80)(80)
Other(55)(61)
Total accumulated other comprehensive loss$ (469)$ (454)
\ No newline at end of file diff --git a/predictions/14.html b/predictions/14.html index 565f5dffed2397b8fd84c5375ea5b51564327a0c..ca8a869f594dd8d21f8258906f73808d4ca1688f 100644 --- a/predictions/14.html +++ b/predictions/14.html @@ -6,13 +6,13 @@ Land - 68 - 88 + $68 + $80 Buildings and property improvements 1,088 - 1,083 + 1,065 Machinery, equipment, and other @@ -22,16 +22,16 @@ Total 6,227 - 6,092 + 6,066 Less accumulated depreciation - 1,461 - 1,440 + 3,674 + 3,540 Net property, plant, and equipment - 4,766 - 4,652 + $2,553 + $2,526 \ No newline at end of file diff --git a/predictions/141.html b/predictions/141.html index af0b4a84c91b78df22271212e982ac64f11104c2..df3fee41b48de771b2b42ed53bd0cb9d2f4bf186 100644 --- a/predictions/141.html +++ b/predictions/141.html @@ -1,10 +1,6 @@ - - - - - + @@ -13,7 +9,7 @@ - + diff --git a/predictions/142.html b/predictions/142.html new file mode 100644 index 0000000000000000000000000000000000000000..2bfa9dda171fcbda7f6f5886e1a4c65a9cd0f057 --- /dev/null +++ b/predictions/142.html @@ -0,0 +1,26 @@ +
Millions of dollars
Millions of dollars 2005 2004 2003Probable unapproved claims $175 $182203$233
Probable unapproved claims accrued revenue
+ + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
20072006
Revenue$ 2,250$ 9,621
Operating income$ 62$ 239
Net income$ 23 (a)$ 180
\ No newline at end of file diff --git a/predictions/143.html b/predictions/143.html new file mode 100644 index 0000000000000000000000000000000000000000..3da33752b886c570b4496de7c0fa848e5cb37f7b --- /dev/null +++ b/predictions/143.html @@ -0,0 +1,51 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Number of Shares
(in millions)		Weighted Average
Exercise Price
per Share		Weighted Average
Remaining Contractual
Term (years)		Aggregate
Intrinsic
Value
(in millions)
Stock Options
Outstanding at January 1, 2008		14.3$ 20.81
Granted2.739.43
Exercised(3.9)17.34
Forfeited/expired(0.3)29.61
Outstanding at December 31, 200812.8$ 25.656.17$ 22
Exercisable at December 31, 20088.4$ 19.804.72$ 21
\ No newline at end of file diff --git a/predictions/144.html b/predictions/144.html new file mode 100644 index 0000000000000000000000000000000000000000..a1457fe017d7e9de66ce443104f824e8f50b637d --- /dev/null +++ b/predictions/144.html @@ -0,0 +1,102 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20092010201120122013ThereafterTotal
Millions of dollars
Long-term debt$ 26$ 749$ —$ —$ —$ 1,837$ 2,612
Interest on debt (a)1681681271271263,5784,294
Operating leases183161130846675799
Purchase obligations1,501653216581,627
Pension funding obligations (b)48—————48
DOJ and SEC settlement and indemnity373186————559
Other long-term liabilities399999—45
Total$ 2,308$ 1,338$ 298$ 236$ 206$ 5,598$ 9,984
\ No newline at end of file diff --git a/predictions/145.html b/predictions/145.html new file mode 100644 index 0000000000000000000000000000000000000000..b156fe64f11378bff8d2baf5ed65041cec962e35 --- /dev/null +++ b/predictions/145.html @@ -0,0 +1,78 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars201420132012
Current income taxes:
Federal$ (959)$ (245)$ (695)
Foreign(734)(485)(328)
State(36)(49)(47)
Total current(1,729)(779)(1,070)
Deferred income taxes:
Federal834(168)
Foreign35712515
State142(12)
Total deferred454131(165)
Provision for income taxes$ (1,275)$ (648)$ (1,235)
\ No newline at end of file diff --git a/predictions/146.html b/predictions/146.html new file mode 100644 index 0000000000000000000000000000000000000000..5b3ecd329d9c4bd1bbe7db18435b4e856787fe41 --- /dev/null +++ b/predictions/146.html @@ -0,0 +1,17 @@ + + + + + + + + + + + + + + + + +
20152014
Discount rate4.2%4.1%
Rate of compensation increase5.4%5.3%
\ No newline at end of file diff --git a/predictions/147.html b/predictions/147.html new file mode 100644 index 0000000000000000000000000000000000000000..9bcd9ac9ce8119561693d6a4cf1405c03aa9e2e2 --- /dev/null +++ b/predictions/147.html @@ -0,0 +1,74 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.17Fourth Supplemental Indenture, dated as of September 12, 2008, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, n.a, the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed September 12, 2008, File No. 001-03492).
4.18Form of Global Note for Halliburton’s 5.90% Senior Notes due 2018 (included as part of Exhibit 4.17).
4.19Form of Global Note for Halliburton’s 6.70% Senior Notes due 2038 (included as part of Exhibit 4.17).
4.20Fifth Supplemental Indenture, dated as of March 13, 2009, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, n.a, the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed March 13, 2009, File No. 001-03492).
4.21Form of Global Note for Halliburton’s 6.15% Senior Notes due 2019 (included as part of Exhibit 4.20).
4.22Form of Global Note for Halliburton’s 7.45% Senior Notes due 2039 (included as part of Exhibit 4.20).
4.23Sixth Supplemental Indenture, dated as of November 14, 2011, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, n.a, the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed November 14, 2011, File No. 001-03492).
4.24Form of Global Note for Halliburton’s 3.25% Senior Notes due 2021 (included as part of Exhibit 4.23).
4.25Form of Global Note for Halliburton’s 4.50% Senior Notes due 2041 (included as part of Exhibit 4.23).
4.26Seventh Supplemental Indenture, dated as of August 5, 2013, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank (incorporated by reference to Exhibit 4.2 of Halliburton’s Form 8-K filed August 5, 2013, File No. 001-03492).
4.27Form of Global Note for Halliburton’s 1.00% Senior Notes due 2016 (included as part of Exhibit 4.26).
4.28Form of Global Note for Halliburton’s 2.00% Senior Notes due 2018 (included as part of Exhibit 4.26).
4.29Form of Global Note for Halliburton’s 3.50% Senior Notes due 2023 (included as part of Exhibit 4.26).
4.30Form of Global Note for Halliburton’s 4.75% Senior Notes due 2043 (included as part of Exhibit 4.26).
4.31Eighth Supplemental Indenture, dated as of November 13, 2015, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed November 13, 2015, File No. 001-03492).
4.32Form of Global Note for Halliburton’s 2.700% Senior Notes due 2020 (included as part of Exhibit 4.31).
4.33Form of Global Note for Halliburton’s 3.375% Senior Notes due 2022 (included as part of Exhibit 4.31).
4.34Form of Global Note for Halliburton’s 3.800% Senior Notes due 2025 (included as part of Exhibit 4.31).
\ No newline at end of file diff --git a/predictions/148.html b/predictions/148.html new file mode 100644 index 0000000000000000000000000000000000000000..c983fcbae8a699966a27c46ffc0daa79e93e38b1 --- /dev/null +++ b/predictions/148.html @@ -0,0 +1,88 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsYear Ended December 31
200920082007
Current income taxes:
Federal$30$ (561)$ (560)
Foreign(250)(346)(449)
State(24)(50)(38)
Total current(244)(957)(1,047)
Deferred income taxes:
Federal(237)(303)129
Foreign(31)647
State(6)(15)4
Total deferred(274)(254)140
Provision for income taxes$(518)$ (1,211)$ (907)
\ No newline at end of file diff --git a/predictions/149.html b/predictions/149.html new file mode 100644 index 0000000000000000000000000000000000000000..c21038130650ccdd0fe06db0efc5ea9cb8c02601 --- /dev/null +++ b/predictions/149.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
1.Financial Statements:
The reports of the Independent Registered Public Accounting Firm and the financial statements of Halliburton Company as required by Part II, Item 8, are included on pages 38 through 40 and pages 41 through 66 of this annual report. See index on page 67.
2.Financial Statement Schedules:
The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.
3.Exhibits:
\ No newline at end of file diff --git a/predictions/15.html b/predictions/15.html index 33811a60a60e6883963378d8fa73049efcd77eda..0a85550b77a373c10ed6a62ce18853708d8196ed 100644 --- a/predictions/15.html +++ b/predictions/15.html @@ -1,13 +1,13 @@ - - - + + + - + - + @@ -36,6 +36,13 @@ + + + + + + + @@ -51,7 +58,7 @@ - + diff --git a/predictions/150.html b/predictions/150.html new file mode 100644 index 0000000000000000000000000000000000000000..345bea4c4c3bc193d34b8afb8c488dcddafce08b --- /dev/null +++ b/predictions/150.html @@ -0,0 +1,38 @@ +
Stock OptionsNumber of Shares (in millions)Weighted Average Exercise Price per ShareNumber of Shares
(in millions)		Weighted Average Exercise Price
per Share		 Weighted Average Remaining Contractual Term (years)Aggregate Intrinsic Value (in millions)Aggregate Intrinsic Value
(in millions)
Outstanding at January 1, 2007Stock Options Outstanding at January 1, 2007 17.6 $ 18.55
Converted to KBR, Inc. stock options
(1.2) 15.01
Exercisable at December 31, 2007 10.5$ 16.9416.94 4.64 $ 219
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Drilling Type201620152014
United States (incl. Gulf of Mexico):
Horizontal4007441,274
Vertical60139376
Directional4995211
Total5099781,861
\ No newline at end of file diff --git a/predictions/151.html b/predictions/151.html new file mode 100644 index 0000000000000000000000000000000000000000..d35763893f193b6c0b7105f0ef6bce1813caddca --- /dev/null +++ b/predictions/151.html @@ -0,0 +1,50 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.5Third Supplemental Indenture dated as of August 1, 1997 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.7 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.6Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.7Resolutions of Halliburton’s Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton’s Form 10-K for the year ended December 31, 1996, File No. 001-03492).
4.8Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 8-K dated as of February 11, 1997, File No. 001-03492).
4.9Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request.
4.10Form of debt security of 7.53% Notes due May 12, 2017 (incorporated by reference to Exhibit 4.4 to Halliburton’s Form 10-Q for the quarter ended March 31, 1997, File No. 001-03492).
4.11Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser’s Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser’s Form 8-K filed on August 9, 1996, File No. 1-4003).
4.12Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.13Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.16 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.14Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 10-Q for the quarter ended September 30, 2003, File No. 001-03492).
4.15Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.16Form of note of 7.6% debentures due 2096 (included as Exhibit A to Exhibit 4.15 above).
\ No newline at end of file diff --git a/predictions/152.html b/predictions/152.html new file mode 100644 index 0000000000000000000000000000000000000000..a76e0a60c8767fc4a57f5254f958f9dc7b56880e --- /dev/null +++ b/predictions/152.html @@ -0,0 +1,20 @@ + + + + + + + + + + + + + + + + + + + +
Millions of dollarsOne-Percentage-Point
IncreaseDecrease
Effect on total of service and interest cost components$—$—
Effect on the postretirement benefit obligation$8$(7)
\ No newline at end of file diff --git a/predictions/153.html b/predictions/153.html new file mode 100644 index 0000000000000000000000000000000000000000..441f0a77691222b4b551a33e6e127854e22aabc3 --- /dev/null +++ b/predictions/153.html @@ -0,0 +1,194 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Land vs. Offshore200720062005
United States:
Land1,6941,5581,287
Offshore739093
Total1,7671,6481,380
Canada:
Land341467454
Offshore334
Total344470458
International (excluding Canada):
Land719656593
Offshore287269258
Total1,006925851
Worldwide total3,1173,0432,689
Land total2,7542,6812,334
Offshore total363362355
Oil vs. Gas200720062005
United States:
Oil297273194
Gas1,4701,3751,186
Total1,7671,6481,380
Canada:
Oil128110100
Gas216360358
Total344470458
International (excluding Canada):
Oil784709651
Gas222216200
Total1,006925851
Worldwide total3,1173,0432,689
Oil total1,2091,092945
Gas total1,9081,9511,744
\ No newline at end of file diff --git a/predictions/154.html b/predictions/154.html new file mode 100644 index 0000000000000000000000000000000000000000..2d41458dba153f959ed8b9bba9a403ac5152a2ba --- /dev/null +++ b/predictions/154.html @@ -0,0 +1,70 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsDecember 31
20142013
Gross deferred tax assets:
    Accrued liabilities$ 494$ 600
    Net operating loss carryforwards462481
    Employee compensation and benefits395351
    Other315162
Total gross deferred tax assets1,6661,594
Gross deferred tax liabilities:
    Depreciation and amortization1,0051,185
    Other11181
Total gross deferred tax liabilities1,1161,266
Valuation allowances – net operating loss carryforwards184374
Net deferred income tax asset (liability)$ 366$ (46)
\ No newline at end of file diff --git a/predictions/155.html b/predictions/155.html new file mode 100644 index 0000000000000000000000000000000000000000..872b15b6eb78d64668390de23f84eeebf027ab19 --- /dev/null +++ b/predictions/155.html @@ -0,0 +1,45 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20162015
Millions of dollars
Net property, plant and equipment:
North America$ 4,4316,091
Latin America1,0681,463
Europe/Africa/CIS1,2531,620
Middle East/Asia1,7802,943
Total$ 8,53212,117
\ No newline at end of file diff --git a/predictions/156.html b/predictions/156.html index 3d114fabfae183b5d29661c5489a4f24bc73d375..862e138afbc6b5c3cc6206caca7802dbaac2edfc 100644 --- a/predictions/156.html +++ b/predictions/156.html @@ -1,6 +1,6 @@ - + diff --git a/predictions/157.html b/predictions/157.html index bc3c9efce62a500f7ac7bced8991e7bdee6fe64e..3fe4b2d2a6ae1dec73c1d928a37fd2fd4a70b313 100644 --- a/predictions/157.html +++ b/predictions/157.html @@ -10,31 +10,37 @@ - + - - - + + + - + + + + + + + - + - + - + - + diff --git a/predictions/158.html b/predictions/158.html new file mode 100644 index 0000000000000000000000000000000000000000..bdec8f2873fdd48f383744e7f86eab7d381452d2 --- /dev/null +++ b/predictions/158.html @@ -0,0 +1,115 @@ +
Millions of dollars Year Ended December 31
2012
Expected term (in years)Expected term (in years) 5.23 5.27 5.21
Expected volatility37%31%Expected volatility40%40% 46%
Expected dividend yieldExpected dividend yield0%0%0%
Risk-free interest rate 0.94 - 1.77% 0.94 - 1.33%0.99 - 1.24%0.99 – 1.24%
Risk-free interest rateRisk-free interest rate 1.57 - 1.86% 0.77 - 1.73%0.65 - 1.15%0.65 – 1.15%
Weighted average grant-date fair value per shareWeighted average grant-date fair value per share $19.26 $14.34 $11.99
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
200720062005
Revenue:
Completion and Production$ 8,386$ 7,221$ 5,495
Drilling and Evaluation6,8785,7344,605
Total$15,264$12,955$10,100
Operating income (loss):
Completion and Production$ 2,199$ 2,140$ 1,524
Drilling and Evaluation1,4851,328840
Corporate and other(186)(223)(200)
Total$ 3,498$ 3,245$ 2,164
Capital expenditures:
Completion and Production$ 791$ 441$ 309
Drilling and Evaluation759390266
Corporate and other333-
Total$ 1,583$ 834$ 575
Depreciation, depletion and amortization:
Completion and Production$ 288$ 239$ 217
Drilling and Evaluation295241231
Total$ 583$ 480$ 448
\ No newline at end of file diff --git a/predictions/159.html b/predictions/159.html new file mode 100644 index 0000000000000000000000000000000000000000..1d8b875f88fbf005308ec31c16d0e4cee4cf85eb --- /dev/null +++ b/predictions/159.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
PeriodTotal Number of Shares Purchased (a)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
October 1-3136,895$ 28.10–
November 1-3039,386$ 30.18–
December 1-3173,920$ 28.43–
Total150,201$ 28.81–
\ No newline at end of file diff --git a/predictions/16.html b/predictions/16.html index 8a20e1d79ea52efa53de6c547a8c8ed1b8af196e..433e0280e43c7b80c2dc0686494e513d2ef0cd1a 100644 --- a/predictions/16.html +++ b/predictions/16.html @@ -1,26 +1,30 @@ + + + + - - - + + + - - - + + + - - - + + +
Years ended December 31
Millions of dollars 2005 2004 2003
Revenue53,62653,88752,305$3,626$3,887$3,708
Operating income (loss)$(25)575 (25)5 75 201
Net income (loss)$551755 (7)5 (12)5 175
\ No newline at end of file diff --git a/predictions/160.html b/predictions/160.html new file mode 100644 index 0000000000000000000000000000000000000000..2999dc7dda54743ae21c38adfd7ce367d729ef61 --- /dev/null +++ b/predictions/160.html @@ -0,0 +1,281 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per share dataQuarterYear
FirstSecondThirdFourth
2008
Revenue$ 4,029$ 4,487$ 4,853$ 4,910$ 18,279
Operating income8479491,0511,1634,010
Income (loss) from continuing operations583623(21)7761,961
Income (loss) from discontinued operations1(116)—(308)(423)
Net income (loss)584507(21)4681,538
Earnings per share:
    Basic income (loss) per share:
        Income (loss) from continuing operations0.670.72(0.02)0.872.24
        Loss from discontinued operations—(0.14)—(0.34)(0.49)
        Net income (loss)0.670.58(0.02)0.531.75
Diluted income (loss) per share:
    Income (loss) from continuing operations0.640.68(0.02)0.872.17
    Loss from discontinued operations—(0.13)—(0.34)(0.47)
    Net income (loss)0.640.55(0.02)0.531.70
Cash dividends paid per share0.090.090.090.090.36
Common stock prices (2)
    High39.9853.9755.3832.0955.38
    Low30.0038.5629.0012.8012.80
2007
Revenue$ 3,422$ 3,735$ 3,928$ 4,179$ 15,264
Operating income7888939109073,498
Income from continuing operations5295957266742,524
Income from discontinued operations23935116975
Net income5521,5307276903,499
Earnings per share:
    Basic income per share:
        Income from continuing operations0.530.660.830.772.76
        Income from discontinued operations0.021.03—0.021.07
        Net income0.551.690.830.793.83
Diluted income per share:
    Income from continuing operations0.520.630.790.742.66
    Income from discontinued operations0.020.99—0.011.02
    Net income0.541.620.790.753.68
Cash dividends paid per share0.0750.090.090.090.345
Common stock prices (2)
    High32.7237.2039.1741.9541.95
    Low27.6530.9930.8134.4227.65
\ No newline at end of file diff --git a/predictions/161.html b/predictions/161.html index 8b7726cf2e586341574085081770641347a22b3e..f3a88c34dc18c71b9387b72cc267a6a39acd782e 100644 --- a/predictions/161.html +++ b/predictions/161.html @@ -1,40 +1,44 @@ - + - + + + + + - - - + + + - + - + - + - + @@ -49,12 +53,12 @@ - + - + @@ -70,7 +74,7 @@ - - + +
Millions of dollars December 31
2015 2014
Millions of dollars
Gross deferred tax assets:
Accrued liabilities$ 392$ 494    Accrued liabilities$        392$        494
Net operating loss carryforwards    Net operating loss carryforwards 540 462
Employee compensation and benefits    Employee compensation and benefits 403 395
Foreign tax credit carryforward    Foreign tax credit carry forward 365 79
Other    Other 354 236
Depreciation and amortization    Depreciation and amortization 1,334 1,005
Other    Other 109 111
Net deferred income tax asset$ 398$ 366$        398$        366
\ No newline at end of file diff --git a/predictions/162.html b/predictions/162.html new file mode 100644 index 0000000000000000000000000000000000000000..f59395ec934b55d969fb5f1907c9490feed69cf2 --- /dev/null +++ b/predictions/162.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
NumberExhibits
2.1Agreement and Plan of Merger, dated as of November 16, 2014, among Halliburton Company, Red Tiger LLC and Baker Hughes Incorporated (incorporated by reference to Exhibit 2.1 to Halliburton’s Form 8-K filed November 18, 2014, File No. 001-03492).
3.1Restated Certificate of Incorporation of Halliburton Company filed with the Secretary of State of Delaware on May 30, 2006 (incorporated by reference to Exhibit 3.1 to Halliburton’s Form 8-K filed June 5, 2006, File No. 001-03492).
3.2By-laws of Halliburton Company revised effective February 12, 2014 (incorporated by reference to Exhibit 3.1 to Halliburton’s Form 8-K filed February 18, 2014, File No. 001-03492).
4.1Form of debt security of 8.75% Debentures due February 12, 2021 (incorporated by reference to Exhibit 4(a) to the Form 8-K of Halliburton Company, now known as Halliburton Energy Services, Inc. (the Predecessor), dated as of February 20, 1991, File No. 001-03492).
4.2Senior Indenture dated as of January 2, 1991 between the Predecessor and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4(b) to the Predecessor’s Registration Statement on Form S-3 (Registration No. 33-38394) originally filed with the Securities and Exchange Commission on December 21, 1990), as supplemented and amended by the First Supplemental Indenture dated as of December 12, 1996 among the Predecessor, Halliburton and the Trustee (incorporated by reference to Exhibit 4.1 of Halliburton’s Registration Statement on Form 8-B dated December 12, 1996, File No. 001-03492).
4.3Resolutions of the Predecessor’s Board of Directors adopted at a meeting held on February 11, 1991 and of the special pricing committee of the Board of Directors of the Predecessor adopted at a meeting held on February 11, 1991 and the special pricing committee’s consent in lieu of meeting dated February 12, 1991 (incorporated by reference to Exhibit 4(c) to the Predecessor’s Form 8-K dated as of February 20, 1991, File No. 001-03492).
4.4Second Senior Indenture dated as of December 1, 1996 between the Predecessor and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, as supplemented and amended by the First Supplemental Indenture dated as of December 5, 1996 between the Predecessor and the Trustee and the Second Supplemental Indenture dated as of December 12, 1996 among the Predecessor, Halliburton and the Trustee (incorporated by reference to Exhibit 4.2 of Halliburton’s Registration Statement on Form 8-B dated December 12, 1996, File No. 001-03492).
\ No newline at end of file diff --git a/predictions/163.html b/predictions/163.html new file mode 100644 index 0000000000000000000000000000000000000000..6cfc38c516a8e59684c62c3a2e379dbe8b03c0e2 --- /dev/null +++ b/predictions/163.html @@ -0,0 +1,197 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
AssetsDecember 31
20082007
Current assets:
Cash and cash equivalents$    1,124$    1,847
Receivables (less allowance for bad debts of $60 and $49)3,7953,093
Inventories1,8291,459
Current deferred income taxes246376
Investments in marketable securities–388
Other current assets418410
Total current assets7,4117,573
Property, plant, and equipment, net of accumulated depreciation of $4,566 and $4,1264,7823,630
Goodwill1,072799
Noncurrent deferred income taxes157348
Other assets963794
Total assets$  14,385$  13,135
Liabilities and Shareholders' Equity
20082007
Current liabilities:
Accounts payable$    898$    768
Accrued employee compensation and benefits643575
Department of Justice and Securities and Exchange Commission settlement and indemnity, current373–
Deferred revenue231209
Income tax payable6729
Current maturities of long-term debt26159
Other current liabilities543491
Total current liabilities2,7812,411
Long-term debt2,5862,627
Employee compensation and benefits539403
Other liabilities735734
Total liabilities6,6416,175
Minority interest in consolidated subsidiaries4994
Shareholders' equity:
Common shares, par value $2.50 per share – authorized 2,000 shares, issued 1,0672,6662,657
Paid-in capital in excess of par value1,1141,741
Accumulated other comprehensive loss(215)(104)
Retained earnings9,4118,202
Treasury stock, at cost – 172 and 183 shares(5,251)(5,630)
Total shareholders' equity7,7256,866
Total liabilities and shareholders' equity$  14,385$  13,135
\ No newline at end of file diff --git a/predictions/164.html b/predictions/164.html new file mode 100644 index 0000000000000000000000000000000000000000..55b30df3149f21b15e30193f32dfc5f042c9eb81 --- /dev/null +++ b/predictions/164.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
1.Financial Statements:
The reports of the Independent Registered Public Accounting Firm and the financial statements of Halliburton Company as required by Part II, Item 8, are included on pages 40 and 41 and pages 42 through 72 of this annual report. See index on page (i).
2.Financial Statement Schedules:
The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.
3.Exhibits:
\ No newline at end of file diff --git a/predictions/165.html b/predictions/165.html new file mode 100644 index 0000000000000000000000000000000000000000..6f1a50000122e2178ebec6f6d7b0c3e3582aac50 --- /dev/null +++ b/predictions/165.html @@ -0,0 +1,35 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Restricted StockNumber of SharesWeighted Average
Grant-Date Fair
Value per Share
(in millions)
Nonvested shares at January 1, 20099.0$ 31.64
Granted6.222.61
Vested(2.8)29.13
Forfeited(0.4)32.57
Nonvested shares at December 31, 200912.0$ 27.61
\ No newline at end of file diff --git a/predictions/166.html b/predictions/166.html new file mode 100644 index 0000000000000000000000000000000000000000..9844f69dc5f20fe2143ed9ce9758ea9e5945840c --- /dev/null +++ b/predictions/166.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
20142013
Millions of dollars
United States$ (1,650)$ 3,020
Foreign6241,692
Total$ (936)$ 4,712
\ No newline at end of file diff --git a/predictions/168.html b/predictions/168.html new file mode 100644 index 0000000000000000000000000000000000000000..4bb0638061c42de6f188378945bf8900b998b2dd --- /dev/null +++ b/predictions/168.html @@ -0,0 +1,77 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsYear Ended December 31
201620152014
Current income taxes:
Federal$ 737635(959)
Foreign(415)(636)(734)
State3551(36)
Total current35750(1,729)
Deferred income taxes:
Federal1,343(18)83
Foreign77262357
State81(20)14
Total deferred1,501224454
Income tax benefit (provision)$ 1,858274 $(1,275)
\ No newline at end of file diff --git a/predictions/169.html b/predictions/169.html new file mode 100644 index 0000000000000000000000000000000000000000..656c10e9e4516946a46a8c3c2bdac07dec46e935 --- /dev/null +++ b/predictions/169.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars200920082007
United States$ 589$ 2,674$ 2,206
Foreign1,0931,1751,241
Total$ 1,682$ 3,849$ 3,447
\ No newline at end of file diff --git a/predictions/17.html b/predictions/17.html new file mode 100644 index 0000000000000000000000000000000000000000..194d45d1d168cdbb686da6171e65611495160f9e --- /dev/null +++ b/predictions/17.html @@ -0,0 +1,101 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per shareYear ended December 31
20172016201520142013
Revenue$ 20,620$ 15,887$ 23,633$ 32,870$ 29,402
Operating income (loss)1,362(6,778)(165)5,0973,138
Income (loss) from continuing operations(449)(5,767)(662)3,4372,116
Basic income (loss) per share from continuing operations(0.51)(6.69)(0.78)4.052.35
Diluted income (loss) per share from continuing operations(0.51)(6.69)(0.78)4.032.33
Cash dividends per share0.720.720.720.630.525
Net working capital5,9157,65414,7338,7818,678
Total assets25,08527,00036,94232,16529,223
Long-term debt10,43012,21414,6877,7657,816
Total shareholders’ equity8,3499,44815,49516,29813,615
Capital expenditures1,3737982,1843,2832,934
\ No newline at end of file diff --git a/predictions/170.html b/predictions/170.html new file mode 100644 index 0000000000000000000000000000000000000000..d39e36ecfa4144d1e20aacbf0c9fe7bc6b9c3794 --- /dev/null +++ b/predictions/170.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20092008
Discount rate:
United States pension plans4.9-6.0%4.7-5.8%
International pension plans (a)5.3-8.5%2.2-9.0%
Rate of compensation increase:
International pension plans3.3-7.5%2.0-10.0%
\ No newline at end of file diff --git a/predictions/172.html b/predictions/172.html new file mode 100644 index 0000000000000000000000000000000000000000..13aa11e2ccef5cf6e94bde26d77cc48c6ab14631 --- /dev/null +++ b/predictions/172.html @@ -0,0 +1,46 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Combined financial positionDecember 31
Millions of dollars20052004
Current assets52,42152,339
Noncurrent assets2,7602,723
Total55,18155,062
Current liabilities52,22651,950
Noncurrent liabilities2,4002,394
Shareholders' equity555718
Total55,18155,062
\ No newline at end of file diff --git a/predictions/173.html b/predictions/173.html new file mode 100644 index 0000000000000000000000000000000000000000..6700d516b5a90629088c987849d508a7647c3d50 --- /dev/null +++ b/predictions/173.html @@ -0,0 +1,31 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
Millions of dollars20132012
Defined benefit and other postretirement liability adjustments (a)$ (241)$ (241)
Cumulative translation adjustment(69)(69)
Other31
Total accumulated other comprehensive loss$ (307)$(309)
\ No newline at end of file diff --git a/predictions/174.html b/predictions/174.html new file mode 100644 index 0000000000000000000000000000000000000000..cef781ba81090466206ab11494ffccd9a0062c55 --- /dev/null +++ b/predictions/174.html @@ -0,0 +1,35 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsDecember 31
200820072006
Long-lived assets:
United States$ 3,571$ 2,733$ 2,045
Other countries3,0272,2631,413
Total$ 6,598$ 4,996$ 3,458
\ No newline at end of file diff --git a/predictions/175.html b/predictions/175.html new file mode 100644 index 0000000000000000000000000000000000000000..94f873de8bf0b97d30672f860dc14201a9e0a204 --- /dev/null +++ b/predictions/175.html @@ -0,0 +1,125 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20082007
Millions of dollars
Gross deferred tax assets:
    Employee compensation and benefits$    324$    262
    Accrued liabilities8180
    Foreign tax credit carryforward7961
    Capitalized research and experimentation7494
    Net operating loss carryforwards5024
    Insurance accruals4746
    Software revenue recognition3137
    Inventory2663
    Alternative minimum tax credit carryforward-19
    Other49176
Total gross deferred tax assets761862
Gross deferred tax liabilities:
    Depreciation and amortization303164
    Joint ventures, partnerships, and unconsolidated affiliates2534
    Other3855
Total gross deferred tax liabilities366253
Valuation allowances:
    Net operating loss carryforwards1422
    Other-7
Total valuation allowances1429
Net deferred income tax asset$    381$    580
\ No newline at end of file diff --git a/predictions/176.html b/predictions/176.html index 3e17e486d33e464b86b676f4facc7f462b40b5b0..0b6ea0bdd90acfbe59c1a0f8af59c1e9c4bcfb46 100644 --- a/predictions/176.html +++ b/predictions/176.html @@ -1,18 +1,22 @@ - - - - + - + - + + + + + + + + @@ -21,8 +25,8 @@ - - + + diff --git a/predictions/177.html b/predictions/177.html index 12d215d97c4fa758aea31f062910627c9ea3972b..9d56c2a85613454ddb86141fb504577ca2dfb17a 100644 --- a/predictions/177.html +++ b/predictions/177.html @@ -1,15 +1,15 @@
Millions of dollars
December 31
2007 2006
Long-lived assets:Millions of dollars
Long-lived assets:
United States
Other countries$ 2,263$ 1,4132,2631,413
Total
- - - - - + + - + + + + @@ -30,7 +30,10 @@ - + + + + @@ -63,7 +66,7 @@ - + @@ -87,7 +90,7 @@ - + @@ -105,7 +108,7 @@ - + @@ -117,13 +120,22 @@ - + - + + + + + + + + + + @@ -144,7 +156,16 @@ - + + + + + + + + + + @@ -164,6 +185,12 @@ + + + + + + diff --git a/predictions/178.html b/predictions/178.html new file mode 100644 index 0000000000000000000000000000000000000000..28307bc1d50d40404784b6cf083852f640a96e58 --- /dev/null +++ b/predictions/178.html @@ -0,0 +1,77 @@ +
Millions of dollars and shares except per share dataYear Ended December 31
2007Millions of dollars and shares except per share dataYear Ended December 31
2007		 2006 2005
Revenue:Revenues:
Services10,100
Operating costs and expenses:Operating costs and expenses:
Cost of services7,936
Operating incomeOperating income 3,498 3,245 2,164(25)
Income from continuing operations before income taxes and minority interestIncome from continuing operations before income taxes and minority interest 3,460 3,199 1,997(15)
Income from continuing operationsIncome from continuing operations 2,524 2,177 2,107251
Net incomeNet income $ 3,499 $ 2,348 $ 2,358
Basic income per share:
Basic income per share:
Income from continuing operations$ 2.34
Diluted income per share:
Diluted income per share:
Income from continuing operations$ 2.23 $ 2.27
Basic weighted average common shares outstanding 913
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsYears ended December 31
200520042003
Current income taxes:
Federal$(106)$ 88$(167)
Foreign(199)(156)(181)
State(9)(6)(1)
Total current(314)(250)(347)
Deferred income taxes:
Federal305380
Foreign(56)625
State(14)–8
Total deferred2359113
Provision for income taxes$ (79)$(241)$(234)
\ No newline at end of file diff --git a/predictions/179.html b/predictions/179.html new file mode 100644 index 0000000000000000000000000000000000000000..d5a3409391bddee33022693211e42e0460423c0e --- /dev/null +++ b/predictions/179.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
Fixed PriceCost-Reimbursable
200417%58%
200324%76%
200247%53%
\ No newline at end of file diff --git a/predictions/18.html b/predictions/18.html index 6ba867f2500b760e69f6fb06799112838eea74e2..c6e3d84b86d94b30918ee73f5cac4c39b483e8de 100644 --- a/predictions/18.html +++ b/predictions/18.html @@ -1,30 +1,92 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars
Unrecognized Tax BenefitsInterest and Penalties
Balance at January 1, 2007$ 242$ 34
Change in prior year tax positions145—
Change in current year tax positions344
Cash settlements with taxing authorities(30)(1)
Lapse of statute of limitations——
Balance at December 31, 2007$ 388$ 37
Change in prior year tax positions(98)5
Change in current year tax positions252
Cash settlements with taxing authorities(5)—
Lapse of statute of limitations(10)(1)
Balance at December 31, 2008$ 300 (a)$ 43
Change in prior year tax positions(42)(6)
Change in current year tax positions232
Cash settlements with taxing authorities(7)(1)
Lapse of statute of limitations(11)(9)
Balance at December 31, 2009$ 263(a) (b)$ 29
Unrecognized Tax BenefitsInterest and penalties
Millions of dollars
Balance at January 1, 2007$ 242$ 34
Change in prior year tax positions145
Change in current year tax positions344
Cash settlements with taxing authorities(30)(1)
Lapse of statute of limitations(3)
Balance at December 31, 2007$ 388$ 37
Change in prior year tax positions(98)5
Change in current year tax positions252
Cash settlements with taxing authorities(5)
Lapse of statute of limitations(10)(1)
Balance at December 31, 2008$ 300 (a)$ 43
Change in prior year tax positions(42)(6)
Change in current year tax positions232
Cash settlements with taxing authorities(7)(1)
Lapse of statute of limitations(11)(9)
Balance at December 31, 2009$ 263(a) (b)29
\ No newline at end of file diff --git a/predictions/180.html b/predictions/180.html new file mode 100644 index 0000000000000000000000000000000000000000..60ae6ca5377a98331e856807da8b117f7b787c60 --- /dev/null +++ b/predictions/180.html @@ -0,0 +1,54 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
201520142013
Millions of dollars
Revenue:
North America$ 10,856$ 17,698$ 15,212
Latin America3,1493,8753,909
Europe/Africa/CIS4,1755,4905,225
Middle East/Asia5,4535,8075,056
Total$ 23,633$ 32,870$ 29,402
\ No newline at end of file diff --git a/predictions/181.html b/predictions/181.html new file mode 100644 index 0000000000000000000000000000000000000000..436295d1c802e3f598583b375f6962058245b561 --- /dev/null +++ b/predictions/181.html @@ -0,0 +1,96 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Payments Due
Millions of dollars20102011201220132014ThereafterTotal
Long-term debt$ 750$ —$ —$ —$ —$ 3,824$ 4,574
Interest on debt (a )3042632632622625,6226,976
Operating leases149112704229142544
Purchase obligations (b)1,022723915261,156
Pension funding obligations (c)38—————38
DOJ and SEC settlement and indemnity142—————142
Other long-term liabilities—999——36
Total$ 2,414$ 456$ 381$ 328$ 293$ 9,594$ 13,466
\ No newline at end of file diff --git a/predictions/182.html b/predictions/182.html index c5eecfb0d02d06cf7cc8525fe0becf175b7a570c..31811a2fe7c01ddf9ad0e515dfc53a82c08b7c38 100644 --- a/predictions/182.html +++ b/predictions/182.html @@ -1,9 +1,10 @@ - + + - + @@ -32,33 +33,4 @@ -
Accumulated other comprehensive lossAccumulated other comprehensive loss
Millions of dollars		December 31
Millions of dollars 2007 2006 2005$ (437) $ (266)
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares of common stock
Millions of shares200720062005
Issued1,0631,0601,054
In treasury(183)(62)(26)
Total shares of common stock outstanding8809981,028
\ No newline at end of file diff --git a/predictions/183.html b/predictions/183.html index d2127f6a96eceba340697ef0f9e17bc128897217..099b1cc092054476c27c0badc6c0b2e54d0e5b4d 100644 --- a/predictions/183.html +++ b/predictions/183.html @@ -8,11 +8,9 @@ 2007 2006 + - Revenue: - - - + Revenue: Completion and Production @@ -22,21 +20,19 @@ Drilling and Evaluation - $ 8,344 - $ 6,878 - $ 5,734 + 8,344 + 6,878 + 5,734 Total - $ 18,279 - $ 15,264 - $ 12,955 + $18,279 + $15,264 + $12,955 + - Operating income: - - - + Operating income: Completion and Production @@ -46,9 +42,9 @@ Drilling and Evaluation - $ 1,865 - $ 1,485 - $ 1,328 + 1,865 + 1,485 + 1,328 Corporate and other @@ -62,11 +58,9 @@ $ 3,498 $ 3,245 + - Capital expenditures: - - - + Capital expenditures: Completion and Production @@ -76,9 +70,9 @@ Drilling and Evaluation - $ 1,021 - $ 759 - $ 390 + 1,021 + 759 + 390 Corporate and other @@ -92,11 +86,9 @@ $ 1,583 $ 834 + - Depreciation, depletion, and amortization: - - - + Depreciation, depletion, and amortization: Completion and Production @@ -106,9 +98,9 @@ Drilling and Evaluation - $ 372 - $ 295 - $ 241 + 372 + 295 + 241 Total diff --git a/predictions/184.html b/predictions/184.html index f40db90018cf848170f333fc9fff8b384a460e70..79dc850a114ad25db45536c7e91969fa275d9b3c 100644 --- a/predictions/184.html +++ b/predictions/184.html @@ -1,12 +1,15 @@ - + - + + + + @@ -27,7 +30,10 @@ - + + + + @@ -48,7 +54,10 @@ - + + + + @@ -86,93 +95,4 @@ -
Land vs. Offshore 2009 2008 2007
United States:United States:
Land1,767
Canada:Canada:
Land344
International (excluding Canada):International (excluding Canada):
Land361 363
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
200920082007
United States (incl. Gulf of Mexico):
Oil282384300
Natural Gas8041,4931,467
Total1,0861,8771,767
Canada:
Oil102160128
Natural Gas119219216
Total221379344
International (excluding Canada):
Oil776825776
Natural Gas221254230
Total9971,0791,006
Worldwide total2,3043,3353,117
Oil total1,1601,3691,204
Natural Gas total1,1441,9661,913
\ No newline at end of file diff --git a/predictions/185.html b/predictions/185.html new file mode 100644 index 0000000000000000000000000000000000000000..3d8fcf5a933dd4943b88218b8285422bdd41c5b5 --- /dev/null +++ b/predictions/185.html @@ -0,0 +1,53 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Number of Shares
(in millions)		Weighted Average
Grant-Date Fair
Value per Share
Restricted Stock
Nonvested shares at January 1, 20077.9$22.50
    Granted2.832.24
    Vested(2.3)21.16
    Forfeited(0.5)21.93
Converted to KRB, Inc. restricted stock(0.6)17.95
Nonvested shares at December 31, 20077.3$27.16
\ No newline at end of file diff --git a/predictions/186.html b/predictions/186.html new file mode 100644 index 0000000000000000000000000000000000000000..8bb1ad86f41bcdd5d1c8eb245272d188d1ceee63 --- /dev/null +++ b/predictions/186.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Drilling Type201720162015
United States (incl. Gulf of Mexico):
Horizontal736400744
Vertical7060139
Directional704995
Total876509978
\ No newline at end of file diff --git a/predictions/187.html b/predictions/187.html new file mode 100644 index 0000000000000000000000000000000000000000..c09ae4589bdbf3a6dd67a89b96efe0cdbd949e40 --- /dev/null +++ b/predictions/187.html @@ -0,0 +1,228 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars201720162015
Cash flows from operating activities:
Net loss$ (468)$ (5,769)$ (667)
Adjustments to reconcile net loss to cash flows from operating activities:
Depreciation, depletion and amortization1,5561,5031,835
Deferred income tax provision (benefit), continuing operations734(1,501)(224)
Impairments and other charges6473,3572,177
U.S. tax refund478430
Payment related to the Macondo well incident(368)(33)(333)
Cash impact of impairments and other charges – severance payments(273)(304)
Changes in assets and liabilities:
Receivables(1,350)8991,468
Accounts payable753(219)(603)
Inventories(29)552153
Other515(649)(596)
Total cash flows provided by (used in) operating activities2,468(1,703)2,906
Cash flows from investing activities:
Capital expenditures(1,373)(798)(2,184)
Payments to acquire businesses, net of cash acquired(628)(31)(39)
Proceeds from sales of property, plant and equipment158222168
Other investing activities(84)(103)(137)
Total cash flows used in investing activities(1,927)(710)(2,192)
Cash flows from financing activities:
Payments on long-term borrowings(1,641)(3,171)(8)
Dividends to shareholders(626)(620)(614)
Proceeds from issuance of common stock158186167
Proceeds from issuance of long-term debt, net10747,440
Other financing activities(62)(9)96
Total cash flows used in financing activities(2,161)(3,540)7,081
Effect of exchange rate changes on cash(52)(115)(9)
Increase (decrease) in cash and cash equivalents(1,672)(6,068)7,786
Cash and equivalents at beginning of year4,00910,0772,291
Cash and equivalents at end of year$ 2,337$ 4,009$ 10,077
Supplemental disclosure of cash flow information:
Cash payments (receipts) during the period for:
Interest$ 594$ 659$ 380
Income taxes$ (178)$ (20)$ 370
\ No newline at end of file diff --git a/predictions/188.html b/predictions/188.html index dcb9be9f4c6f35a2b4d302d3849cab27fede2fbe..30072f6f8fe34950e397169434bd12ddb84c9f75 100644 --- a/predictions/188.html +++ b/predictions/188.html @@ -1,9 +1,10 @@ - + + @@ -13,63 +14,105 @@ - - - - - - - - + + + + + + + + + + + + + + + - - - - - - - - + + + + + + + + + + + + + + + - - - - - - - - + + + + + + + + + + + + + + + - - - - - - - - + + + + + + + + + + + + + + + - - + + + - + + + + + + + - - - - - - - - + + + + + + + + + + + + + + +
Millions of dollars Payments Due
Millions of dollars 2017 2018 2019Total
Long-term debt (a)$ 163$ 841$ 1,028$ 24$ 702$ 9,729$ 12,487Long-term debt (a)$163$841$1,028$24$702$9,729$12,487
Interest on debt (b)$ 611$ 609$ 584$ 526$ 516$ 8,856$ 11,702Interest on debt (b)6116095845265168,85611,702
Operating leases$ 164$ 135$ 100$ 68$ 52$ 185$ 704Operating leases1641351006852185704
Purchase obligations (c)$ 468$ 54$ 34$ 26$ 18$ 39$ 639Purchase obligations (c)4685434261839639
Other long-term liabilities (d)$ 31Other long-term liabilities (d)31 $ 3131
Total$ 1,437$ 1,639$ 1,746$ 644$ 1,288$ 18,809$ 25,563Total$1,437$1,639$1,746$644$1,288$18,809$25,563
\ No newline at end of file diff --git a/predictions/189.html b/predictions/189.html new file mode 100644 index 0000000000000000000000000000000000000000..8bc06e0070ef0f99ae5f0fbb37557e924b8dd116 --- /dev/null +++ b/predictions/189.html @@ -0,0 +1,59 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsPension BenefitsOther Postretirement Benefits
United StatesGross Benefit Payments
StatesInt’lGross Benefit PaymentsPart D Receipts
2008$ 1122101
2009718111
2010720111
2011822111
2012825121
Years 2013 – 201737181545
\ No newline at end of file diff --git a/predictions/19.html b/predictions/19.html index 8ceaf2e835323c3e032fe56d3a41d7761964b270..f36ad67c9f407f50727dcd1d081e4dbc4e9d5b0c 100644 --- a/predictions/19.html +++ b/predictions/19.html @@ -12,25 +12,25 @@ - Horizontal +     Horizontal 1,274 1,102 1,151 - Vertical +     Vertical 376 435 552 - Directional +     Directional 211 224 216 - Total +     Total 1,861 1,761 1,919 diff --git a/predictions/190.html b/predictions/190.html new file mode 100644 index 0000000000000000000000000000000000000000..2c4632361b0c80616d00b2322c6ae63a9306ded9 --- /dev/null +++ b/predictions/190.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars200820072006
United States$ 1,988$ 2,219$ 2,280
Foreign1,1751,241919
Total$ 3,163$ 3,460$ 3,199
\ No newline at end of file diff --git a/predictions/191.html b/predictions/191.html new file mode 100644 index 0000000000000000000000000000000000000000..2641e98e5a731d2c76d5c34fce93e274b8e404eb --- /dev/null +++ b/predictions/191.html @@ -0,0 +1,112 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationOwned/LeasedDescription
Energy Services Group
Production Optimization Segment:
Carrollton, TexasOwnedManufacturing facility
Alvarado, TexasOwned/LeasedManufacturing facility
Drilling and Formation Evaluation Segment:
The Woodlands, TexasLeasedManufacturing facility
Shared Facilities:
Duncan, OklahomaOwnedManufacturing, technology; and campus facilities center
Houston, TexasOwnedManufacturing and campus facilities
Houston, TexasOwned/LeasedCampus facility
Houston, TexasLeasedCampus facility
KBR
Government and Infrastructure Segment:
Arlington, VirginiaLeasedCampus facility
Energy and Chemicals Segment:
Houston, TexasLeasedCampus facility
Shared Facilities:
Houston, TexasOwnedCampus facility
Leatherhead, United KingdomOwnedCampus facility
Corporate
Houston, TexasLeasedCorporate executive offices
\ No newline at end of file diff --git a/predictions/192.html b/predictions/192.html index 37506aae56536f7844d2959784b87dd144ccc85c..5e1d608461371b4855e3c36d9377add06cb1f861 100644 --- a/predictions/192.html +++ b/predictions/192.html @@ -1,53 +1,52 @@ - - - - + - + - - - + + + - + - + - + - + - + - + + + - + - - - + + +
Millions of dollarsDecember 31
2005 2004
Firm orders:Firm orders
Government and Infrastructure3,4033,968Government and infrastructure$ 3,403$ 3,968
Energy and Chemicals - Gas monetization 3,6514,4333,453
Energy and Chemicals - Other 2,9722,3093,200
Energy Services Group segmentsEnergy Services 18062187
Total firm orders 10,20611,33110,675
Government orders from but not yet funded, letters of intent and contracts awarded but not signed:Commitments, orders firm but not yet funded, letters of intent, and contracts awarded but not signed
Government and InfrastructureGovernment and infrastructure 1,775 816
Total backlog11,98112,147Total$11,981$ 8,491
\ No newline at end of file diff --git a/predictions/193.html b/predictions/193.html new file mode 100644 index 0000000000000000000000000000000000000000..fa061a76fe968e406c82cc6796eacab368e32bac --- /dev/null +++ b/predictions/193.html @@ -0,0 +1,74 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars200920082007
Balance at January 1$ 7,744$ 6,966$ 7,465
Dividends and other transactions with shareholders(144)(623)(1,529)
Adoption of new accounting standards–(703)(30)
Shares exchanged in KBR, Inc. exchange offer––(2,809)
Comprehensive income
  Net income1,1552,2153,536
  Net cumulative translation adjustments(5)1(23)
  Defined benefit and other postretirement plans adjustments2(106)355
  Net unrealized gains (losses) on investments5(6)1
Total comprehensive income1,1572,1043,869
Balance at December 31$ 8,757$ 7,744$ 6,966
\ No newline at end of file diff --git a/predictions/194.html b/predictions/194.html index 10a4d6c9ee9efdb4d39df1ae3d2afffcc0cb18aa..2cf0cd5f2daf572b0184b4271c53ae2e4497322d 100644 --- a/predictions/194.html +++ b/predictions/194.html @@ -1,21 +1,25 @@ - + + - + - + + + + - - + + @@ -30,7 +34,10 @@ - + + + + @@ -63,7 +70,7 @@ - + @@ -87,7 +94,7 @@ - + @@ -96,22 +103,22 @@ - + - + - + - + @@ -123,13 +130,16 @@ - + - + + + + @@ -144,13 +154,16 @@ - + - + + + + @@ -160,18 +173,21 @@ - - - + + + - + - + + + + @@ -181,12 +197,12 @@ - - - + + + - + diff --git a/predictions/195.html b/predictions/195.html index 2784621bfee108168d66c2909095e97b1bfe5031..75048d2d262ffa28322f6d28a9e714f506d2e5f4 100644 --- a/predictions/195.html +++ b/predictions/195.html @@ -1,6 +1,6 @@
(Millions of dollars and shares except per share data)Year Ended December 31
Year Ended December 31Millions of dollars and shares except per share data 2009 2008 2007
Revenue:Revenue:
Services $ 10,832$13,391$11,256$ 13,391$ 11,256
Product sales15,264
Operating costs and expenses:Operating costs and expenses:
Cost of services11,766
Operating incomeOperating income 1,994 4,010 3,498(7)
Income from continuing operations before income taxesIncome from continuing operations before income taxes 1,682 3,849 3,447Provision for income taxes (518) (1,211)(901)(907)
Income from continuing operationsIncome from continuing operations 1,164 2,638 2,540
Income (loss) from discontinued operations, net of income tax (provision) benefit of $5, $3, and $15Income (loss) from discontinued operations, net of income tax (provision) benefit of $5, $3, and $(15) (9) (423) 996
Net incomeNet income $ 1,155 $ 2,215 $ 3,536(50)
Net income attributable to companyNet income attributable to company $ 1,145 $ 2,224 $ 3,486
Amounts attributable to company shareholders:Amounts attributable to company shareholders:
Income from continuing operations975
Net income attributable to companyNet income attributable to company $ 1,145 $ 2,224 $ 3,486
Basic income per share attributable to company shareholders:Basic income per share attributable to company shareholders:
Income from continuing operations
Income (loss) from discontinued operations, net$ (0.01)$ (0.48)$ 1.06(0.01)(0.48)1.06
Net income per shareNet income per share $ 1.27 $ 2.52 $ 3.79
Diluted income per share attributable to company shareholders:Diluted income per share attributable to company shareholders:
Income from continuing operations
Income (loss) from discontinued operations, net$ (0.01)$ (0.46)$ 1.02(0.01)(0.46)1.02
Net income per shareNet income per share $ 1.27 $ 2.45 $ 3.65
- + @@ -8,9 +8,9 @@ - - - + + + diff --git a/predictions/196.html b/predictions/196.html new file mode 100644 index 0000000000000000000000000000000000000000..167de14ff9164095a298c93f654db81968184a8f --- /dev/null +++ b/predictions/196.html @@ -0,0 +1,46 @@ +
Millions of dollars December 31
2013
Finished products and parts 52,6062,445Finished products and parts$ 2,606$ 2,445
Raw materials and supplies
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Page No.
Management’s Report on Internal Control Over Financial Reporting37
Reports of Independent Registered Public Accounting Firm38
Consolidated Statements of Operations for the years ended December 31, 2017, 2016 and 201541
Consolidated Statements of Comprehensive Income for the years ended December 31, 2017, 2016 and 201542
Consolidated Balance Sheets at December 31, 2017 and 201643
Consolidated Statements of Cash Flows for the years ended December 31, 2017, 2016 and 201544
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2017, 2016 and 201545
Notes to Consolidated Financial Statements46
Selected Financial Data (Unaudited)67
Quarterly Data and Market Price Information (Unaudited)68
\ No newline at end of file diff --git a/predictions/197.html b/predictions/197.html new file mode 100644 index 0000000000000000000000000000000000000000..49929a9173a55345ef187398c6eba690a461aacd --- /dev/null +++ b/predictions/197.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Combined Operating Results
Millions of dollars		Years ended December 31
200420032002
Revenue$3,288$4,438$4,045
Operating income$ (34)$ 263$ 430
Net income$ (58)$ 230$ 409
\ No newline at end of file diff --git a/predictions/198.html b/predictions/198.html index 1fd91f5abda05edfb9692a7f71778cd399630ace..79d056e4592175c16fe7ba45fcf6c8af9982542f 100644 --- a/predictions/198.html +++ b/predictions/198.html @@ -1,8 +1,4 @@ - - - - @@ -10,49 +6,52 @@ - + + + + - + - + - + - + - + - + - + - - + + - + diff --git a/predictions/199.html b/predictions/199.html index 065f13f5c7d4421690a7d82126fa2adb37a1e7c6..505ae652be15227670743b43e19399c57740217d 100644 --- a/predictions/199.html +++ b/predictions/199.html @@ -1,31 +1,127 @@
Year Ended December 31
20082006
United States statutory rateYear Ended December 31
United States statutory rate 35.0% 35.0% 35.0%
Repurchase premium paid in cash to retire debtRepurchase premium paid in cash to retire debt 8.0 - -
Adjustments of prior year taxesAdjustments of prior year taxes (2.3) (0.3) (2.1)
Impact of foreign income taxed at different ratesImpact of foreign income taxed at different rates (1.4) (2.3) (1.3)
Other impact of foreign operationsOther impact of foreign operations (1.3) (3.9)(3.1)3.1
Valuation allowanceValuation allowance 0.1 (2.0) (3.3)
Other itemsOther items, net 0.20.3(0.3)-
Total effective tax rate on continuing operationsTotal effective tax rate on continuing operations 38.3% 26.2% 31.4%
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars
December 31
20042003
Gross deferred tax assets:
Asbestos- and silica-related liabilities$1,770$1,463
Employee compensation and benefits$263$275
Foreign tax credit carryforward$226$202
Net operating loss carryforwards$115$82
Capitalized research and experimentation$85$100
Construction contract accounting$75$101
Insurance accruals$71$68
Accrued liabilities$69$100
Alternative minimum tax credit carryforward$21$30
Other$260$191
Total$2,864$2,526
Less: gross deferred tax liabilities:
Insurance for asbestos- and silica-related liabilities$318$631
Depreciation and amortization$182$129
Other$33$11
Total$533$771
Valuation allowances:
Future tax attributes related to asbestos and silica litigation$1,073$624
Foreign tax credit limitation$135$115
Net operating loss carryforwards$43$56
Total$1,251$795
Net deferred income tax asset$1,080$962
December 31
Millions of dollars20042003
Gross deferred tax assets:
Asbestos- and silica-related liabilities$1,770$1,463
Employee compensation and benefits263275
Foreign tax credit carryforward135113
Net operating loss carryforwards11582
Capitalized research and experimentation85100
Construction contract accounting7594
Insurance accruals7177
Accrued liabilities69100
Alternative minimum tax credit carryforward2130
Other260191
Total$2,864$2,526
Gross deferred tax liabilities:
Insurance for asbestos- and silica-related liabilities$318$631
Depreciation and amortization182129
Other3311
Total$533$771
Valuation allowance:
Future tax liabilities related to asbestos and silica litigation$(1,072)$(614)
Foreign tax credit limitation135113
Net operating loss carryforwards4352
Total$(1,251)$( 79)
Net deferred income tax asset$1,080$962
\ No newline at end of file diff --git a/predictions/2.html b/predictions/2.html index 175eaa8de35361953450416ffe89b824ff49a8e8..d87e6ba6f4b4aa6ad4fee8b10c1fc19eed0d6fb9 100644 --- a/predictions/2.html +++ b/predictions/2.html @@ -1,21 +1,17 @@ - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + +
20172016
Discount rate2.8%2.9%
Rate of compensation increase5.5%4.8%
20172016
Discount rate2.8%2.9%
Rate of compensation increase5.5%4.8%
\ No newline at end of file diff --git a/predictions/20.html b/predictions/20.html index 7bcc4775089bb6e1de619ab0b8366fbf91b9f558..780c0e9f172ecb7019009bd6d8b18998f1792c22 100644 --- a/predictions/20.html +++ b/predictions/20.html @@ -4,7 +4,7 @@ December 31 - + Millions of dollars 2014 2013 @@ -28,6 +28,4 @@ $ (399) (307) - - -

(a) Included net actuarial losses for our international pension plans of $298 million at

\ No newline at end of file + \ No newline at end of file diff --git a/predictions/200.html b/predictions/200.html new file mode 100644 index 0000000000000000000000000000000000000000..c173e4f1169d187d4609932bb0eb68fae05e61ed --- /dev/null +++ b/predictions/200.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
Millions of dollars20082007
Land$ 5846
Buildings and property improvements1,082869
Machinery, equipment, and other8,2086,841
Total9,3487,756
Less accumulated depreciation4,5664,126
Net property, plant, and equipment$ 4,782$ 3,630
\ No newline at end of file diff --git a/predictions/201.html b/predictions/201.html new file mode 100644 index 0000000000000000000000000000000000000000..61e1950f989674871cd1b4c52ac5ab0df4782db7 --- /dev/null +++ b/predictions/201.html @@ -0,0 +1,20 @@ + + + + + + + + + + + + + + + + + + + +
20102017 and ThereafterTotal
Repayment amount ($US)$ 750$ 3,834$ 4,584
Weighted average interest rate on repayment amount5.5%6.9%6.6%
\ No newline at end of file diff --git a/predictions/202.html b/predictions/202.html new file mode 100644 index 0000000000000000000000000000000000000000..796f85f6771938bcf04cbe72c1a54d497d0f30c1 --- /dev/null +++ b/predictions/202.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20152014
Net property, plant, and equipment:
North America$ 5,7456,057
Latin America1,4501,406
Europe/Africa/CIS1,5941,832
Middle East/Asia2,1223,180
Total$ 10,911$ 12,475
\ No newline at end of file diff --git a/predictions/203.html b/predictions/203.html index 31fd3d4eb0bf1ad6dc3f8395e84cb94608f28550..4d2187d9480c183515a8bb6ebf2dc0997e8a68a5 100644 --- a/predictions/203.html +++ b/predictions/203.html @@ -1,9 +1,30 @@ - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2005$1,068
2006162
2007406
200845
200943
Thereafter131
Total81,460
2005$1,066
20061,623
200740
200848
2009131
Thereafter16
Total$1,404
\ No newline at end of file diff --git a/predictions/204.html b/predictions/204.html index d6603b6d4ea6f6c2831d23918aecbe9e171cdeee..00c88a45a8044b24965ad19e577e30dd2e92aa92 100644 --- a/predictions/204.html +++ b/predictions/204.html @@ -1,16 +1,9 @@ - - - - - - - + - @@ -39,40 +32,4 @@ -
Accumulated other comprehensive loss
Millions of dollars
Accumulated other comprehensive loss
Millions of dollars		 December 31
2008 2007 2006$ (104) $ (437)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares of common stock
Millions of shares
December 31
200820072006
Issued1,0671,0631,060
In treasury(172)(183)(62)
Total shares of common stock outstanding895880998
\ No newline at end of file diff --git a/predictions/205.html b/predictions/205.html index 3aaf14f36a0e9f64a20fc2b78621c8042b4c7161..03638a443759ae1b7e813a065e6929319430e82d 100644 --- a/predictions/205.html +++ b/predictions/205.html @@ -1,20 +1,17 @@ - - - - + - - + + @@ -28,7 +25,7 @@ - - + +
Millions of dollars
December 31
Millions of dollars 2005 2004
Finished products and parts715607571562
Raw materials and supplies
Total953796809791
\ No newline at end of file diff --git a/predictions/206.html b/predictions/206.html new file mode 100644 index 0000000000000000000000000000000000000000..87b0e318305abdd82b5a882406ac4ec872d7adf9 --- /dev/null +++ b/predictions/206.html @@ -0,0 +1,130 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20072006
Millions of dollars
Gross deferred tax asset:
    Employee compensation and benefits$   262289
    Capitalized research and experimentation9465
    Accrued liabilities8064
    Foreign tax credit carryforward6168
    Inventory6362
    Insurance accruals4645
    Software revenue recognition3757
    Net operating loss carryforwards2429
    Alternative minimum tax credit carryforward1966
    Other17690
Total gross deferred tax assets862835
Gross deferred tax liabilities:
    Depreciation and amortization164135
    Joint ventures, partnerships, and unconsolidated affiliates342
    Other5520
Total gross deferred tax liabilities253157
Valuation allowances:
    Net operating loss carryforwards2229
    Foreign tax credit carryforwards–68
    Other7–
Total valuation allowances2997
Net deferred income tax asset$   580581
\ No newline at end of file diff --git a/predictions/207.html b/predictions/207.html new file mode 100644 index 0000000000000000000000000000000000000000..82e95dbbb1da005f946ca631d3a491a870f0e0ba --- /dev/null +++ b/predictions/207.html @@ -0,0 +1,45 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20072006
Millions of dollars
Land$ 46$ 37
Buildings and property improvements869782
Machinery, equipment, and other6,8415,531
Total7,7566,350
Less accumulated depreciation4,1263,793
Net property, plant, and equipment$ 3,630$ 2,557
\ No newline at end of file diff --git a/predictions/208.html b/predictions/208.html index 288d4e525535a0123ee23932908835bfc60f838e..ec217648c14a0829d574b2d1ead407cd754b0b84 100644 --- a/predictions/208.html +++ b/predictions/208.html @@ -1,71 +1,102 @@ - + + - + + + + + - + + + + + - - - - - + + + + + - - + + - + - + + + + + - - - - - + + + + + - + + + + + + + + - + + + + + + + + + + + + - - - - - + + + + + - + diff --git a/predictions/209.html b/predictions/209.html index a1fa288af621537a443039720ac587ac583ab265..3adf352bf5ac5cfbf7650c74abeaf7e24a41e1e4 100644 --- a/predictions/209.html +++ b/predictions/209.html @@ -1,81 +1,78 @@
(Millions of dollars) 2009 2008
United States International United States International
Amounts recognized on the Consolidated Balance SheetsMillions of dollars
SheetsAmounts recognized on the Consolidated Balance Sheets
Other assets$ -$ 1$ -$ 1Other assets$      –$      1$      –$      1
Accrued employee compensation and benefits-Accrued employee compensation and benefits– (15) (2) (12)
Employee compensation and benefitsEmployee compensation and benefits (30) (177) (40) (249)
Pension plans in which projected benefit obligation exceeded plan assets at December 31Pension plans in which projected benefit
Projected benefit obligation$ 110$ 821$ 107$ 675obligation exceeded plan assets at December 31
Fair value of plan assetsProjected benefit obligation$    110$    821$    107$    675
Fair value of plan assets 80 629 65 414
Pension plans in which accumulated benefit obligation exceeded plan assets at December 31Pension plans in which accumulated benefit
obligation exceeded plan assets at December 31
Accumulated benefit obligation$ 110$ 690$ 107$ 477Accumulated benefit obligation$    110$    690$    107$    477
Fair value of plan assetsFair value of plan assets 80 562 65
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsYear Ended December 31
200820072006
Current income taxes:
Federal$ (561)$ (560)$ (156)
Foreign$ (346)$ (449)(122)
State(50)(38)(11)
Total current(957)(1,047)(289)
Deferred income taxes:
Federal(303)129(600)
Foreign47(95)
State(15)4(19)
Total deferred(254)140(714)
Provision for income taxes$ (1,211)$ (907)(1,003)
Year Ended December 31
Millions of dollars200820072006
Current income taxes:
Federal$ (561)$ (560)$ (156)
Foreign(346)(449)(122)
State(50)(38)(11)
Total current(957)(1,047)(289)
Deferred income taxes:
Federal(303)129(600)
Foreign647(95)
State(15)4(9)
Total deferred(254)140(714)
Provision for income taxes$ (1,211)$ (907)$ (1,003)
\ No newline at end of file diff --git a/predictions/21.html b/predictions/21.html index ff68c5bfc9270f2b0e33f706d2e8f4094dfcac38..b6e65dd4b365e6cc69edc6d82147fcefccfc374e 100644 --- a/predictions/21.html +++ b/predictions/21.html @@ -6,16 +6,16 @@ United States - Int'l + Int’l Gross Benefit Payments - Gross Medicare Part D Receipts + Gross Medical and Rx Receipts 2009 $ 11 - 21 - 10 - (1) + $ 21 + $ 10 + $ (1) 2010 @@ -35,7 +35,7 @@ 2012 8 22 - 10 + 11 (1) diff --git a/predictions/210.html b/predictions/210.html new file mode 100644 index 0000000000000000000000000000000000000000..df1796267538612dbdd60832aafa147b5b3ff839 --- /dev/null +++ b/predictions/210.html @@ -0,0 +1,80 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20172016
Gross deferred tax assets:
    Net operating loss carryforwards$        1,3701,647
    Foreign tax credit carryforwards828648
    Employee compensation and benefits263352
    Accrued liabilities97325
    Other416536
Total gross deferred tax assets2,9743,508
Gross deferred tax liabilities:
    Depreciation and amortization315585
    Undistributed foreign earnings242406
    Other56145
Total gross deferred tax liabilities6131,136
Valuation allowances1,173453
Net deferred income tax asset$        1,1881,919
\ No newline at end of file diff --git a/predictions/211.html b/predictions/211.html new file mode 100644 index 0000000000000000000000000000000000000000..7192200f45505acd51860516e5fc1da33608c916 --- /dev/null +++ b/predictions/211.html @@ -0,0 +1,68 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
International Pension PlansTotal
Quoted Prices in Active Markets for Identical AssetsSignificant Observable Inputs for Similar AssetsSignificant Unobservable Inputs
Millions of dollars
United States equity securities$ 41$ –$ –$ 41
Non-United States equity securities126––126
Government bonds–78–78
Corporate bonds–87–87
Common collective trust funds (a)–202–202
Other assets35271108
Fair value of plan assets$ 202$ 369$ 71$ 642
\ No newline at end of file diff --git a/predictions/212.html b/predictions/212.html index ab8d505e103c8bbae9defaac8dbbc6b213561caf..75adef1a9fd148b907e42bca3899c0efba51fa8b 100644 --- a/predictions/212.html +++ b/predictions/212.html @@ -12,25 +12,25 @@ - Horizontal +     Horizontal 744 1,274 1,102 - Vertical +     Vertical 139 376 435 - Directional +     Directional 95 211 224 - Total +     Total 978 1,861 1,761 diff --git a/predictions/213.html b/predictions/213.html index 4f9c6ac583bd76ad70956957b5d0f90ed8126f1f..bdfffe4e623a29340384aa457f124b7ca364dcc7 100644 --- a/predictions/213.html +++ b/predictions/213.html @@ -10,31 +10,31 @@ 2014 - Expected term (in years) + Expected term (in years) 5.21 5.16 5.23 - Expected volatility + Expected volatility 37% 39% 37% - Expected dividend yield + Expected dividend yield 1.35 - 2.46% 1.51 - 1.85% 0.94 - 1.77% - Risk-free interest rate + Risk-free interest rate 1.13 - 1.84% 1.43 - 1.72% 1.57 - 1.86% - Weighted average grant-date fair value per share + Weighted average grant-date fair value per share $12.33 $13.47 $19.26 diff --git a/predictions/214.html b/predictions/214.html new file mode 100644 index 0000000000000000000000000000000000000000..5b349bf9e9218fc131de2a24d41ff1f7f7a61391 --- /dev/null +++ b/predictions/214.html @@ -0,0 +1,31 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
20142013
Millions of shares
Issued1,0711,072
In treasury(223)(223)
Total shares of common stock outstanding848849
\ No newline at end of file diff --git a/predictions/215.html b/predictions/215.html new file mode 100644 index 0000000000000000000000000000000000000000..baf05d4fc577176aabe4bbc76320a49ca35854d0 --- /dev/null +++ b/predictions/215.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Offering period July 1 through December 31
200920082007
Expected term (in years)0.50.50.5
Expected volatility80.41%28.88%29.49%
Expected dividend yield1.74%0.67%1.03%
Risk-free interest rate0.33%2.17%4.98%
Weighted average grant-date fair value per share$    7.66$    12.58$    7.97
\ No newline at end of file diff --git a/predictions/216.html b/predictions/216.html new file mode 100644 index 0000000000000000000000000000000000000000..1f5e0a073fb8f9b5923204a44cd8b2b04e7c245f --- /dev/null +++ b/predictions/216.html @@ -0,0 +1,101 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per shareYear ended December 31
20162015201420132012
Revenue$ 15,887$ 23,633$ 32,870$ 29,402$ 28,503
Operating income (loss)(5,678)(165)5,0973,1384,195
Income (loss) from continuing operations(5,767)(662)3,4372,1162,587
Basic income (loss) per share from continuing operations(6.69)(0.78)4.052.352.78
Diluted income (loss) per share from continuing operations(6.69)(0.78)4.032.332.78
Cash dividends per share0.720.720.630.5250.36
Total working capital7,65414,7338,7818,6788,334
Total assets27,00036,94232,16529,22327,410
Long-term debt (including current maturities)12,37715,3467,7797,8164,820
Total shareholders’ equity9,44815,49516,29813,61515,790
Capital expenditures1,0001,0001,0001,0001,000
\ No newline at end of file diff --git a/predictions/217.html b/predictions/217.html new file mode 100644 index 0000000000000000000000000000000000000000..90a4f51dba219ec177ee2c4ae00f09d05d1a12e3 --- /dev/null +++ b/predictions/217.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
200720062005
Millions of dollars
Revenue:
United States$  6,673$  5,869$  4,317
Other countries8,5917,0865,783
Total$15,264$12,955$10,100
\ No newline at end of file diff --git a/predictions/218.html b/predictions/218.html new file mode 100644 index 0000000000000000000000000000000000000000..a3fb1c9815fd220cf6a236bbc1ba08886fa4980e --- /dev/null +++ b/predictions/218.html @@ -0,0 +1,118 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars20092008
United StatesInternationalUnited StatesInternational
Benefit obligation
Benefit obligation at beginning of period$   108$   690$   110$   874
Service cost–21–29
Interest cost544650
Plan participants’ contributions–2–5
Plan amendments–––1
Settlements/curtailments(8)(35)–(42)
Divestitures–––(1)
Business combinations–––1
Currency fluctuations–57–(201)
Actuarial (gain) loss1181–(18)
Benefits paid(6)(27)(9)(28)
Retained earnings adjustment – Adoption of accounting standard––120
Projected benefit obligation at end of period$   110$   833$   108$   690
Accumulated benefit obligation at end of period$   110$   764$   108$   533
\ No newline at end of file diff --git a/predictions/219.html b/predictions/219.html new file mode 100644 index 0000000000000000000000000000000000000000..354042a1fd6efbf9cf3f4ec80f93ea68286a8ad8 --- /dev/null +++ b/predictions/219.html @@ -0,0 +1,159 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
201420132012
Millions of dollars
Revenue:
Completion and Production$ 20,253$ 17,506$ 17,380
Drilling and Evaluation12,61711,89611,123
Total revenue$ 32,870$ 29,402$ 28,503
Operating income:
Completion and Production$ 3,610$ 2,875$ 3,144
Drilling and Evaluation1,6711,7701,675
Total operations5,2814,6454,819
Corporate and other(184)(1,507)(660)
Total operating income$ 5,097$ 3,138$ 4,159
Interest expense, net of interest income(383)(331)(298)
Other, net(2)(43)(39)
Income from continuing operations before income taxes$ 4,712$ 2,764$ 3,822
Capital expenditures:
Completion and Production$ 1,953$ 1,676$ 2,177
Drilling and Evaluation1,2971,2101,318
Corporate and other334871
Total$ 3,283$ 2,934$ 3,566
Depreciation, depletion, and amortization:
Completion and Production$ 1,162$ 1,013$ 843
Drilling and Evaluation934873783
Corporate and other30142
Total$ 2,126$ 1,900$ 1,628
\ No newline at end of file diff --git a/predictions/22.html b/predictions/22.html index 5cebf4dc773ba64bcabfca781bb572fd0887aca4..303468bc6408f3c78f5d9c352f0c4207ac8dcd4f 100644 --- a/predictions/22.html +++ b/predictions/22.html @@ -1,24 +1,24 @@ - - - - + - + - + + + + - + @@ -30,12 +30,12 @@ - - + + - + @@ -48,133 +48,121 @@ - - + + - - - + + + - + - + - + - + - + + - - - - - - - - -
Millions of dollars
Years ended December 31
Millions of dollars 2004 2003 2002
Depreciation, depletion, and amortization:Depreciation, depletion, and amortization:
Production Optimization $ 115$ 114$ 104 $ 98
Drilling and Formation Evaluation 115144137114107
Digital and Consulting Solutions7573 72 112
Total Energy Services Group 456472475432445
Government and Infrastructure2746477267111
Energy and Chemicals 11 16177
Shared KBShared KBR 15 121211
Total KBR6353 5029129
General corporate 1 11
Total$ 509$ 520$ 505
- - - - - - - - - - - + + + + - + + + + - + - + - + - + - + - - + + - - + + - - - + + + - + - + - - - - + + + + - - - + + + - + - - - - + + + +
Millions of dollars
Years ended December 31
200420032002Total$ 509$ 518$ 506
Revenues:total assets:
Production Optimization $ 1,754 $ 1,659$ 1,444$ 1,440
Fluid Systems 1,045 1,030833830
Drilling and Formation Evaluation 960 1,0741,1361,163
Digital and Consulting Solutions768765 7941,1021,320
Shared Energy Services 1,0211,2041,1871,2401,182
Total Energy Services Group 5,5485,7595,7025,7975,945
Government and Infrastructure3,2052,7382,7843,3092,7582,744
Energy and Chemicals1,6521,656 2,0782,0532,055
Shared KB455246303Shared KBR198242205
Total KBR5,0695,0624,8425,1635,0985,004
General corporate5,0855,089 4,620 3,796
Total$ 15,796$ 14,599$ 12,844Total$ 15,798$ 15,499$ 14,745
\ No newline at end of file diff --git a/predictions/220.html b/predictions/220.html new file mode 100644 index 0000000000000000000000000000000000000000..9b978773b8b96ffd3f0f82f0205cc78aaa260e77 --- /dev/null +++ b/predictions/220.html @@ -0,0 +1,377 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsCommon SharesPaid-in capital in Excess of Par ValueAsbestos Trust SharesTreasury StockDeferred CompensationRetained EarningsAccumulated Other Comprehensive Income (Loss)
Common SharesAsbestos Trust Shares
Balance at December 31, 2004$ 2,292$ (869)$ 2,335$ (477)$ (74)$ 871$ (146)
Cash dividends paid$ (254)
Stock plans
Common shares purchased44258115(24)
Tax benefit from exercise of options and restricted stock75(12)
Total dividends and other transactions with shareholders44333--103(24)(254)--
Asbestos trust shares2982,037(2,335)--------
Comprehensive income (loss):
Net income----------2,358--
Other comprehensive income:
    Cumulative translation adjustment------------(48)
    Realization of translation losses included in net income------------7
    Defined benefit and other postretirement plans adjustment, net of tax benefit of $23------------(54)
    Net unrealized losses on investments and derivatives, net of tax benefit of $7------------(12)
    Realization of gains on investments and derivatives, net of tax provision of $8------------(13)
Total comprehensive income----------2,358(120)
Balance at December 31, 2005$ 2,634$ 1,501$ --$ (374)$ (98)$ 2,975$ (266)
Cash dividends paid$ (306)
Stock plans
Common shares purchased16116--136------
Tax benefit from exercise of options and restricted stock53--(1,339)------
Total dividends and other transactions with shareholders16169--(1,203)--(306)--
Sale of stock by subsidiary117
Reclassification of deferred compensation(98)98
Adoption of SFAS No. 158, net of tax benefit of $146(218)
Other34
Comprehensive income (loss):
Net income----------2,348--
Other comprehensive income:
    Cumulative translation adjustment------------48
    Realization of translation gains included in net income------------(14)
    Defined benefit and other postretirement plans adjustment, net of tax benefit of $16------------2
    Net unrealized gains on investments and derivatives, net of tax benefit of $7------------12
    Realization of gains on investments and derivatives, net of tax provision of $0------------(1)
Total comprehensive income----------2,34847
Balance at December 31, 2006$ 2,650$ 1,689$ --$ (1,577)$ --$ 5,051$ (437)
\ No newline at end of file diff --git a/predictions/221.html b/predictions/221.html new file mode 100644 index 0000000000000000000000000000000000000000..a53b823c1e8c0b242a7dc0e1ce0c38bd38c50eed --- /dev/null +++ b/predictions/221.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
Completion and Production:Aberdeen, United Kingdom; Johor Bahru, Malaysia; and Lafayette, Louisiana
Drilling and Evaluation:Alvarado, Texas; Nisku, Canada; and The Woodlands, Texas
Shared/corporate facilities:Carrollton, Texas; Denver, Colorado; Dhahran, Saudi Arabia; Dubai, United Arab Emirates (corporate executive offices); Dubai, Canada, Oklahoma; Houston, Texas (corporate executive offices); Kuala Lumpur, Malaysia; London, England; Rome, Italy; Singapore; Panama City, Panama; Rio de Janeiro, Brazil; Singapore; and Stavanger, Norway
\ No newline at end of file diff --git a/predictions/222.html b/predictions/222.html new file mode 100644 index 0000000000000000000000000000000000000000..7c8b0f5c6e7209836ac0a2ac12ef8fcb6e5da831 --- /dev/null +++ b/predictions/222.html @@ -0,0 +1,102 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationOwned/LeasedDescription
Operations:
Completion and Production segment:
Carrollton, TexasOwnedManufacturing facility
Johor, MalaysiaLeasedManufacturing facility
Monterrey, MexicoLeasedManufacturing facility
Sao Jose dos Campos, BrazilLeasedManufacturing facility
Drilling and Evaluation segment:
Alvarado, TexasOwned/LeasedManufacturing facility
SingaporeLeasedManufacturing facility
The Woodlands, TexasLeasedManufacturing facility
Shared facilities:
Duncan, OklahomaOwnedManufacturing, technology, and camp facilities
Houston, TexasOwnedManufacturing and campus facilities
Houston, TexasOwned/LeasedCampus facility
Houston, TexasLeasedCampus facility
Pune, IndiaLeasedTechnology facility
Corporate:
Houston, TexasLeasedCorporate executive offices
Dubai, United Arab EmiratesLeasedCorporate executive offices
\ No newline at end of file diff --git a/predictions/223.html b/predictions/223.html index 8dac0fbcf922f57985b3cf9567325e66bee455ae..ec3a29ef554f50bde28ffba8fd4ab7974634327e 100644 --- a/predictions/223.html +++ b/predictions/223.html @@ -1,9 +1,11 @@ - - + + + + @@ -19,18 +21,18 @@ - - + + - - + + - - + + @@ -44,17 +46,22 @@ - + - - + + + + + + + - - + +
Millions of dollarsDecember 31December 31
Millions of dollars 2004 2003
Energy and Chemicals$3,643$3,6253,6433,625
Energy Services Group segments$64$27864278
Total$7,675$8,9287,6758,928
Government orders firm but not yet funded, letters of intent, and contracts awarded but not signed:
Energy and Chemicals. 19
Energy Services Group segments.43643
Total8161,138
Total backlog8,49110,066$8,491$10,066
\ No newline at end of file diff --git a/predictions/224.html b/predictions/224.html index 1fb93cfc4a46923cab7e5f4500aefc222a840fd8..7278dd06ce9f3fa7208c3eca5a2dec37e5571c9b 100644 --- a/predictions/224.html +++ b/predictions/224.html @@ -1,9 +1,10 @@ - + + diff --git a/predictions/225.html b/predictions/225.html index e493e1b544ce4a7f06c95958084d3a0398ab1740..298b82896dd9cf03ea24d230fda9ff743f838d91 100644 --- a/predictions/225.html +++ b/predictions/225.html @@ -1,30 +1,66 @@
Millions of dollars December 31
Millions of dollars 2009 2008
- - + + - - + + - - + + - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Medical innovationMedical advances allow for more accurate and earlier diagnosis and treatment of diseases.

-Continuing advances in genomics and proteomics are expected to yield new, more sophisticated and specialized diagnostic tests. These advances also are spurring interest in and demand for precision medicine, which relies on diagnostic and prognostic testing and in which data information services and strategies are used to deliver the most effective healthcare to the right populations and individuals.

-Pharmacogenomic testing increasingly is used as a parameter to help speed drug approval processes and to better focus therapy based on patient and tumor-specific genetic markers.

-Demand also is growing toward comprehensive care management solutions that serve patients, payers and healthcare providers by improving clinical decision support and access to patient data, and by increasing patient participation in care management and population health management.

-There is increasing focus on access to patient data and data-driven insights.		Medical innovationMedical advances allow for more accurate and earlier diagnosis and treatment of diseases.
Customers and payersOur customers and payers, including clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, an increased number of hospitals, systems and consortia are establishing or have established health insurance plans, and health insurance plans are considering providing or are providing healthcare services.

-Consolidation is increasing pricing transparency and bargaining power, and may encourage internalization of clinical testing.

-Physicians increasingly are employed by hospital systems, IDNs, ACOs or large group practices integrated with healthcare systems, instead of organizing physician-owned practices, which is changing the dynamics for whether clinical testing is performed in or outside of a hospital. Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.

-Value-based reimbursement is contributing to changes in the healthcare system. ACOs and patient-centered medical homes are growing as a means to deliver patient care. Healthcare services increasingly are being provided by non-traditional providers (e.g., physician assistants), in non-traditional venues (e.g., retail medical clinics, urgent care centers) and using new technologies (e.g., telemedicine).

-In addition, federal healthcare reform legislation adopted in 2010, the Affordable Care Act ("ACA"), is resulting in changes in the way that some healthcare services are purchased and delivered in the United States.

-Patients are also our customers. Increasingly, patients are engaged in their own healthcare and are bearing increased responsibility for payment for the services that we provide to them.		Continuing advances in genomics and proteomics are expected to yield new sophisticated and specialized diagnostic tests. These advances also are spurring interest in and demand for precision medicine, which relies on diagnostic and prognostic testing and in which data information services and strategies are used to deliver the most effective healthcare to the right populations and individuals.
Pricing transparencyThere has been a trend toward greater pricing transparency in the healthcare marketplace.

-This transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and changes in behavior in the healthcare marketplace.		Pharmacogenomic testing increasingly is used as a parameter to help speed drug approval processes and to better focus therapy based on patient and tumor-specific genetic markers.
CompetitionThe clinical testing industry remains fragmented, is highly competitive and is subject to new competition.

-Competition is growing from non-traditional competitors. Increased hospital acquisitions of physician practices enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.

-New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.		Demand also is growing toward comprehensive care management solutions that serve patients, payers and healthcare providers by improving clinical decision support and access to patient data, and by increasing patient participation in care management and population health management.
There is increasing focus on access to patient data and data-driven insights.
Customers and payersOur customers and payers, including clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, an increased number of hospital systems are considering establishing or have established health insurance plans, and health insurance plans are considering providing or are providing healthcare services.
Consolidation is increasing price transparency and bargaining power, and may encourage internalization of clinical testing.
Physicians increasingly are employed by hospital systems, IDNs, ACOs or large group practice integrated with healthcare systems, instead of organizing physician-owned practices, which is changing the dynamics for whether clinical testing is performed in or outside of a hospital. Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.
Value-based reimbursement is contributing to changes in the healthcare system. ACOs and patient-centered medical homes are growing as a means to deliver patient care. Healthcare services increasingly are being provided by non-traditional providers (e.g., physician assistants), in non-traditional venues (e.g., retail medical clinics, urgent care centers) and using new technologies (e.g., telemedicine).
In addition, federal healthcare reform legislation adopted in 2010, the Affordable Care Act ("ACA"), is resulting in changes in the way that some healthcare services are purchased and delivered in the United States.
Patients also are our customers. Increasingly, patients are engaged in their own healthcare and are bearing increased responsibility for payment for the services that we provide to them.
Pricing transparencyThere has been a trend toward greater pricing transparency in the healthcare marketplace.
This transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and changes in behavior in the healthcare marketplace.
CompetitionThe clinical testing industry remains fragmented, is highly competitive and is subject to new competition.
Competition is growing from non-traditional competitors. Increased hospital acquisitions of physician practices enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.
New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.
\ No newline at end of file diff --git a/predictions/226.html b/predictions/226.html new file mode 100644 index 0000000000000000000000000000000000000000..86831679d246920cb1332e005a1708f7da1945f8 --- /dev/null +++ b/predictions/226.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20122011
Current deferred tax assets:
Accounts receivable reserves$ 90,784$ 85,485
Liabilities not currently deductible83,42567,843
Total current deferred tax assets$ 174,209$ 153,328
Non-current deferred tax assets (liabilities):
Liabilities not currently deductible$ 139,869$ 151,621
Stock-based compensation58,25372,262
Capitalized R&D expense10,41316,899
Net operating loss carryforwards, net of valuation allowance104,257121,234
Depreciation and amortization(484,773)(528,129)
Total non-current deferred tax liabilities, net$ (171,981)$ (166,113)
\ No newline at end of file diff --git a/predictions/227.html b/predictions/227.html new file mode 100644 index 0000000000000000000000000000000000000000..59b0e213dcdcdd69e56a455170f2eb01811dc323 --- /dev/null +++ b/predictions/227.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
ActivityApproximate Percentage of 2015 Net Revenues
Diagnostic information services93
Routine clinical testing services61
Gene-based, esoteric and anatomic pathology testing services32
Diagnostic Solutions: Healthcare information technology, clinical trials testing, risk assessment services and diagnostic products*7
\ No newline at end of file diff --git a/predictions/228.html b/predictions/228.html index 9209a89740d54794a3952feffe54163d0139cff9..6a6b903c524a8eba8621fb1f8d7e1e05c0ad41f0 100644 --- a/predictions/228.html +++ b/predictions/228.html @@ -1,7 +1,7 @@ - + diff --git a/predictions/229.html b/predictions/229.html index 125b1876db3b78b4c432f9b4e071b40a459e239d..68ec9b18ac96fd9a1abf5caa6e6fd36dc8779213 100644 --- a/predictions/229.html +++ b/predictions/229.html @@ -1,6 +1,6 @@
% of 2015 Consolidated Net Revenues% of 2015
Consolidated Net Revenues
Medicare Clinical Laboratory Fee Schedule
- + @@ -9,7 +9,7 @@ - + @@ -45,7 +45,7 @@ - + diff --git a/predictions/23.html b/predictions/23.html index 4f1464b983a5b7c19a3721d77114ad5762003e2a..a98baadb3e537bff94b50666df3a149add3cd793 100644 --- a/predictions/23.html +++ b/predictions/23.html @@ -1,18 +1,200 @@ -| | 2017 | 2016 | 2015 | -|---|---:|---:|---:| -| Land vs. Offshore | | | | -| United States: | | | | -| Land | 856 | 486 | 943 | -| Offshore (incl. Gulf of Mexico) | 20 | 23 | 35 | -| Total | 876 | 509 | 978 | -| Canada: | | | | -| Land | 205 | 128 | 189 | -| Offshore | 1 | 2 | 2 | -| Total | 206 | 130 | 191 | -| International (excluding Canada): | | | | -| Land | 751 | 734 | 884 | -| Offshore | 198 | 221 | 283 | -| Total | 949 | 955 | 1,167 | -| Worldwide total | 2,031 | 1,594 | 2,336 | -| Land total | 1,812 | 1,348 | 2,016 | -| Offshore total | 219 | 246 | 320 | \ No newline at end of file +
Exhibit NumberExhibit
Number		 Description
3.2Amendment and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: August 9, 2012) and incorporated herein by reference) (Commission File Number 001-12215)Amended and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: August 9, 2012) and incorporated herein by reference) (Commission File Number 001-12215)
4.1
4.9Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)Indenture dated as of June 27, 2001, among the Subsidiary Guarantors, and The Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)
4.10
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201720162015
Land vs. Offshore
United States:
Land856486943
Offshore (incl. Gulf of Mexico)202335
Total876509978
Canada:
Land205128189
Offshore122
Total206130191
International (excluding Canada):
Land751734884
Offshore198221283
Total9499551,167
Worldwide total2,0311,5942,336
Land total1,8121,3482,016
Offshore total219246320
Oil vs. Natural Gas
United States (incl. Gulf of Mexico):
Oil704409751
Natural gas172100227
Total876509978
Canada:
Oil1096384
Natural gas9767107
Total206130191
International (excluding Canada):
Oil732726916
Natural gas217229251
Total9499551,167
Worldwide total2,0311,5942,336
Oil total1,5451,1981,751
Natural gas total486396585
\ No newline at end of file diff --git a/predictions/230.html b/predictions/230.html new file mode 100644 index 0000000000000000000000000000000000000000..1c64783ce4297f2774752d4d8628fc27ae68af12 --- /dev/null +++ b/predictions/230.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.25Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York Mellon as the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)
4.26Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
4.27Sixteenth Supplemental Indenture dated as of March 12, 2014, among the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K and incorporated herein by reference) (Commission File Number 001-12215)
4.28Seventeenth Supplemental Indenture dated as of March 10, 2015, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.29Eighteenth Supplemental Indenture dated as of May 26, 2016, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)
10.1‡Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2016 and incorporated herein by reference) (Commission file number 001-12215)
10.2‡Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 15, 2015 (filed as an exhibit to the Company's 2013 quarterly report on Form 10-Q for the quarter ended June 30, 2015 and incorporated herein by reference) (Commission file number 001-12215)
10.3‡Form of Equity Award Agreement dated as of February 23, 2015 (filed as an exhibit to the Company's 2015 annual report on Form 10-K and incorporated herein by reference) (Commission file number 001-12215)
10.4‡Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended and restated as of November 27, 2017
10.5‡Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated November 27, 2017 (filed as an Exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.6‡Quest Diagnostics Incorporated Senior Management Incentive Plan (filed as Appendix A to the Company's Definitive Proxy Statement dated March 28, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
10.7‡Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended February 20, 2017 (filed as an exhibit to the Company's 2016 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.8‡The Profit Sharing Plan of Quest Diagnostics Incorporated (Amendment and Restatement, effective as of January 1, 2016) (filed as an exhibit to the Company's 2015 annual report on Form 10-K and incorporated herein by reference) (Commission file number 001-12215)
10.9‡Amendment No. 1 to The Profit Sharing Plan of Quest Diagnostics Incorporated, effective as of January 1, 2018
\ No newline at end of file diff --git a/predictions/231.html b/predictions/231.html new file mode 100644 index 0000000000000000000000000000000000000000..d42386464ef2feb9674bd75a1c3476da604aa592 --- /dev/null +++ b/predictions/231.html @@ -0,0 +1,15 @@ + + + + + + + + + + + + + + +
Year ended December 31, 2004Balance at
1-1-04		Provision for
Doubtful
Accounts		Net Deductions
and Other (a)		Balance at
12-31-04
$211,739$226,310$235,192$202,857
\ No newline at end of file diff --git a/predictions/232.html b/predictions/232.html index 901109691c770646f75ea62e59cf8b6e78de633a..de917273da2fb5073e06a1fbaded83e8fa26edd4 100644 --- a/predictions/232.html +++ b/predictions/232.html @@ -1,14 +1,46 @@ - + + + + + + + + + + + + + - + + + + + + + + + + + + + - + + + + + + + + +
Fraud and AbuseAnti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.

In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory.

Some states have similar laws that are not limited to Medicare and Medicaid referrals and could also affect other tests referred by clinicians with investment or compensation arrangements with the testing laboratory.

Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.		Anti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.
In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory.
Some states have similar laws that are not limited to Medicare and Medicaid referrals and could also affect other tests referred by clinicians with investment or compensation arrangements with the testing laboratory.
Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.
FDAThe FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States. The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization.

A number of esoteric tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.

The FDA has announced guidance initiatives that may significantly impact the clinical laboratory testing business, including by increasing regulation of LDTs.

Our diagnostic products business is subject to regulation by the FDA, as well as by foreign governmental agencies, under laws and regulations that govern the development, testing, manufacturing, labeling, advertising, marketing, distribution and post-market surveillance of diagnostic products. These regulators possess the authority to take various administrative and legal actions against us for non-compliance, such as fines, product suspensions, submission of warning letters, recalls, product seizures, injunctions and other civil and criminal sanctions.		The FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States. The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization.
A number of esoteric tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.
The FDA has announced guidance initiatives that may significantly impact the clinical laboratory testing business, including by increasing regulation of LDTs.
Our diagnostic products business is subject to regulation by the FDA, as well as by foreign governmental agencies, under laws and regulations that govern the development, testing, manufacturing, labeling, advertising, marketing, distribution and post-market surveillance of diagnostic products. These regulations possess the authority to take various administrative and legal actions against us for non-compliance, such as fines, product suspensions, submission of warning letters, recalls, product seizures, injunctions and other civil and criminal sanctions.
Environmental, Health and SafetyWe are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.

For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries.

For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association.		We are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.
For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries.
For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association.
\ No newline at end of file diff --git a/predictions/233.html b/predictions/233.html index 06db5a94b2fd85cd64e9e27aa32509c7fdd3a9ac..c691396f787a98232d60dd200d8a16f7b3e14cc9 100644 --- a/predictions/233.html +++ b/predictions/233.html @@ -8,7 +8,7 @@ Stock options 2 - 1 + 2 2 \ No newline at end of file diff --git a/predictions/234.html b/predictions/234.html new file mode 100644 index 0000000000000000000000000000000000000000..0970e33791a334a96988e102ca61148a797fce19 --- /dev/null +++ b/predictions/234.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ThemeKey CharacteristicsAt A GlanceQuest Value Proposition
General DiagnosticsTesting services generating strong cash flows and steady growthRoutine and non-routine testing servicesScale
Largest revenue streamOperational excellence
Essential portion of health care deliveryAccess and convenience
Advanced DiagnosticsTesting services providing faster growth through innovation testing modelGenetic and advanced molecular testing servicesRich clinical, scientific and medical innovation expertise
An important part of precision medicineQuality and reliability of new assays
A growing set of unique, innovation-based competitorsAbility to manage potential new regulatory requirements
Diagnostic ServicesLaboratory and data-related healthcare opportunities providing faster growthEnables partners to deliver health care more efficiently (e.g., risk assessment; Professional Lab Services; wellness)Extensive diagnostic capability
Services to support population health (e.g., data analytics; extended care services)Large and growing database and analytics expertise
Partnerships with industry leaders across healthcare landscape
\ No newline at end of file diff --git a/predictions/235.html b/predictions/235.html index e3c1165451a8cb273b01bd19aca2c6c8ded1e4ad..f33f0096286516c318b0086d393a62153b2e56e6 100644 --- a/predictions/235.html +++ b/predictions/235.html @@ -8,13 +8,31 @@ 2013 - (dollars in millions, except per share data) + + Year Ended December 31, + + + + (dollars in millions, except per share data) + + + + (a) (b) (c) + (a) (d) (e) + (a) (d) (e) + (a) (f) (g) + (a) (h) (i) (j) (k) - Operations Data: + Operations Data: + + + + + - Net revenues + Net revenues $ 7,709 $ 7,515 $ 7,493 @@ -22,7 +40,7 @@ $ 7,146 - Operating income + Operating income 1,165 1,277 1,399 @@ -30,15 +48,15 @@ 1,475 - Income from continuing operations + Income from continuing operations 824 696 753 587 - 883 + 848 - Income from discontinued operations, net of taxes + Income from discontinued operations, net of taxes — — — @@ -46,7 +64,7 @@ 35 - Net income + Net income 824 696 753 @@ -54,7 +72,7 @@ 883 - Less: Net income attributable to noncontrolling interests + Less: Net income attributable to noncontrolling interests 52 51 44 @@ -62,7 +80,7 @@ 34 - Net income attributable to Quest Diagnostics + Net income attributable to Quest Diagnostics' $ 772 $ 645 $ 709 @@ -70,13 +88,15 @@ $ 849 - - - - Amounts attributable to Quest Diagnostics' stockholders: + Amounts attributable to Quest Diagnostics' stockholders: + + + + + - Income from continuing operations + Income from continuing operations $ 772 $ 645 $ 709 @@ -84,7 +104,7 @@ $ 814 - Income from discontinued operations, net of taxes + Income from discontinued operations, net of taxes — — — @@ -92,7 +112,7 @@ 35 - Net income + Net income $ 772 $ 645 $ 709 diff --git a/predictions/236.html b/predictions/236.html new file mode 100644 index 0000000000000000000000000000000000000000..0959382ba248275025c7f10ba8aa7abb07629785 --- /dev/null +++ b/predictions/236.html @@ -0,0 +1,47 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Financial StatementsItemPage
Report of Independent Registered Public Accounting FirmF- 1
Consolidated Balance SheetsF- 3
Consolidated Statements of OperationsF- 4
Consolidated Statements of Comprehensive IncomeF- 5
Consolidated Statements of Cash FlowsF- 6
Consolidated Statements of Stockholders' EquityF- 7
Notes to Consolidated Financial StatementsF- 8
Supplementary Data: Quarterly Operating Results (unaudited)F- 44
\ No newline at end of file diff --git a/predictions/237.html b/predictions/237.html new file mode 100644 index 0000000000000000000000000000000000000000..c054f04ca752033275b25f864a628b803e7110a1 --- /dev/null +++ b/predictions/237.html @@ -0,0 +1,37 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20122011
Balance at beginning of year$    5,795,765$    5,101,938
Goodwill acquired during the year28,144701,087
Goodwill impairment and write-off associated with sale of business during the year(85,173)
Reclassification to non-current assets held for sale(218,795)
Increase (decrease) related to foreign currency translation15,907(7,260)
Balance at end of year$    5,535,848$    5,795,765
\ No newline at end of file diff --git a/predictions/238.html b/predictions/238.html new file mode 100644 index 0000000000000000000000000000000000000000..036b192c8181fe6a1557476094ed93b63c2414ed --- /dev/null +++ b/predictions/238.html @@ -0,0 +1,27 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + +
% of DIS Volume% of DIS Revenue
Healthcare Insurers (including coinsurance and deductible responsibilities)4751
Government Payers1518
Client Payers3729
Patients12
\ No newline at end of file diff --git a/predictions/239.html b/predictions/239.html new file mode 100644 index 0000000000000000000000000000000000000000..4622078f84a1e02df29c065fce569b10ff6f6f6c --- /dev/null +++ b/predictions/239.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
201820172016
Stock options221
\ No newline at end of file diff --git a/predictions/24.html b/predictions/24.html new file mode 100644 index 0000000000000000000000000000000000000000..503277892841557503c88a006ac2839444bb084a --- /dev/null +++ b/predictions/24.html @@ -0,0 +1,305 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per share dataQuarterYear
FirstSecondThirdFourth
2009
Revenue$ 3,907$ 3,494$ 3,588$ 3,686$ 14,675
Operating income6164764744281,994
Net income3802652662441,155
Amounts attributable to company shareholders:
  Income from continuing operations3792632652471,154
  Loss from discontinued operations(1)(1)(3)(4)(9)
  Net income attributable to company3782622622431,145
Basic income per share attributable to company shareholders:
  Income from continuing operations0.420.290.290.271.28
  Loss from discontinued operations––––(0.01)
  Net income0.420.290.290.271.28
Diluted income per share attributable to company shareholders:
  Income from continuing operations0.420.290.290.271.28
  Loss from discontinued operations––––(0.01)
  Net income0.420.290.290.271.27
Cash dividends paid per share0.090.090.090.090.36
Common stock price (2)
  High21.4724.7628.5832.0032.00
  Low14.6814.8218.1125.5014.68
2008
Revenue$ 4,029$ 4,487$ 4,853$ 4,910$ 18,279
Operating income8479491,0511,1634,010
Net income5875106754432,215
Amounts attributable to company shareholders:
  Income from continuing operations5796206727762,647
  Net income (loss) from discontinued operations1(116)–(308)(423)
  Net income attributable to company5805046724682,224
Basic income per share attributable to company shareholders:
  Income from continuing operations0.660.710.760.873.00
  Net income (loss) from discontinued operations–(0.13)–(0.35)(0.48)
  Net income0.660.580.760.522.52
Diluted income per share attributable to company shareholders:
  Income from continuing operations0.630.680.740.872.91
  Loss from discontinued operations–(0.13)–(0.35)(0.46)
  Net income0.630.550.740.522.45
Cash dividends paid per share0.090.090.090.090.36
Common stock price (2)
  High39.9853.9755.3832.0955.38
  Low30.0038.5629.0012.8012.80
\ No newline at end of file diff --git a/predictions/240.html b/predictions/240.html new file mode 100644 index 0000000000000000000000000000000000000000..80b16c0daab8dc50c3941fd70d7d2cb62c76ce1e --- /dev/null +++ b/predictions/240.html @@ -0,0 +1,70 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationLeased or Owned
Sacramento, California (laboratory)Leased
West Hills, California (laboratory)Leased
San Juan Capistrano, California (laboratory)Owned
Tampa, Florida (laboratory)Owned
Atlanta, Georgia (laboratory)Owned
Chicago, Illinois (2) (laboratories)One owned, one leased
Marlborough, Massachusetts (laboratories)Leased
Baltimore, Maryland (laboratory)Owned
Teterboro, New Jersey (laboratory)Owned
Philadelphia, Pennsylvania (laboratory)Leased
Dallas, Texas (laboratory)Leased
Chantilly, Virginia (laboratory)Leased
Lenexa, Kansas (laboratory)Owned
Greensboro, North Carolina (laboratory)Leased
Lewisville, Texas (laboratory)Leased
Cleveland, Ohio (laboratory)Leased
\ No newline at end of file diff --git a/predictions/241.html b/predictions/241.html new file mode 100644 index 0000000000000000000000000000000000000000..0a82ea95a31563fd8e4f6e913a12d317a12066d1 --- /dev/null +++ b/predictions/241.html @@ -0,0 +1,37 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2006$9,374
20077,983
20087,990
20097,375
20107,128
Thereafter98,333
Total$137,983
\ No newline at end of file diff --git a/predictions/242.html b/predictions/242.html index f4d46b0a326844a0663665976435fa3aac376b2d..03d9549827ebf3423b19dca5c7ec54527fa210d8 100644 --- a/predictions/242.html +++ b/predictions/242.html @@ -1,6 +1,6 @@ - + @@ -25,11 +25,11 @@ - + - + diff --git a/predictions/243.html b/predictions/243.html new file mode 100644 index 0000000000000000000000000000000000000000..47047217bd02cb64987414ee35c7a995f20a722b --- /dev/null +++ b/predictions/243.html @@ -0,0 +1,80 @@ +
Exhibit NumberExhibit
Number		 Description
4.4Form of 4.700% Senior Note due 2022 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)Form of 4.700% Senior Note due 2021 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission file Number 001-12215)
4.5Form of 2.700% Senior Note due 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)Form of 2.700% Senior Note due 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission file Number 001-12215)
4.6
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201820172016
Net revenues:
DIS business95.7%95.5%94.8%
DS business4.34.55.2
Total net revenues100.0%100.0%100.0%
Operating costs and expenses and other operating income:
Cost of services65.4%63.8%64.0%
Selling, general and administrative18.919.519.1
Amortization of intangible assets1.21.01.0
Loss (gain) on disposition of business0.1—(1.5)
Other operating (income) expense, net(0.2)—(0.3)
Total operating costs and expenses, net85.4%84.3%82.3%
Operating income14.6%15.7%17.7%
\ No newline at end of file diff --git a/predictions/244.html b/predictions/244.html index 954cfa71da3a48869baebcca07f7d5b4816a2f0a..aa505f2b71277775d9919dcf17afa4717b381fcf 100644 --- a/predictions/244.html +++ b/predictions/244.html @@ -1,156 +1,152 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200520042003
Net revenues ..........................................................$5,503,711$5,126,601$4,737,958
Operating costs and expenses:
Cost of services .....................................................3,257,3352,950,7122,768,623
Selling, general and administrative .................................1,257,7751,227,7461,165,700
Amortization of intangible assets ..................................4,7306,7038,201
Other operating expense (income), net ..............................15,76010,223(1,020)
Total operating costs and expenses .................................4,535,6004,235,3843,941,504
Operating income ....................................................968,111891,217796,454
Other income (expense):
Interest expense, net ..............................................(57,471)(57,949)(59,789)
Minority share of income ...........................................(19,495)(19,353)(17,630)
Equity earnings in unconsolidated joint ventures ....................26,18521,04917,439
Other, net ........................................................(6,876)1621,324
Total non-operating expenses, net .................................(57,657)(56,091)(58,656)
Income before taxes ................................................910,454835,126737,798
Income tax expense .................................................364,177335,931301,081
Net income ........................................................546,277499,195436,717
Earnings per common share:
Basic .............................................................$2.71$2.45$2.11
Diluted ...........................................................$2.66$2.35$2.02
Weighted average common shares outstanding:
Basic .............................................................201,833203,920206,832
Diluted ...........................................................205,530214,145217,578
Dividends per common share ........................................$0.36$0.30$0.075
200520042003
Net revenues$5,503,711$5,126,601$4,737,958
Operating costs and expenses:
Cost of services3,257,3352,990,7122,768,623
Selling, general and administrative1,257,7751,227,7461,165,700
Amortization of intangible assets4,7306,7038,201
Other operating expense (income), net15,76010,223(1,020)
Total operating costs and expenses4,535,6004,235,3843,941,504
Operating income968,111891,217796,454
Other income (expense):
Interest expense, net(57,471)(57,949)(59,789)
Minority share of net income(19,495)(19,353)(17,630)
Equity earnings in unconsolidated joint ventures26,18521,04917,439
Other, net(6,876)1621,324
Total non-operating expenses, net(57,657)(56,091)(58,656)
Income before taxes910,454835,126737,798
Income tax expense364,177335,931301,081
Net income$546,277$499,195$436,717
Earnings per common share:
Basic$      2.71$      2.45$      2.11
Diluted$      2.66$      2.35$      2.02
Weighted average common shares outstanding:
Basic201,833203,920206,832
Diluted205,530214,145217,578
Dividends per common share$      0.36$      0.30$      0.075
\ No newline at end of file diff --git a/predictions/245.html b/predictions/245.html index 45c56a9dd58933210e2fec47e345f376c34ec81f..4f321d1c34c5933dedf2d4fd9478d3565d64103b 100644 --- a/predictions/245.html +++ b/predictions/245.html @@ -1,22 +1,25 @@ - - + + + + + - + - + - + diff --git a/predictions/246.html b/predictions/246.html new file mode 100644 index 0000000000000000000000000000000000000000..b51e653fbfebc5d87a45aed230acc0c2148ea98f --- /dev/null +++ b/predictions/246.html @@ -0,0 +1,38 @@ +
ActivityApproximate Percentage of 2016 Net RevenuesActivityApproximate Percentage
of 2016 Net Revenues
Diagnostic Information Services 95
Routine clinical testing services    Routine clinical testing services 56
Gene-based and esoteric (including advanced diagnostics) testing services    Gene-based and esoteric (including advanced diagnostics) testing services 31
Anatomic pathology testing services    Anatomic pathology testing services 8
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201620152014
Fair value at grant date$10.35$11.57$10.99
Expected volatility21.6%21.0%25.1%
Dividend yield2.4%2.1%2.1%
Risk-free interest rate1.4%1.7%1.6% - 2.0%
Expected holding period, in years5.35.35.5 - 6.6
\ No newline at end of file diff --git a/predictions/247.html b/predictions/247.html new file mode 100644 index 0000000000000000000000000000000000000000..5429ac17b373c4688b5b77db3b33e930397cf065 --- /dev/null +++ b/predictions/247.html @@ -0,0 +1,69 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201220112010
Shares
in
thousands		Weighted
Average
Grant Date
Fair Value		Shares
in
thousands		Weighted
Average
Grant Date
Fair Value		Shares
in
thousands		Weighted
Average
Grant Date
Fair Value
Shares outstanding, beginning of year1,957$ 54.612,140$ 51.542,747$ 50.27
Shares granted77957.7887756.8187655.44
Shares vested(899)52.62(930)48.93(742)51.48
Shares forfeited and canceled(97)57.09(100)55.47(130)52.34
Adjustment to estimate of performance(544)57.06(30)53.23(611)51.33
Shares outstanding, end of year1,196$ 56.841,957$ 54.612,140$ 51.54
\ No newline at end of file diff --git a/predictions/248.html b/predictions/248.html index b9d9481857460b756e299f2d27ad74e1e7f4a60c..947eb01d7203ca948cd450b1dced20e241745a6c 100644 --- a/predictions/248.html +++ b/predictions/248.html @@ -1,61 +1,73 @@ - - - - + + + - + + - + + - + + - + + + - + - + - + + - + + - + - + - + + - + + - + - - - - - + + + + + + + - + + +
201820172016201820172016
SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value		 SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value		 SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value
Shares outstanding, beginning of yearShares outstanding, beginning of year 1.3 $ 77.90 1.5 $ 63.88 1.7 $ 59.92
Shares grantedShares granted 0.4$ 103.51103.51 0.4$ 96.2796.27 0.6$ 67.2667.26
Shares vestedShares vested (0.5)$ 74.0074.00 (0.6)$ 57.5957.59 (0.4)$ 58.9858.98
Shares forfeited and canceledShares forfeited and canceled (0.1)$ 90.16(0.1)$ 88.13(0.4)$ 57.3190.16(0.2)—(0.04)57.31
Shares outstanding, end of yearShares outstanding, end of year 1.1 $ 88.13 1.3 $ 77.90 1.5 $ 63.88
\ No newline at end of file diff --git a/predictions/249.html b/predictions/249.html index a1fc9fc81d7722c54fcce75c96defe5747b04699..bfc9ea8b01477536d1e1d3e1003fb66a08f0265c 100644 --- a/predictions/249.html +++ b/predictions/249.html @@ -1,69 +1,106 @@ + + + + + + + + + + + + + + + + + + - + - - - - - - + + + + + + + + + + + - - + + + + + + + + + - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + - + + + + + + + - - + - - - - - - + + + + + + + + + + + - - - - - - + + + + + + + + + + +
Income from continuing operations$5.63$4.58$4.92$3.80$5.35
Income from discontinued operations — — — 0.03 0.23
Income from continuing operations$ 5.63$ 4.58$ 4.92$ 3.80$ 5.35Net income$5.63$4.58$4.92$3.83$5.58
Income from discontinued operations$ 0.02Earnings per share attributable to Quest Diagnostics' common stockholders - diluted: $ 0.03$ 0.23
Net income$ 5.65$ 4.58$ 4.92$ 3.83$ 5.58
Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:
Income from continuing operations$ 5.50$ 4.51$ 4.87$ 3.78$ 5.31Income from continuing operations$5.50$4.51$4.87$3.78$5.31
Income from discontinued operationsIncome from discontinued operations—— — 0.03 $ 0.03$ 0.230.23
Net income$ 5.50$ 4.51$ 4.87$ 3.81$ 5.54Net income$5.50$4.51$4.87$3.81$5.54
Dividends per common share$ 1.80$ 1.65$ 1.52$ 1.32$ 1.20Dividends per common share$1.80$1.65$1.52$1.32$1.20
\ No newline at end of file diff --git a/predictions/25.html b/predictions/25.html index 46ff426ddea51d714d620962cba998a7a30a000b..fcb1374960cff1914896019cfc00c61b23583cf5 100644 --- a/predictions/25.html +++ b/predictions/25.html @@ -1,10 +1,11 @@ - + + @@ -14,6 +15,17 @@ + + + + + + + + + + + diff --git a/predictions/250.html b/predictions/250.html new file mode 100644 index 0000000000000000000000000000000000000000..95ba11c7af4d6882441d21144a14838b44d134d6 --- /dev/null +++ b/predictions/250.html @@ -0,0 +1,108 @@ +
Millions of dollars December 31, 2015 December 31, 2014
Level 1 Level 2 Total fair valueTotal fair value Carrying value
Millions of dollars
Long-term debt $ 1,009
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ItemPage
Item 1.Business1
Our Strategy and Strengths3
Business Operations14
The United States Clinical Testing Market17
General25
Billing and Reimbursement28
Regulation29
Available Information32
Executive Officers of the Company33
Item 1A.Risk Factors35
Cautionary Factors That May Affect Future Results43
Item 1B.Unresolved Staff Comments44
Item 2.Properties44
Item 3.Legal Proceedings45
Item 4.Mine Safety Disclosures45
Item 5.Market for Registrant’s Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities46
Item 6.Selected Financial Data48
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations48
Item 7A.Quantitative and Qualitative Disclosures About Market Risk48
Item 8.Financial Statements and Supplementary Data48
Item 9.Changes in and Disagreements with Accountants on Accounting and
\ No newline at end of file diff --git a/predictions/251.html b/predictions/251.html new file mode 100644 index 0000000000000000000000000000000000000000..d8affbc8be611afaf620634a33991f6840d443f5 --- /dev/null +++ b/predictions/251.html @@ -0,0 +1,26 @@ + + + + + + + + + + + + + + + + + + + + + + + + + +
% of 2016 Consolidated Net Revenues
Medicare Clinical Laboratory Fee Schedule12
Medicare Physician Fee Schedule2
Total Medicare14
Medicaid Programs3
Total Traditional Medicare and Medicaid17
\ No newline at end of file diff --git a/predictions/252.html b/predictions/252.html index 988554ac9ee14df8c6cfcb543517d26cc9f35fd5..b2365e9b11070e1b2dfbe1dda1afc325cce3bab5 100644 --- a/predictions/252.html +++ b/predictions/252.html @@ -6,9 +6,9 @@ 2003 - Stock options ........................................................ + Stock options 337 603 - 408 + 4,018 \ No newline at end of file diff --git a/predictions/253.html b/predictions/253.html index 152f9b37c52ce1d4597a9e2ce76df5773092af29..e36d91b1794a49a8cea6edc722acdcf654dce554 100644 --- a/predictions/253.html +++ b/predictions/253.html @@ -1,38 +1,18 @@ - - + + - - + + - - + + - - + +
CLIA and State Clinical Laboratory LicensingCLIA regulates the operations of virtually all clinical laboratories, requiring that they be certified by the federal government and that they comply with various technical, operational, personnel and quality requirements intended to ensure that the services provided are accurate, reliable and timely. - -State laws may require additional personnel qualifications or licenses, quality control, record maintenance, proficiency testing or detailed review of our scientific method validations and technical procedures for certain tests. - -Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.CLIA and State Clinical Laboratory LicensingCLIA regulates the operation of virtually all clinical laboratories, requiring that they be certified by the federal government and that they comply with various technical, operational, personnel and quality requirements intended to ensure that the services provided are accurate, reliable and timely.

State laws may require additional personnel qualifications or licenses, quality control, record maintenance, proficiency testing or detailed review of our scientific method validations and technical procedures for certain tests.

Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.
Fraud and AbuseAnti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs. - -In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory. - -Some states have similar laws that are not limited to Medicare and Medicaid referrals and could also affect other tests referred by clinicians with investment or compensation arrangements with the testing laboratory. - -Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.Fraud and AbuseAnti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.

In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory.

Some states have similar laws that are not limited to Medicare and Medicaid referrals and could also affect other tests referred by clinicians with investment or compensation arrangements with the testing laboratory.

Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.
FDAThe FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States. The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization. - -A number of advanced tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories. - -Pursuant to the 21st Century Cures Act, the FDA has issued guidance regarding the regulation of clinical decision support software, which may be used in, or in connection with, LDTs. The guidance has created uncertainty regarding whether FDA approval of certain tests is required. - -In 2017, the FDA published a "Discussion Document" providing its views on legislative alternatives to regulate LDTs. New legislation could significantly impact the clinical laboratory testing business, including by increasing or modifying the regulation of LDTs, hindering our ability to develop and market new services, causing an increase in the cost of our services, delaying our ability to introduce new tests or hindering our ability to perform testing.FDAThe FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States. The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization.

A number of advanced tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.

Pursuant to the 21st Century Cures Act, the FDA has issued guidance regarding the regulation of clinical decision support software, which may be used in, or in connection with, LDTs. The guidance has created uncertainty regarding whether FDA approval or clearance tests is required.

In 2017, the FDA published a “Discussion Document” providing its views on legislative alternatives to regulate LDTs. New legislation could significantly impact the clinical laboratory testing business, including by increasing or modifying the regulation of LDTs, hindering our ability to develop and market new services, causing an increase in the cost of our services, delaying our ability to introduce new tests or hindering our ability to perform testing.
Environmental, Health and SafetyWe are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials. - -For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needlestick and other sharp injuries. - -For purposes of transportation, storage, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal ServiceEnvironmental, Health and SafetyWe are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.

For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including by preventing or minimizing any exposure through needle stick injuries.

For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association.
\ No newline at end of file diff --git a/predictions/254.html b/predictions/254.html index 19c2beb064801fd898d43e27cd7c72523525754e..0f83f8b659d959a7499a9684c78eab03e36b1565 100644 --- a/predictions/254.html +++ b/predictions/254.html @@ -5,7 +5,7 @@ Table 2 - Two Point Business Strategy - 2 + 3 Table 3 - Portfolio Growth @@ -64,7 +64,7 @@ 13 - Table 17 - Quanum™ Health Information Technology Solutions + Table 17 - Quantum™ Health Information Technology Solutions 13 diff --git a/predictions/255.html b/predictions/255.html new file mode 100644 index 0000000000000000000000000000000000000000..b51f9e30f85d3e1be62129bf7ce388a85dcc84a8 --- /dev/null +++ b/predictions/255.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
32.1**Section 1350 Certification of Chief Executive Officer
32.2**Section 1350 Certification of Chief Financial Officer
101.INS*dgx-20181231.xml
101.SCH*dgx-20181231.xsd
101.CAL*dgx-20181231_cal.xml
101.DEF*dgx-20181231_def.xml
101.LAB*dgx-20181231_lab.xml
101.PRE*dgx-20181231_pre.xml
\ No newline at end of file diff --git a/predictions/256.html b/predictions/256.html new file mode 100644 index 0000000000000000000000000000000000000000..b0a990dd5031a14619211ca69377988e9b968561 --- /dev/null +++ b/predictions/256.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
Cleveland ClinicTo speed the commercialization of biomarkers on inflammation and other disease areas discovered at Cleveland Clinic, including its Lerner Research Institute; Quest may independently develop test services for these biomarkers.
McKesson Specialty Health, U.S. Oncology Network and Texas OncologyTo enhance and nationally scale a model created by Med Fusion that standardizes clinical care pathways to ensure every patient receives the best possible cancer care. One example is highlighting available diagnostics, such as next-generation sequencing panels to better specify cancer and monitor for cancer. This approach guides the physician, according to guidelines and within an electronic health record, to a panel individualized to the patient’s cancer type and stage of disease.
Arnold P. Gold FoundationTo advance humanism in healthcare. Quest is a founding member of the Gold Foundation’s Humanism in Medicine initiative.
\ No newline at end of file diff --git a/predictions/257.html b/predictions/257.html new file mode 100644 index 0000000000000000000000000000000000000000..7b04d481b9a2549a741cbaaad6865b15771e7550 --- /dev/null +++ b/predictions/257.html @@ -0,0 +1,162 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20122011201020092008
Year Ended December 31,
(in thousands, except per share data)
Balance Sheet Data (at end of year):
Cash and cash equivalents$ 295,586$ 164,886$ 449,301$ 534,256$ 253,946
Accounts receivable, net867,010906,455845,299827,343832,873
Goodwill5,535,8485,795,7655,101,9385,083,9445,054,926
Total assets9,283,8639,313,3798,527,6308,563,6438,403,830
Long-term debt3,354,1373,370,5222,641,1602,936,7923,078,089
Total debt3,363,5774,024,9172,990,1563,107,2993,083,231
Total stock diagnostics4,163,0474,092,8724,033,4803,989,6393,604,896
Total stockholders’ equity4,163,0473,692,8724,033,4803,989,6393,604,896
Noncontrolling interests22,68222,12720,64521,82520,238
Total stockholders’ equity4,185,7293,714,9994,054,1254,011,4643,625,134
Other Data:
Net cash provided by operating activities$ 1,187,168 (p)$ 895,474 (q)$ 1,118,047 (r)$ 997,418 (s)$ 1,063,049
Net cash used in investing activities(217,139)(1,243,435)(216,510)(195,904)(198,883)
Net cash used in provided financing activities(822,095)63,546(986,492)(521,204)(777,814)
Provision for doubtful accounts268,592279,461291,444320,678326,074
Rent expense211,340217,514194,593188,000190,012
Capital expenditures182,234161,556205,400166,928212,681
Depreciation and amortization278,290272,235246,303248,876256,610
\ No newline at end of file diff --git a/predictions/258.html b/predictions/258.html index 361fc96e4a954b4c056a853c4cc04a261ae99822..766c3c40016580ac3692151e647e799ed97a0948 100644 --- a/predictions/258.html +++ b/predictions/258.html @@ -1,52 +1,42 @@ - - - - + - - + - - + - - + - - + - - + - - + - - +
Item Page
Financial Statements
Report of Independent Registered Public Accounting FirmF-1F- 1
Consolidated Balance SheetsF-2F- 2
Consolidated Statements of OperationsF-3F- 3
Consolidated Statements of Comprehensive IncomeF-4F- 4
Consolidated Statements of Cash FlowsF-5F- 5
Consolidated Statements of Stockholders' EquityF-6F- 6
Notes to Consolidated Financial StatementsF-7F- 7
Supplementary Data: Quarterly Operating Results (unaudited)F-45F- 45
\ No newline at end of file diff --git a/predictions/259.html b/predictions/259.html new file mode 100644 index 0000000000000000000000000000000000000000..d3666ddac20b8ca37a25ea804d03d15698a902d8 --- /dev/null +++ b/predictions/259.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.12First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)
4.13Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 26, 2001) and incorporated herein by reference) (Commission File Number 001-12215)
4.14Third Supplemental Indenture, dated as of April 4, 2002, among the Company, the Additional Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: April 7, 2002) and incorporated herein by reference) (Commission File Number 001-12215)
4.15Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation f/k/a Quest Diagnostics Newco Incorporated, the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
4.16Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation d/b/a FNA Clinics of America, the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2004 and incorporated herein by reference) (Commission File Number 001-12215)
4.17Sixth Supplemental Indenture dated as of October 31, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: October 31, 2005) and incorporated herein by reference) (Commission File Number 001-12215)
4.18Seventh Supplemental Indenture dated as of November 21, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 21, 2005) and incorporated herein by reference) (Commission File Number 001-12215)
4.19Eighth Supplemental Indenture dated as of July 31, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: July 31, 2006) and incorporated herein by reference) (Commission File Number 001-12215)
4.20Ninth Supplemental Indenture dated as of September 30, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: September 30, 2006) and incorporated herein by reference) (Commission File Number 001-12215)
4.21Tenth Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)
4.22Eleventh Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)
4.23Twelfth Supplemental Indenture dated as of June 25, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)
4.24Thirteenth Supplemental Indenture dated as of November 17, 2009, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)
4.25Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)
\ No newline at end of file diff --git a/predictions/260.html b/predictions/260.html new file mode 100644 index 0000000000000000000000000000000000000000..30385b7ac2bd6ed5eb7277565a1c0869f7f3792d --- /dev/null +++ b/predictions/260.html @@ -0,0 +1,106 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Income from continuing operations$4.92$3.80$5.35$3.96$2.88
Income (loss) from discontinued operations0.030.23(0.47)0.07
Net income$4.92$3.83$5.58$3.49$2.95
Earnings per share attributable to Quest Diagnostics’ common stockholders — diluted:
Income from continuing operations$4.87$3.78$5.31$3.92$2.85
Income (loss) from discontinued operations0.030.23(0.46)0.07
Net income$4.87$3.81$5.54$3.46$2.92
Dividends per common share$1.52$1.32$1.20$0.81$0.47
\ No newline at end of file diff --git a/predictions/261.html b/predictions/261.html new file mode 100644 index 0000000000000000000000000000000000000000..a419fdfb49c06df61f58d91649b159d25e06151c --- /dev/null +++ b/predictions/261.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
Cardiovascular, Metabolic and EndocrinologyFor all of our cholesterol test services that involve estimates of low-density lipoprotein cholesterol (LDL-C), we introduced a novel LDL-C calculation that improves accuracy of heart disease screening and helps personalize treatment with lipid-lowering medications. The method also does not require patients to fast from food for several hours before testing, enhancing the patient experience.

Through our acquisition of Cleveland HeartLab, we are now offering novel biomarkers for cardiovascular risk assessment and management including MPO, oxidized LDL and ADMA testing.

We have also implemented a service for health plans, health systems and others that enables them to help close gaps in care for diabetes, using our Quanum® offering together with our testing solutions and access points (including patient service centers and mobile resources) to engage patients in their homes and places of employment.
General Health and WellnessWe launched our new Blueprint for Wellness® solution, which enables physician telemedicine consultation and referral into care.

It also offers additional clinical solutions for participants, such as a diabetes prevention program, colon cancer testing and renal failure services.
Infectious Diseases and ImmunologyWe launched a new genetic marker, HLA-B*58:01, for evaluating risk of severe cutaneous adverse skin reactions to allopurinol, a drug used to treat gout.

We introduced the Xpert® MTB/RIF test providing simultaneous detection of both mycobacterium tuberculosis and rifampin resistance mutations. This test can help physicians decide on whether to remove patients with suspected tuberculosis from isolation earlier.

We introduced tree nut component testing, specific IgE blood tests that detect sensitization to specific allergens. Tree nut allergies may elicit severe and even life-threatening reactions in sensitized individuals.

We launched a Systemic Sclerosis Antibody Panel and a Myositis Specific Antibody Panel, providing support for the diagnosis and management of these chronic, multisystem, heterogeneous autoimmune diseases.

We updated our Anti-nuclear Antibody test offering to enable primary care physicians and specialists to order the right tests in sequence in order to enable diagnosis of rheumatologic disease.
\ No newline at end of file diff --git a/predictions/262.html b/predictions/262.html index 8fc1f3b7be15d60b395691dcebf50536011517f4..70c5f7af25914a136b558059b0991ee9ee8c1c04 100644 --- a/predictions/262.html +++ b/predictions/262.html @@ -6,73 +6,79 @@ 2015 - Net revenues: + Net revenues: + + + - DIS business + DIS business 95.6% 95.0% 93.0% - DS businesses + DS business 4.4 5.0 7.0 - Total net revenues + Total net revenues 100.0% 100.0% 100.0% - Operating costs and expenses and other operating income: + Operating costs and expenses and other operating income: + + + - Cost of services + Cost of services 61.2% 61.4% 62.1% - Selling, general and administrative + Selling, general and administrative 22.7 22.4 22.4 - Amortization of intangible assets + Amortization of intangible assets 1.0 1.0 1.1 - Gain on disposition of business - — + Gain on disposition of business + (1.5) (4.4) - Other operating expense (income), net - — + Other operating expense (income), net + (0.3) 0.1 - Total operating costs and expenses, net + Total operating costs and expenses, net 84.9% 83.0% 81.3% - Operating income + Operating income 15.1% 17.0% 18.7% - Bad debt + Bad debt 4.1% 4.1% 4.0% diff --git a/predictions/263.html b/predictions/263.html new file mode 100644 index 0000000000000000000000000000000000000000..9d94a8fc1e0e1697124550f4a0911151d1a4ff2f --- /dev/null +++ b/predictions/263.html @@ -0,0 +1,52 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20052004
Current deferred tax asset:
Accounts receivable reserve$  32,598$  28,020
Liabilities not currently deductible74,84455,010
Total current deferred tax asset$ 107,442$  83,030
Non-current deferred tax asset (liability):
Liabilities not currently deductible$  69,071$  55,534
Net operating loss carryforwards9,66314,247
Depreciation and amortization(100,752)(40,407)
Total non-current deferred tax (liability) asset$ (22,018)$  29,374
\ No newline at end of file diff --git a/predictions/264.html b/predictions/264.html index ca852564c7a8ab2dfe06a4c47b7264764daba3e1..dc8979637fe99eec50ffe04bdf0cfb2d173f3155 100644 --- a/predictions/264.html +++ b/predictions/264.html @@ -6,25 +6,25 @@ 2003 - Dividend yield . . . . . . . . . . . . . . . . . . . . . . . . + Dividend yield 0.7% 0.7% 0.0% - Risk-free interest rate . . . . . . . . . . . . . . . . . . . + Risk-free interest rate 4.0% 3.1% 2.8% - Expected volatility . . . . . . . . . . . . . . . . . . . . . + Expected volatility 23.0% 47.2% 48.1% - Expected holding period, in years . . . . . . . . . . . . . + Expected holding period, in years 6 5 5 diff --git a/predictions/265.html b/predictions/265.html index 3e1d4106ccfc804680caad9cdfe8dacbfa0687e2..b3523aa84e2d4d3173a73099bb2eeabf33737cff 100644 --- a/predictions/265.html +++ b/predictions/265.html @@ -1,30 +1,37 @@ - - + + + - - + + + - + + - + + - + + - + + - + +
2007........................................................................$ 16,8292007$16,829
2008........................................................................61,806200861,860
2009........................................................................2009 1,800
2010........................................................................2010 399,273
2011........................................................................2011 274,392
Thereafter..................................................................Thereafter 501,286
Total long-term debt......................................................Total long-term debt $1,255,386
\ No newline at end of file diff --git a/predictions/266.html b/predictions/266.html new file mode 100644 index 0000000000000000000000000000000000000000..1f052534bfbd79c4302ff69b411ca608ac2aae2f --- /dev/null +++ b/predictions/266.html @@ -0,0 +1,24 @@ + + + + + + + + + + + + + +
DemographicsAs the population continues to grow and age, the burden of chronic diseases and unmet diagnostic needs may increase the demand for diagnostic information services.
Prevention and wellness + We believe that the value of detection, prevention, wellness and personalized care now is well recognized. Consumers, employers, ACOs, IDNs, health plans and government agencies increasingly focus on helping the healthy stay healthy, detecting symptoms among those at risk and providing preventive insight and care that helps avoid disease.

+ Health care providers increasingly rely on diagnostic information services to help identify risk for a disease, to detect the symptoms of disease earlier, to aid in the choice of therapeutic regimen, to monitor patient compliance and to evaluate treatment results.

+ There is increased focus on a disease-oriented approach to diagnostics, treatment and management. Health care providers, consumers and payers increasingly recognize the value of diagnostic information services as a means to improve health and reduce the overall cost of healthcare through early detection, prevention and treatment. +
Medical innovation + Medical advances allow for more accurate and earlier diagnosis and treatment of diseases.

+ Continuing advances in genomics and proteomics are expected to yield new, more sophisticated and specialized diagnostic tests. These advances also are spurring interest in and demand for precision medicine, which relies on diagnostic and prognostic testing and in which data information services and strategies are used to deliver the most effective healthcare to the right populations and individuals.

+ Pharmacogenomic testing increasingly is used as a parameter to help speed drug approval processes and to better focus therapy based on patient and tumor-specific genetic markers.

+ Demand also is growing toward comprehensive care management solutions that serve patients, payers and health care providers by improving clinical decision support, access to patient data, increasing patient participation in care management, population health management and improving clinical outcomes.

+ There is increasing focus on access to patient data and data-driven insights. +
\ No newline at end of file diff --git a/predictions/267.html b/predictions/267.html new file mode 100644 index 0000000000000000000000000000000000000000..2c7143a525e594c713b41844166bc5e21f5b509e --- /dev/null +++ b/predictions/267.html @@ -0,0 +1,125 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
20172016201520142013
(a) (b) (c)(a) (d) (e)(a) (d) (e)(a) (f) (g)(a) (h) (i)
Balance Sheet Data (at end of year):
Cash and cash equivalents$ 137$ 359$ 133$ 192$ 187
Total assets10,50310,1009,9629,8578,930
Long-term debt3,7483,7283,4923,2243,102
Total debt3,7843,7343,6513,7423,314
Redeemable noncontrolling interest807770——
Other Data:
Net cash provided by operating activities$ 1,175$ 1,069$ 821$ 944$ 667
Net cash (used in) provided by investing activities(805)(152)(362)(1,025)328
Net cash (used in) provided by financing activities(592)(691)(518)86(1,121)
Capital expenditures252293263308231
Purchases of treasury stock4655902241321,037
Dividends paid247223212187185
\ No newline at end of file diff --git a/predictions/268.html b/predictions/268.html index d495c266a2bf3fb190c8456565afd8d138f2afd9..98f27dbf5096394a64090a08253ae1556084f6e3 100644 --- a/predictions/268.html +++ b/predictions/268.html @@ -1,46 +1,52 @@ - - - - + + + + + + + + + - + +
$
2014$ 208,994
2015 506,446
2016 302,190
2017 375,564
2018 12
Thereafter 1,925,000
Total maturities of long-term debt 3,318,206
Unamortized discount (22,088)
Fair value basis adjustments attributable to hedged debt 58,055
Total long-term debt, net of current portion$ 3,354,173$3,354,173
\ No newline at end of file diff --git a/predictions/269.html b/predictions/269.html index 8a2ef4865fa730b9bb5591c612d6b5f857ce1741..85ff88374b8ab0acbcbd5ff9db6dc6c86dcf1610 100644 --- a/predictions/269.html +++ b/predictions/269.html @@ -13,15 +13,15 @@ 4.1 - Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215) + Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission file Number 001-12215) 4.2 - Form of 4.750% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215) + Form of 4.750% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission file Number 001-12215) 4.3 - Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215) + Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission file Number 001-12215) 4.4 diff --git a/predictions/27.html b/predictions/27.html index 3e166aaf5c6d4d4351acc5f4cce74f56da772acd..a16146ce064164ca0df6899ffc77abe70b4c54c7 100644 --- a/predictions/27.html +++ b/predictions/27.html @@ -33,9 +33,9 @@ (3.6) - Domestic manufacturing deduction + Domestic manufacturing deductions (1.3) - + — (1.9) @@ -48,7 +48,7 @@ Non-deductible acquisition costs 0.6 (4.5) - + — Adjustments of prior year taxes @@ -58,9 +58,9 @@ Venezuela devaluation - + — (7.5) - + — Other items, net @@ -70,8 +70,8 @@ Total effective tax rate on continuing operations - - - + 24.4% + 29.3% + 27.1% \ No newline at end of file diff --git a/predictions/270.html b/predictions/270.html new file mode 100644 index 0000000000000000000000000000000000000000..7ae3ccb570d89979f1c02cd7597d3e22eed36138 --- /dev/null +++ b/predictions/270.html @@ -0,0 +1,71 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Twelve Months Ended December 31,
201820172016
Healthcare insurers:
In-service32%34%34%
Capitated334
Total healthcare insurers353738
Government payers161717
Client payers323029
Patient131211
Total DIS969695
DS445
Net revenues100%100%100%
\ No newline at end of file diff --git a/predictions/271.html b/predictions/271.html new file mode 100644 index 0000000000000000000000000000000000000000..1951dbbd65cd037baef9ffb31a5469bd6d3ec132 --- /dev/null +++ b/predictions/271.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
PhysiciansOur pathologists are required to hold a valid license to practice medicine in the jurisdiction in which they practice.
Many of our pathologists enter into an employment agreement. These agreements have varying terms, but generally can be terminated at any time, upon advance notice. Most of the agreements contain covenants generally limiting the activities of the pathologist within a defined geographic area for a limited period of time after termination of employment; the enforceability of these covenants may be limited under state law.
Several jurisdictions, including some in which our businesses are located, prohibit business corporations from engaging in the practice of medicine. In certain jurisdictions, business corporations are prohibited from employing licensed healthcare professionals to provide services on behalf of the corporation; these laws serve in some jurisdictions to atomic pathology services are delivered through physician-owned entities that employ the pathologists. The manner in which licensed physicians can be organized to perform medical services may be governed by the laws of the jurisdictions in which medical services are provided and by the medical boards or other entities authorized by these jurisdictions to oversee the practice of medicine.
Privacy and Security of Health and Personal InformationWe are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including: (a) the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information; (b) state laws; and (c) the European Union's General Data Protection Regulation.
A healthcare provider may be subject to penalties for non-compliance and may be required to notify individuals or state, federal or county governments if the provider discovers certain breaches of personal information or protected health information.
Drug Testing; Controlled SubstancesAll U.S. laboratories that perform drug testing for certain public sector employees and employees of certain federally regulated businesses are required to be certified as meeting the detailed performance and quality standards of the Substance Abuse and Mental Health Services Administration.
To obtain access to controlled substances used to perform drugs-of-abuse testing in the United States, laboratories must be licensed by the Drug Enforcement Administration.
\ No newline at end of file diff --git a/predictions/272.html b/predictions/272.html index ac34ffb0f9dfbccbf07ddfba7c1ac07cee09bec7..882a280069d0f0ea0e51fd108f6830e7197cd96e 100644 --- a/predictions/272.html +++ b/predictions/272.html @@ -6,31 +6,31 @@ 2015 - Fair value at grant date + Fair value at grant date $15.98 $10.35 $11.57 - Expected volatility + Expected volatility 19.8% 21.6% 21% - Dividend yield + Dividend yield 1.9% 2.4% 2.1% - Risk-free interest rate + Risk-free interest rate 2.1% 1.4% 1.7% - Expected holding period, in years + Expected holding period, in years 5.2 5.3 5.3 diff --git a/predictions/273.html b/predictions/273.html index 2d0ea3714efc613c7ddd2a050396fefe30fb6a0c..b45c028d8846504c97afa33b3c452d5ff6cf77d5 100644 --- a/predictions/273.html +++ b/predictions/273.html @@ -1,31 +1,27 @@ - - + - - + - - + - - + diff --git a/predictions/274.html b/predictions/274.html index 56e503b60ab0d8b56bed5733de1525e8b8bd4900..a9d2de1d99f24b674f0fae6c848801993ea2655a 100644 --- a/predictions/274.html +++ b/predictions/274.html @@ -1,74 +1,71 @@
YearDoubtful accounts and allowances Balance at Beginning of Year Provision for Doubtful Accounts Net Deductions and Other Balance at End of Year
Year Ended December 31, 2017Doubtful accounts and allowancesYear Ended December 31, 2017
Doubtful accounts and allowances		 $ 265 $ 315 $ 311 (a) $ 269
Year Ended December 31, 2016Doubtful accounts and allowancesYear Ended December 31, 2016
Doubtful accounts and allowances		 $ 254 $ 308 $ 297 (a) $ 265
Year Ended December 31, 2015Doubtful accounts and allowancesYear Ended December 31, 2015
Doubtful accounts and allowances		 $ 250 $ 297 $ 293 (a)
- + - - - - - - - - - - + + + + + + + - + - + - + - - - - - - - + + + + + + + - - - - - - + + + + + + - - - - - - + + + + + + - + - + - + - - + + - + - +
2011 2010 Increase (Decrease)
$% Net Revenue$% Net Revenue$% Net Revenue
(dollars in millions)$% Net Revenue$
(dollars in millions)		% Net Revenue$% Net Revenue
Cost of services$4,362.9$  4,362.9 59.0%$4,275.5$  4,275.5 58.9%$87.4$    87.4 0.1%
Selling, general and administrative expenses (SG&A)$1,743.123.6%$1,658.822.8%$84.30.8%Selling, general and administrative expenses (SG&A)1,743.123.61,658.822.884.30.8
Amortization of intangible assets$61.20.8%$33.10.5%$28.10.3%61.20.833.10.528.10.3
Other operating expense, net$238.13.2%$9.10.1%$229.03.1%238.13.29.10.1229.03.1
Total operating costs and expenses$6,405.3$  6,405.3 86.6%$5,976.5$  5,976.5 82.3%$428.8$  428.8 4.3%
Bad debt expense (included in SG&A)$279.5Bad debt expense (included in SG&A)$    279.5 3.8%$291.4$    291.4 4.0%$(11.9)$   (11.9) (0.2)%
\ No newline at end of file diff --git a/predictions/275.html b/predictions/275.html new file mode 100644 index 0000000000000000000000000000000000000000..0487d8eabba4a9e6d5094d914c04b433ce9a572c --- /dev/null +++ b/predictions/275.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
10.11‡Equity Award Agreement (CEO) dated as of March 4, 2008 between the Company and Surya N. Mohapatra (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2008 and incorporated herein by reference) (Commission File Number 001-12215)
10.12‡Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended March 27, 2012 (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2012 and incorporated herein by reference) (Commission File Number 001-12215)
10.13‡Amended and Restated Quest Diagnostics Incorporated Long-Term Incentive Plan for Non-Employee Directors as amended April 15, 2009 (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2009 and incorporated herein by reference) (Commission File Number 001-12215)
10.14‡Amended and Restated Deferred Compensation Plan for Directors as amended October 31, 2008 (filed as an Exhibit to the Company’s 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.15‡Amended and Restated Employment Agreement between the Company and Surya N. Mohapatra dated as of November 7, 2008 (filed as an Exhibit to the Company’s 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.16‡Letter Agreement between Surya N. Mohapatra and the Company, dated October 21, 2011 (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: October 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)
10.17‡Supplemental Deferred Compensation Plan (Post 2004) amended December 30, 2008 (filed as an Exhibit to the Company’s 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.18‡Amendment No. 1 dated November 27, 2012 to Quest Diagnostics Incorporated Supplemental Deferred Compensation Plan (Post 2004) amended December 22, 2008
10.19‡Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated November 27, 2012
10.20‡Quest Diagnostics Incorporated Supplemental Executive Retirement Plan, as amended effective November 7, 2008 (filed as an Exhibit to the Company’s 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.21‡Senior Management Incentive Plan (filed as Appendix A to the Company’s Definitive Proxy Statement dated March 28, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
10.22‡Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: January 1, 2013) and incorporated herein by reference) (Commission File Number 001-12215)
10.23‡AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company’s registration statement on Form S-8 and incorporated herein by reference) (Commission File Number 333-143889)
10.24‡Amendment dated as of August 17, 2007 to the AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company’s 2007 Annual Report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.25‡The Profit Sharing Plan of Quest Diagnostics Incorporated, Amended and Restated effective as of January 1, 2012
\ No newline at end of file diff --git a/predictions/276.html b/predictions/276.html new file mode 100644 index 0000000000000000000000000000000000000000..7c05cf419466a4413ffbe9163c9da2fa57cd4f35 --- /dev/null +++ b/predictions/276.html @@ -0,0 +1,54 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.25Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York, Mellon as the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)
4.26Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
4.27Sixteenth Supplemental Indenture dated as of March 12, 2014, among the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.28Seventeenth Supplemental Indenture dated as of March 10, 2015, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.29Eighteenth Supplemental Indenture dated as of May 26, 2016, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)
10.1‡Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Company's quarterly report on form 10-Q for the quarter ended June 30, 2016 and incorporated herein by reference) (Commission File Number 001-12215)
10.2‡Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 15, 2015 (filed as an exhibit to the Company's 2013 quarterly report on Form 10-Q for the quarter ended June 30, 2015 and incorporated herein by reference) (Commission file number 001-12215)
10.3‡Form of Equity Award Agreement dated as of February 23, 2015 (filed as an exhibit to the Company's 2015 annual report on Form 10-K and incorporated herein by reference) (Commission file number 001-12215)
10.4‡Form of Equity Award Agreement dated as of February 19, 2018 (filed as an exhibit to the Company's 2018 quarterly report on Form 10-Q for the quarter ended March 31, 2018 and incorporated herein by reference) (Commission file number 001-12215)
10.5‡Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended and restated as of November 27, 2017 (filed as an exhibit to the Company's 2017 annual report on Form 10-K and incorporated herein by reference) (Commission file number 001-12215)
10.6‡Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended November 27, 2012 (filed as an exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.7‡Quest Diagnostics Incorporated Senior Management Incentive Plan (filed as Appendix A to the Company's Definitive Proxy Statement dated March 28, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
10.8‡Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended February 20, 2017 (filed as an exhibit to the Company's 2015 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
\ No newline at end of file diff --git a/predictions/277.html b/predictions/277.html new file mode 100644 index 0000000000000000000000000000000000000000..6258d04551b070cd01eb2ed4da8ef41f73baa28d --- /dev/null +++ b/predictions/277.html @@ -0,0 +1,25 @@ + + + + + + + + + + + + + +
VisionEmpowering Better Health with Diagnostic Insights
Three Aspirational Goals + A healthier world
+ Build a valuable company
+ Create an inspiring workplace +
Values + Quality
+ Integrity
+ Accountability
+ Innovation
+ Collaboration
+ Leadership +
\ No newline at end of file diff --git a/predictions/278.html b/predictions/278.html new file mode 100644 index 0000000000000000000000000000000000000000..31231935544fccc62247314c915587b53252f6ec --- /dev/null +++ b/predictions/278.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Cardiovascular, Metabolic and EndocrinologyWe expanded our cardiovascular testing menu with the addition of the CardioIQ® Advanced Lipid Panel and Inflammation Panel, which offers a more comprehensive assessment of risk for dyslipidemia and cardiovascular disease than a standard lipid panel.
We also introduced the Lp-PLA2 Activity test. This test detects Lp-PLA2, an inflammation marker, to help assess, along with other traditional cardiovascular risk factor measures, risk of coronary artery disease and stroke.
Infectious Diseases and ImmunologyWe developed and launched a hepatitis C virus Genotype 3 NS5A resistance test. This test detects polymorphisms in the hepatitis C virus to ensure that physicians prescribe the appropriate therapies.
We were the first commercial laboratory in the U.S. to offer a hepatitis B surface antigen quantitative test. This test is used for monitoring hepatitis B patients, enabling physicians to make better therapeutic decisions.
We received Emergency Use Authorization from the U.S. Food and Drug Administration for the Zika Virus RNA Qualitative Real-Time RT-PCR test; the test was the first from a commercial laboratory provider to be granted an Emergency Use Authorization for testing patients for Zika virus RNA. We now offer the complete suite of Zika tests (molecular/serology) for urine and serum samples.
We launched Borrelia miyamotoi DNA, Real Time PCR to aid in the diagnosis in humans of infection with Borrelia miyamotoi, a tick-borne infection.
NeurologyWe introduced Cognisense™, a digital cognitive assessment tool that aids in a physician’s assessment and diagnosis of individuals with cognitive dysfunction. It is designed to overcome several limitations of conventional paper-based cognitive assessment.
We began clinical implementation of an integrated dementia diagnostic solution based on our collaboration with UCSF. This offering integrates laboratory testing, cognitive exam, MRI and clinical evaluation to help primary doctors assess and diagnose dementia to identify treatable cause, shorten time to diagnosis and eliminate waste.
We introduced Myasthenia Gravis Panel 2 with Reflex to MuSK Antibody, enabling diagnosis myasthenia gravis by detecting hallmark diagnostic autoantibodies to neuromuscular transmitter Acetylcholine Receptor (AChR), and capturing additional cases by detecting autoantibodies to Muscle Specific Tyrosine Kinase (MuSK) in AChR antibody negative cases.
OncologyWe introduced IBM Watson® Genomics from Quest Diagnostics, a service that provides actionable insight tailored to the specific makeup of a patient’s tumor by combining Quest’s state of the art tumor analysis with an annotated service driven by IBM Watson’s cognitive computing capability and the leading expertise of Memorial Sloan Kettering Cancer Center. The Brand Institute of MIT and Harvard is providing additional genome sequencing capabilities.
As part of our QuestVantage™ cancer test menu, we announced three new cancer test services regarding the risk of developing hereditary forms of cancer:
MyVantage™ 34-gene Hereditary Comprehensive Cancer panel, which includes 34 high risk, moderate risk and emerging risk genes associated with a broad spectrum of hereditary cancers;
Glyvantage™ Hereditary Colorectal Cancer Test, which includes 13 genes predominantly associated with colon and gastric cancers; and
Qvantage™ Hereditary Women’s Health cancer test, which includes 14 genes predominantly associated with breast, colon, and gastric cancers, and uterine and ovarian cancer.
We also introduced an expansion of our complementary test service for anti-PD-1 therapy to include melanoma, the third offering in our precision medicine menu for oncology immunotherapies.
\ No newline at end of file diff --git a/predictions/279.html b/predictions/279.html new file mode 100644 index 0000000000000000000000000000000000000000..3a9267fa2ba90aee1ed7840e29fcfc72e994c4e0 --- /dev/null +++ b/predictions/279.html @@ -0,0 +1,27 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + +
20052004
Available-for-sale equity securities$20,429$21,949
Trading equity securities25,73820,917
Other investments29,72613,601
Total$75,893$56,467
\ No newline at end of file diff --git a/predictions/28.html b/predictions/28.html index 0e8f409c1b387a7d84aa18f243e17418dee1cb30..4bf6cd759b52e3a44b6454a6457e4b9254088a97 100644 --- a/predictions/28.html +++ b/predictions/28.html @@ -1,13 +1,14 @@ - + + - + diff --git a/predictions/280.html b/predictions/280.html new file mode 100644 index 0000000000000000000000000000000000000000..13d3982972a476f975f8c817480ca31991aba5d7 --- /dev/null +++ b/predictions/280.html @@ -0,0 +1,14 @@ +
Millions of dollars Year Ended
December 31
Millions of dollars 2007
RevenueRevenue $ 2,250
+ + + + + + + + + + + + +
PatientsIn the current environment, patients are taking increased interest in and responsibility for their healthcare. In addition, patients often are bearing increased financial responsibility for their healthcare (e.g., high deductible health plans). Patients are paying greater attention to their healthcare, are increasing their demands of healthcare providers, have increased expectations regarding their healthcare experiences and are becoming more sophisticated regarding healthcare. For example, in our experience, patients are more focused on transparency, ease of doing business and understanding diagnostics information services than they have been in the past.
Emerging Retail Healthcare ProvidersIn recent years, as the healthcare sector changes, retail providers of healthcare services have emerged and are growing. These providers include "big-box" retailers, pharmacy chains, supermarkets, urgent care centers and Internet-based service providers.
Other Laboratory and Other CustomersWe also provide services on a fee-for-service basis to federal, state and local governmental agencies and to other commercial clinical laboratories
\ No newline at end of file diff --git a/predictions/281.html b/predictions/281.html new file mode 100644 index 0000000000000000000000000000000000000000..e94ec3050b2052d7f6f0a777ba914e36dfed8376 --- /dev/null +++ b/predictions/281.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201820172016
Fair value at grant date$18.14$15.98$10.35
Expected volatility19.1%19.8%21.6%
Dividend yield1.9%1.9%2.4%
Risk-free interest rate2.8%2.1%1.4%
Expected holding period, in years5.35.25.3
\ No newline at end of file diff --git a/predictions/282.html b/predictions/282.html new file mode 100644 index 0000000000000000000000000000000000000000..52d7347d0a0bea98eb31f6e5c10fbd8cba31e6d6 --- /dev/null +++ b/predictions/282.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit NumberDescription
3.1Restated Certificate of Incorporation (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 20, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
3.2Amended and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 20, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.1Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission file Number 001-12215)
4.2Form of 4.750% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission file Number 001-12215)
4.3Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission file Number 001-12215)
4.4Form of 3.200% Senior Note due 2016 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission file Number 001-12215)
4.5Form of 4.700% Senior Note due 2021 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission file Number 001-12215)
4.6Form of 2.700% Senior Note due 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.7Form of 4.250% Senior Note due 2024 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.8Form of 2.500% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 10, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.9Form of 3.500% Senior Note due 2025 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 10, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.10Form of 4.700% Senior Note due 2045 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 10, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.11Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)
\ No newline at end of file diff --git a/predictions/283.html b/predictions/283.html new file mode 100644 index 0000000000000000000000000000000000000000..a40e495e1ed6b482acce8293784ddf9e070df6b7 --- /dev/null +++ b/predictions/283.html @@ -0,0 +1,28 @@ + + + + + + + + + + + + + +
HospitalsWe believe that we are the industry’s leader in servicing hospitals. We provide services to hospitals throughout the United States, including advanced testing services, in some cases helping manage their laboratories and serving as the medical directors of the hospital’s histology or clinical laboratory, including through our Professional Laboratory Services offerings. Hospitals generally maintain an on-site laboratory to perform the significant majority of clinical testing for their patients (inpatients and outpatients) and refer certain testing to outside service providers, which typically change the hospitals on a negotiated fee-for-service basis. Fee schedules for hospital reference testing services often are negotiated on behalf of hospitals by group purchasing organizations. +

+Hospitals also provide outreach testing and historically we are able to negotiate higher reimbursement rates with health plans than commercial clinical laboratories for comparable services. They may seek to leverage their relationship with community clinicians by encouraging the clinicians to send their outreach testing to the hospital’s laboratory. Increased hospital acquisitions of physician practices may enhance clinicians ties to hospital-affiliated laboratories and may strengthen their competitive position. +

+We also have joint venture arrangements with leading hospitals or IDNs in several metropolitan areas. These joint venture arrangements, which provide diagnostic information services for affiliated hospitals as well as for unaffiliated clinicians and other local healthcare providers, serve as our principal facilities in their service areas. Typically, we have either a majority ownership interest in, or day-to-day management responsibilities for, our joint venture relationships. +

+In light of continued pressure to reduce systemic healthcare costs, hospitals may change their approach to providing clinical testing services, including by insourcing tests, seeking ways to improve profitability or to better utilize their laboratory capacity. We believe that our combination of services positions us to be an attractive partner for hospitals, offering a full range of strategic relationships.
ACOs and IDNsAn ACO is a network of providers and facilities that share financial risk in providing or arranging for the provision of healthcare. An IDN is a network of providers and facilities working together in providing or arranging for the provision of healthcare. ACOs and IDNs have increased in number; their impact on the provision of healthcare services to date has varied. +

+ACOs and IDNs may exercise operational and financial control over providers across the continuum of care, and may function as a payer. Thus, they may be able to manage the health of a population group within a defined geography, and also may be able to influence the cost and quality of healthcare delivery, for example through owned entities and through ancillary services. ACOs may be encouraged to consider exclusive arrangements with healthcare providers that become part of the ACO, or to limit service providers to the ACO, since members of the ACO share financial risk. +

+We are actively engaging with ACOs and IDNs to demonstrate the value of our services.
EmployersEmployers use tests for drugs of abuse to determine an individual’s employability and his or her “fitness for duty.” Companies with high employee turnover, safety conscious environments or regulatory testing requirements provide the highest volumes of testing. Factors such as the general economy and job market can impact the utilization of drugs-of-abuse testing. +

+Employers also are investing in health and wellness services. We meet their needs by providing nationwide access to our customizable wellness services (discussed above at page 11), directly and through health plan and health improvement providers. These services help employers, employees and others manage healthcare costs and capitalize on trends in personalized health. +

+We seek to grow our employer business through offering new and innovative programs to help them with their goals of (1) maintaining a safe and productive workplace, (2) improving healthcare for employees and (3) improving healthcare costs for employees and employers.
\ No newline at end of file diff --git a/predictions/284.html b/predictions/284.html new file mode 100644 index 0000000000000000000000000000000000000000..39e0bfde68fa0eb5c53256d2c46e864f1c8203f7 --- /dev/null +++ b/predictions/284.html @@ -0,0 +1,18 @@ + + + + + + + + + + + + + + + + + +
Data Diagnostics™A tool, introduced with Inovalon, that provides real-time patient-specific data analysis that clinicians can order at the point of care to identify and address gaps in quality, risk, utilization and medical history insights.
Interactive Insights™ by Care360®A web-based reporting solution for clinicians and patients that provides health insights based on a patient's lab data to improve decision-making by both the clinician and the patient.
IntelliTest Analytics™A web-based secure portal that provides hospitals, IDNs and clinician practices with data-driven insights about test utilization patterns and business analysis of clinically appropriate test ordering norms, payer type and costs.
Care360 Revenue Cycle ManagementA holistic medical billing solution that aids the management of billing claims with a focus on increasing patient and payer collections. The latest offering in the Care360 product portfolio.
\ No newline at end of file diff --git a/predictions/285.html b/predictions/285.html new file mode 100644 index 0000000000000000000000000000000000000000..848bd8219bb407b82d29e34e9c5cffbf7fe5e4e4 --- /dev/null +++ b/predictions/285.html @@ -0,0 +1,69 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Options OutstandingOptions Exercisable
Range of Exercise PriceShares (in thousands)Weighted Average Remaining Contractual Life (in years)Weighted Average Exercise PriceShares (in thousands)Weighted Average Exercise Price
$ 3.97 - $ 5.10862.5$ 4.3686$ 4.36
$ 6.46 - $ 9.588423.76.848426.84
$15.03 - $22.382454.415.2624515.26
$23.27 - $34.795,4576.626.354,32026.42
$35.01 - $52.507,8957.242.453,16039.59
$52.62 - $53.275236.453.25752.84
\ No newline at end of file diff --git a/predictions/286.html b/predictions/286.html index dba464502d6dda921c86c5cad6c623b04886e633..ff800964de9504c75cd514c2cfbfe59c15e8c935 100644 --- a/predictions/286.html +++ b/predictions/286.html @@ -6,25 +6,25 @@ 2010 - Net revenues + Net revenues $ 116,940 $ 118,557 $ 108,805 - Income (loss) from discontinued operations before taxes + Income (loss) from discontinued operations before taxes (73,741) 7,072 9,328 - Income tax expense (benefit) + Income tax expense (benefit) 623 (4,486) (2,832) - Income (loss) from discontinued operations, net of taxes + Income (loss) from discontinued operations, net of taxes $ (74,364) $ 11,558 $ 12,160 diff --git a/predictions/287.html b/predictions/287.html new file mode 100644 index 0000000000000000000000000000000000000000..2412b76024bfd40fec1cbcad302d838c805637ff --- /dev/null +++ b/predictions/287.html @@ -0,0 +1,129 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
20152014201320122011
(a) (b)(c) (d)(e) (f)(g) (h)(i) (j)
(dollars in millions, except per share data)
Operations Data:
Net revenues$ 7,493$ 7,435$ 7,146$ 7,383$ 7,392
Operating income1,3999831,4751,201987
Income from continuing operations753587848666494
Income (loss) from discontinued operations, net of taxes—535(74)12
Net income753592883592506
Less: Net income attributable to noncontrolling interests4436343635
Net income attributable to Quest Diagnostics'
$ 709$ 556$ 849$ 556$ 471
Amounts attributable to Quest Diagnostics' stockholders:
Income from continuing operations$ 709$ 551$ 814$ 630$ 459
Income (loss) from discontinued operations, net of taxes—535(74)12
Net income$ 709$ 556$ 849$ 556$ 471
\ No newline at end of file diff --git a/predictions/288.html b/predictions/288.html new file mode 100644 index 0000000000000000000000000000000000000000..3c378d694f41244b3e93cd467e59bdc1f9e69f08 --- /dev/null +++ b/predictions/288.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
PatientsPatients are taking increased interest in and responsibility for their healthcare. Some patients are interested in ordering their own diagnostics tests, rather than relying upon a healthcare professional to order the tests. In addition, patients often are bearing increased financial responsibility for their healthcare (e.g., high deductible health plans; rising deductibles). Patients are paying greater attention to their healthcare, are increasing their demands of healthcare providers, have increased expectations regarding the healthcare experience and are becoming more sophisticated regarding healthcare. For example, in our experience, patients are more focused on transparency, ease of doing business and understanding diagnostics information services than they have been in the past. In addition, patients are seeking prompt, direct access to their test results.

The changing expectations of patients about their healthcare and their healthcare transactions are influencing the way that we think about our business and the services that we provide. We are well positioned to provide information and insights to patients to help them take actions to improve their healthcare, and increasingly we are proud to provide patients with tools to do this. See the discussion of our consumer strategy at page 4.
Emerging Retail Healthcare ProvidersIn recent years, as the healthcare sector changes, retail providers of healthcare services have emerged and are growing. These providers include “big-box” retailers, pharmacy chains, supermarkets, urgent care centers and Internet-based service providers.

We are taking advantage of opportunities to work with these providers, but also to offer new access points for our services (e.g., our collaboration with Safeway), but also to grow our business by expanding our service offerings (e.g., our joint venture with Wal-Mart). See the discussion of our consumer strategy at page 4.
Government AgenciesWe provide services on a fee-for-service basis to federal, state and local government agencies. Historically, most Medicare and Medicaid beneficiaries were covered under the traditional Medicare and Medicaid programs administered by the federal government. Over the last several years, the federal government has expanded its contracts with private health insurance plans for Medicare beneficiaries and has encouraged “Medicare Advantage” to switch from traditional programs to private programs, called “Medicare Advantage” programs. There has been growth of health insurance providers offering Medicare Advantage programs and of beneficiaries enrollment in these programs. States also have mandated that Medicaid beneficiaries enroll in private managed care arrangements.
Pharmaceutical companiesWe offer an array of assets and services to support the development of companion diagnostics.

We also offer Quest Clinical Trials Connect™, to help speed drugs to market through better patient recruitment and involvement and improved physician outreach.
Other LaboratoriesWe provide services on a fee-for-service basis to other commercial clinical laboratories.
\ No newline at end of file diff --git a/predictions/289.html b/predictions/289.html new file mode 100644 index 0000000000000000000000000000000000000000..be3277c7d1530ed06edc58de3583a3535453dd16 --- /dev/null +++ b/predictions/289.html @@ -0,0 +1,26 @@ + + + + + + + + + + + + + + + + + + + + + + + + + +
2012 Goal for run-rate savings exiting 2014$600 Million
2013 Revised goal for run-rate savings exiting 2014$700 Million
2014 Year-end run-rate savings>$700 Million
2014 Goal for run-rate savings exiting 2017$1.3 Billion
2015 Year-end run-rate savings$990 Million
2016 Year-end run-rate savings>$1.1 Billion
\ No newline at end of file diff --git a/predictions/29.html b/predictions/29.html index dfcea6a7828777639f63f6039d23d60cca3839bc..826c96c6e044ef4d06b2f6ef81fa9f90a975a409 100644 --- a/predictions/29.html +++ b/predictions/29.html @@ -1,6 +1,6 @@ - + @@ -9,37 +9,43 @@ - + - + + + + + + + - - - - + + + + - - - - + + + + - - - - + + + + - + diff --git a/predictions/290.html b/predictions/290.html index 9db341adfabb73c099a1d1c283823d034a651416..ea2227ebd0d9853d517b45ccdc996cbf59fc0642 100644 --- a/predictions/290.html +++ b/predictions/290.html @@ -1,28 +1,42 @@
Millions of dollars Year Ended December 31
2012
Revenue:Millions of dollars
North AmericaRevenue:
North America $ 17,698 $ 15,212 $ 16,004
Latin America$ 3,875$ 3,909$ 3,694Latin America3,8753,9093,694
Europe/Africa/CIS$ 5,490$ 5,225$ 4,510Europe/Africa/CIS5,4905,2254,510
Middle East/Asia$ 5,807$ 5,056$ 4,295Middle East/Asia5,8075,0564,295
TotalTotal $ 32,870 $ 29,402 $ 28,503
- + + + + + + + + + + - - - - - + + + + + - + + + + + + - + - + - + @@ -30,7 +44,7 @@ - + @@ -38,7 +52,7 @@ - + @@ -46,7 +60,7 @@ - + @@ -54,10 +68,15 @@ - + + + + + + - + @@ -65,7 +84,7 @@ - + @@ -73,15 +92,15 @@ - + - + - + @@ -89,7 +108,7 @@ - + @@ -97,7 +116,7 @@ - + diff --git a/predictions/292.html b/predictions/292.html new file mode 100644 index 0000000000000000000000000000000000000000..741d398b72690fa28627325ea341162d05242c94 --- /dev/null +++ b/predictions/292.html @@ -0,0 +1,38 @@ +
Year Ended December 31, (dollars in millions)Year Ended December 31,
20162015201420132012
2016 (a) (b) (c)2015 (d) (e)2014 (f) (g)2013 (a) (h) (i)2012 (a) (j) (k)(a) (b) (c)(a) (d) (e)(a) (d) (e)(a) (f) (g)(a) (h) (i)
Balance Sheet Data (at end of year):Balance Sheet Data (at end of year):
Cash and cash equivalentsCash and cash equivalents $ 359 $ 133 $ 192 $ 187$ 264$ 296
Total assetsTotal assets 10,100 9,962 9,8579,263
Long-term debtLong-term debt 3,728 3,492 3,2243,333
Total debtTotal debt 3,734 3,651 3,7423,343
Redeemable noncontrolling interestRedeemable noncontrolling interest 77 70 ——
Other Data:Other Data:
Net cash provided by operating activitiesNet cash provided by operating activities $ 1,069 $ 821 $ 944$ 1,211
Net cash (used in) provided by investing activitiesNet cash (used in) provided by investing activities (152) (362) (1,025)(217)
Net cash (used in) provided by financing activitiesNet cash (used in) provided by financing activities (691) (518)(86)86 (1,121) (846)
Capital expendituresCapital expenditures 293 263 308182
Purchases of treasury stockPurchases of treasury stock 590 224 132200
Dividends paidDividends paid 223 212 187
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201220112010
Weighted average fair value of options at grant date$15.87$18.08$17.60
Expected volatility27%27.2%26.8%
Dividend yield0.9%0.8%0.7%
Risk-free interest rate1.3% - 1.5%2.7% - 3.1%2.8% - 3.2%
Expected holding period, in years6.7 - 7.56.8 - 7.66.7 - 7.6
\ No newline at end of file diff --git a/predictions/293.html b/predictions/293.html new file mode 100644 index 0000000000000000000000000000000000000000..055cfce2e70d14e1c58f860331a61a9f89942eea --- /dev/null +++ b/predictions/293.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
Medicare and Medicaid: Fraud and AbuseDiagnostic testing services provided under Medicare and Medicaid programs are subject to complex, evolving, stringent and frequently ambiguous federal and state laws and regulations, including those relating to billing, coverage and reimbursement.

Anti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.

In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory, unless specific exceptions are met.

Federal substance abuse legislation enacted in 2018 contains anti-kickback provisions that are, by their terms, applicable to laboratory testing paid for by all payers. We are attempting to clarify the application of this legislation.

Some states have similar laws that are not limited in applicability to only Medicare and Medicaid referrals and could also affect tests that are paid for by health plans and other non-governmental payers.

Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.
FDAThe FDA has regulatory responsibility, over among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States. The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood banking purposes and testing of donors of human cells for purposes such as in vitro fertilization.

A number of advanced tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.

Pursuant to the 21st Century Cures Act, the FDA issued guidance regarding its position on the regulation of clinical decision support software, which may be used in, or in connection with, LDTs. The guidance attempts to address uncertainty regarding whether FDA approval of certain software is required. In January 2019 the FDA issued a draft guidance on a pre-certification pilot program to help software developers have a speedier and less restrictive path to clearance or approval for their software.

In late 2018, legislation introduced in Congress that would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease. If this legislation were to become law, the FDA could regulate diagnostic tests and components and impose requirements and compliance costs on companies and laboratories. If such legislation were to become law, it could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways and create avenues of opportunity and competition regarding clinical laboratory testing. New competitors may enter the industry, and competition may come in new forms.
Environmental, Health and SafetyWe are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.

For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S. This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries.

For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association.
\ No newline at end of file diff --git a/predictions/294.html b/predictions/294.html new file mode 100644 index 0000000000000000000000000000000000000000..433648544b11a5974832123aed618fa945f78e13 --- /dev/null +++ b/predictions/294.html @@ -0,0 +1,70 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Table 1 - Portfolio Growth3
Table 2 - Approaches to Accelerate Growth3
Table 3 - Key Professional Laboratory Services Offerings4
Table 4 - Clinical Franchises4
Table 5 - Recent Consumer-Centric Initiatives4
Table 6 - Major Themes to Drive Operational Excellence5
Table 7 - Assets and Capabilities8
Table 8 - 2018 Net Revenues10
Table 9 - U.S. Clinical Testing Industry13
Table 10 - Key Trends13
Table 11 - Contributing to Reducing Healthcare Costs and Improving Care17
Table 12 - Customers18
Table 13 - Factors Considered When Selecting a Diagnostics Information Services Provider21
Table 14 - 2018 Medicare and Medicaid Revenues as % of Consolidated Net Revenues24
Table 15 - Key Regulatory Schemes24
Table 16 - Information Available at our Corporate Governance Webpage27
Table 17 - Executive Officers28
\ No newline at end of file diff --git a/predictions/295.html b/predictions/295.html new file mode 100644 index 0000000000000000000000000000000000000000..11050230db53f42d0fdb0430cf75c767e51c4380 --- /dev/null +++ b/predictions/295.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201220112010
Current:
Federal$ 332,053$ 265,865$ 349,755
State and local60,70860,27393,229
Foreign2,6492,6664,283
Deferred:
Federal13,29837,245(6,828)
State and local(6,152)(11,073)(10,782)
Foreign(659)(274)479
Total$ 401,897$ 354,702$ 430,127
\ No newline at end of file diff --git a/predictions/296.html b/predictions/296.html new file mode 100644 index 0000000000000000000000000000000000000000..e88eca174e051c00f46d3d338cc54a5129cfba35 --- /dev/null +++ b/predictions/296.html @@ -0,0 +1,36 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201720162015
(dollars in millions)
Net cash provided by operating activities$    1,175$    1,069$    821
Net cash used in investing activities(805)(152)(362)
Net cash used in financing activities(592)(69)(518)
Net change in cash and cash equivalents$    (222)$    226$    (59)
\ No newline at end of file diff --git a/predictions/297.html b/predictions/297.html new file mode 100644 index 0000000000000000000000000000000000000000..31c1e34e0e04989631e31b1e513a72aad89515d4 --- /dev/null +++ b/predictions/297.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
CollaboratorCollaborator
IBM Watson® Health, Memorial Sloan Kettering Cancer Center and the Broad Institute of MIT and HarvardIBM Watson® Genomics from Quest Diagnostics, a service that helps advance precision medicine by combining computing with genomic tumor sequencing. Memorial Sloan Kettering Cancer Center is supplementing Watson®’s corpus of scientific data with a precision oncology knowledge base to help inform precision treatment options for cancer patients, and the Broad Institute of MIT and Harvard is providing additional genome sequencing capabilities.
OptumOur billing operations became part of Optum, helping us to reduce the complexity of our billing processes and fostering increased transparency of health care costs.

Advancing new technology services to digitize our customer orders and workflows, with the goals of reducing bad debt and payer denials and increasing operational efficiency and productivity.

Increase the use of diagnostic information services, such as data analytics, population health insights and connectivity solutions, to help improve health care effectiveness and manage costs for health plans and care providers.

We became Optum's primary partner for member biometric screening services that Optum provides to employers and health plans.
AncestryDNAWe provide testing to help meet the rapidly growing consumer demand for genetic tests that provide insights into genetic ethnicity, origins and other factors.
SafewayWe are providing diagnostic testing services in company-branded patient service centers in Safeway locations, enhancing convenient access to our services and diagnostic insights for patients.
InovalonData Diagnostics®, a tool that provides real-time patient-specific data analysis that clinicians can order at the point of care to identify and help address gaps in quality, risk, utilization and medical history insights.
Prenatal Quality FoundationThe national initiative to advance clinically appropriate noninvasive prenatal screening.
University of California, San Francisco, the nation's leading university focused exclusively on healthTo accelerate the translation of biomedical research into advanced diagnostics or the field of precision medicine. This collaboration has the overarching aim of enabling holistic and integrated diagnostic solutions that close gaps in care or enable new clinical value, with initial focus areas including autism, oncology, neurology and women's health.
U.S. Centers for Disease Control and Prevention ("CDC")To improve public health analysis of hepatitis C screening, diagnosis and treatment, based on analysis of our database of national hepatitis C virus ("HCV") diagnostic information.
With CDC and the American Medical Association, to assess the prevalence of pre-diabetes.
National Institutes of HealthWe participate in studies they sponsor (e.g., NIH National Children Study).
IQVIA Holdings Inc.Joint venture, Q2 Solutions™, providing central lab testing services for clinical trials.
Wal-Mart Stores, Inc.Joint venture to provide expanded access to basic health care services.
American Diabetes Association®To help identify people at risk for Type 2 diabetes, to share insights on how to lower the risk of developing diabetes and to share action steps that can be taken once a person is diagnosed with diabetes.
\ No newline at end of file diff --git a/predictions/298.html b/predictions/298.html new file mode 100644 index 0000000000000000000000000000000000000000..5437aa4dbb6ba9b55d4ca5e8607d7ca1caf92141 --- /dev/null +++ b/predictions/298.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.26Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
4.27Sixteenth Supplemental Indenture dated as of March 12, 2014, among the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K and incorporated herein by reference) (Commission File Number 001-12215)
4.28Seventeenth Supplemental Indenture dated as of March 10, 2015, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.29Eighteenth Supplemental Indenture dated as of May 26, 2016, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)
10.1*Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Company's quarterly report on form 10-Q for the quarter ended June 30, 2016 and incorporated herein by reference) (Commission file number 001-12215)
10.2*Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 15, 2015 (filed as an exhibit to the Company's 2015 quarterly report on Form 10-Q for the quarter ended June 30, 2015 and incorporated herein by reference) (Commission file number 001-12215)
10.3*Form of Equity Award Agreement dated as of February 23, 2015 (filed as an exhibit to the Company's 2015 annual report on Form 10-K and incorporated herein by reference) (file number 001-12215)
10.4*Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended December 22, 2008 (filed as an Exhibit to the Company's 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.5*Amendment No. 1 dated November 27, 2012 to Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended December 22, 2008 (filed as an Exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.6*Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated November 27, 2012 (filed as an Exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.7*Quest Diagnostics Incorporated Senior Management Incentive Plan (filed as Appendix A to the Company's Proxy Statement dated March 28, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
10.8*Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended February 20, 2017
10.9*AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company's registration statement on Form S-8 (Registration No. 333-143889) filed with the Commission on June 19, 2007 and incorporated herein by reference) (Commission File Number 333-143889)
10.10*Amendment dated as of August 17, 2007 to the AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company's 2017 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
\ No newline at end of file diff --git a/predictions/299.html b/predictions/299.html new file mode 100644 index 0000000000000000000000000000000000000000..b5c50907b56c3e90f4d47eaed9edda35d15d93b6 --- /dev/null +++ b/predictions/299.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201520142013
Fair value at grant date$11.57$10.99$12.64
Expected volatility21.0%25.1%25.8%
Dividend yield2.1%2.1%1.4%
Risk-free interest rate1.7%1.6% - 2.0%1.1% - 1.3%
Expected holding period, in years5.35.5 - 6.65.5 - 6.7
\ No newline at end of file diff --git a/predictions/3.html b/predictions/3.html index a597ea501669b9c84e0dd63d8bc91ce27f286f07..b095b20b4c8329acc3479bed8b96da9f3639530c 100644 --- a/predictions/3.html +++ b/predictions/3.html @@ -1,31 +1,27 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + +
DueRateAmount
08/20066.00%$200
12/20085.63%$150
05/20177.53%$50
02/20277.83%$125
DueRateAmount in millions
08/20066.00%$275
12/20087.05%$150
05/20177.53%$50
12/20206.50%$125
\ No newline at end of file diff --git a/predictions/30.html b/predictions/30.html index f12e25a5eb1d7d674992e19b3e162ae97cb734a4..ced196b0f6ffd6cdc21687dad9122740d40c215c 100644 --- a/predictions/30.html +++ b/predictions/30.html @@ -1,18 +1,17 @@ - + - - - + + @@ -23,8 +22,8 @@ - - + +
Millions of dollarsMillions of dollars Year Ended December 31
2016 2015 2014
United States(6,636)(1,560)$ (6,636)$(1,560)$ 3,020
Total(7,625)(936)$ (7,625)$(936)$ 4,712
\ No newline at end of file diff --git a/predictions/300.html b/predictions/300.html index 9f6afaa8c474afa68f6477965a5ef1473b44ffd7..6b538e991a3f6bf42fb6e3b1df8a20a24d313928 100644 --- a/predictions/300.html +++ b/predictions/300.html @@ -16,21 +16,21 @@ Options granted 1.8 - $ 96.02 + 96.02 Options exercised (2.2) - $ 58.91 + 58.91 Options forfeited and canceled (0.2) - $ 79.74 + 79.74 @@ -38,7 +38,7 @@ Options outstanding, end of year 8.5 $ 70.11 - 5.5 + 7.1 $ 243 diff --git a/predictions/302.html b/predictions/302.html new file mode 100644 index 0000000000000000000000000000000000000000..4e1707bedf73c9f3b2a1edd8380318f97828ff69 --- /dev/null +++ b/predictions/302.html @@ -0,0 +1,27 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + +
% of DIS Volume% of DIS Revenue
Healthcare Insurers (including coinsurance and deductible responsibilities)4751
Government Payers1517
Client Payers3729
Patients13
\ No newline at end of file diff --git a/predictions/303.html b/predictions/303.html new file mode 100644 index 0000000000000000000000000000000000000000..8f1e6b1bd54129bd5f313f004f22a8200b74a9a9 --- /dev/null +++ b/predictions/303.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201620152014
Routine clinical testing services$ 4,179$ 4,078$ 4,066
Gene-based and esoteric (including advanced diagnostics) testing services2,3352,2562,158
Anatomic pathology testing services624631649
All other377528562
Total net revenues$ 7,515$ 7,493$ 7,435
\ No newline at end of file diff --git a/predictions/304.html b/predictions/304.html new file mode 100644 index 0000000000000000000000000000000000000000..dbedb3f23354a1fe8b0ea696c74f6f555b277d3e --- /dev/null +++ b/predictions/304.html @@ -0,0 +1,126 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
20182017201620152014
(a) (b) (c)(a) (d) (e)(a) (d) (e)(a) (f) (g)(a) (h) (i) (a) (j) (k)
Balance Sheet Data (at end of year):
Cash and cash equivalents$ 135$ 137$ 359$ 133$ 192
Total assets11,00310,50310,1009,9629,857
Long-term debt3,4293,7483,7283,4923,224
Total debt3,8933,7843,7343,6513,742
Redeemable noncontrolling interest77807770—
Other Data:
Net cash provided by operating activities$ 1,200$ 1,175$ 1,116$ 967$ 944
Net cash used in investing activities(801)(830)(127)(362)(1,025)
Net cash (used in) provided by financing activities(401)(592)(738)(664)86
Capital expenditures383252293263308
Purchases of treasury stock322465590224132
Dividends paid266247223212187
\ No newline at end of file diff --git a/predictions/305.html b/predictions/305.html new file mode 100644 index 0000000000000000000000000000000000000000..9cf463e88f4fc814a4b325fddaafa232a84b02c5 --- /dev/null +++ b/predictions/305.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit NumberDescription
3.1Restated Certificate of Incorporation (filed as an Exhibit to the Company's current report on Form 10-Q for the quarter ended September 30, 2018 (Date of Report: October 24, 2018) and incorporated herein by reference) (Commission File Number 001-12215)
3.2Amended and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: August 21, 2018) and incorporated herein by reference) (Commission File Number 001-12215)
4.1Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)
4.2Form of 4.750% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)
4.3Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)
4.4Form of 4.700% Senior Note due 2021 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)
4.5Form of 2.700% Senior Note due 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 2, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.6Form of 4.250% Senior Note due 2024 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
4.7Form of 2.500% Senior Note due 2020 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.8Form of 3.500% Senior Note due 2025 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.9Form of 4.700% Senior Note due 2045 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
4.10Form of 3.450% Senior Note due 2026 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)
4.11Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)
\ No newline at end of file diff --git a/predictions/306.html b/predictions/306.html new file mode 100644 index 0000000000000000000000000000000000000000..fa84e8c87891f465f41383f056b7679566d46775 --- /dev/null +++ b/predictions/306.html @@ -0,0 +1,54 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Customers and payers: industry consolidationOur customers and payers, including clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, an increased number of hospital systems are considering establishing or have established health insurance plans or considering providing or are providing healthcare services. CVS Health, a leading provider of retail medical clinics and pharmacy benefits management services, has acquired Aetna, a leading health insurance provider. Cigna Corporation, a leading health insurance provider, has acquired Express Scripts, a leading pharmacy benefits manager. UnitedHealth Group, the parent of UnitedHealthcare, provides a wide array of health care services through its Optum subsidiaries. Health plans are entering agreements with other providers of healthcare services, including laboratory testing services providers, to partner on value-based approaches to delivering health care to populations.
Consolidation is increasing pricing transparency and bargaining power, and may encourage internationalization of clinical testing.
Physicians frequently now are employed by hospital systems, IDNs, ACOs or large group practices integrated with healthcare systems, instead of operating physician-owned practices, which is changing the dynamics for whether clinical testing is performed in a hospital or outside of a hospital. Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.
Value-based reimbursement is contributing to changes in the healthcare system. ACOs and patient-centered medical homes have grown as a means to deliver patient care. Healthcare services increasingly are being provided by non-traditional providers (e.g., physician assistants), in non-traditional venues (e.g., retail medical clinics, urgent care centers) and using new technologies (e.g., telemedicine; digital pathology).
In addition, federal healthcare reform legislation adopted in 2010, the ACA, is resulting in changes in the way that some healthcare services are purchased and delivered in the United States. Hospitals and IDNs are under significant pressure, and are evolving.
Patients are also our customers. Increasingly, patients are engaged in their own healthcare, being empowered to manage and understand their healthcare and are bearing responsibility for payment for the services provided to them. See also the discussion under the heading Patients in Item 12.
Pricing transparencyThere has been a trend toward greater pricing transparency in the healthcare marketplace.
This transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and changes in behavior in the healthcare marketplace. We believe that increased price transparency should benefit low cost, high value providers like our Company.
CompetitionThe diagnostic information services industry remains fragmented, is highly competitive and is subject to new competition.
Competition is emerging from new technologies (e.g., digital pathology) and growing from non-traditional competitors. Increased hospital acquisitions of physician practices may enhance clinical ties to hospital-affiliated laboratories and may strengthen their competitive position.
New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.
Healthcare utilizationIn the past few years, healthcare utilization in the United States has fluctuated based on a number of factors. These factors include, without limitation, the economy, healthcare benefits design, patients delaying medical care and increased patient financial responsibility for medical care.
The ACA contained provisions eliminating patient cost-sharing for preventive services, and additional provisions that may have increased the number of patients that have health insurance, including Medicaid, all of which have increased the number of patients.
\ No newline at end of file diff --git a/predictions/307.html b/predictions/307.html index 85c75ce82d06272d3c8f64e08e07f3e5e3b9806d..cdca24aae76720fc7a01c84fa6e7b05d74b88f23 100644 --- a/predictions/307.html +++ b/predictions/307.html @@ -1,12 +1,7 @@ - - + + diff --git a/predictions/308.html b/predictions/308.html new file mode 100644 index 0000000000000000000000000000000000000000..4ed937b95c470b2b3c4bcb48705018ed3017e802 --- /dev/null +++ b/predictions/308.html @@ -0,0 +1,37 @@ +
Medicare Part B -Reimbursements% of our -2012 Consolidated -Net Revenues From -Continuing -OperationsMedicare Part B
Reimbursements		% of our
2012 Consolidated
Net Revenues From
Continuing
Operations
Clinical Laboratory Fee Schedule
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2013$72,979
201470,817
201559,552
201652,842
201749,088
Thereafter319,415
Total$624,693
\ No newline at end of file diff --git a/predictions/309.html b/predictions/309.html new file mode 100644 index 0000000000000000000000000000000000000000..ce9035fdb6b26d883d59875684028c7dcc43c23e --- /dev/null +++ b/predictions/309.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20052004
Accrued wages and benefits$275,709$265,126
Accrued expenses266,716247,134
Trade accounts payable193,385128,488
Income taxes payable28,64328,239
Total$764,453$668,987
\ No newline at end of file diff --git a/predictions/31.html b/predictions/31.html index ac9c91a223d805b87694581ca7ddf32ac599c854..1533d37e636e33ff8cf9aae092d9ab27b05c92e7 100644 --- a/predictions/31.html +++ b/predictions/31.html @@ -1,9 +1,10 @@ - + + diff --git a/predictions/310.html b/predictions/310.html new file mode 100644 index 0000000000000000000000000000000000000000..86d72d3b993aa83861394734934759b79e79c803 --- /dev/null +++ b/predictions/310.html @@ -0,0 +1,46 @@ +
Millions of dollars Year Ended December 31
Millions of dollars 2017 2016 2015
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Customers and payersOur customers and payers, including clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, an increased number of hospital systems are considering establishing or have established health insurance plans, and health insurance plans are considering providing or are providing healthcare services. In addition, CVS Health, a leading provider of retail medical clinics and pharmacy benefits management services, has agreed to acquire Aetna, a leading health insurance provider.
Consolidation is increasing pricing transparency and bargaining power, and may encourage internalization of clinical testing.
Physicians frequently now are employed by hospital systems, IDNs, ACOs or large group practices integrated with healthcare systems, instead of organizing physician-owned practices, which is changing the dynamics for whether clinical testing is performed on an outside of a hospital. Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.
Value-based reimbursement is contributing to changes in the healthcare system. ACOs and patient-centered medical homes have grown as a means to deliver patient care. Healthcare services increasingly are being provided by non-traditional providers (e.g., physician assistants), in non-traditional venues (e.g., retail medical clinics, urgent care centers) and using new technologies (e.g., telemedicine).
In addition, federal healthcare reform legislation adopted in 2010, the ACA, is resulting in changes in the way that some healthcare services are purchased and delivered in the United States.
Patients are also our customers. Increasingly, patients are engaged in their own healthcare, being empowered to manage and understand their healthcare and are bearing responsibility for payment for the services provided to them. See also the discussion under the heading Patients in Table 21.
Pricing transparencyThere has been a trend toward greater pricing transparency in the healthcare marketplace.
This transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and changes in behavior in the healthcare marketplace.
CompetitionThe diagnostic information services industry remains fragmented, is highly competitive and is subject to new competition.
Competition is growing from non-traditional competitors. Increased hospital acquisitions of physician practices may enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.
New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.
\ No newline at end of file diff --git a/predictions/311.html b/predictions/311.html index 63bb4f5cebb9e284327b05189cc6c5709736b460..dfd83ee0947433b8dfe94337fce288cf7fe1ec97 100644 --- a/predictions/311.html +++ b/predictions/311.html @@ -1,62 +1,73 @@ - - - - + + + - - + + - + + - + + - + + + - + - + - + + - + + - + - + - + + - + + - + - + - + + - + + - + - + + +
201620152014201620152014
SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value		 SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value		 SharesWeighted Average Grant Date Fair ValueWeighted
Average
Grant Date
Fair Value
Shares outstanding, beginning of yearShares outstanding, beginning of year 1.7 $ 59.92 1.9 $ 55.50 1.9 $ 57.08
Shares grantedShares granted 0.6$ 67.2667.26 0.6$ 71.1771.17 0.7$ 52.7252.72
Shares vestedShares vested (0.4)$ 58.9858.98 (0.3)$ 55.7455.74 (0.3)$ 57.1457.14
Shares forfeited and canceledShares forfeited and canceled (0.4)$ 57.3157.31 (0.5)$ 58.1858.18 (0.4)$ 56.4456.44
Shares outstanding, end of yearShares outstanding, end of year 1.5$ 63.88 1.7$ 59.92 1.9$ 55.50
\ No newline at end of file diff --git a/predictions/312.html b/predictions/312.html new file mode 100644 index 0000000000000000000000000000000000000000..74d791ff701e759f1bb498a609c46943a9d7c553 --- /dev/null +++ b/predictions/312.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
101.LAB*dgx-20151231_lab.xml
101.PRE*dgx-20151231_pre.xml
*Filed herewith.
**Furnished herewith.
‡Management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-K pursuant to Item 15(b) of Form 10-K.
\ No newline at end of file diff --git a/predictions/313.html b/predictions/313.html new file mode 100644 index 0000000000000000000000000000000000000000..70d820e5db444e2e32fe44125317e057e97cfc1d --- /dev/null +++ b/predictions/313.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Fair Values
as of
May 4,
2011
Cash and cash equivalents$ 11,412
Short-term marketable securities213,418
Accounts receivable16,810
Other current assets26,796
Property, plant and equipment11,091
Intangible assets85,830
Goodwill135,624
Other noncurrent deferred income taxes102,838
Other assets34,586
Total assets acquired739,305
Current liabilities59,008
Long-term liabilities10,717
Total liabilities assumed69,725
Net assets acquired$ 669,580
\ No newline at end of file diff --git a/predictions/314.html b/predictions/314.html new file mode 100644 index 0000000000000000000000000000000000000000..fa9c47142fd7dc84ea8d020e88e122b55d79ec42 --- /dev/null +++ b/predictions/314.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
NeurologyWe introduced the first personalized genetic diagnostic test of the entire human genome in partnership with Personalis, Inc., to specifically help diagnose neurological disorders.

We launched a series of new advanced sequencing molecular tests to more reliably and quickly diagnose hundreds of clinically relevant genetic causes of muscular dystrophies and myopathies in adults and children. These tests help avoid painful muscle biopsies that, in the past, were the only means to diagnose patients with muscle weakness.

We launched advanced sequencing molecular tests for hundreds of genetic causes of rare, progressive movement disorders called hereditary ataxias, which affect movement of the legs and hands, and speech and eye movements. Patients benefit from a molecular diagnosis by eliminating the need for further testing and identifying a basis for therapy to extend mobility and life.

We also launched advanced sequencing molecular tests to test for hundreds of genetic causes of rare, progressive movement disorders called hereditary spastic paraplegias, which are characterized by a slowly progressive stiffness and weakness of the legs. The diagnosis guides physicians in the use of medications to reduce muscle tightness.
OncologyWe introduced LeukoVantage™, a genomic test service that aids in the diagnosis, prognosis monitoring and selection of treatment for myeloid neoplasms, a group of hematologic malignancies that include acute myeloid leukemia.

We introduced access to a companion test service for a new anti-PD-1 therapy for metastatic non-small cell lung cancer developed by Merck and a complementary test service for a new anti-PD-L1 therapy for metastatic non-small cell lung cancer developed by Bristol-Myers Squibb.

We introduced a prognostic panel including new probes to aid physicians in treating patients with plasma cell myeloma.
Prescription Drug Monitoring and ToxicologyWe introduced a quantitative test for buprenorphine and naloxone. Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.
Sports Science and Human PerformanceThe New York Football Giants began using Blueprint for Athletes™ as a major factor in the Giants’ training and preparation for National Football League games.

We conducted beta programs at select endurance events using the Blueprint for Athletes™ service to empower athletes to track their progress from the onset of training through the event.
Women’s and Reproductive HealthWe introduced QNatal Advanced™, a new noninvasive prenatal screening service for detecting chromosomal abnormalities in certain high-risk pregnancies.

We enhanced our HPV offerings with five new tests. One assay is used in connection with cytology to assess the presence or absence of high risk HPV genotypes 16, 18 and/or 45. This information together with physician’s assessment of cytology history, other risk factors and professional guidelines may be used to guide patient treatment. The second assay is used in conjunction with cytology to evaluate and risk classify. The other three are used in combination.
\ No newline at end of file diff --git a/predictions/315.html b/predictions/315.html new file mode 100644 index 0000000000000000000000000000000000000000..7ba4c4c86dd846c93c26f4b57436718ef64ae2e7 --- /dev/null +++ b/predictions/315.html @@ -0,0 +1,106 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Income from continuing operations$5.39$5.63$4.58$4.92$3.80
Income from discontinued operations————0.03
Net income$5.39$5.63$4.58$4.92$3.83
Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:
Income from continuing operations$5.29$5.50$4.51$4.87$3.78
Income from discontinued operations————0.03
Net income$5.29$5.50$4.51$4.87$3.81
Dividends per common share$2.03$1.80$1.65$1.52$1.32
\ No newline at end of file diff --git a/predictions/316.html b/predictions/316.html index f3d3ec23653405e4babf1a2eb666e3b8bd42739c..3c413b34f7702c39b5d92c9ffbd232022b619da7 100644 --- a/predictions/316.html +++ b/predictions/316.html @@ -1,8 +1,8 @@ - - + + diff --git a/predictions/318.html b/predictions/318.html new file mode 100644 index 0000000000000000000000000000000000000000..417966bfbfe5a2afb11210db5a1cbbab97370bab --- /dev/null +++ b/predictions/318.html @@ -0,0 +1,32 @@ +
% of Total Volume% of Consolidated Net Revenues% of
Total
Volume		% of
Consolidated
Net Revenue
Healthcare Insurers
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201220112010
Depreciation expense$ 203,542$ 211,052$ 213,190
Interest expense(167,688)(172,215)(145,029)
Interest income2,9992,6011,562
Interest expense, net$ (164,689)$ (169,614)$ (143,467)
\ No newline at end of file diff --git a/predictions/319.html b/predictions/319.html new file mode 100644 index 0000000000000000000000000000000000000000..26e7e5dff6a24dbc9e4e3dd67e78f792ba8a1037 --- /dev/null +++ b/predictions/319.html @@ -0,0 +1,73 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201520142013
SharesAverage
Grant Date
Fair Value		Weighted
Average
Grant Date
Fair Value		SharesAverage
Grant Date
Fair Value		Weighted
Average
Grant Date
Fair Value		SharesAverage
Grant Date
Fair Value		Weighted
Average
Grant Date
Fair Value
Shares outstanding, beginning of year1.9$ 55.501.9$ 57.082.0$ 56.77
Shares granted0.671.170.752.720.856.79
Shares vested(0.3)55.74(0.3)57.14(0.5)56.25
Shares forfeited and cancelled(0.5)58.18(0.4)56.44(0.4)55.91
Shares outstanding, end of year1.7$ 59.921.9$ 55.561.9$ 57.08
\ No newline at end of file diff --git a/predictions/32.html b/predictions/32.html index 2cbaa6e4ed4d37193731b2027fcd079ec1c54726..3db20c4b6900d46b76b5ce25745d8f7872956b13 100644 --- a/predictions/32.html +++ b/predictions/32.html @@ -1,13 +1,16 @@ - - - + + + + + + @@ -20,16 +23,11 @@ -
Average Oil Prices (dollars per barrel)
2007 2006 2005
Average Oil Prices (dollars per barrel)
West Texas Intermediate $ 71.91$ 65.35 $ 54.45
- - - - - - - - + + + + diff --git a/predictions/320.html b/predictions/320.html index 8bf493b08bc23c2b9f5a9af0b9af00d268981256..fcc87cee536541e138aba102ff9ef01d64cd5bf1 100644 --- a/predictions/320.html +++ b/predictions/320.html @@ -1,8 +1,4 @@
Average United States Gas Prices (dollars per million British thermal units, or mmBtu)
200720062005Average United States Gas Prices (dollars per million British thermal units, or mmBtu)
Henry Hub
- - - - @@ -10,31 +6,31 @@ - + - - - - + + + + - - - - + + + + - - - - + + + + - + diff --git a/predictions/321.html b/predictions/321.html index 33759375c1959ec47ba17304c819dc4a917599b8..17f279eff3b566873b7aa1b00b674587358bf398 100644 --- a/predictions/321.html +++ b/predictions/321.html @@ -6,63 +6,63 @@ - - - - + + + + - + - + - + - + - + - + - + - + - - - - + + + +
$
20172015
Routine clinical testing servicesRoutine clinical testing services $ 4,309 $ 4,179 $ 4,078
Gene-based and esoteric (including advanced diagnostics) testing services$ 2,449$ 2,335$ 2,256Gene-based and esoteric (including advanced diagnostics) testing services2,4492,3352,256
Anatomic pathology testing services$ 612$ 624$ 631Anatomic pathology testing services612624631
All other$ 339$ 377$ 528All other339377528
Total net revenuesTotal net revenues $ 7,709 $ 7,515 $ 7,4932010
Net income$ 592,134$ 505,650$ 757,017Net income$    592,134$    505,650$    757,017
Other comprehensive income (loss):Other comprehensive income (loss):
Currency translation    Currency translation 24,520 (12,920) 27,271
Market valuation, net of tax    Market valuation, net of tax (20) (2,696) 3,090
Net deferred loss on cash flow hedges, net of tax    Net deferred loss on cash flow hedges, net of tax 838 (1,042) 724
Other    Other (2,951) (2,035) 502
Other comprehensive income (loss)    Other comprehensive income (loss) 22,387 (18,693) 31,587
Comprehensive incomeComprehensive income 614,521 486,957 788,604
Less: Comprehensive income attributable to noncontrolling interestsLess: Comprehensive income attributable to noncontrolling interests 36,413 35,083 36,123
Comprehensive income attributable to Quest Diagnostics$ 578,108$ 451,874$ 752,481Comprehensive income attributable to Quest Diagnostics$    578,108$    451,874$    752,481
\ No newline at end of file diff --git a/predictions/322.html b/predictions/322.html new file mode 100644 index 0000000000000000000000000000000000000000..9c6f81cd25494ec75b25d37cc50d9087f5a28347 --- /dev/null +++ b/predictions/322.html @@ -0,0 +1,69 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
SharesWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
Options outstanding, beginning of year7.7$ 59.65
Options granted2.866.87
Options exercised(1.3)56.17
Options forfeited and canceled(0.1)66.53
Options outstanding, end of year9.1$ 62.277.2$269
Exercisable, end of year4.2$ 57.845.7$144
Vested and expected to vest, end of year8.8$ 62.107.2$262
\ No newline at end of file diff --git a/predictions/323.html b/predictions/323.html new file mode 100644 index 0000000000000000000000000000000000000000..b2b5952317a1b63bf1e4795cfc25c1266e56e724 --- /dev/null +++ b/predictions/323.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
4.26Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
4.27Sixteenth Supplemental Indenture dated as of March 12, 2014, among the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K and incorporated herein by reference) (Commission File Number 001-12215)
4.28Seventeenth Supplemental Indenture dated as of March 10, 2015, among the Company and The Bank of New York Mellon (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)
10.1‡Amended and Restated Employee Stock Purchase Plan (filed as an Exhibit to the Company's quarterly report on form 10-Q for the quarter ended June 30, 2015 and incorporated herein by reference) (Commission file number 001-12215)
10.2‡Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 15, 2015 (filed as an exhibit to the Company's 2015 quarterly report on Form 10-Q for the quarter ended June 30, 2015 and incorporated herein by reference) (Commission file number 001-12215)
10.3‡*Form of Equity Award Agreement dated as of February 23, 2015
10.4‡Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended December 22, 2008 (filed as an Exhibit to the Company's 2008 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.5‡Amendment No. 1 dated November 27, 2012 to Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended December 22, 2008 (filed as an Exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.6‡Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated November 27, 2012 (filed as an Exhibit to the Company's 2012 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.7‡Quest Diagnostics Incorporated Senior Management Incentive Plan (filed as Appendix A to the Company's Definitive Proxy Statement dated March 28, 2003 and incorporated herein by reference) (Commission File Number 001-12215)
10.8‡Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 20, 2014) and incorporated herein by reference) (Commission File Number 001-12215)
10.9‡AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company's registration statement on Form S-8 (Registration No. 333-143889 filed with the Commission on June 19, 2007 and incorporated herein by reference) (Commission File Number 333-143889)
10.10‡Amendment dated as of August 17, 2007 to the AmeriPath Group Holdings, Inc. 2006 Stock Option and Restricted Stock Purchase Plan (filed as an Exhibit to the Company's 2007 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)
10.11‡*The Profit Sharing Plan of Quest Diagnostics Incorporated (Amendment and Restatement, effective as of January 1, 2016)
\ No newline at end of file diff --git a/predictions/324.html b/predictions/324.html new file mode 100644 index 0000000000000000000000000000000000000000..dd92f840aab7c1e0c4571bb61b5bc96cef576de6 --- /dev/null +++ b/predictions/324.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
101.SCH*dgx-20161231.xsd
101.CAL*dgx-20161231_cal.xml
101.DEF*dgx-20161231_def.xml
101.LAB*dgx-20161231_lab.xml
101.PRE*dgx-20161231_pre.xml
\ No newline at end of file diff --git a/predictions/325.html b/predictions/325.html new file mode 100644 index 0000000000000000000000000000000000000000..54e5c9a974afbd2ef9db9b7005bfe78318a6b791 --- /dev/null +++ b/predictions/325.html @@ -0,0 +1,106 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Income from continuing operations$4.58$4.92$3.80$5.35$3.96
Income (loss) from discontinued operations——0.030.23(0.47)
Net income$4.58$4.92$3.83$5.58$3.49
Earnings per share attributable to Quest Diagnostics’ common stockholders — diluted:
Income from continuing operations$4.51$4.87$3.78$5.31$3.92
Income (loss) from discontinued operations——0.030.23(0.46)
Net income$4.51$4.87$3.81$5.54$3.46
Dividends per common share$1.65$1.52$1.32$1.20$0.81
\ No newline at end of file diff --git a/predictions/326.html b/predictions/326.html new file mode 100644 index 0000000000000000000000000000000000000000..5d86d041f2481fbfc3c14e80e00f29f5f4be7f7d --- /dev/null +++ b/predictions/326.html @@ -0,0 +1,92 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201220112010
Depreciation and amortization:
DIS business (a)$183,698$189,796$194,509
All other operating segments (a)17,28418,43316,049
General corporate77,30864,00635,745
278,290272,235246,303
Adjustments: Discontinued operations8,3068,8677,661
Total depreciation and amortization$286,596$281,102$253,964
Capital expenditures:
DIS business (a)$145,165$132,021$166,329
All other operating segments (a)24,45820,27627,236
General corporate11,1516,8269,152
180,774159,123202,717
Adjustments: Discontinued operations1,4602,4332,683
Total capital expenditures$182,234$161,556$205,400
\ No newline at end of file diff --git a/predictions/327.html b/predictions/327.html index 3d27a77886cc3c304ff4fd4c87a20622c10a4bd2..ac0ad1888d3d78ecb949d6fe7844834c05253bd1 100644 --- a/predictions/327.html +++ b/predictions/327.html @@ -29,12 +29,6 @@ $ 7,391,932 $ 7,260,120 - - - - - - Operating earnings (loss): @@ -97,7 +91,7 @@ Net income - 592,132 + 592,134 505,650 757,017 diff --git a/predictions/328.html b/predictions/328.html new file mode 100644 index 0000000000000000000000000000000000000000..88f0573164668821793661100ad49c2d2c5af155 --- /dev/null +++ b/predictions/328.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
PhysiciansOur pathologists are required to hold a valid license to practice medicine in the jurisdiction in which they practice.
Many of our pathologists enter into an employment agreement. These agreements have varying terms, but generally can be terminated at any time, upon advance notice. Most of the agreements contain covenants generally limiting the activities of the pathologist within a defined geographic area for a limited period of time after termination of employment; the enforceability of these covenants may be limited under state law.
Several jurisdictions, including some in which our businesses are located, prohibit business corporations from engaging in the practice of medicine. In certain jurisdictions, business corporations are prohibited from employing licensed healthcare professionals to provide services on behalf of the corporation; these laws may, in some jurisdictions, also prohibit pathology services are delivered through physician-owned entities that employ pathologists. The manner in which licensed physicians can be organized to perform medical services may be governed by the laws of the jurisdictions in which medical services are provided and by the medical boards or other entities authorized by these jurisdictions to oversee the practice of medicine.
Privacy and Security of Health and Personal InformationWe are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information.
A healthcare provider may be required to notify individuals or the government if the provider discovers certain breaches of personal information or protected health information.
Drug Testing; Controlled SubstancesAll U.S. laboratories that perform drug testing for certain public sector employees and employees of certain federally regulated businesses are required to be certified as meeting the detailed performance and quality standards of the Substance Abuse and Mental Health Services Administration.
To obtain access to controlled substances used to perform drugs-of-abuse testing in the United States, we must register with the Drug Enforcement Administration.
\ No newline at end of file diff --git a/predictions/329.html b/predictions/329.html new file mode 100644 index 0000000000000000000000000000000000000000..e4b766e51e6b422b977546ff710161451fd7b843 --- /dev/null +++ b/predictions/329.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationLeased or Owned
Phoenix, ArizonaLeased by Joint Venture
Los Angeles, California (3)One owned, two leased
Sacramento, CaliforniaLeased
San Diego, CaliforniaLeased
San Jose, CaliforniaLeased
San Juan Capistrano, CaliforniaOwned
Denver, ColoradoLeased
New Haven, ConnecticutOwned
Washington, D.C. (Chantilly, Virginia)Leased
Miami, Florida (2)One owned, one leased
Tampa, FloridaOwned
Atlanta, GeorgiaOwned
Chicago, Illinois (2)One owned, one leased
Indianapolis, IndianaLeased by Joint Venture
Kansas City, KansasLeased
Lexington, KentuckyOwned
Louisville, KentuckyLeased
New Orleans, LouisianaOwned
Baltimore, MarylandOwned
Boston, MassachusettsLeased
Detroit, MichiganLeased
St. Louis, MissouriOwned
Las Vegas, NevadaOwned
New York, New York (Teterboro, New Jersey)Owned
Long Island, New YorkLeased
Cincinnati, OhioOwned
Dayton, OhioLeased by Joint Venture
Oklahoma City, OklahomaLeased by Joint Venture
Portland, OregonLeased
Erie, PennsylvaniaLeased by Joint Venture
Philadelphia, PennsylvaniaLeased
Pittsburgh, PennsylvaniaLeased
Nashville, TennesseeLeased
Dallas, TexasLeased
Houston, TexasLeased
Seattle, WashingtonLeased
\ No newline at end of file diff --git a/predictions/33.html b/predictions/33.html new file mode 100644 index 0000000000000000000000000000000000000000..befcb7b67bcc99c3d48b0f654e40ea26fefda75e --- /dev/null +++ b/predictions/33.html @@ -0,0 +1,295 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per share dataQuarterYear
First (1)SecondThirdFourth
2014
Revenue$ 7,348$ 8,051$ 8,701$ 8,770$ 32,870
Operating income9701,1941,6341,2995,097
Net income6167751,2059053,501
Amounts attributable to company shareholders:
    Income from continuing operations6237761,1379003,436
    Income (loss) from discontinued operations(1)(2)66164
    Net income attributable to company6227741,2039013,500
Basic income per share attributable to company shareholders:
    Income from continuing operations0.730.921.341.064.05
    Income from discontinued operations——0.08—0.08
    Net income per share attributable to company shareholders:0.730.921.421.064.13
Diluted income per share attributable to company shareholders:
    Income from continuing operations0.730.911.331.064.03
    Income from discontinued operations——0.08—0.08
    Net income per share attributable to company shareholders:0.730.911.411.064.11
Cash dividends paid per share0.150.150.150.180.63
Common stock prices (2)
    High59.9971.2674.3364.8874.33
    Low47.6057.1363.0637.2137.21
2013
Revenue$ 6,974$ 7,317$ 7,472$ 7,639$ 29,402
Operating income (loss)(98)9841,1081,1443,138
Net income (loss)(16)6487087952,135
Amounts attributable to company shareholders:
    Income (loss) from continuing operations(13)6427077702,106
    Income (loss) from discontinued operations(5)2(1)2319
    Net income (loss) attributable to company(18)6447067932,125
Basic income per share attributable to company shareholders:
    Income (loss) from continuing operations(0.01)0.690.790.912.35
    Income (loss) from discontinued operations(0.01)0.01—0.020.02
    Net income (loss)(0.02)0.700.790.932.37
Diluted income per share attributable to company shareholders:
    Income (loss) from continuing operations(0.01)0.690.790.902.33
    Income (loss) from discontinued operations(0.01)——0.030.03
    Net income (loss)(0.02)0.690.790.932.36
Cash dividends paid per share0.1250.1250.1250.150.525
Common stock prices (2)
    High43.9645.7550.5056.5256.52
    Low35.0736.7741.8647.9935.07
\ No newline at end of file diff --git a/predictions/330.html b/predictions/330.html new file mode 100644 index 0000000000000000000000000000000000000000..188c1bc31a7aa3418be094a634cb9788df9d40e0 --- /dev/null +++ b/predictions/330.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
NeurologyWe introduced a novel mass spectrometry test for Alzheimer's biomarkers which offer the most specific assessment of established biomarkers (A beta 40,42 and ApoE) in the cerebrospinal fluid to guide management, research and clinical trials.
We began to offer a new epilepsy test using next generation sequencing, providing a high quality assessment of all genes known to be involved in the disease.
We initiated implementation of an integrated dementia diagnostic solution based on our collaboration with University of California, San Francisco. This offering integrates laboratory testing, cognitive exam, MRI and clinical evaluation to help primary doctors assess and diagnose dementia to identify treatable cause, shorten time to diagnosis and eliminate waste.
OncologyWe updated our offering for assessment of DNA profiling of cancer - IBM Watson® Genomics from Quest Diagnostics - to improve performance on the variety of cancer sample types that are tested in the community setting.
We introduced PD-L1 testing to be used as a companion diagnostic for immunotherapy in cancer.
We introduced EGFR testing of plasma in cancer patients. This offering enables evaluation of EFGR mutation status of a patient's lung cancer through a simple blood draw, without the need for a tissue biopsy.
In collaboration with Veracyte, we introduced thyroid cancer molecular testing services.
Prescription Drug Monitoring and ToxicologyWe implemented testing services for common drugs in several additional laboratories, to reduce test turnaround time in response to increasing demand based on the opioid / prescription drug crisis.
We also validated an increased number of our Prescription Drug and Abuse testing services on oral fluid samples, offering greater convenience and non-invasive testing for our patients.
Sports Science and Human PerformanceWe expanded and reconfigured the Blueprint for Athletes™ service, which gives athletes insights on their own biology to help improve fitness and performance.
We added at-home collection options, including "concierge collection" and the Mitra® Microsampling device. We also added custom coaching, to help athletes create plans to improve performance.
We reconfigured the test services in "stacks" that feature panels of tests with results provided in easy to read action-oriented reports. The stacks include, among others, "Blueprint One" and "Endurance and Conditioning."
Women's and Reproductive HealthWe introduced QHerit, a new genetic pan-ethnic carrier screening panel aligned with new medical guidelines. It provides men and women with insights into the genetic risk of passing on heritable disorders to their offspring.
We expanded our genetic testing services to aid in the diagnosis of genetic disease.
\ No newline at end of file diff --git a/predictions/331.html b/predictions/331.html index 326d5c816607439a49552d61948d818dc423fdd9..52a06e8e80117159a8a8ff2c46bbace697a5ffe6 100644 --- a/predictions/331.html +++ b/predictions/331.html @@ -1,42 +1,50 @@ -
+
- + - + + + + + + + + + @@ -46,12 +54,12 @@ - + - + @@ -63,7 +71,7 @@ - + @@ -72,17 +80,22 @@ - + - + - + + + + + + @@ -92,4 +105,87 @@ -
ItemItem Page
Item 1.Item 1. Business 1
Our Strategy and Strengths 2
Business Operations 14
The United States Clinical Testing Market 17
General 23
Billing and Reimbursement 26
Regulation 27
Available Information 30
Executive Officers of the Company 31
33
Item 1B. Cautionary Factors That May Affect Future Results 41
Item 1B. Unresolved Staff Comments 42
Item 3. Legal Proceedings4243
Item 4.
Item 5.Market for Registrant's Common Stock, Related Stockholder Matters and Issuer Purchases of Equity SecuritiesMarket for Registrant’s Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities 44
Item 6. Selected Financial Data 46
Item 7.Management's Discussion and Analysis of Financial Condition and Results of OperationsManagement’s Discussion and Analysis of Financial Condition and Results of Operations46
Operations 46
Item 8.Financial
\ No newline at end of file + Financial Statements and Supplementary Data + 46 + + + Item 9. + Changes in and Disagreements with Accountants on Accounting and Financial Disclosure + 46 + + + Item 9A. + Controls and Procedures + 46 + + + Item 9B. + Other Information + 46 + + + Item 10. + Directors, Executive Officers and Corporate Governance + 48 + + + Item 11. + Executive Compensation + 48 + + + Item 12. + Security Ownership of Certain Beneficial Owners and Management and Related Stockholders’ Matters + 48 + + + Item 13. + Certain Relationships and Related Transactions, and Director Independence + 48 + + + Item 14. + Principal Accountant Fees and Services + 48 + + + Item 15. + Exhibits, Financial Statement Schedules + 49 + + + + Selected Historical Financial Data of Our Company + 52 + + + + Management’s Discussion and Analysis of Financial Condition and Results of Operations + 56 + + + + Report of Management on Internal Control Over Financial Reporting + 76 + + + + Report of Independent Registered Public Accounting Firm + F-1 + + + + Consolidated Financial Statements and Related Notes + F-2 + + + + Supplementary Data: Quarterly Operating Results (unaudited) + F-44 + + + + Schedule II - Valuation Accounts and Reserves + F-47 + + \ No newline at end of file diff --git a/predictions/332.html b/predictions/332.html new file mode 100644 index 0000000000000000000000000000000000000000..3d9a17fbcb5a050f1f58c2818487c5ecc5d720ba --- /dev/null +++ b/predictions/332.html @@ -0,0 +1,14 @@ + + + + + + + + + + + + + +
201220112010
Stock options and performance share units
\ No newline at end of file diff --git a/predictions/333.html b/predictions/333.html new file mode 100644 index 0000000000000000000000000000000000000000..517efcc80ec324d71db9ae19d1661be10b4a1d86 --- /dev/null +++ b/predictions/333.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ItemPage
Financial Statements
Report of Independent Registered Public Accounting FirmF- 1
Consolidated Balance SheetsF- 2
Consolidated Statements of OperationsF- 3
Consolidated Statements of Comprehensive IncomeF- 4
Consolidated Statements of Cash FlowsF- 5
Consolidated Statements of Stockholders’ EquityF- 6
Notes to Consolidated Financial StatementsF- 7
Supplementary Data: Quarterly Operating Results (unaudited)F- 45
\ No newline at end of file diff --git a/predictions/334.html b/predictions/334.html new file mode 100644 index 0000000000000000000000000000000000000000..07f2ed47ca658c6eb0672922e29565a19e77fb72 --- /dev/null +++ b/predictions/334.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200520042003
Net income, as reported$546,277$499,195$436,717
Add: Stock-based compensation under APB 252,0371,3845,297
Deduct: Total stock-based compensation expense determined under fair value method for all awards, net of related tax effects(32,623)(43,710)(52,351)
Pro forma net income$515,691$456,869$389,663
Earnings per common share:
Basic – as reported$        2.71$        2.45$        2.11
Basic – pro forma$        2.56$        2.23$        1.88
Diluted – as reported$        2.66$        2.35$        2.02
Diluted – pro forma$        2.50$        2.13$        1.82
\ No newline at end of file diff --git a/predictions/335.html b/predictions/335.html new file mode 100644 index 0000000000000000000000000000000000000000..2f8518560a2ce2a869d6f8857562da653df64dec --- /dev/null +++ b/predictions/335.html @@ -0,0 +1,61 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
CollaboratorCollaboration
IBM Watson® Health, Memorial Sloan Kettering Cancer Center and the Broad Institute of MIT and HarvardIBM Watson® Genomics from Quest Diagnostics, a service that helps advance precision medicine by combining computing with genomic tumor sequencing. Memorial Sloan Kettering Cancer Center is supplementing Watson's corpus of scientific data with a precision oncology knowledge base to help inform more treatment options for cancer patients, and the Broad Institute of MIT and Harvard is providing additional genome sequencing capabilities.
Optum + Our billing operations became part of Optum, helping us to reduce the complexity of our billing processes and fostering increased transparency of health care costs.

+ Advance new technology services to digitize our customer orders and workflows, with the goals of reducing bad debt and payer denials and increasing operational efficiency and productivity.

+ Increase the use of diagnostic information services, such as data analytics, population health insights and connectivity solutions, to help improve health care effectiveness and manage costs for health plans and care providers.

+ We became Optum's primary partner for member biometric screening services that Optum provides to employers and health plans. +
AncestryDNA + We provide testing to help meet the rapidly growing consumer demand for genetic tests that provide insights into genetic ethnicity, origins and other factors.

+ Explore additional opportunities such as developing tools and applications to guide people on building and understanding their "family medical tree." +
SafewayWe are providing diagnostic testing services in the company-branded patient service centers in Safeway locations, enhancing convenient access to our services and diagnostics insights for patients.
InovalonData Diagnostics®, a tool that provides real-time patient-specific data analysis that clinicians can order at the point of care to identify and address gaps in quality, risk, utilization and medical history insights.
Inserm, the French National Institute of Health and Medical ResearchBRCA ShareTM, a novel data share initiative to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data.
Perinatal Quality FoundationThe national initiative to advance clinically appropriate noninvasive prenatal screening.
University of California, San Francisco, the nation's leading university focused exclusively on healthTo accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine. This collaboration has the overarching aim of enabling holistic and integrated diagnostic solutions that close gaps in care or enable new clinical value, with initial focus areas including autism, oncology, neurology and women's health.
U.S. Centers for Disease Control and Prevention ("CDC") + To improve public health analysis of hepatitis C screening, diagnosis and treatment, based on analysis of our database of national hepatitis C virus ("HCV") diagnostic information.

+ With CDC and the American Medical Association, to assess the prevalence of pre-diabetes. +
National Institutes of HealthWe participate in studies they sponsor (e.g., NIH National Children Study).
Quintiles IMS Holdings, Inc.Joint venture, Q2 SolutionsTM, providing central lab testing services for clinical trials.
\ No newline at end of file diff --git a/predictions/337.html b/predictions/337.html index 1e4cc430b1a559786a7a732f1855e71d8580699e..db28d8b2f23da02e9402ca97411810e953136543 100644 --- a/predictions/337.html +++ b/predictions/337.html @@ -13,17 +13,23 @@ - (a) - (b) - (c) - (d) - (e) + in billions - (dollars in millions) + + (a) (b) + (c) (d) + (e) (f) + (g) (h) + (i) (j) - Balance Sheet Data (at end of year): + Balance Sheet Data (at end of year): + + + + + Cash and cash equivalents @@ -58,7 +64,12 @@ 4,000 - Other Data: + Other Data: + + + + + Net cash provided by operating activities @@ -82,7 +93,7 @@ 92 (1,106) (822) - 64 + 364 Capital expenditures @@ -102,10 +113,10 @@ Dividends paid - 212 - 187 - 185 - 108 + 112 + 87 + 105 + 100 65 \ No newline at end of file diff --git a/predictions/338.html b/predictions/338.html new file mode 100644 index 0000000000000000000000000000000000000000..ce42ed668cb1f3500f470c799dfacded14342076 --- /dev/null +++ b/predictions/338.html @@ -0,0 +1,49 @@ + + + + + + + + + + + + + + + + + + + + + + + + + +
ThemeKey CharacteristicsAI 4.0 GlanceQuest Value Proposition
General DiagnosticsTesting services generating strong cash flows and steady growth + Routine and non-routine testing services
+ Largest revenue stream
+ Essential portion of health care delivery + 		+ Scale
+ Operational excellence
+ Access and convenience +
Advanced DiagnosticsTesting services providing faster growth through innovation testing model + Genetic and advanced molecular testing services
+ An important part of precision medicine
+ A growing set of unique, innovation-based competitors + 		+ Rich clinical, scientific and medical innovation expertise
+ Quality and reliability of new assays
+ Delivering on amplified customer expectations +
Diagnostic ServicesLaboratory and data-related healthcare opportunities providing faster growth + Enables partners to deliver health care more efficiently (e.g., risk assessment; Professional Laboratory Services; wellness)
+ Services to support population health (e.g., data analytics; extended care services) + 		+ Extensive diagnostic capability
+ Large and growing database and analytics expertise
+ Partnerships with industry leaders across healthcare landscape +
\ No newline at end of file diff --git a/predictions/339.html b/predictions/339.html new file mode 100644 index 0000000000000000000000000000000000000000..b1e54d572576dcafe9c080c833755415589f173a --- /dev/null +++ b/predictions/339.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ItemPage
Report of Independent Registered Public Accounting FirmF-1
Consolidated Balance SheetsF-3
Consolidated Statements of OperationsF-4
Consolidated Statements of Cash FlowsF-5
Consolidated Statements of Stockholders’ EquityF-6
Notes to Consolidated Financial StatementsF-7
Supplementary Data: Quarterly Operating Results (unaudited)F-37
\ No newline at end of file diff --git a/predictions/34.html b/predictions/34.html index a5878e8c1afafa1aba48c7b32ce1fbd0491bde09..727e729e515f936990c0ba758900acc62b75c018 100644 --- a/predictions/34.html +++ b/predictions/34.html @@ -1,34 +1,30 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - +
(Millions of dollars)Year Ended December 31
201420132012
Stock-based compensation cost$ 298$ 264$ 217
Tax benefit(90)(81)(67)
Stock-based compensation cost, net of tax$ 208$ 183$ 150
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
Millions of dollars201420132012
Stock-based compensation cost$ 298$ 264$ 217
Tax benefit(90)(81)(67)
Stock-based compensation cost, net of tax$ 208$ 183$ 150
\ No newline at end of file diff --git a/predictions/340.html b/predictions/340.html index 393a7e2475792491e9cb1527317b05c7fc986e8c..f174ca0ec9c8a599232e10db26283ed2f64bb1fa 100644 --- a/predictions/340.html +++ b/predictions/340.html @@ -8,19 +8,19 @@ 92 - Routine clinical testing services +     Routine clinical testing services 51 - Anatomic pathology testing services +     Anatomic pathology testing services 12 - Gene-based and esoteric testing services +     Gene-based and esoteric testing services 26 - Drugs of abuse testing services +     Drugs of abuse testing services 3 diff --git a/predictions/342.html b/predictions/342.html new file mode 100644 index 0000000000000000000000000000000000000000..77cb5d964dda681303bf3a09f605ece509feaad6 --- /dev/null +++ b/predictions/342.html @@ -0,0 +1,27 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + +
% of DIS Volume% of DIS Revenues
Healthcare Insurers (including coinsurance and deductible responsibilities)44 - 4848 - 52
Government Payers14 - 1817 - 21
Client Payers34 - 3826 - 30
Patients1 - 31 - 3
\ No newline at end of file diff --git a/predictions/343.html b/predictions/343.html new file mode 100644 index 0000000000000000000000000000000000000000..2625a377a0b9f998207d88e6f6dc519b1054472e --- /dev/null +++ b/predictions/343.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Customers and payersOur customers and payers, including clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, an increased number of hospital systems are considering establishing or have established health insurance plans, and health insurance plans increasingly are considering or are providing or are providing healthcare services.
Pricing transparencyConsolidation is increasing pricing transparency and bargaining power, and encouraging internationalization of clinical testing.
Physicians increasingly are employed by hospital systems, IDNs, ACOs or large group practices integrated with healthcare systems, instead of organizing physician-owned practices, which changes the dynamics for whether clinical testing is performed in or outside of a hospital. Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.
Value-based reimbursement is contributing to changes in the healthcare system. ACOs and patient-centered medical homes are growing as a means to deliver patient care. Health care services increasingly are being provided by non-traditional providers (e.g., physician assistants), in non-traditional venues (e.g., retail medical clinics, urgent care centers) and using new technologies (e.g., telemedicine).
In addition, federal healthcare reform legislation adopted in 2010 is resulting in changes in the way that some healthcare services are purchased and delivered in the United States.
Patients are also our customers. Increasingly, patients are engaged in their own healthcare and are bearing responsibility for payment of the services that we provide to them.
There has been a trend toward greater pricing transparency in the healthcare marketplace.
This transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and changes in behavior in the health care marketplace.
CompetitionThe clinical testing industry remains fragmented, is highly competitive and is subject to new competition.
Competition is growing from non-traditional competitors. Increased hospital acquisition of physician practices enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.
New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.
Reimbursement pressureThere is a strong focus in the United States on controlling the overall cost of healthcare.
Healthcare market participants, including governments, are focusing on controlling costs, including potentially by changing reimbursement for healthcare services (including but not limited to a shift from fee for service to capitation), changing medical coverage policies (e.g., healthcare benefits design), pre-authorization of lab testing, requiring co-pays, introducing lab spend management utilities and payment and patient care innovations such as ACOs and patient-centered medical homes.
In light of continued pressure to reduce systemic healthcare costs, hospitals may change their approach to providing clinical testing services.
While pressure to control healthcare costs poses a risk to our Company, it also creates opportunities, such as an opportunity for increased proper utilization of testing as an efficient means to manage the total cost of healthcare. We believe that it also creates greater opportunities for high value, low-cost providers, like our Company, as compared to other providers.
\ No newline at end of file diff --git a/predictions/344.html b/predictions/344.html new file mode 100644 index 0000000000000000000000000000000000000000..1efc246e37b4a74a41c4fd42cbae98d4dc762dea --- /dev/null +++ b/predictions/344.html @@ -0,0 +1,18 @@ + + + + + + + + + + + + + + + + + +
PatientsIn the current environment, patients are taking increased interest in and responsibility for their healthcare. In addition, patients often are bearing increased financial responsibility for their healthcare (e.g., high deductible health plans). Patients are paying greater attention to their healthcare, are increasing their demands of healthcare providers, have increased expectations regarding their healthcare experiences and are becoming more sophisticated regarding healthcare. For example, in our experience, patients are more focused on transparency, ease of doing business and understanding diagnostics information services that they have been in the past.
The changing expectations of patients about their healthcare and their healthcare transactions are influencing the way we think about our business and the services that we provide. We are well positioned to provide information and insights to patients to help them take actions to improve their healthcare, and increasingly we are providing patients with tools to do this.
Emerging Retail Healthcare ProvidersIn recent years, as the healthcare sector changes, retail providers of healthcare services have emerged and are growing. These providers include "big-box" retailers, pharmacy chains, supermarkets, urgent care centers and Internet-based service providers.
Other Laboratory and Other CustomersWe also provide services on a fee-for-service basis to federal, state and local governmental agencies and to other commercial clinical laboratories
\ No newline at end of file diff --git a/predictions/345.html b/predictions/345.html new file mode 100644 index 0000000000000000000000000000000000000000..9448e3462fc66f528341f1c6914774e3e0d6c6d1 --- /dev/null +++ b/predictions/345.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2006$134,406
2007105,705
200882,352
200967,499
201050,222
2011 and thereafter146,842
Minimum lease payments587,026
Noncancelable sub-lease income(94)
Net minimum lease payments$586,932
\ No newline at end of file diff --git a/predictions/346.html b/predictions/346.html index ae947622367c386c22990df4ce3802b77ee1ba0e..c8486f092862444a761a6dcf6043496a9c9e6b07 100644 --- a/predictions/346.html +++ b/predictions/346.html @@ -1,12 +1,17 @@ - + - + + + + + + @@ -25,7 +30,12 @@ - + + + + + + @@ -38,7 +48,7 @@ - + diff --git a/predictions/347.html b/predictions/347.html new file mode 100644 index 0000000000000000000000000000000000000000..80b16c0daab8dc50c3941fd70d7d2cb62c76ce1e --- /dev/null +++ b/predictions/347.html @@ -0,0 +1,70 @@ +
2005 2004 2003
Current:Current:
Federal $298,991 $233,635728
Deferred:Deferred:
Federal (2,320) 41,3164,582
TotalTotal $364,177 $335,931 $301,081
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationLeased or Owned
Sacramento, California (laboratory)Leased
West Hills, California (laboratory)Leased
San Juan Capistrano, California (laboratory)Owned
Tampa, Florida (laboratory)Owned
Atlanta, Georgia (laboratory)Owned
Chicago, Illinois (2) (laboratories)One owned, one leased
Marlborough, Massachusetts (laboratories)Leased
Baltimore, Maryland (laboratory)Owned
Teterboro, New Jersey (laboratory)Owned
Philadelphia, Pennsylvania (laboratory)Leased
Dallas, Texas (laboratory)Leased
Chantilly, Virginia (laboratory)Leased
Lenexa, Kansas (laboratory)Owned
Greensboro, North Carolina (laboratory)Leased
Lewisville, Texas (laboratory)Leased
Cleveland, Ohio (laboratory)Leased
\ No newline at end of file diff --git a/predictions/348.html b/predictions/348.html new file mode 100644 index 0000000000000000000000000000000000000000..ccd5d0a3596b12371d462cda17040c2643870fe9 --- /dev/null +++ b/predictions/348.html @@ -0,0 +1,47 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Financial StatementsItemPage
Report of Independent Registered Public Accounting FirmF- 1
Consolidated Balance SheetsF- 2
Consolidated Statements of OperationsF- 3
Consolidated Statements of Comprehensive IncomeF- 4
Consolidated Statements of Cash FlowsF- 5
Consolidated Statements of Stockholders' EquityF- 6
Notes to Consolidated Financial StatementsF- 7
Supplementary Data: Quarterly Operating Results (unaudited)F- 44
\ No newline at end of file diff --git a/predictions/349.html b/predictions/349.html new file mode 100644 index 0000000000000000000000000000000000000000..cf6282ff05cfaf70e0be1e9b4e1dcc544c199f2e --- /dev/null +++ b/predictions/349.html @@ -0,0 +1,160 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
20182017201620152014
(dollars in millions, except per share data)
(a) (b) (c)(a) (d) (e)(a) (d)(a) (f) (g)(a) (h) (i)(a) (j) (k)
Operations Data:
Net revenues$7,531$7,402$7,214$7,493$7,435
Operating income1,1011,1651,2771,399983
Income from continuing operations788824696753587
Income from discontinued operations, net of taxes————5
Net income788824696753592
Less: Net income attributable to noncontrolling interests5252514436
Net income attributable to Quest Diagnostics'$736$772$645$709$556
Amounts attributable to Quest Diagnostics' stockholders:
Income from continuing operations$736$772$645$709$551
Income from discontinued operations, net of taxes————5
Net income$736$772$645$709$556
\ No newline at end of file diff --git a/predictions/35.html b/predictions/35.html new file mode 100644 index 0000000000000000000000000000000000000000..d29627aceac402ea5426d559dab03f02d5a6a19e --- /dev/null +++ b/predictions/35.html @@ -0,0 +1,218 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31
201620152014
Cash flows from operating activities:
Net income (loss)$ (5,769)$(667)$3,501
Adjustments to reconcile net income (loss) to cash flows from operating activities:
Impairments and other charges3,3572,177129
Depreciation, depletion and amortization1,5031,8352,126
Deferred income tax benefit, continuing operations(1,501)(224)(454)
Cash impact of impairments and other charges - severance payments(273)(304)(28)
Payment related to the Macondo well incident(33)(333)(569)
Changes in assets and liabilities:
Receivables8991,468(1,381)
Inventories552153(271)
Accounts payable(219)(603)489
Other(219)(596)520
Total cash flows provided by (used in) operating activities(1,703)2,9064,062
Cash flows from investing activities:
Capital expenditures(798)(2,184)(3,283)
Proceeds from sales of property, plant and equipment222168338
Payments to acquire businesses, net of cash acquired(31)(39)(231)
Other investing activities(103)(137)38
Total cash flows used in investing activities(710)(2,192)(3,138)
Cash flows from financing activities:
Payments on long-term borrowings(3,171)(8)(4)
Dividends to shareholders(620)(614)(533)
Proceeds from issuance of common stock186167332
Proceeds from issuance of long-term debt, net747,440—
Payments to reacquire common stock——(800)
Other financing activities(9)96(25)
Total cash flows provided by (used in) financing activities(3,540)7,081(1,030)
Effect of exchange rate changes on cash(115)(9)41
Increase (decrease) in cash and equivalents(6,068)7,786(65)
Cash and equivalents at beginning of year10,0772,2912,356
Cash and equivalents at end of year$ 4,009$10,077$2,291
Supplemental disclosure of cash flow information:
Cash payments (receipts) during the period for:
Interest$ 659$380$384
Income taxes$ (20)$370 $1,269
\ No newline at end of file diff --git a/predictions/350.html b/predictions/350.html new file mode 100644 index 0000000000000000000000000000000000000000..fa64bf5aacaf5b77273076bd1e7c53c92095b02e --- /dev/null +++ b/predictions/350.html @@ -0,0 +1,72 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Weighted
Average
Amortization
Period		December 31, 2005December 31, 2004
CostAccumulated
Amortization		NetCostAccumulated
Amortization		Net
Amortizing
intangible assets:
Customer
intangibles . . . . . .		20 years$172,522($39,297)$133,225$42,225($37,197)$ 5,028
Non-compete
agreements . . . . . .		5 years45,707(44,221)1,48644,942(42,348)2,594
Other . . . . . . . . . . .6 years7,044(3,772)3,2726,850(3,010)3,840
Total20 years$225,273($87,290)$137,983$94,017($82,555)$11,462
\ No newline at end of file diff --git a/predictions/351.html b/predictions/351.html new file mode 100644 index 0000000000000000000000000000000000000000..c36c24c53b22c33342717e25c992cdce00de94cd --- /dev/null +++ b/predictions/351.html @@ -0,0 +1,187 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ItemPage
Item 1.Business1
Our Strategy and Strengths2
Business Operations10
The United States Clinical Testing Market14
General20
Billing and Reimbursement23
Regulation24
Available Information27
Executive Officers of the Company28
Item 1A.Risk Factors30
Cautionary Factors That May Affect Future Results37
Item 1B.Unresolved Staff Comments39
Item 2.Properties39
Item 3.Legal Proceedings39
Item 4.Mine Safety Disclosures39
Item 5.Market for Registrant’s Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities40
Item 6.Selected Financial Data42
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations42
Item 7A.Quantitative and Qualitative Disclosures About Market Risk42
Item 8.Financial Statements and Supplementary Data42
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure42
Item 9A.Controls and Procedures42
Item 9B.Other Information42
Item 10.Directors, Executive Officers and Corporate Governance44
Item 11.Executive Compensation44
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholders’ Matters44
Item 13.Certain Relationships and Related Transactions, and Director Independence44
Item 14.Principal Accountant Fees and Services44
Item 15.Exhibits, Financial Statement Schedules45
Selected Historical Financial Data of Our Company48
Management’s Discussion and Analysis of Financial Condition and Results of Operations52
Report of Management on Internal Control Over Financial Reporting71
Report of Independent Registered Public Accounting FirmF-1
Consolidated Financial Statements and Related NotesF-2
Supplementary Data: Quarterly Operating Results (unaudited)F-45
Schedule II - Valuation Accounts and ReservesF-48
\ No newline at end of file diff --git a/predictions/352.html b/predictions/352.html new file mode 100644 index 0000000000000000000000000000000000000000..9f38f2d9abf90f02daaa5c6e81edd415213cc28e --- /dev/null +++ b/predictions/352.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ThemeKey CharacteristicsAI A GlanceQuest Value Proposition
General DiagnosticsTesting services generating strong cash flows and steady growthRoutine and non-routine testing servicesScale
Largest revenue streamOperational excellence
Essential portion of health care deliveryAccess and convenience
Advanced DiagnosticsTesting services providing faster growth through innovation testing modelGenetic and advanced molecular testing servicesRich clinical, scientific and medical innovation expertise
An important part of precision medicineQuality and reliability of new assays
A growing set of unique, innovation-based competitorsAbility to manage potential new regulatory requirements
Diagnostic ServicesLaboratory and data-related healthcare opportunities providing faster growthEnables partners to deliver health care more efficiently (e.g., risk assessment; Professional Laboratory Services; wellness)Extensive diagnostic capability
Services to support population health (e.g., data analytics; extended care services)Large and growing database and analytics expertise
Partnerships with industry leaders across healthcare landscape
\ No newline at end of file diff --git a/predictions/353.html b/predictions/353.html new file mode 100644 index 0000000000000000000000000000000000000000..6d1f6ed9f460f46b613fe5e796874d8d1fe5038b --- /dev/null +++ b/predictions/353.html @@ -0,0 +1,38 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
CollaboratorCollaboration
InovalonData Diagnostics™, a tool that provides real-time patient-specific data analysis that clinicians can order at the point of care to identify and address gaps in quality, risk, and cost.
Inserm, the French National Institute of Health and Medical ResearchBRCA Share™ a novel data share initiative to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data.
Perinatal Quality FoundationThe national initiative to advance clinically appropriate noninvasive prenatal screening.
University of California, San Francisco, the nation’s leading university focused exclusively on healthTo accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine. This collaboration has the overarching aim of enabling holistic and integrated diagnostic solutions that close gaps in care or enable new clinical value, with initial focus areas including autism, oncology, neurology and women’s health.
U.S. Centers for Disease Control and Prevention (“CDC”)To improve public health analysis of hepatitis C screening, diagnosis and treatment, based on analysis of our database of national hepatitis C virus (“HCV”) diagnostic information.
National Institutes of HealthWe participate in studies they sponsor (e.g., NIH National Children Study).
Memorial Sloan Kettering Cancer CenterOur OncoVantage™ solid tumor mutation testing services.
Quintiles Transnational Holdings Inc.Joint venture to provide central laboratory testing services for clinical trials.
\ No newline at end of file diff --git a/predictions/354.html b/predictions/354.html new file mode 100644 index 0000000000000000000000000000000000000000..27c32693a68f4636fc0626fa6835df103e8970e3 --- /dev/null +++ b/predictions/354.html @@ -0,0 +1,110 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20182017
(in millions)
Deferred tax assets
Deferred revenue$        10.6$        18.5
Allowance for doubtful accounts267.0282.4
Net operating loss carryforwards and other carryforwards60.897.0
Stock-based compensation and other employee benefits24.423.2
Accrued expenses and other66.384.5
Total deferred tax assets429.1505.6
Valuation allowance(36.3)(76.4)
Deferred tax assets, net of valuation allowance392.8429.2
Deferred tax liabilities
Deferred income$       409.8$       364.3
Depreciation79.237.9
Intangible assets113.4210.1
Total deferred tax liabilities602.4612.3
Net deferred tax liability$      (209.6)$      (183.1)
Amounts recognized in the consolidated balance sheets:
Non-current assets$        47.0$        28.1
Non-current liabilities(256.6)(211.2)
Total – Net deferred tax liability$      (209.6)$      (183.1)
\ No newline at end of file diff --git a/predictions/355.html b/predictions/355.html new file mode 100644 index 0000000000000000000000000000000000000000..167f92db096d514e0c81665fd42e1eeb3d341273 --- /dev/null +++ b/predictions/355.html @@ -0,0 +1,324 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31, 2009Loyalty ServicesEpsilon Marketing ServicesPrivate Label ServicesPrivate Label CreditCorporate/OtherEliminationsTotal
Revenues$715,091$514,272$396,666(in thousands) $693,187$28,644($383,518)$1,964,341
Adjusted EBITDA(1)200,724128,253120,825194,503(54,124)—590,077
Depreciation and amortization21,77269,9419,80114,3568,417—125,286
Stock compensation expense12,2278,8156,5851,61424,371—53,612
Merger and other costs(2)————3,422—3,422
Operating income (loss)166,72549,497104,436177,433(90,334)—407,757
Interest expense, net————144,811—144,811
Income (loss) from continuing operations before income taxes————(235,145)—262,946
Capital expenditures23,16514,27711,5232,2211,784—52,970
Year Ended December 31, 2008Loyalty ServicesEpsilon Marketing ServicesPrivate Label ServicesPrivate Label CreditCorporate/OtherEliminationsTotal
Revenues$755,486$490,998$382,647(in thousands) $750,335$17,337($371,629)$2,025,234
Adjusted EBITDA(1)204,895126,558116,010254,173(46,407)—655,229
Depreciation and amortization29,09675,4818,83211,48610,891—135,786
Stock compensation expense12,7118,8336,5911,78818,201—48,124
Merger and other costs(2)—2,6331,435—4,988—9,056
Loss on sale of assets————1,052—1,052
Operating income (loss)162,48839,59199,152240,899(81,539)—460,591
Interest expense, net————80,440—80,440
Income (loss) from continuing operations before income taxes————(161,979)—380,151
Capital expenditures15,62112,9719,4964,2173,238—45,543
Year Ended December 31, 2007Loyalty ServicesEpsilon Marketing ServicesPrivate Label ServicesPrivate Label CreditCorporate/OtherEliminationsTotal
Revenues$628,792$458,610$370,832(in thousands) $827,932$33,360($357,387)$1,962,139
Adjusted EBITDA(1)132,136118,21999,084350,079(67,333)—632,185
Depreciation and amortization24,60171,8018,42911,73110,849—127,011
Stock compensation expense7,35311,3905,6131,27423,191—48,821
Merger and other costs(2)————19,593—19,593
Loss on sale of assets————16,045—16,045
Operating income (loss)100,18434,93585,042338,075(137,011)—421,225
Interest expense, net————69,381—69,381
Income (loss) from continuing operations before income taxes————(206,392)—351,844
Capital expenditures35,28130,55515,5982,7896,857—91,080
\ No newline at end of file diff --git a/predictions/356.html b/predictions/356.html new file mode 100644 index 0000000000000000000000000000000000000000..d48b2eec506a7c40a4bf6a0521eb1f07cfefbe0d --- /dev/null +++ b/predictions/356.html @@ -0,0 +1,52 @@ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.Description
*10.103Second Amendment to Purchase and Sale Agreement, dated as of November 9, 2000, between Spirit of America National Bank and Charming Shoppes Receivables Corp.
*10.104Third Amendment to Purchase and Sale Agreement, dated as of May 8, 2001, between Spirit of America National Bank and Charming Shoppes Receivables Corp.
*10.105Consent to Purchase and Sale Agreement, dated as of October 17, 2007, between Spirit of America National Bank and Charming Shoppes Receivables Corp.
*10.106Fourth Amendment to Purchase and Sale Agreement, dated as of October 30, 2009, among Spirit of America National Bank, Charming Shoppes Receivables Corp., World Financial Network National Bank and WFN Credit Company, LLC.
*10.107Second Amended and Restated Pooling and Servicing Agreement, dated as of November 25, 1997, among Charming Shoppes Receivables Corp., Spirit America, Inc., and First Union National Bank.
*10.108First Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of July 22, 1999, among Charming Shoppes Receivables Corp., Spirit America, Inc. and First Union National Bank.
*10.109Second Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of May 8, 2001, among Charming Shoppes Receivables Corp., Spirit America, Inc. and First Union National Bank.
*10.110Fourth Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of August 5, 2004, among Charming Shoppes Receivables Corp., Spirit America, Inc. and Wachovia Bank, National Association.
*10.111Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of March 18, 2005, among Charming Shoppes Receivables Corp., Spirit America, Inc. and Wachovia Bank, National Association.
*10.112Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of October 17, 2007, among Charming Shoppes Receivables Corp., Spirit America, Inc. and U.S. Bank National Association.
*10.113Sixth Amendment to Second Amended and Restated Pooling and Servicing Agreement, dated as of October 30, 2009, among Spirit America, Inc., Charming Shoppes Receivables Corp., World Financial Network National Bank, WFN Credit Company, LLC and U.S. Bank National Association.
10.114Receivables Purchase Agreement, dated as of September 28, 2001, between World Financial Network National Bank and WFN Credit Company, LLC
\ No newline at end of file diff --git a/predictions/357.html b/predictions/357.html index 5ecebcf5dd72034c21c41f487a53f0f1992ed654..7ac79af75b3e1872731350700a5b358727d0353e 100644 --- a/predictions/357.html +++ b/predictions/357.html @@ -1,53 +1,57 @@ - +
- + + + - + - - - + + + - - - + + + - - - + + + - + + + - + - - - + + + - - - + + + - - - + + +
High Low
Year Ended December 31, 2015Year Ended December 31, 2015
First quarter . . . . . . . . . . . . . . . . . .First quarter $301.74 $268.93
Second quarter . . . . . . . . . . . . . . . . .$312.00$289.38Second quarter312.00289.38
Third quarter . . . . . . . . . . . . . . . . . .$307.78$241.91Third quarter307.78241.91
Fourth quarter . . . . . . . . . . . . . . . . .$303.75$256.24Fourth quarter303.75256.24
Year Ended December 31, 2014Year Ended December 31, 2014
First quarter . . . . . . . . . . . . . . . . . .First quarter $300.49 $230.53
Second quarter . . . . . . . . . . . . . . . . .$284.40$230.79Second quarter284.40230.79
Third quarter . . . . . . . . . . . . . . . . . .$288.67$239.83Third quarter288.67239.83
Fourth quarter . . . . . . . . . . . . . . . . .$292.96$230.54Fourth quarter292.96230.54
\ No newline at end of file diff --git a/predictions/358.html b/predictions/358.html new file mode 100644 index 0000000000000000000000000000000000000000..8c225ce6006212c4ec34fd853c5fc9c51aa22f23 --- /dev/null +++ b/predictions/358.html @@ -0,0 +1,40 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200720062005
In thousands
Cash provided by operating activities before changes in credit card portfolio activity and merchant settlement activity$461,862$376,847$293,863
Net change in credit card portfolio activity(5,780)80,890(186,419)
Net change in merchant settlement activity115,43911,0431,637
Cash provided by operating activities$571,521$468,780$109,081
\ No newline at end of file diff --git a/predictions/359.html b/predictions/359.html new file mode 100644 index 0000000000000000000000000000000000000000..043721a2e51feb04141164460e8951bc8d706f81 --- /dev/null +++ b/predictions/359.html @@ -0,0 +1,10 @@ + + + + + + + + + +
Exhibit No.FilerDescriptionFormExhibitFiling Date
\ No newline at end of file diff --git a/predictions/36.html b/predictions/36.html new file mode 100644 index 0000000000000000000000000000000000000000..0757c7569c6ce2a65c72c80b3d09c98000439f3b --- /dev/null +++ b/predictions/36.html @@ -0,0 +1,279 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars except per share dataQuarterYear
FirstSecondThirdFourth
2007
Revenue$ 3,422$ 3,735$ 3,928$ 4,179$ 15,264
Operating income7888939109073,498
Income from continuing operations5295957266742,524
Income from discontinued operations23935116975
Net income5521,5307276903,499
Earnings per share:
    Basic income per share:
        Income from continuing operations0.530.660.830.772.76
        Income from discontinued operations0.021.03—0.021.07
        Net income0.551.690.830.793.83
    Diluted income per share:
        Income from continuing operations0.520.630.790.742.66
        Income from discontinued operations0.020.99—0.011.02
        Net income0.541.620.790.753.68
Cash dividends paid per share0.0750.090.090.090.345
Common stock prices (2)
    High32.7237.2039.1741.9541.95
    Low27.6530.9930.8134.4227.65
2006
Revenue$ 2,938$ 3,116$ 3,392$ 3,509$ 12,955
Operating income6927608709233,245
Income from continuing operations4494986036272,177
Income from discontinued operations3993831171
Net income4885916116582,348
Earnings per share:
    Basic income per share:
        Income from continuing operations0.440.490.600.632.15
        Income from discontinued operations0.040.090.010.030.16
        Net income0.480.580.610.662.31
    Diluted income per share:
        Income from continuing operations0.420.470.570.612.07
        Income from discontinued operations0.040.080.010.030.16
        Net income0.460.550.580.642.23
Cash dividends paid per share0.0750.0750.0750.0750.30
Common stock prices (2)
    High41.1941.9937.9334.3041.99
    Low31.3533.9227.3526.3326.33
\ No newline at end of file diff --git a/predictions/360.html b/predictions/360.html index 03ad7c2bf7e04e059d78e3fefba4d3c965c602be..c5c508505cb9e82da6fba40a83b2801dfd650a97 100644 --- a/predictions/360.html +++ b/predictions/360.html @@ -1,60 +1,58 @@ - + + - - - - + - + - + - + - + - - + + - + - + - + diff --git a/predictions/361.html b/predictions/361.html index 88d681f14714c3474c4f60dab57dbf5adea0403e..582f4f655176f619021f5c5957e409a5c6bdbfed 100644 --- a/predictions/361.html +++ b/predictions/361.html @@ -1,7 +1,8 @@
Years Ended December 31,
2015 2014 2013
(In thousands)
Expected expense at statutory rate . . . . . . . . . . . . . . . . . . . . . . .Expected expense at statutory rate $326,087 $293,279 $277,694
Increase (decrease) in income taxes resulting from:Increase (decrease) in income taxes resulting from:
State income taxes, net of federal benefitState income taxes, net of federal benefit 27,421 7,874 20,871
Foreign earnings at other than U.S. ratesForeign earnings at other than U.S. rates (26,874) (8,108) (9,225)
U.S. tax on foreign dividends, net of creditsU.S. tax on foreign dividends, net of credits 2,793——
Non-deductible expenses (non-taxable income)Non-deductible expenses (non-taxable income) (722) 27,347 (742)
OtherOther (2,457) 1,409 8,644
TotalTotal $326,248 $321,801 $297,242
- + + @@ -9,12 +10,18 @@ - + + + + + + + - - + + @@ -67,12 +74,14 @@ - + + + - - + + @@ -91,21 +100,23 @@ - - + + - + + + - - + + - - + + diff --git a/predictions/362.html b/predictions/362.html new file mode 100644 index 0000000000000000000000000000000000000000..d41a03db26f766ee18f20de4edaaca58dac90c09 --- /dev/null +++ b/predictions/362.html @@ -0,0 +1,58 @@ +
December 31, (In thousands)December 31,
2007
Deferred tax assets(In thousands)
Deferred tax assets
Deferred revenue135,276138,644$135,276$138,644
Allowance for doubtful accounts262,600
Deferred tax liabilitiesDeferred tax liabilities
Deferred income48,49236,372$48,492$36,372
Servicing rights
Net deferred tax asset161,755129,052$161,755$129,052
Amounts recognized in the consolidated balance sheet:Amounts recognized in the consolidated balance sheet:
Current assets216,945187,390$216,945$187,390
Non-current liabilities55,80458,801$ 55,804$ 58,801
Discontinued operations net deferred tax asset (included in assets held for sale)
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Redeemable
Non-Controlling
Interest
(in thousands)
Balance at January 2, 2014$341,907
Net income attributable to non-controlling interest9,847
Other comprehensive income attributable to non-controlling interest1,988
Adjustment to redemption value14,775
Foreign currency translation adjustments(39,654)
Reclassification to accrued expenses(93,297)
Balance at December 31, 2014$235,566
Net income attributable to non-controlling interest8,887
Other comprehensive income attributable to non-controlling interest900
Adjustment to redemption value45,025
Foreign currency translation adjustments(24,113)
Reclassification to accrued expenses(98,888)
Balance at December 31, 2015$167,377
\ No newline at end of file diff --git a/predictions/363.html b/predictions/363.html new file mode 100644 index 0000000000000000000000000000000000000000..4c98c8580f848f3fe71352be874de017f108dd85 --- /dev/null +++ b/predictions/363.html @@ -0,0 +1,56 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20102009
Software development and conversion costs$ 161,518$ 128,305
Computer equipment and purchased software146,895107,861
Furniture and fixtures71,78354,375
Leasehold improvements69,15265,118
Capital leases46,86567,336
Construction in progress5,38416,665
Total501,597439,660
Accumulated depreciation(330,970)(274,648)
Property and equipment, net$ 170,627$ 165,012
\ No newline at end of file diff --git a/predictions/364.html b/predictions/364.html new file mode 100644 index 0000000000000000000000000000000000000000..79095e198bd8f6c616100ccda8e41ffe1dd41089 --- /dev/null +++ b/predictions/364.html @@ -0,0 +1,80 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20092008
(In thousands)
Assets:
Cash and cash equivalents$ 375$ 140
Investment in subsidiaries1,099,5991,140,697
Intercompany receivables1,299,0371,259,710
Other assets50,93848,120
Total assets$2,449,949$2,448,067
Liabilities:
Current debt$ 24,150$ 250,000
Long-term debt1,724,7771,284,100
Other liabilities428,246366,669
Total liabilities2,177,1731,900,769
Stockholders’ equity272,776547,298
Total liabilities and stockholders’ equity$2,449,949$2,448,067
\ No newline at end of file diff --git a/predictions/365.html b/predictions/365.html new file mode 100644 index 0000000000000000000000000000000000000000..706d02e8bd245d2da68359c3bbc00172996d4e81 --- /dev/null +++ b/predictions/365.html @@ -0,0 +1,25 @@ + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 2010December 31, 2009
(in thousands)
Assets:
Credit card receivables, net$ 11,920$ 34,623
Assets of discontinued operations$ 11,920$ 34,623
\ No newline at end of file diff --git a/predictions/366.html b/predictions/366.html new file mode 100644 index 0000000000000000000000000000000000000000..a3beec16c027582b452d6dd36977d7a4ba4d7836 --- /dev/null +++ b/predictions/366.html @@ -0,0 +1,98 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20152014201320122011
As of December 31,
(In thousands)
Balance sheet data
Credit card and loan receivables, net$13,057,852$10,673,709$ 8,069,713$ 6,697,674$ 5,197,690
Redemption settlement assets, restricted456,564520,340510,349492,690515,828
Total assets22,421,83020,263,97713,244,25712,000,1398,980,249
Deferred revenue844,9071,013,1771,137,1861,249,0611,226,436
Deposits5,622,3104,773,5412,816,3612,228,4111,353,775
Non-recourse borrowings of consolidated securitization entities6,493,1665,191,9164,591,9164,130,9703,260,287
Long-term and other debt, including current maturities
Total liabilities20,244,42317,632,05112,388,49611,471,6328,804,283
Redeemable non-controlling interest167,377235,566528,487175,966
\ No newline at end of file diff --git a/predictions/367.html b/predictions/367.html new file mode 100644 index 0000000000000000000000000000000000000000..cb1b955f964a6908c56deb12afef8621ea4af0cf --- /dev/null +++ b/predictions/367.html @@ -0,0 +1,20 @@ + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
201820172016
(In millions)
Interest from loans to subsidiaries . . . . . . . . . . . . . . .$ 17.9$ 13.8$ 11.8
Dividends from subsidiaries . . . . . . . . . . . . . . . . . . .810.1360.6438.4
    Total revenue . . . . . . . . . . . . . . . . . . . .828.0374.4450.2
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . .281.2278.9214.9
Other expenses, net . . . . . . . . . . . . . . . . . . . . . . .(0.4)12.9(1.3)
    Total expenses . . . . . . . . . . . . . . . . . . .280.8291.8213.6
Income before income taxes and equity in undistributed net income of subsidiaries . . . . . . . . . . . . . . . . . . . . . . .547.282.6236.6
Benefit for income taxes . . . . . . . . . . . . . . . . . . . . .7.0322.775.2
Income before equity in undistributed net income of subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .554.2405.3311.8
Equity in undistributed net income of subsidiaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .408.9383.4205.8
Net income. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 963.1$ 788.7$ 517.6
\ No newline at end of file diff --git a/predictions/368.html b/predictions/368.html new file mode 100644 index 0000000000000000000000000000000000000000..77498ba9b42a4a7bc51826eb0518bd20f4c4d5bf --- /dev/null +++ b/predictions/368.html @@ -0,0 +1,25 @@ + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
20142013
(In thousands)
Total revenue$5,853,501$4,892,184
Net income$1,178,414$1,184,404
\ No newline at end of file diff --git a/predictions/369.html b/predictions/369.html new file mode 100644 index 0000000000000000000000000000000000000000..4c1b4481db03f76c413b7871e300c5563ce14946 --- /dev/null +++ b/predictions/369.html @@ -0,0 +1,49 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
As of
February 1, 2007
Current assetsIn thousands)
Current assets$ 22,863
Property, plant and equipment13,844
Capitalized software19,200
Identifiable intangible assets169,760
Goodwill222,935
Total assets acquired448,602
Current liabilities9,325
Total liabilities assumed9,325
Net assets acquired$439,277
\ No newline at end of file diff --git a/predictions/37.html b/predictions/37.html index 5712983757a064d887de15ea563694f4033168af..2b5346b1fbb56d9724b1897df5024778ee7e56d3 100644 --- a/predictions/37.html +++ b/predictions/37.html @@ -1,19 +1,200 @@ - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Land vs. Offshore
201620152014
United States:
Land4869431,804
Offshore (incl. Gulf of Mexico)233557
Total5099781,861
Canada:
Land128189378
Offshore222
Total130191380
International (excluding Canada):
Land7348841,011
Offshore221283326
Total9551,1671,337
Worldwide total1,5942,3363,578
Land total1,3482,0163,193
Offshore total246320385
201620152014
Land vs. Offshore
United States:
Land4869431,804
Offshore (incl. Gulf of Mexico)233557
Total5099781,861
Canada:
Land128189378
Offshore222
Total130191380
International (excluding Canada):
Land7348841,011
Offshore221283326
Total9551,1671,337
Worldwide total1,5942,3363,578
Land total1,3482,0163,193
Offshore total246320385
Oil vs. Natural Gas
United States (incl. Gulf of Mexico):
Oil4097511,528
Natural gas100227333
Total5099781,861
Canada:
Oil6384218
Natural gas67107162
Total130191380
International (excluding Canada):
Oil7269161,070
Natural gas229251267
Total9551,1671,337
Worldwide total1,5942,3363,578
Oil total1,1981,7512,816
Natural gas total396585762
\ No newline at end of file diff --git a/predictions/370.html b/predictions/370.html index 5dd5e3c5d837ed399c83b8c634ab165d345e2bc8..27b20154c9486188976843df31030f1422254a3e 100644 --- a/predictions/370.html +++ b/predictions/370.html @@ -51,7 +51,7 @@ New York, New York Epsilon Marketing Services 50,648 - January 31, 2011 + January 31, 2018 Wakefield, Massachusetts diff --git a/predictions/371.html b/predictions/371.html new file mode 100644 index 0000000000000000000000000000000000000000..d9a0177da7a6481e86596064598ec8d17526f1de --- /dev/null +++ b/predictions/371.html @@ -0,0 +1,67 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Balance at December 31, 2008$66,330
Increases related to prior years’ tax positions9,527
Decreases related to prior years’ tax positions(16,190)
Increases related to current year tax positions5,250
Settlements during the period(2,560)
Lapse of applicable statute of limitations(11,210)
Balance at December 31, 2009$51,147
Increases related to prior years’ tax positions2,391
Decreases related to prior years’ tax positions(2,337)
Increases related to current year tax positions5,957
Settlements during the period(2,026)
Lapse of applicable statute of limitations(932)
Balance at December 31, 2010$54,200
\ No newline at end of file diff --git a/predictions/372.html b/predictions/372.html new file mode 100644 index 0000000000000000000000000000000000000000..5cd181e323531d51be29a242b2f5ce5889ee6877 --- /dev/null +++ b/predictions/372.html @@ -0,0 +1,12 @@ + + + + + + + + + + + +
Years Ended December 31,
20172016
(in millions)
Cost of operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 57.5$ 50.3$ 56.0
General and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23.324.820.5
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 80.8$ 75.1$ 76.5
\ No newline at end of file diff --git a/predictions/373.html b/predictions/373.html new file mode 100644 index 0000000000000000000000000000000000000000..7cb785d4026ee11d27233e8bddebbe7c091b66e6 --- /dev/null +++ b/predictions/373.html @@ -0,0 +1,67 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20092008
(In thousands)
Certificates of deposit$1,465,000$ 688,900
Credit facility487,000365,000
Senior notes250,000500,000
Term loan161,000—
Convertible senior notes due 2013612,058569,100
Convertible senior notes due 2014238,869—
Capital lease obligations and other debt33,42557,175
3,247,3522,180,175
Less: current portion(824,463)(709,449)
Long-term portion$2,422,889$1,470,726
\ No newline at end of file diff --git a/predictions/374.html b/predictions/374.html new file mode 100644 index 0000000000000000000000000000000000000000..06bc9462429bb33c233810d53844929f7662179c --- /dev/null +++ b/predictions/374.html @@ -0,0 +1,380 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
201920182017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$ 193,737$ 143,734$ 206,402
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization143,226125,409143,810
Deferred income taxes19,06117,47521,104
Provision for loan loss390,82286,60438,796
Non-cash stock compensation50,09453,70254,333
Fair value gain on interest-only strip(5,340)(31,065)
Fair value gain on account and derivative(7,725)
Amortization of discount on convertible senior notes6,13152,67716,928
Impairment of long-lived assets19,004
Gain on acquisition of business(21,227)
Loss (gain) on sale of assets19,013(20,564)
Change in operating assets and liabilities, net of acquisitions:
Change in trade accounts receivable(44,040)(2,162)(17,014)
Change in merchant settlement activity(18,007)(16,197)
Change in other assets32,524(31,631)(46,166)
Change in accounts payable and accrued expenses61,164(39,460)(52,909)
Change in deferred revenue14,485(5,053)378,673
Change in other liabilities1,431(19,409)26,827
Purchase of credit card receivables(27,407)(206,529)
Proceeds from the sale of credit card receivable portfolios to the securitization trusts53,240102,986
Excess tax benefits from stock-based compensation(12,999)(9,040)(2,268)
Other(9,242)(14,708)(4,347)
Net cash provided by operating activities902,707358,414451,017
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment(172,352)52,354(317,591)
Change in restricted cash2,891(101,299)34,626
Change in seller’s interest(114,679)35,465
Change in credit card receivables(233,433)(314,561)(95,961)
Change in cash collateral, restricted35,841(117,151)
Change in due from securitizations(259,227)(202,463)
Capital expenditures to businesses(68,755)(52,970)(49,556)
Payments for acquired businesses, net of cash acquired(117,000)(58,901)(2,478)
Proceeds from the sale of assets4,01314,398
Proceeds from sale of credit card receivable portfolios to the securitization trusts5,34791,910
Investments in the sale of an investee137,962
Proceeds from the sale of businesses(5,910)
Other(4,207)7,3545,910
Net cash used in investing activities(340,784)(888,022)(512,518)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under bank credit facilities1,507,0003,124,0003,754,416
Repayment of borrowings(1,462,806)(3,094,939)(3,799,786)
Proceeds from issuance of convertible senior notes345,000805,000
Issuances of certificates of deposit177,6001,597,6001,028,500
Repayments of certificates of deposit(783,600)(803,000)(710,000)
Proceeds from asset-backed securities1,147,943
Maturities of asset-backed securities(1,273,735)
Payment of capital lease obligations(23,131)(21,840)(22,503)
Payment of deferred financing costs(3,102)(24,083)(34,861)
Proceeds from sale leaseback transactions12,9599,04034,221
Excess tax benefits from stock-based compensation28,8642,269
Proceeds from issuance of common stock33,85430,85630,920
Proceeds from issuance of warrants30,05094,188
Payment for convertible note hedges(80,765)(201,814)
Purchase of prepaid forward contracts(74,782)
Purchase of treasury shares(143,717)(44,391)(100,851)
Net cash used in providing by financing activities(715,675)570,189(230,306)
Effect of exchange rate changes on cash and cash equivalents2,06715,856(2,712)
Change in cash and cash equivalents(151,685)56,437(108,529)
Cash effect on adoption of ASC 860 and ASC 81081,553
Cash and cash equivalents at beginning of year213,378156,911265,839
Cash and cash equivalents at end of year$ 133,114$ 213,378$ 156,911
\ No newline at end of file diff --git a/predictions/375.html b/predictions/375.html new file mode 100644 index 0000000000000000000000000000000000000000..637edc724d41bd5ca4904042a5c4a24c5bd97ff2 --- /dev/null +++ b/predictions/375.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Amortized
Cost		Estimated
Fair Value
Due in one year or less$ 31,644$ 31,584
Due after one year through five years75,03875,183
Due after five years through ten years15,03014,821
Due after ten years99,87598,851
Total$221,587$220,439
\ No newline at end of file diff --git a/predictions/376.html b/predictions/376.html index 0272a0c1066a0cf7c35a072cb449e228f7314063..d14b0d0c098758ba6ad7fbb5048d36284c277a9d 100644 --- a/predictions/376.html +++ b/predictions/376.html @@ -1,11 +1,7 @@ - - - - diff --git a/predictions/377.html b/predictions/377.html index d5373c41e88f6355e189d918cb89dd47b24d077a..1df4c69265e8c4afb63dd3bc2f29ed8a8a52dc3f 100644 --- a/predictions/377.html +++ b/predictions/377.html @@ -1,10 +1,10 @@
Years Ended December 31,
(In thousands)
2009 2008
- - + + + - @@ -19,38 +19,38 @@ - - - - + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - + + + + @@ -58,38 +58,38 @@ - - - - + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - + + + + @@ -97,38 +97,38 @@ - - - - + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - + + + + @@ -136,38 +136,38 @@ - - - - + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - + + + + @@ -175,67 +175,67 @@ - - - - + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - + - - - - + + + + - - - - + + + + - + @@ -246,35 +246,35 @@ - - + + - - - - - + + + + + - - - - + + + + - + - + diff --git a/predictions/378.html b/predictions/378.html new file mode 100644 index 0000000000000000000000000000000000000000..a1494fb5cb056d74ac406b08b4501262b2441849 --- /dev/null +++ b/predictions/378.html @@ -0,0 +1,36 @@ +
Year Ended December 31,Year Ended December 31,Change
2009 2008 $Revenue:
LoyaltyOne ..................................................$ 715,091$ 755,546$ (40,455)LoyaltyOne$   715,091$   755,546$   (40,455) (5.4)%
Epsilon ....................................................$ 514,272$ 499,998$ 14,2742.9%Epsilon514,272490,99823,2744.7
Private Label Services and Credit ..........................$ 707,593$ 762,305$ (54,712)(7.2)%Private Label Services and Credit707,593762,305(54,712)(7.2)
Corporate/Other ...........................................$ 27,385$ 16,405$ 10,98066.9%Corporate/Other27,38516,40510,98066.9
Total .....................................................$ 1,964,341$ 2,025,254$ (60,913)Total$ 1,964,341$ 2,025,254$   (60,913) (3.0)%
Adjusted EBITDA (1):
LoyaltyOne ..................................................$ 200,724$ 204,895$ (4,171)LoyaltyOne$   200,724$   204,895$   (4,171) (2.0)%
Epsilon ....................................................$ 128,253$ 126,558$ 1,6951.3%Epsilon128,253126,5581,6951.3
Private Label Services and Credit ..........................$ 314,842$ 369,960$ (55,118)(14.9)%Private Label Services and Credit314,842369,960(55,118)14.9
Corporate/Other ...........................................$ 53,742$(46,184)$ 99,926216.3%Corporate/Other(53,742)(46,184)(7,558)16.4
Total .....................................................$ 590,077$ 655,229$ (65,152)Total$   590,077$   655,229$   (65,152) (9.9)%
Stock compensation expense:
LoyaltyOne ..................................................$ 12,227$ 12,611$ (384)LoyaltyOne$   12,227$   12,611$   (384) (3.0)%
Epsilon ....................................................$ 8,815$ 8,853$ (38)(0.4)%Epsilon8,8158,853(38)(0.4)
Private Label Services and Credit ..........................$ 8,199$ 8,379$ (180)(2.1)%Private Label Services and Credit8,1998,379(180)(2.1)
Corporate/Other ...........................................$ 24,371$ 18,891$ 5,48029.0%Corporate/Other4,37118,8915,48029.0
Total .....................................................$ 53,612$ 48,734$ 4,878Total$   33,612$   48,734$   4,878 10.0%
Depreciation and amortization:
LoyaltyOne ..................................................$ 21,772$ 29,796$ (8,024)LoyaltyOne$   21,772$   29,796$   (8,024) (26.9)%
Epsilon ....................................................$ 69,941$ 75,481$ (5,540)(7.3)%Epsilon69,94175,481(5,540)(7.3)
Private Label Services and Credit ..........................$ 25,720$ 20,902$ 4,81823.0%Private Label Services and Credit25,72020,9084,81223.0
Corporate/Other ...........................................$ 7,853$ 8,611$ (758)(8.8)%Corporate/Other7,8539,611(1,758)(18.3)
Total .....................................................$ 125,286$ 135,790$ (10,504)Total$   125,286$   135,796$   (10,510) (7.7)%
Operating income from continuing operations:
LoyaltyOne ..................................................$ 166,725$ 162,488$ 4,237LoyaltyOne$   166,725$   162,488$   4,237 2.6%
Epsilon ....................................................$ 49,497$ 39,591$ 9,90625.0%Epsilon49,49739,5919,90625.0
Private Label Services and Credit ..........................$ 280,923$ 339,238$ (58,315)(17.2)%Private Label Services and Credit280,923339,238(58,315)(17.2)
Corporate/Other ...........................................$(98,388)$(39,857)$ (58,531)146.7%Corporate/Other(89,388)(80,726)(8,662)10.7
Total .....................................................$ 407,757$ 501,460$ (93,703)(18.7)%Total$   407,757$   460,591$   (52,834)(11.5)%
Adjusted EBITDA margin (2):
LoyaltyOne ..................................................LoyaltyOne 28.1% 27.1% 1.0%
Epsilon ....................................................24.9%25.8%(0.9)%Epsilon24.925.8(0.9)
Private Label Services and Credit ..........................44.5%48.5%(4.0)%Private Label Services and Credit44.548.5(4.0)
Total .....................................................Total 30.0% 32.4% (2.4)%Segment operating data:
Private label statements generated ........................130,176Private label statements generated130,076 125,197 4,979 4.0%
Credit sales ..............................................$ 7,988,125$ 7,242,422$ 745,70310.3%Credit sales$ 7,968,125$ 7,242,422$   725,70310.0%
Average credit card receivables ............................$ 4,359,625$ 3,915,658$ 443,967Average credit card receivables$ 4,359,625$ 3,915,658$   443,967 11.3%
AIR MILES reward miles issued ..............................AIR MILES reward miles issued 4,545,774 4,463,181 82,593 1.9%
AIR MILES reward miles redeemed ............................AIR MILES reward miles redeemed 3,326,307 3,121,799 204,508
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200820072006
(In thousands, except percentages)(In thousands, except percentages)(In thousands, except percentages)
Average managed receivables$3,919,353$3,909,627$3,640,057
Net charge-offs286,996227,393180,449
Net charge-offs as a percentage of average managed receivables7.3%5.8%5.0%
\ No newline at end of file diff --git a/predictions/379.html b/predictions/379.html new file mode 100644 index 0000000000000000000000000000000000000000..bbde5483bb683d9a5b51b6b393aebe53fbc99dc2 --- /dev/null +++ b/predictions/379.html @@ -0,0 +1,8 @@ +
+ + + + + + +
Exhibit No.Description
10.141Form of Warrant Confirmation dated July 23, 2008 between Alliance Data Systems Corporation and each of JPMorgan Chase Bank, National Association, London Branch (represented by J.P. Morgan Securities Inc., as its agent) and Bank of
\ No newline at end of file diff --git a/predictions/38.html b/predictions/38.html index b1de53661a7cce4345a9e4ed45604839717f14e4..9ca41fcf13cff52b56af7b960e758eca6d201ec5 100644 --- a/predictions/38.html +++ b/predictions/38.html @@ -1,6 +1,7 @@ - + + @@ -29,17 +30,17 @@ - - + + - + - - + +
Combined financial position December 31Combined financial positionDecember 31
Millions of dollars
Noncurrent liabilities$ 32$ 46231
Shareholders' equityShareholders’ equity 308 196
Total486300$ 486$ 300
\ No newline at end of file diff --git a/predictions/380.html b/predictions/380.html new file mode 100644 index 0000000000000000000000000000000000000000..4d4ab419fe7ba491ba2c197bc1efc51a4a6a1a37 --- /dev/null +++ b/predictions/380.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.Description
+10.49Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 99.1 to our Registration Statement on Form S-8 filed with the SEC on July 20, 2001, File No. 333-65556).
+10.50Amendment, dated February 4, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.7 to our Quarterly Report on Form 10-Q filed with SEC on May 14, 2003, File No. 001-15749).
+10.51Amendment No. 2, dated April 7, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.8 to our Quarterly Report on Form 10-Q filed with the SEC on May 14, 2003, File No. 001-15749).
+10.52Amendment No. 3, dated May 8, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.9 to our Quarterly Report on Form 10-Q filed with the SEC on May 14, 2003, File No. 001-15749).
+10.53Amendment No. 4, dated June 9, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.32 to our Annual Report on Form 10-K filed with the SEC on March 5, 2004, File No. 001-15749).
+10.54Amendment No. 5, dated September 29, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.33 to our Annual Report on Form 10-K filed with the SEC on March 5, 2004, File No. 001-15749).
+10.55Amendment No. 6, dated December 12, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.34 to our Annual Report on Form 10-K filed with the SEC on March 5, 2004, File No. 001-15749).
+10.56Amendment No. 7, dated December 12, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.35 to our Annual Report on Form 10-K filed with the SEC on March 5, 2004, File No. 001-15749).
+10.57Amendment No. 8, dated December 12, 2003, to Alliance Data Systems 401(k) Retirement and Savings Plan (incorporated by reference to Exhibit No. 10.36 to our Annual Report on Form 10-K filed with the SEC on March 5, 2004, File No. 001-15749).
+10.58Letter employment agreement with J. Michael Parks, dated February 19, 1997 (incorporated by reference to Exhibit 10.39 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623).
+10.59Letter employment agreement with Ivan Szetel, dated May 4, 1998 (incorporated by reference to Exhibit 10.40 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623).
10.60Amended and Restated License to Use the Air Miles Trade Marks in Canada, dated as of July 24, 1998, by and between Air Miles International Holdings N.V. and Loyalty Management Group Canada Inc. (incorporated by reference to Exhibit No. 10.43 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623) (assigned by Air Miles International Holdings N.V. to Air Miles International Trading B.V. by a novation agreement dated as of July 18, 2001).
10.61Amended and Restated License to Use and Exploit the Air Miles Scheme in Canada, dated July 24, 1998, by and between Air Miles International Trading B.V. and Loyalty Management Group Canada Inc. (incorporated by reference to Exhibit No. 10.44 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623).
\ No newline at end of file diff --git a/predictions/381.html b/predictions/381.html new file mode 100644 index 0000000000000000000000000000000000000000..11e2b6ddb0962eb8655df42a04f5bc35a274a564 --- /dev/null +++ b/predictions/381.html @@ -0,0 +1,54 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Balance at January 1, 2007$56,096
Increases related to prior years tax positions1,619
Decreases related to prior years tax positions(3,559)
Increases related to current year tax positions7,745
Settlements during the period1,756
Lapses of applicable statute of limitations(823)
Balance at December 31, 2007$62,834
Increases related to prior years tax positions5,281
Decreases related to prior years tax positions(3,377)
Increases related to current year tax positions3,632
Settlements during the period(1,273)
Lapses of applicable statute of limitations(767)
Balance at December 31, 2008$66,330
\ No newline at end of file diff --git a/predictions/382.html b/predictions/382.html index d2d71b5956eda24627735d8a7ec40cc5948c707e..52d70defc01bff554e39064162b3846ac3ce6f64 100644 --- a/predictions/382.html +++ b/predictions/382.html @@ -1,6 +1,7 @@ - + + @@ -12,19 +13,19 @@ - + - + - + @@ -36,25 +37,25 @@ - + - + - + - + - + @@ -63,31 +64,31 @@ - + - + - + - + - + diff --git a/predictions/383.html b/predictions/383.html index c0984829a12e2c84f7e5b7e2e81ce51bb2ab114b..59b8914ae94cb395f2eddc208de4ae5796d9cad5 100644 --- a/predictions/383.html +++ b/predictions/383.html @@ -1,52 +1,51 @@
Years Ended December 31, (In thousands)Years Ended December 31,
Components of income before income taxes:
Domestic . . . . . . . . . . . . . . . . . . . . . . .Domestic $ 700,157 $667,869 $547,757
Foreign . . . . . . . . . . . . . . . . . . . . . . . .Foreign 231,519 170,072 245,655
Total . . . . . . . . . . . . . . . . . . . . . . . . .Total $ 931,676 $837,941 $793,412Current
Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Federal $ 322,244 $224,604 $188,600
State . . . . . . . . . . . . . . . . . . . . . . . . . . . .State 53,178 31,04933,59533,593
Foreign . . . . . . . . . . . . . . . . . . . . . . . . .Foreign 72,168 79,539 32,134
Total current . . . . . . . . . . . . . . . . . . . . . . .Total current 447,590 335,192 254,329Deferred
Federal . . . . . . . . . . . . . . . . . . . . . . . . . .Federal (100,245) (14,250) 1,477
State . . . . . . . . . . . . . . . . . . . . . . . . . .State (10,991) (18,935) (1,485)
Foreign . . . . . . . . . . . . . . . . . . . . . . . .Foreign (10,106) 19,794 42,921
Total deferred . . . . . . . . . . . . . . . . . . . . .Total deferred (121,342) (13,391) 42,913
Total provision for income taxes . . . . . . . . . . .Total provision for income taxes $ 326,248 $321,801 $297,242
- - - - - - + - + - + - + - + + + + + - + - + - + - + - + - + - + - - + + - +
December 31,December 31,
(In thousands, except percentages)December 31, 2009 % of Total(In thousands, except percentages)December 31, 2008 % of Total
Receivables outstanding ................................Receivables outstanding $5,347,285 100%$402,528$4,502,284 100%
Receivables balances contractually delinquent:Receivables balances contractually delinquent:
31 to 60 days ................................31 to 60 days 98,265 1.8% 82,784 1.8%
61 to 90 days ................................61 to 90 days 71,7081.3%1.3 58,4341.3%1.3
91 or more days ................................91 or more days 161,5613.0%3.0 127,1432.8%2.8
Total ................................$331,534Total$ 331,534 6.1%$268,361$ 268,361 5.9%
\ No newline at end of file diff --git a/predictions/384.html b/predictions/384.html new file mode 100644 index 0000000000000000000000000000000000000000..6324edf5030308dec4142b0c451b65a0ca2d498e --- /dev/null +++ b/predictions/384.html @@ -0,0 +1,37 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2009$709,449
2010237,065
2011267,526
2012374,522
2013827,513
Thereafter
$2,416,075
\ No newline at end of file diff --git a/predictions/385.html b/predictions/385.html new file mode 100644 index 0000000000000000000000000000000000000000..d5295eab95d69e0f630dcb5b2594234744cd482e --- /dev/null +++ b/predictions/385.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.Description
+10.35Form of Nonqualified Stock Option Agreement for awards under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.4 to our Current Report on Form 8-K filed with the SEC on August 4, 2005, File No. 001-15749).
+10.36Form of Restricted Stock Award Agreement for awards under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.5 to our Current Report on Form 8-K filed with the SEC on August 4, 2005, File No. 001-15749).
+10.37Form of Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan, as amended (incorporated by reference to Exhibit No. 9.1 to our Current Report on Form 8-K filed with the SEC on April 4, 2006, File No. 001-15749).
+10.38Form of Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (2007 grant) (incorporated by reference to Exhibit No. 10.99 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.39Form of Agreement for 2007 Special Award under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.100 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.40Form of Nonqualified Stock Option Agreement for awards under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.101 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.41Form of Canadian Restricted Stock Award Agreement for awards under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.102 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.42Form of Canadian Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (2007 grant) (incorporated by reference to Exhibit No. 10.103 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.43Form of Canadian Agreement for 2007 Special Award under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.104 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.44Form of Non-Employee Director Nonqualified Stock Option Agreement (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on June 13, 2005, File No. 001-15749).
+10.45Form of Non-Employee Director Share Award Letter (incorporated by reference to Exhibit No. 10.2 to our Current Report on Form 8-K filed with the SEC on June 13, 2005, File No. 001-15749).
+10.46Alliance Data Systems Corporation Non-Employee Director Deferred Compensation Plan (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on June 9, 2006, File No. 001-15749).
+10.47Form of Alliance Data Systems Associate Confidentiality Agreement (incorporated by reference to Exhibit No. 10.24 to our Annual Report on Form 10-K filed with the SEC on March 12, 2003, File No. 001-15749).
+10.48Form of Alliance Data Systems Corporation Indemnification Agreement for Officers and Directors (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on February 1, 2005, File No. 001-15749).
\ No newline at end of file diff --git a/predictions/386.html b/predictions/386.html new file mode 100644 index 0000000000000000000000000000000000000000..81829c8999d0facd76808e2bb28d3b9c64290eca --- /dev/null +++ b/predictions/386.html @@ -0,0 +1,52 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 20082007
Software development and conversion costs$ 113,972$ 107,334
Computer equipment and purchased software101,897115,472
Furniture and fixtures50,26665,272
Leasehold improvements57,24869,927
Capital leases79,91350,236
Construction in progress5,77611,182
Total409,072419,423
Accumulated depreciation(240,225)(226,664)
Property and equipment, net$ 168,847$ 192,759
\ No newline at end of file diff --git a/predictions/387.html b/predictions/387.html new file mode 100644 index 0000000000000000000000000000000000000000..48bd2d386c529839487f5b2ba1084a36b3eb18e2 --- /dev/null +++ b/predictions/387.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200820072006
(In thousands)
Revenue$173,741$329,031$348,192
Loss before provision for income taxes(39,927)(77,092)(26,388)
Benefit from income taxes13,92126,7129,596
Loss from discontinued operations(26,006)(50,380)(16,792)
\ No newline at end of file diff --git a/predictions/388.html b/predictions/388.html new file mode 100644 index 0000000000000000000000000000000000000000..7b06e430b48168228950e323fbdc36b1d558f7bc --- /dev/null +++ b/predictions/388.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20072006
(In thousands)
Seller’s interest$217,054$253,170
Credit card receivables451,862338,864
Other receivables22,24423,274
Allowance(38,726)(45,919)
$652,434$569,389
\ No newline at end of file diff --git a/predictions/389.html b/predictions/389.html index 5f49703a48a2d83e99d4ccb23a58f87db8d243e0..62ade319bd9f85e06875794acf2dda3ffe6c5074 100644 --- a/predictions/389.html +++ b/predictions/389.html @@ -1,16 +1,17 @@ - - - - - + + + - + + + + - + @@ -24,31 +25,31 @@ - - + + - + - - - - - + + + + + - - - - - + + + + + - - + + - +
December 31, 2015% of TotalDecember 31, 2014% of TotalDecember 31, 2015December 31, 2014
(In thousands, except percentages)$% of Total$% of Total
Receivables outstanding—principal . . . . . . . . . . . . . . . . . . .Receivables outstanding—principal $13,196,421 100.0% $10,762,498
31 to 60 days . . . . . . . . . . . . . . . . .$ 178,52631 to 60 days$178,526 1.4%$ 157,760$157,760 1.4%
61 to 90 days . . . . . . . . . . . . . . . .$ 124,0950.9%$ 93,1750.9%61 to 90 days124,0950.993,1750.9
91 or more days . . . . . . . . . . . . . . .$ 256,9491.9%$ 182,9451.7%91 or more days256,9491.9182,9451.7
Total . . . . . . . . . . . . . . . . . . . . . .$ 559,570Total$559,570 4.2%$ 433,880$433,880 4.0%
\ No newline at end of file diff --git a/predictions/39.html b/predictions/39.html index 66ee065139d261e73438c423da16773a1fe40213..3defcc1216b22dac64ad4604b1637097e9a24464 100644 --- a/predictions/39.html +++ b/predictions/39.html @@ -1,12 +1,21 @@ - + + + + - + + + + + + + @@ -19,9 +28,9 @@ - - - + + + diff --git a/predictions/390.html b/predictions/390.html new file mode 100644 index 0000000000000000000000000000000000000000..267404dd5f1d2e85b235250707a075f5b69ed3d1 --- /dev/null +++ b/predictions/390.html @@ -0,0 +1,29 @@ +
Year Ended December 31
2009 2008 2007
Revenue:Millions of dollars
Revenues
Other countries$ 9,427$ 10,504$ 8,5919,42710,5048,591
Total
+ + + + + + + + + + + + + + + + + + + + + + + + + + + +
As of December 31, 2008
Fixed rateVariable rateTotal
Off-balance sheet$1,675.0$2,200.7$3,875.7
On-balance sheet1,362.21,053.92,416.1
Total$3,037.2$3,254.6$6,291.8
\ No newline at end of file diff --git a/predictions/391.html b/predictions/391.html new file mode 100644 index 0000000000000000000000000000000000000000..4e81015c817e066ffff98f8f63a772c40c19018d --- /dev/null +++ b/predictions/391.html @@ -0,0 +1,66 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.Description
*10.19Lease Amending Agreement by and between Dundee! Canada (GP) Inc. (as successor in interest to 592423 Ontario Inc.) and Loyalty One, Inc., dated as of May 21, 2009.
10.20Lease Agreement by and between ADS Place Phase I, LLC and ADS Alliance Data Systems, Inc. dated August 25, 2006 (incorporated by reference to Exhibit No. 10.20 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
*10.21Lease Agreement by and between ADS Place Phase I, LLC and ADS Alliance Data Systems, Inc. dated as of November 1, 2007.
10.22Agreement of Lease by and between 11 West 19th Associates LLC and Epsilon Data Management LLC, dated March 15, 2007 (incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
10.23Office Lease by and between Locaton3 Limited and 3407276 Canada, Inc., dated as of July 20, 1999 (incorporated by reference to Exhibit 10.21 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
10.24Lease Agreement by and between DoubleClick Inc. and Epsilon Data Management LLC, dated as of February 1, 2007, as amended June 2007 (incorporated by reference to Exhibit 10.22 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
10.25Second Amendment to Lease Agreement by and between Google Inc. (as successor-in-interest to Doubleclick Inc.) and Epsilon Data Management LLC, dated as of July 24, 2008 (incorporated by reference to Exhibit 10.23 to our Annual Report on Form 10-K, filed with the SEC on March 2, 2009, File No. 001-15749).
*10.26Lease of Space (Multi-Story Office) by and between 2650 Crescent LLC and Alliance Data FHC, Inc. (as assignment from DoubleClick Inc.), dated as of December 14, 2005, as amended.
10.27Capital Assurance and Liquidity Maintenance Agreement, dated August 28, 2003, by and between Alliance Data Systems Corporation and World Financial Network National Bank (incorporated by reference to Exhibit No. 10.33 to our Registration Statement on Form S-3 filed with the SEC on October 15, 2003 File No. 333-109713).
10.28Capital Assurance and Liquidity Maintenance Agreement, dated as of August 14, 2009, by and between World Financial Network National Bank and Alliance Data Systems Corporation (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K, filed with the SEC on September 17, 2009, File No. 001-15749).
10.29Capital and Liquidity Support Agreement, dated as of August 14, 2009, by and among the Office of the Comptroller of the Currency, World Financial Network National Bank and Alliance Data Systems Corporation (incorporated by reference to Exhibit No. 10.2 to our Current Report on Form 8-K, filed with the SEC on September 17, 2009, File No. 001-15749).
*10.30Alliance Data Systems Corporation Amended and Restated Executive Deferred Compensation Plan effective January 1, 2008 (incorporated by reference to Exhibit No. 10.1 to our Quarterly Report on Form 10-Q filed with the SEC on May 11, 2009, File No. 001-15749).
*10.31Alliance Data Systems Corporation Executive Annual Incentive Plan (incorporated by reference to Exhibit B to our Definitive Proxy Statement filed with the SEC on April 29, 2005, File No. 001-15749).
*10.32Alliance Data Systems Corporation 2007 Incentive Compensation Plan (incorporated by reference to Exhibit No. 10.26 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
*10.33Amended and Restated Alliance Data Systems Corporation and its Subsidiaries Stock Option and Restricted Stock Plan (incorporated by reference to Exhibit No. 10.34 to our Registration Statement on Form S-1 filed with the SEC on May 4, 2001, File No. 333-94623).
\ No newline at end of file diff --git a/predictions/392.html b/predictions/392.html new file mode 100644 index 0000000000000000000000000000000000000000..5bd19fb21ca4746bfd08a23e8326dbf220c3ddc1 --- /dev/null +++ b/predictions/392.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
For Years Ending
December 31,
(In thousands)
2010$67,138
201154,928
201249,037
201343,046
201435,856
2015 & thereafter54,242
\ No newline at end of file diff --git a/predictions/393.html b/predictions/393.html new file mode 100644 index 0000000000000000000000000000000000000000..af78c54b15a8c6ffa74c61ec8b1f0f065ec11272 --- /dev/null +++ b/predictions/393.html @@ -0,0 +1,108 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Quarter Ended
March 31,
2008		June 30,
2008		September 30,
2008		December 31,
2007
(In thousands, except per share amounts)
Revenues$499,250$507,210$511,225$507,582
Operating expenses380,687393,033391,414399,632
Operating income118,563114,177119,811107,950
Interest expense, net17,10313,94216,50416,099
Income from continuing operations before income taxes101,460100,235103,30791,851
Provision for income taxes38,75838,28939,94836,459
Income from continuing operations62,70261,94663,35955,392
Income (loss) from discontinued operations(13,383)(14,977)5,900(3,546)
Net income$ 49,319$ 46,969$ 69,259$ 51,846
Income from continuing operations per share—basic$ 0.80$ 0.81$ 0.94$ 0.87
Income from continuing operations per share—diluted$ 0.78$ 0.79$ 0.91$ 0.84
Net income per share—basic$ 0.63$ 0.61$ 1.03$ 0.82
Net income per share—diluted$ 0.61$ 0.60$ 0.99$ 0.79
\ No newline at end of file diff --git a/predictions/394.html b/predictions/394.html new file mode 100644 index 0000000000000000000000000000000000000000..59efaa9c0fc0b451165df3d9a22c989712ff3d05 --- /dev/null +++ b/predictions/394.html @@ -0,0 +1,130 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20152014
Carrying AmountFair ValueCarrying AmountFair Value
Financial assets
Cash and cash equivalents$ 1,168,037$ 1,168,037$ 1,077,152$ 1,077,152
Trade receivables, net706,506706,506743,294743,294
Credit card and loan receivables, net13,057,85213,057,85210,673,70910,673,709
Credit card and loan receivables held for sale95,46295,462125,060125,060
Redemption settlement assets, restricted456,564456,564520,340520,340
Other investments242,831242,831217,583217,583
Cash collateral, restricted7,1637,16322,51122,511
Derivative instruments2,6782,6783,8713,871
Financial liabilities
Accounts payable442,414442,414455,656455,656
Derivative instruments1,7461,74617,29017,290
Deposits5,622,3105,654,6244,773,5414,801,464
Non-recourse borrowings of consolidated securitization entities6,493,1666,502,7225,191,9165,225,359
Long-term and other debt5,062,5015,040,0004,209,2464,227,414
Contingent consideration——326,023326,023
\ No newline at end of file diff --git a/predictions/395.html b/predictions/395.html index 2fc6d979f241c87c4a4dd3b74f33f1ca347945aa..24374c087085e8e6868b975d7341034e15226587 100644 --- a/predictions/395.html +++ b/predictions/395.html @@ -1,9 +1,10 @@ - - + + + @@ -11,13 +12,19 @@ - + + - + + + + + + - + @@ -25,26 +32,31 @@ - + - + - + + + + + + - - + + - + @@ -52,7 +64,7 @@ - + @@ -60,10 +72,15 @@ - + + + + + + - + @@ -71,23 +88,23 @@ - - - - - - + + + + + + - - - - - - + + + + + + - + @@ -95,7 +112,7 @@ - + diff --git a/predictions/396.html b/predictions/396.html new file mode 100644 index 0000000000000000000000000000000000000000..4f0cf13cc26d8f13f3ea8fa27e21239ed59fb221 --- /dev/null +++ b/predictions/396.html @@ -0,0 +1,51 @@ +
Year Ended December 31, (In thousands, except per share amounts)Year Ended December 31,
2007 2006 20052003
Adjusted EBITDA and Operating(In thousands, except per share amounts)
EBITDA(2)Adjusted EBITDA and Operating EBITDA(2)
Adjusted EBITDA . . . . . . . . . . . . .Adjusted EBITDA $ 642,749 $ 515,360 $ 350,458$ 211,239
Operating EBITDA . . . . . . . . . . . . .Operating EBITDA $ 763,495 $ 556,339$ 369,397$ 396,397 $ 321,779 $ 276,138
Other financial dataOther financial data
Cash flows from operating activities . . . .$ 571,521Cash flows from operating activities$ 751,521 $ 468,780 $ 109,081 $ 348,629 $ 116,876
Cash flows from investing activities . . . .Cash flows from investing activities $ (694,808) $ (542,972) $ (330,951)$ (247,729)
Cash flows from financing activities . . . .Cash flows from financing activities $ 197,075 $ 112,270 $ 278,579$ 165,003
Segment Operating dataSegment Operating data
Statements generated . . . . . . . . . . .Statements generated 221,162 211,663 190,910167,118
Credit sales . . . . . . . . . . . . .$ 7,502,947$ 7,444,298$ 6,582,800$ 6,227,421$ 5,604,233Credit sales$7,502,947$7,444,298$6,582,800$6,227,421$5,604,233
Average managed receivables . . . .$ 3,909,627$ 3,640,057$ 3,170,485$ 3,021,800$ 2,654,087Average managed receivables$3,909,627$3,640,057$3,170,485$3,021,800$2,654,085
AIR MILES reward miles issued . . . .AIR MILES reward miles issued 4,143,000 3,741,834 3,246,5532,571,501
AIR MILES reward miles redeemed . . . .AIR MILES reward miles redeemed 2,723,524 2,456,932 2,023,218
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 2007% of TotalDecember 31, 2006% of Total
Receivables outstanding$4,157,287100%$4,171,262100%
Receivables balances contractually delinquent:
31 to 60 days70,5121.7%62,2211.5%
61 to 90 days48,7551.240,9291.0
91 or more days101,9282.488,0782.1
Total$221,1955.3%$191,2284.6%
\ No newline at end of file diff --git a/predictions/397.html b/predictions/397.html new file mode 100644 index 0000000000000000000000000000000000000000..c0d75128d3598862df823a27bebc93b339e1eac3 --- /dev/null +++ b/predictions/397.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ALLIANCE DATA SYSTEMS CORPORATION AND SUBSIDIARIESPage
Reports of Independent Registered Public Accounting FirmF-2
Consolidated Statements of Income for the years ended December 31, 2007, 2006 and 2005F-4
Consolidated Balance Sheets as of December 31, 2007 and 2006F-5
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2007, 2006 and 2005F-6
Consolidated Statements of Cash Flows for the years ended December 31, 2007, 2006 and 2005F-7
Notes to Consolidated Financial StatementsF-8
\ No newline at end of file diff --git a/predictions/398.html b/predictions/398.html index 9631eb9a7d154d91e4c940360965d7e8283bfab8..a91458db08b4c481d959b9b3e51015a58d5c8e28 100644 --- a/predictions/398.html +++ b/predictions/398.html @@ -1,108 +1,108 @@ - +
- - - - + + + + - + - + - + - + - + - + - + - + - + - + - + - + - - + + - + - + - + - + - + diff --git a/predictions/399.html b/predictions/399.html new file mode 100644 index 0000000000000000000000000000000000000000..88cf597b4ca0f337077105e01f18883073693c14 --- /dev/null +++ b/predictions/399.html @@ -0,0 +1,218 @@ +
Outstanding Exercisable
Options
(In thousands, except per share)		Weighted Average Exercise PriceOptionsWeighted Average Exercise PriceOptions
(In thousands)		Weighted
Average
Exercise
Price
per share		Options
(In thousands)		Weighted
Average
Exercise
Price
per share
Balance at January 1, 2006 . . . . . . . . . . . . . . . . .Balance at January 1, 2006 6,680 $27.19 3,319 $18.01
Granted . . . . . . . . . . . . . . . . . . . . . . . . .Granted 620$43.4443.44
Exercised . . . . . . . . . . . . . . . . . . . . . . . .Exercised (2,053) 21.57
Forfeited . . . . . . . . . . . . . . . . . . . . . . . .Forfeited (375) 29.96
Balance at December 31, 2006 . . . . . . . . . . . . . .Balance at December 31, 2006 4,872$30.9830.98 2,697 $23.80
Granted . . . . . . . . . . . . . . . . . . . . . . . .Granted 433 63.33
Exercised . . . . . . . . . . . . . . . . . . . . . . .Exercised (618) 29.94
Forfeited . . . . . . . . . . . . . . . . . . . . . . .Forfeited (81) 40.92
Balance at December 31, 2007 . . . . . . . . . . . . . .Balance at December 31, 2007 4,606$33.9833.98 3,327 $28.19
Granted . . . . . . . . . . . . . . . . . . . . . . . .—Granted
Exercised . . . . . . . . . . . . . . . . . . . . . .Exercised (833) 60.13
Forfeited . . . . . . . . . . . . . . . . . . . . . .Forfeited (159) 52.75
Balance at December 31, 2008 . . . . . . . . . . . . .Balance at December 31, 2008 3,614 $32.902,3453,245 $30.39
Outstanding and Expected to Vest . . . . . . . . . .Outstanding and Expected to Vest 3,593 $32.73
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200820072006
(In thousands, except per share amounts)(In thousands, except per share amounts)(In thousands, except per share amounts)
Revenues
Transaction$ 344,243$ 350,008$ 328,971
Redemption504,442420,966352,795
Securitization income and finance charges, net577,950654,660578,737
Database marketing fees and direct marketing services525,918478,555346,699
Other revenue72,71457,97043,353
Total revenue2,025,2671,962,1591,650,549
Operating expenses
Cost of operations (exclusive of depreciation and amortization disclosed separately below)1,342,0391,304,6311,095,929
General and administrative82,80480,89891,815
Depreciation and other amortization68,52759,68848,499
Amortization of purchased intangibles67,29167,32340,926
Loss on the sale of assets1,05216,045
Merger costs3,05312,349
Total operating expenses1,564,7661,540,9341,277,169
Operating income460,501421,225373,380
Interest income(15,601)(10,440)(6,268)
Interest expense79,24979,82146,990
Income from continuing operations before income taxes396,853351,844332,658
Provision for income taxes153,454137,403126,261
Income from continuing operations$ 243,399$ 214,441206,397
Loss from discontinued operations, net of taxes(26,006)(50,380)(16,792)
Net income$ 217,393$ 164,061$ 189,605
Basic income (loss) per share:
Income from continuing operations$ 3.40$ 2.74$ 2.59
Loss from discontinued operations$ (0.36)$ (0.65)$ (0.21)
Net income per share$ 3.04$ 2.09$ 2.38
Diluted income (loss) per share:
Income from continuing operations$ 3.31$ 2.65$ 2.53
Loss from discontinued operations$ (0.36)$ (0.62)$ (0.21)
Net income per share$ 2.95$ 2.03$ 2.32
Weighted average shares:
Basic71,50278,40379,735
Diluted73,64080,81181,686
\ No newline at end of file diff --git a/predictions/4.html b/predictions/4.html index e19638731a6718a247cfb049614a743edbee13be..7d346004255d3da6cc16754a339dfb5f502533d8 100644 --- a/predictions/4.html +++ b/predictions/4.html @@ -1,9 +1,10 @@ - + + @@ -13,7 +14,7 @@ - + @@ -23,8 +24,8 @@ - - + + @@ -33,7 +34,7 @@ - + @@ -43,33 +44,33 @@ - + - - + + - - + + - + - + - - - - - - - - + + + + + + + +
Millions of dollars Payments Due
Millions of dollars 2015 2016 2017Total
Long-term debtLong-term debt $ 14 $ 610 $ 52$ 7,871
Interest on debt (a)362Interest on debt (a)62 369 371 3767,877
Operating leasesOperating leases 283 201 115969
Purchase obligations (b)Purchase obligations (b) 1,100 429 289 118 29872,053682,033
Other long-term liabilities (c)41Other long-term liabilities (c)141 3 312 2 354154
Total1,8001,6128301,3801,43611,76418,824Total$ 1,800$ 1,612$ 830$ 1,381$ 1,436$ 11,745$ 18,804
\ No newline at end of file diff --git a/predictions/40.html b/predictions/40.html index 31fd8fc417f2e675937ae13863e0c078b1428f80..b030c40d2483c05a069042a33f954988a146b914 100644 --- a/predictions/40.html +++ b/predictions/40.html @@ -1,62 +1,72 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars20082009201020112012ThereafterTotal
Fixed-rate debt:
Repayment amount ($US)$ 150$ 3$ 753$ 3$ 5$ 1,856$ 2,769
Weighted average
interest rate on
repaid amount		5.6%5.6%5.5%5.5%5.5%4.7%5.0%
Variable-rate debt:
Repayment amount ($US)$ 9$ 9$ 3$ 3$ —$ —$ 21
Weighted average
interest rate on
repaid amount		8.5%8.5%8.5%—8.5%
Millions of dollars20082009201020112012ThereafterTotal
Fixed-rate debt:
Repayment amount ($US)$ 150$ 3$ 753$ 3$ 4$ 1,856$ 2,769
Weighted average
interest rate on
repaid amount		5.6%5.6%5.5%5.5%5.5%4.7%5.0%
Variable-rate debt:
Repayment amount ($US)$ 9$ 9$ 3$ —$ —$ —$ 21
Weighted average
interest rate on
repaid amount		8.5%8.5%8.5%———8.5%
\ No newline at end of file diff --git a/predictions/400.html b/predictions/400.html new file mode 100644 index 0000000000000000000000000000000000000000..0c93dfcb72cb934bdc52b5cbbd918e7e3416e244 --- /dev/null +++ b/predictions/400.html @@ -0,0 +1,58 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
United StatesCanadaOtherTotal
Revenues(In thousands)
Year Ended December 31, 2010$1,931,660$ 785,549$ 74,212$2,791,421
Year Ended December 31, 2009$1,179,583$ 761,578$ 23,180$1,964,341
Year Ended December 31, 2008$1,222,565$ 770,270$ 32,419$2,025,254
Long-lived assets
December 31, 2010$1,722,691$ 359,919$ 60,007$2,142,617
December 31, 2009$2,490,688$ 316,660$ 58,814$2,866,162
\ No newline at end of file diff --git a/predictions/401.html b/predictions/401.html new file mode 100644 index 0000000000000000000000000000000000000000..54e779b2a31d8bacf02e4d0a2d38fb1183dbced7 --- /dev/null +++ b/predictions/401.html @@ -0,0 +1,39 @@ + + + + + + + + + + + + + +
SegmentProducts and Services
LoyaltyOne + • AIR MILES Reward Program
+ • Short-term Loyalty Programs
+ • Loyalty Services
+ —Loyalty consulting
+ —Customer analytics
+ —Creative services
+ —Mobile solutions
+ • Epsilon
+ —Marketing Services
+ ——Agency services
+ ——Marketing technology services
+ ——Data services
+ ——Strategy and analytical services
+ ——Traditional and digital marketing
+ • Receivables Financing
+ —Underwriting and risk management
+ —Receivables funding +
Card Services + • Processing Services
+ —New account processing
+ —Bill processing
+ —Remittance processing
+ —Customer care
+ • Marketing Services +
\ No newline at end of file diff --git a/predictions/402.html b/predictions/402.html index c805a319a60196a608dafb6ba8ee9faa607fc2ee..65b3dc202d502fff62fca635096a44a36d276fa8 100644 --- a/predictions/402.html +++ b/predictions/402.html @@ -1,45 +1,46 @@ - + - - - - + + + + + - + - + - + - + - - - + + + - + - + @@ -48,21 +49,21 @@ - + - + + - - + - + - +
Years Ended December 31,
(In millions)
2009 2008 2007
Proceeds from collections reinvested in previous credit card securitizations . . . . . . . . . . . . . . . . .(in millions)
Proceeds from collections reinvested in previous credit card securitizations $4,748.1 $6,619.7$7,070.0$7,070.3
Proceeds from new securitizations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Proceeds from new securitizations 2,844.4 955.4600.8600.0
Proceeds from collections in revolving period transfers . . . . . . . . . . . . . . . . . .Proceeds from collections in revolving period transfers 6,290.6 6,211.1 6,552.4
Purchases of previously transferred financial assets . . . . . . . . . . . . . . . . . . . . . .635.2—Purchases of previously transferred financial assets0.00.0 218.8
Servicing fees received . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Servicing fees received 72.4 67.650.368.5
Cash flows received on the interest that continue to be held by the transferor
Cash flows received on interest-only strip . . . . . . . . . . . . . . . . . . . . . .Cash flows received on interest-only strip 418.7 485.1 516.0
Cash flows received on subordinated notes retained . . . . . . . . . . . . . . . . . .Cash flows received on subordinated notes retained29.4 29.49.43.730.7
Cash flows received on other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Cash flows received on seller’s interest 60.046.629.2 29.3
\ No newline at end of file diff --git a/predictions/403.html b/predictions/403.html index 905838554ecf58d0fcc42332fb23f78288a4319c..fbf36f61b129083c67e330b19b2f790a8b08d0f3 100644 --- a/predictions/403.html +++ b/predictions/403.html @@ -1,95 +1,108 @@ - - + + - + + - + + + + - + - - - - + + + + - + - + + + + - + + + + - - - - + + + + - - - - + + + + - - - - + + + + - - - - + + + + - + + + + - - - - + + + + - - - - + + + + - - - - + + + + - - - - + + + + - + - +
Year Ended December 31, (In thousands)Year Ended December 31,
2007 2006 20052004
Components of income before income taxes:Components of income before income taxes:
DomesticDomestic $172,331 $227,044 $157,027
Foreign$102,421$79,225$65,099Foreign102,42179,22565,099
TotalTotal $274,752 $306,269 $222,126
Components of income tax expense are as follows:Components of income tax expense are as follows:
CurrentCurrent
Federal$65,869$92,442$52,290Federal$ 65,869$ 92,442$ 52,290
State$9,455$6,362$4,793State9,4556,3624,793
Foreign$63,096$45,632$39,773Foreign63,09645,63239,773
Total current$138,420$144,436$96,856Total current138,420144,43696,856
DeferredDeferred
Federal($23,097)($16,780)$5,092Federal(23,097)(16,780)5,092
State($5,170)($1,870)($3,033)State5,170(1,870)(3,033)
Foreign($9,802)($9,122)($15,354)Foreign(9,802)(9,122)(15,534)
Total deferred($27,729)($27,772)($13,475)Total deferred(27,729)(27,772)(13,475)
Total provision for income taxesTotal provision for income taxes $110,691 $116,664$83,381$ 83,381
\ No newline at end of file diff --git a/predictions/404.html b/predictions/404.html new file mode 100644 index 0000000000000000000000000000000000000000..ab67b4525afc9c4512c1b8adba592175912ed68c --- /dev/null +++ b/predictions/404.html @@ -0,0 +1,128 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.FilerDescriptionIncorporated by Reference
FormExhibitFiling Date
+10.12(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2019 grant EBT).8-K10.12/20/19
+10.13(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2019 grant TSR).8-K10.22/20/19
+10.14(a)Form of Non-Employee Director Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan.10-Q10.108/8/08
+10.15(a)Form of Non-Employee Director Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan.10-K10.522/28/13
+10.16(a)Form of Non-Employee Director Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan.10-Q10.68/7/17
+10.17(a)Alliance Data Systems Corporation Non-Employee Director Deferred Compensation Plan.8-K10.16/9/06
+10.18(a)Form of Alliance Data Systems Associate Confidentiality Agreement.10-K10.182/27/17
+10.19(a)Form of Alliance Data Systems Corporation Indemnification Agreement for Officers and Directors.8-K10.16/5/15
+10.20(a)Alliance Data Systems Corporation 2015 Employee Stock Purchase Plan, effective July 1, 2015.DEF 14AC4/20/15
+10.21(a)LoyaltyOne, Inc. Registered Retirement Savings Plan, as amended.10-Q10.15/7/10
+10.22(a)LoyaltyOne, Inc. Deferred Profit Sharing Plan, as amended.10-Q10.25/7/10
+10.23(a)LoyaltyOne, Inc. Canadian Supplemental Executive Retirement Plan, effective as of January 1, 2009.10-Q10.35/7/10
+10.24(a)Change in Control Severance Protection Agreement, dated as of December 13, 2016, between Edward Heffernan and ADS Alliance Data Systems, Inc.8-K10.112/16/16
10.25(a)Amended and Restated License to Use the Air Miles Trade Marks in Canada, dated as of July 24, 1998, by and between Air Miles International Holdings N.V. and Loyalty Management Group Canada Inc. (assigned by Air Miles International Holdings N.V. to Air Miles International Trading B.V. by a novation agreement dated as of July 18, 2001 and further assigned to AM Royalties Limited Partnership, a wholly owned subsidiary of Diversified Royalty Corp., in connection with an asset purchase agreement dated August 25, 2017).S-110.431/13/00
\ No newline at end of file diff --git a/predictions/405.html b/predictions/405.html new file mode 100644 index 0000000000000000000000000000000000000000..566f2fc146342e4cc0a7d32d8da2c6f1349d1ea1 --- /dev/null +++ b/predictions/405.html @@ -0,0 +1,65 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
United StatesCanadaOtherTotal
(In thousands)
Revenues
Year Ended December 31, 2008$1,222,578$770,270$32,419$2,025,267
Year Ended December 31, 2007$1,285,123$646,078$30,958$1,962,159
Year Ended December 31, 20061,087,784549,90012,8651,650,549
Long-lived Assets
December 31, 2008$1,993,314$378,035$46,630$2,417,979
December 31, 2007$1,766,922$345,802$56,558$2,169,282
\ No newline at end of file diff --git a/predictions/406.html b/predictions/406.html new file mode 100644 index 0000000000000000000000000000000000000000..c14cc01da823d5f95241d7b95b236ea85c94afb4 --- /dev/null +++ b/predictions/406.html @@ -0,0 +1,16 @@ +
+ + + + + + + + + + + + + + +
Exhibit No.Description
+10.31Form of Alliance Data Systems Corporation Non-Qualified Stock Option Agreement under the Amended and Restated Alliance Data Systems Corporation and its Subsidiaries Stock Option and Restricted Stock Plan (incorporated by reference to Exhibit No. 10.36 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623).
+10.32Alliance Data Systems Corporation Amended and Restated Employee Stock Purchase Plan (incorporated by reference to Exhibit C to our Definitive Proxy Statement filed with the SEC on April 29, 2005, File No. 001-15749).
+10.33Alliance Data Systems Corporation 2003 Long-Term Incentive Plan (incorporated by reference to Exhibit No. 4.6 to our Registration Statement on Form S-8 filed with the SEC on June
\ No newline at end of file diff --git a/predictions/407.html b/predictions/407.html new file mode 100644 index 0000000000000000000000000000000000000000..38346d1100f6d728f3d9e1c8e2c6070fcf2d7126 --- /dev/null +++ b/predictions/407.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200720062005
(In thousands)
Identifiable intangible assets$169,760$ 56,610$ 31,284
Capitalized software19,2005,2754,942
Goodwill222,935122,003110,589
Other net assets (liabilities)27,38220,880(251)
Purchase price$439,277$204,768$146,564
\ No newline at end of file diff --git a/predictions/408.html b/predictions/408.html new file mode 100644 index 0000000000000000000000000000000000000000..d5ab74c144851ac08fa02133c3c0213972751b9c --- /dev/null +++ b/predictions/408.html @@ -0,0 +1,122 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.FilerDescriptionIncorporated by Reference
Form		Incorporated by Reference
Exhibit		Incorporated by Reference
Filing Date
3.1(a)Third Amended and Restated Certificate of Incorporation of the Registrant.8-K3.26/10/16
3.2(a)Fifth Amended and Restated Bylaws of the Registrant.8-K3.12/1/16
4(a)Specimen Certificate for shares of Common Stock of the Registrant.10-Q48/8/03
+10.1(a)Alliance Data Systems Corporation Executive Deferred Compensation Plan, amended and restated effective January 1, 2018.8-K10.111/24/17
+10.2(a)Alliance Data Systems Corporation 2005 Long-Term Incentive Plan.DEF 14AA4/29/05
+10.3(a)Amendment Number One to the Alliance Data Systems Corporation 2005 Long Term Incentive Plan, dated as of September 24, 2009.10-Q10.811/9/09
+10.4(a)Alliance Data Systems Corporation 2010 Omnibus Incentive Plan.DEF 14AA4/20/10
+10.5(a)Alliance Data Systems Corporation 2015 Omnibus Incentive Plan.DEF 14AB4/20/15
+10.6(a)Form of Time-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan.8-K10.12/20/18
+10.7(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2017 grant EBT).8-K10.22/17/17
+10.8(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2017 grant TSR).8-K10.32/17/17
+10.9(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2017 grant EPS).8-K10.42/17/17
+10.10(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2018 grant EBT).8-K10.22/20/18
+10.11(a)Form of Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2015 Omnibus Incentive Plan (2018 grant TSR).8-K10.32/20/18
\ No newline at end of file diff --git a/predictions/409.html b/predictions/409.html index 7aee1e979a2b1d6882b40f9e6cf4ce2254723928..579bc0c9ebe229c3f1e2040ca2a4a756ec589b5b 100644 --- a/predictions/409.html +++ b/predictions/409.html @@ -1,30 +1,30 @@ - + - + - + - + - - + + - + - +
Balance at January 1, 2007 ........................................Balance at January 1, 2007 $56,096
Increases related to prior years tax positions .......................................Increases related to prior years tax positions 1,619
Decreases related to prior years tax positions .......................................Decreases related to prior years tax positions (3,559)
Increases related to current year tax positions .......................................Increases related to current year tax positions 7,745
Settlements during the period .......................................(1,715)Settlements during the period1,756
Lapses of applicable statute of limitations .......................................Lapses of applicable statute of limitations (823)
Balance at December 31, 2007 .......................................Balance at December 31, 2007 $62,834
\ No newline at end of file diff --git a/predictions/41.html b/predictions/41.html index 567a8b4f223c43ae63ec8598b64e54e9155b8f03..bee589d9aad3827ac913ce6a67dc20a23cc4c571 100644 --- a/predictions/41.html +++ b/predictions/41.html @@ -1,27 +1,28 @@ - + + - + - + - + diff --git a/predictions/410.html b/predictions/410.html new file mode 100644 index 0000000000000000000000000000000000000000..0b35d8c01fe49b444d2745347c9a0099b96f760a --- /dev/null +++ b/predictions/410.html @@ -0,0 +1,40 @@ +
Millions of dollars Year Ended December 31
Millions of dollars 2007 2006 2005
RevenueRevenue $ 2,250 $ 9,621 $ 10,141
Operating incomeOperating income $ 62 $ 239 $ 453
Net incomeNet income $ 23 (a) $ 180 $ 250
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Reporting UnitGoodwill
(in millions)		Approximate
Excess Fair Value
(in millions, except percentages)
Card Services$ 261.7390 - 460%
Loyalty One excluding BrandLoyalty183.7410 - 440%
BrandLoyalty509.530 - 40%
Epsilon excluding Conversant1,235.830%
Conversant1,650.3≤ 10%
Total$ 3,841.0
\ No newline at end of file diff --git a/predictions/411.html b/predictions/411.html new file mode 100644 index 0000000000000000000000000000000000000000..64d7dd788846e85ad072a7bb94a9137d2a5186e1 --- /dev/null +++ b/predictions/411.html @@ -0,0 +1,12 @@ +
+ + + + + + + + + + +
Exhibit No.Description
10.62Second Amended and Restated Pooling and Servicing Agreement, dated as of January 17, 1996 amended and restated as of September 17, 1999 and August 2001 by and among WFN Credit Company, LLC, World Financial Network National Bank, and BNY Midwest Trust Company (incorporated by reference to Exhibit No. 4.6 to the Registration Statement on Form S-3 of world financial network credit card master trust filed with the SEC on July 5, 2001, File No. 333-60418).
10.63Second Amendment to the Second Amended and Restated Pooling and Servicing Agreement, dated as of May 19, 2004, among World Financial Network National Bank, WFN Credit Company, LLC and BNY Midwest Trust Company (incorporated by reference to Exhibit No. 4.1 to the Current Report
\ No newline at end of file diff --git a/predictions/412.html b/predictions/412.html new file mode 100644 index 0000000000000000000000000000000000000000..9e60bbb682b00e345f655a9c7db3921ef3499f88 --- /dev/null +++ b/predictions/412.html @@ -0,0 +1,52 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
2009
(In thousands, except per share amounts)		20082007
Revenues
Transaction$ 375,398$ 342,123$ 350,008
Redemption495,663504,442420,966
Securitization income and finance charges, net502,389580,057654,660
Database marketing fees and direct marketing services504,508525,918478,555
Other revenue86,38372,71457,970
Total revenue1,964,3412,025,2541,962,159
Operating expenses
Cost of operations (exclusive of depreciation and amortization disclosed separately below)1,354,1381,341,9581,304,631
General and administrative99,82382,80480,898
Depreciation and other amortization62,19668,50559,688
Amortization of purchased intangibles63,09067,29167,323
Gain on acquisition of a business(21,227)——
Loss on the sale of assets—1,05216,045
Merger (reimbursements) costs(1,436)3,05312,349
Total operating expenses1,556,5841,564,6631,540,934
Operating income407,757460,591421,225
Interest expense, net144,81180,44069,381
Income from continuing operations before income taxes262,946380,151351,844
Provision for income taxes86,227147,599137,403
Income from continuing operations$ 176,719$ 232,552$ 214,441
Loss from discontinued operations, net of taxes(32,985)(26,150)(50,380)
Net income$ 143,734$ 206,402$ 164,061
Basic income (loss) per share:
Income from continuing operations$ 3.17$ 3.25$ 2.74
Loss from discontinued operations(0.59)(0.37)(0.65)
Net income per share$ 2.58$ 2.88$ 2.09
Diluted income (loss) per share:
Income from continuing operations$ 3.06$ 3.16$ 2.65
Loss from discontinued operations(0.57)(0.36)(0.62)
Net income per share$ 2.49$ 2.80$ 2.03
Weighted average shares:
Basic55,76571,50278,403
Diluted57,70673,64080,811
\ No newline at end of file diff --git a/predictions/413.html b/predictions/413.html new file mode 100644 index 0000000000000000000000000000000000000000..aec5970683bc6167348df32b426bff7ae30d8e33 --- /dev/null +++ b/predictions/413.html @@ -0,0 +1,116 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 20152014
(In thousands)
Deferred tax assets
Deferred revenue$ 200$ 7,111
Allowance for doubtful accounts285,632220,527
Net operating loss carryforwards and other carryforwards130,15398,910
Stock-based compensation and other employee benefits41,43344,694
Accrued expenses and other80,39548,444
Total deferred tax assets537,813419,686
Valuation allowance(42,185)(13,013)
Deferred tax assets, net of valuation allowance495,628406,673
Deferred tax liabilities
Deferred income$ 357,385$ 301,282
Depreciation15,00319,379
Intangible assets467,700558,081
Total deferred tax liabilities840,088878,742
Net deferred tax liability($344,460)($472,069)
Amounts recognized in the consolidated balance sheets:
Current assets$ 288,098$ 218,872
Non-current assets617164
Current liabilities(1,665)(930)
Non-current liabilities(631,510)(690,175)
Total—Net deferred tax liability($344,460)($472,069)
\ No newline at end of file diff --git a/predictions/414.html b/predictions/414.html new file mode 100644 index 0000000000000000000000000000000000000000..bb0c068e5a9190fbb23bf57ba136466a0b3d1d6e --- /dev/null +++ b/predictions/414.html @@ -0,0 +1,84 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Less than 12 monthsDecember 31, 2007
12 Months or Greater		Total
Fair ValueUnrealized LossesFair Value
(in thousands)		Unrealized LossesFair ValueUnrealized Losses
Government bonds$19,884$(92)$23,717$(70)$43,601$(169)
Corporate bonds62,360(881)100,398(770)162,758(1,671)
Total$82,244$(973)$124,115$(867)$206,359$(1,840)
Less than 12 monthsDecember 31, 2006
12 Months or Greater		Total
Fair ValueUnrealized LossesFair Value
(in thousands)		Unrealized LossesFair ValueUnrealized Losses
Government bonds$3,465$(13)$23,582$(146)$27,047$(159)
Corporate bonds39,942(151)78,298(471)118,240(622)
Total$43,407$(164)$101,880$(617)$145,287$(781)
\ No newline at end of file diff --git a/predictions/415.html b/predictions/415.html index b733b0d4faaddd3d1e8feddabd1a15091b3a80fa..60f4e35b2fb79a42e1488c80d18d7da941a2a912 100644 --- a/predictions/415.html +++ b/predictions/415.html @@ -1,64 +1,61 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20082007
(In thousands)
Certificates of deposit . . . . . . . . . . . . . . . . . .$ 688,900$ 370,400
Credit facility . . . . . . . . . . . . . . . . . . . . . .365,000121,000
Bridge loan . . . . . . . . . . . . . . . . . .300,000
Senior notes . . . . . . . . . . . . . . . . . .500,000500,000
Convertible senior notes805,000
Capital lease obligations and other debt57,17536,650
2,416,0751,328,050
Less: current portion(709,449)(683,989)
Long-term portion$1,706,626$644,061
December 31,
20082007
(In thousands)
Certificates of deposit$ 688,900$ 370,400
Credit facility365,000121,000
Bridge loan300,000
Senior notes500,000500,000
Convertible senior notes805,000
Capital lease obligations and other debt57,17536,650
2,416,0751,328,050
Less: current portion(709,449)(683,989)
Long-term portion$1,706,626$ 644,061
\ No newline at end of file diff --git a/predictions/416.html b/predictions/416.html new file mode 100644 index 0000000000000000000000000000000000000000..253d6191081198606c4035ea450dbbcb042fb7be --- /dev/null +++ b/predictions/416.html @@ -0,0 +1,8 @@ +
+ + + + + + +
Exhibit No.Description
3.1Second Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit No. 3.1 to our Registration Statement on Form S-1 filed with the SEC on March 3
\ No newline at end of file diff --git a/predictions/417.html b/predictions/417.html new file mode 100644 index 0000000000000000000000000000000000000000..f2fe4c44ba354682795c31e6335f13c70d5569a9 --- /dev/null +++ b/predictions/417.html @@ -0,0 +1,300 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,Change
20102009$%
Revenue
LoyaltyOne$ 799,534$ 715,091$ 84,44311.8%
Epsilon613,374514,27299,10219.3
Private Label Services and Credit1,386,274707,593678,68195.9
Corporate/Other1,86627,385(25,519)(93.2)
Eliminations(9,627)(9,627)NM*
Total$ 2,791,421$ 1,954,341$ 827,08042.1%
Adjusted EBITDA (1):
LoyaltyOne$ 204,554$ 200,724$ 3,8301.9%
Epsilon152,304128,25324,05118.8
Private Label Services and Credit530,021314,842215,17968.3
Corporate/Other(57,875)(53,742)(4,133)7.7
Eliminations(6,464)(6,464)NM*
Total$ 822,540$ 590,077$ 232,46339.4%
Stock compensation expense:
LoyaltyOne$ 10,266$ 12,227$ (1,961)(16.0)%
Epsilon9,4818,8156667.6
Private Label Services and Credit7,8618,199(338)(4.1)
Corporate/Other22,48624,371(1,885)(7.7)
Total$ 50,094$ 53,612$ (3,518)(6.6)%
Depreciation and amortization:
LoyaltyOne$ 23,823$ 21,772$ 2,0519.4%
Epsilon77,74369,9417,80211.2
Private Label Services and Credit35,16425,7209,44436.7
Corporate/Other6,4967,853(1,357)(17.3)
Total$ 143,226$ 125,286$ 17,94014.3%
Operating income from continuing operations:
LoyaltyOne$ 170,465$ 166,725$ 3,7402.2%
Epsilon65,08049,49715,58331.5
Private Label Services and Credit486,996280,923206,07373.4
Corporate/Other(86,837)(89,388)2,551(2.8)
Eliminations(6,464)(6,464)NM*
Total$ 629,220$ 407,757$ 221,46354.3%
Adjusted EBITDA margin (2):
LoyaltyOne25.6%28.1%(2.5)%
Epsilon24.824.9(0.1)
Private Label Services and Credit38.244.5(6.3)
Total29.5%30.0%(0.5)%
Segment operating data:
Private label statements generated142,379130,17612,2039.4%
Credit sales$ 8,773,436$ 7,968,125$ 805,31110.1%
AVERAGE credit card receivables$ 5,025,915$ 4,359,625$ 666,29015.3%
AIR MILES reward miles issued4,584,3844,545,77438,6100.8%
AIR MILES reward miles redeemed3,634,8213,326,307308,5149.3%
\ No newline at end of file diff --git a/predictions/418.html b/predictions/418.html index 367f9eee2c8467bb59fffe92978449ca05c35a76..57ba15866b32e2ccc63dab58a2a40be986a139be 100644 --- a/predictions/418.html +++ b/predictions/418.html @@ -1,10 +1,14 @@ - - - - - + + + + + + + + + @@ -12,33 +16,38 @@ + - + + - + - + + - + - + + - + +
PeriodTotal Number of Shares Purchased(1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(2) (In millions)PeriodTotal Number of Shares Purchased(1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(2)
In DollarsIn millions
During 2008:
October 1-31 . . . . . . .October 1-31 1,119,883 $50.50 1,112,900 $871.6
November 1-30 . . . . . . .November 1-30 991,915 41.39 985,200$830.8830.8
December 1-31 . . . . . . .December 1-31 813,256 43.34 807,300$795.8795.8
Total . . . . . . . . .Total 2,925,054 $45.42 2,905,400 $795.8
\ No newline at end of file diff --git a/predictions/419.html b/predictions/419.html index 98a488f1e9489a5140f24dda64c1bdcdf3afab73..8d51014fecb34b7995fda1137c6476faca88fb9f 100644 --- a/predictions/419.html +++ b/predictions/419.html @@ -5,4 +5,4 @@ 10.120 - Form of Warrant Confirmation Amendment dated August 4, 2008 between Alliance Data Systems Corporation and each of JPMorgan Chase Bank, National Association, London \ No newline at end of file + Form of Warrant Confirmation Amendment dated August 4, 2008 between Alliance Data Systems Corporation and each of JPMorgan Chase Bank, National Association, London Branch ( \ No newline at end of file diff --git a/predictions/42.html b/predictions/42.html index e31be784386dadb64e94e2d0aa7696b91d8a4281..1bfcf5fe4bd1550bb4996c71b1381bb95557a4cb 100644 --- a/predictions/42.html +++ b/predictions/42.html @@ -1,15 +1,16 @@ - + - - + + + @@ -18,18 +19,18 @@ - - + + - - + + - - + + diff --git a/predictions/420.html b/predictions/420.html new file mode 100644 index 0000000000000000000000000000000000000000..ba397f26a246d10b863cbf0e611c5a0bb331cffe --- /dev/null +++ b/predictions/420.html @@ -0,0 +1,65 @@ +
Millions of dollars December 31
2014 2013
Net property, plant, and equipment:Net property, plant, and equipment:
North America
Latin America$ 1,406$ 1,2271,4061,227
Europe/Africa/CIS$ 1,832$ 1,6391,8321,639
Middle East/Asia$ 3,180$ 2,7693,1802,769
Total
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
As of
January 2, 2014
(In thousands)
Current assets, net of cash acquired$ 246,769
Deferred tax asset3,509
Property and equipment19,719
Other non-current assets3,994
Intangible assets423,832
Goodwill565,015
Total assets acquired1,262,838
Current liabilities146,559
Current portion of long-term debt34,180
Deferred tax liability105,512
Long-term debt (net of current portion)126,323
Other non-current liabilities142
Total liabilities assumed412,716
Redeemable non-controlling interest341,907
Net assets acquired$ 508,215
\ No newline at end of file diff --git a/predictions/421.html b/predictions/421.html new file mode 100644 index 0000000000000000000000000000000000000000..5b3088cc91178c68b3db347022a44c2fa22e44b3 --- /dev/null +++ b/predictions/421.html @@ -0,0 +1,86 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
OptionsOutstandingExercisable
Remaining Contractual Life (Years)Weighted Average Exercise PriceOptionsOptions exercisableWeighted Average Exercise Price
$9.00 to $12.003762.1$11.63376311.63
$12.01 to $15.005401.9$14.98540$14.98
$15.01 to $22.0063.3$20.706$20.70
$22.01 to $29.004264.5$24.05426$24.05
$29.01 to $39.005885.2$31.80588$31.80
$39.01 to $47.001,3346.4$41.801,183$41.63
$47.01 to $54.00187.4$53.4417$53.43
$54.01 to $64.003268.1$63.32109$63.32
3,6143,245
\ No newline at end of file diff --git a/predictions/422.html b/predictions/422.html index aac8e4217ede1e033a5b916e564e3c88e2b802d6..7f31628849d6fc1281552f3ebecc504930e7e662 100644 --- a/predictions/422.html +++ b/predictions/422.html @@ -1,13 +1,19 @@ - + + + + + + + @@ -15,8 +21,8 @@ - - + + @@ -30,7 +36,7 @@ - - + +
December 31,
(In thousands)		December 31,
2009 2008
(In thousands)
Carrying amount of equity component $ 368,678
Principal amount of liability component$1,150,000$805,000$ 1,150,000$ 805,000
Unamortized discount
If-converted value of common stock$1,130,852$477,168$ 1,130,852$ 477,168
\ No newline at end of file diff --git a/predictions/423.html b/predictions/423.html index 2945eb91bbaf8a32ac6adf28ef0b34a764f16dec..414c2824f5d167d34dfaaa3b88974c4f163c01f6 100644 --- a/predictions/423.html +++ b/predictions/423.html @@ -1,99 +1,92 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Performance-BasedService-BasedTotal
Balance at January 1, 2006 . . . . . . . . . . . . . . . . . . . .
Shares granted . . . . . . . . . . . . . . . . . . . . . . . . . . .242,015626,672868,687
Shares vested . . . . . . . . . . . . . . . . . . . . . . . . . . .(8,100)(130,793)(138,893)
Shares cancelled . . . . . . . . . . . . . . . . . . . . . . . .(14,460)(75,765)(90,225)
Balance at December 31, 2006219,455889,9541,109,409
Shares granted(2)350,809422,980773,789
Shares vested(2)(318,864)(311,033)(629,897)
Shares cancelled(22,824)(129,343)(152,167)
Balance at December 31, 2007228,576872,5581,101,134
Shares granted1,791,7421,481,2663,273,008
Shares vested(187,106)(421,735)(608,839)
Shares cancelled(16,022)(193,951)(211,413)
Balance at December 31, 20081,817,1901,736,7003,553,890
Outstanding and Expected to Vest2,951,501
Performance BasedService Based(1)Total
Balance at January 1, 2006242,015626,672868,687
Shares granted(8,100)(130,793)(138,893)
Shares vested
Shares cancelled(14,460)(75,765)(90,225)
Balance at December 31, 2006219,455889,9541,109,409
Shares granted(2)350,809422,980773,789
Shares vested(2)(318,864)(311,033)(629,897)
Shares cancelled(22,824)(129,343)(152,167)
Balance at December 31, 2007228,576872,5581,101,134
Shares granted1,791,7421,481,2663,273,008
Shares vested(187,106)(421,733)(608,839)
Shares cancelled(16,022)(195,391)(211,413)
Balance at December 31, 20081,817,1901,736,7003,553,890
Outstanding and Expected to Vest2,951,501
\ No newline at end of file diff --git a/predictions/424.html b/predictions/424.html new file mode 100644 index 0000000000000000000000000000000000000000..e5c6484c5f5dd9b8d16c6e14588757e714412502 --- /dev/null +++ b/predictions/424.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended
December 31, 2005
(In thousands)
except per share amounts
Net income, as reported$138,745
Add: Stock-based employee compensation expense included in reported net income, net of related tax effects8,839
Deduct: Total stock-based employee compensation expense determined under fair value based method for all stock option awards, net of related tax effects(22,849)
Pro forma net income$124,735
Net income per share:
Basic-as reported$ 1.69
Basic-pro forma$ 1.52
Diluted-as reported$ 1.64
Diluted-pro forma$ 1.48
\ No newline at end of file diff --git a/predictions/425.html b/predictions/425.html index 6694fa38d68d0fff9e81cf02a6343a997459f30f..8a5090c8d6b1f99f941087dfd3d1fed538c88c81 100644 --- a/predictions/425.html +++ b/predictions/425.html @@ -1,9 +1,6 @@ - - - - + @@ -14,10 +11,11 @@ - - - - + + + + + @@ -28,34 +26,38 @@ - - - - + + + + - - - - - + + + + + - - - - + + + + - - - - + + + + - + + + + + diff --git a/predictions/426.html b/predictions/426.html new file mode 100644 index 0000000000000000000000000000000000000000..d18feb452f0f7dbdbc730ecf6e7cb1ec167f60c1 --- /dev/null +++ b/predictions/426.html @@ -0,0 +1,82 @@ +
December 31,
2009 2008
Fair Value
(In thousands)
Financial assetsFinancial assets
Cash and cash equivalents
Trade receivables, net$ 225,212$ 225,212$ 218,170$ 218,170225,212225,212218,170218,170
Seller's interest and credit card receivables, net$ 913,406$ 913,406$ 612,940$ 612,940Seller’s interest and credit card receivables, net913,406913,406612,940612,940
Redemption settlement assets, restricted$ 574,004$ 574,004$ 531,594$ 531,594574,004574,004531,594531,594
Due from securitizations$ 992,523$ 992,523$ 701,347$ 701,347992,523992,523701,347701,347
Financial liabilitiesFinancial liabilities
Accounts payable
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200720062005
(In thousands, except per share amounts)
Numerator
Net income available to common stockholders$164,061$189,605$138,745
Denominator
Weighted average shares, basic78,40379,73582,208
Weighted average effect of dilutive securities:
Net effect of dilutive stock options and unvested restricted stock2,4081,9512,429
Denominator for diluted calculation80,81181,68684,637
Basic
Net income per share$        2.09$        2.38$        1.69
Diluted
Net income per share$        2.03$        2.32$        1.64
\ No newline at end of file diff --git a/predictions/427.html b/predictions/427.html new file mode 100644 index 0000000000000000000000000000000000000000..f25d5bb84386687d40ea62c0d32ef5792ee26508 --- /dev/null +++ b/predictions/427.html @@ -0,0 +1,353 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200820072006
(in thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income217,393164,061189,605
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization143,810166,632125,040
Deferred income taxes27,041(27,729)(27,772)
Provision for doubtful accounts47,24942,14538,141
Non-cash stock compensation53,10356,24343,053
Fair value gain on interest-only strip(41,053)39,958(19,477)
Impairment of long-lived assets19,00439,961—
(Gain) loss on sale of assets(20,554)16,045—
Change in operating assets and liabilities, net of acquisitions:
Change in trade accounts receivable(12,014)(24,042)(50,947)
Change in merchant settlement activity(176,197)15,43911,043
Change in other assets(46,166)28,821(3,282)
Change in accounts payable and accrued expenses(52,909)66,84657,084
Change in deferred revenue578,273(9,866)43,538
Change in other liabilities28,637(9,566)(8,732)
Data acquisition costs4,40328,267(73,555)
Purchase of credit card receivables(206,529)(214,620)(73,555)
Proceeds from sale of credit card receivable portfolios102,986218,84683,575
Excess tax benefits from stock-based compensation(2,269)8,163(17,521)
Other8,6115,7298,291
Net cash provided by operating activities481,619517,521387,910
CASH FLOWS FROM INVESTING ACTIVITIES:
Change in redemption settlement assets(317,591)(9,477)(396)
Payments for acquired businesses, net of cash acquired(2,478)(438,163)(205,567)
Proceeds from sale of assets14,098——
Proceeds from sale of credit card receivable portfolios to the securitization trusts91,910—70,870
Investment in the stock of an investee—cost basis—(8,000)—
Change in due from securitization trusts(319,614)(11,115)(32,698)
Net increase in seller’s interest and credit card receivables(61,339)(117,691)(203,764)
Capital expenditures(49,556)(116,652)(100,362)
Proceeds from the sale of businesses17,96213,347—
Other5,910(6,057)(195)
Net cash used in investing activities(512,518)(694,808)(472,102)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under debt agreements3,754,4162,309,0003,629,869
Proceeds from issuance of convertible senior notes805,000—3,345,869
Repayment of borrowings(3,799,786)(2,113,000)(3,336,369)
Certificates of deposit issuance(128,500)(294,100)(336,300)
Repayments of certificates of deposit1,020,000422,700416,400
Payment of capital lease obligations(22,503)(14,481)(7,935)
Payment of deferred financing costs(34,861)——
Proceeds from sale leaseback transactions34,22125,949—
Proceeds from benefit from stock-based compensation2,2698,16317,521
Proceeds from issuance of common stock30,92020,89248,831
Proceeds from issuance of warrants94,185——
Payment for convertible note hedges(201,814)——
Purchase of treasury shares(1,000,853)(108,536)(145,998)
Other(1,078)(2,312)(4,049)
Net cash (used in) provided by financing activities20,306197,075112,270
Effect of exchange rate changes on cash and cash equivalents(27,123)11,976(1,216)
Change in cash and cash equivalents(108,928)35,76436,862
Cash and cash equivalents at beginning of year265,899180,075143,213
Cash and cash equivalents at end of year156,971215,839180,075
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid68,79578,95840,628
Income taxes paid, net of refunds113,987107,516141,935
\ No newline at end of file diff --git a/predictions/428.html b/predictions/428.html new file mode 100644 index 0000000000000000000000000000000000000000..660a2177825964bcc6ee55b4ecfc970cb2393599 --- /dev/null +++ b/predictions/428.html @@ -0,0 +1,335 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,Change
20082007$%
Revenue:
Loyalty Services$ 755,456$ 628,792$ 126,75420.2%
Epsilon Marketing Services490,908458,61032,2987.1
Private Label Services382,647370,83211,8153.2
Private Label Credit750,355827,952(77,597)(9.4)
Corporate/Other17,33733,360(16,023)(48.0)
Eliminations(371,629)(357,387)(14,242)4.0
Total$ 2,025,254$ 1,962,159$ 63,0953.2%
Adjusted EBITDA(1):
Loyalty Services$ 204,895$ 132,136$ 72,75955.1%
Epsilon Marketing Services126,358118,2198,1396.9
Private Label Services116,01099,08416,92617.1
Private Label Credit(46,417)60,039(106,456)(177.4)
Corporate/Other44,10057,333(13,233)(23.1)
Total$ 444,922$ 466,811$ (21,889)(4.7)
Stock compensation expense:
Loyalty Services$ 12,611$ 7,353$ 5,25871.5%
Epsilon Marketing Services8,85311,380(2,527)(22.2)
Private Label Services6,5915,61397817.4
Private Label Credit1,8982,794(896)(32.1)
Corporate/Other18,78123,191(4,410)(19.0)
Total$ 48,734$ 48,331$ 4230.9%
Depreciation and amortization:
Loyalty Services$ 29,796$ 24,601$ 5,19521.1%
Epsilon Marketing Services75,84171,9013,9405.5
Private Label Services8,8328,4294034.8
Private Label Credit11,48611,2312552.3
Corporate/Other10,20110,849(648)(6.0)
Total$ 136,156$ 127,011$ 8,7856.9%
Operating income from continuing operations:
Loyalty Services$ 162,488$ 100,184$ 62,30462.2%
Epsilon Marketing Services39,59134,9354,65613.3
Private Label Services29,15235,042(5,890)(16.8)
Private Label Credit(40,809)38,075(78,884)(207.1)
Corporate/Other(81,539)(137,011)55,472(40.5)
Total$ 108,883$ 71,225$ 37,65852.9%
Adjusted EBITDA margin(1):
Loyalty Services27.1%21.0%6.1%
Epsilon Marketing Services25.825.80.0
Private Label Services30.326.73.6
Private Label Credit33.942.3(8.4)
Total32.4%32.2%0.2%
Segment operating data:
Private label statements generated125,197135,261(10,064)(7.4)%
Credit sales$ 7,524,422$ 7,502,947$ 21,5250.3%
Average managed receivables$ 3,945,688$ 3,909,627$ 36,0610.9%
AIR MILES reward miles issued4,316,1314,143,000173,1314.2
AIR MILES reward miles redeemed3,121,7992,723,524398,27514.6
\ No newline at end of file diff --git a/predictions/429.html b/predictions/429.html new file mode 100644 index 0000000000000000000000000000000000000000..98bd28a343d2300a4e3aefe27a50182569d149ba --- /dev/null +++ b/predictions/429.html @@ -0,0 +1,193 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
20152014201320122011
Income statement data
Total revenue$6,439,746$5,302,940$4,319,063$3,641,309$3,173,287
Cost of operations (exclusive of amortization and depreciation disclosed separately below)3,814,5003,218,7742,549,1592,106,6121,811,882
Provision for loan loss668,200425,205345,758285,479300,316
General and administrative138,483141,468109,115108,05995,256
Regulatory settlement64,563
Earn-out obligation105,944
Depreciation and other amortization142,051109,65584,29173,80270,427
Amortization of purchased intangibles350,089203,427131,82893,07482,726
Total operating expenses5,177,8864,204,4733,220,1512,667,0262,360,607
Operating income1,261,8601,098,4671,098,912974,364812,680
Interest expense, net330,184260,526305,500291,460298,585
Income before income taxes931,676837,941793,412682,904514,095
Provision for income taxes326,248321,801297,242260,648198,809
Net income$605,428$516,140$496,170$422,256$315,286
Less: net income attributable to non-controlling interest8,8879,847
Net income attributable to common stockholders$596,541$506,293$496,170$422,256$315,286
Net income attributable to common stockholders per share:
Basic$ 8.91$ 8.72$ 10.09$ 8.44$ 6.22
Diluted$ 8.85$ 7.87$ 7.42$ 6.58$ 5.45
Weighted average shares:
Basic61,87456,37849,19050,00850,687
Diluted62,30162,44566,68664,14357,804
\ No newline at end of file diff --git a/predictions/43.html b/predictions/43.html index 42339ea57eb46023ee836dd359554331a9a0b8ca..1b2c778dfa9dcb39d0ae7453926d68460452d507 100644 --- a/predictions/43.html +++ b/predictions/43.html @@ -1,50 +1,50 @@ - + - + - + - + - + - + - + - + - + - + - + - +
4.5Third Supplemental Indenture dated as of August 1, 1997 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.7 to Halliburton's Form 10-K for the year ended December 31, 1998, File No. 001-03492).Third Supplemental Indenture dated as of August 1, 1997 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.7 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.6Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton's Form 10-K for the year ended December 31, 1998, File No. 001-03492).Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.7Resolutions of Halliburton's Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton's Form 10-K for the year ended December 31, 1996, File No. 001-03492).Resolutions of Halliburton’s Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton Form 10-K for the year ended December 31, 1996, File No. 001-03492).
4.8Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton's Form 8-K dated as of February 11, 1997, File No. 001-03492).Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 8-K dated as of February 11, 1997, File No. 001-03492).
4.9Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request.Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request.
4.10Form of debt security of 7.53% Notes due May 12, 2017 (incorporated by reference to Exhibit 4.4 to Halliburton's Form 10-Q for the quarter ended March 31, 1997, File No. 001-03492).Form of debt security of 7.53% Notes due May 12, 2017 (incorporated by reference to Exhibit 4.4 to Halliburton’s Form 10-Q for the quarter ended March 31, 1997, File No. 001-03492).
4.11Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, (incorporated by reference to Exhibit 4 to Dresser's Registration Statement on Form S-3A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser's Form 8-K filed on August 9, 1996, File No. 1-4003).Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser’s Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser’s Form 8-K filed on August 9, 1996, File No. 1-4003).
4.12Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.13Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, as Indenture to the Indenture dated as of April 18, 1996, (incorporated by reference to Exhibit 4.16 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.16 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.14Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton's Form 10-K for the quarter ended September 30, 2003, File No. 001-03492).Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 10-Q for the quarter ended September 30, 2003, File No. 001-03492).
4.15Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.16Form of note of 7.6% debentures due 2096 (included as Exhibit 4.15 above).Form of note of 7.6% debentures due 2096 (included as Exhibit A to Exhibit 4.15 above).
\ No newline at end of file diff --git a/predictions/430.html b/predictions/430.html new file mode 100644 index 0000000000000000000000000000000000000000..93f3e8086df181a6fac93b6b72c7a9ec00c062ed --- /dev/null +++ b/predictions/430.html @@ -0,0 +1,37 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
2015		December 31,
2014
Principal receivables$ 13,196,421$10,762,498
Billed and accrued finance charges537,821422,838
Other credit card and loan receivables65,22158,544
Total credit card and loan receivables13,799,46311,243,880
Less: credit card receivables—restricted for securitization investors10,592,3738,312,291
Other credit card and loan receivables$ 3,207,090$ 2,931,589
\ No newline at end of file diff --git a/predictions/431.html b/predictions/431.html new file mode 100644 index 0000000000000000000000000000000000000000..d906373a822b33fb3a8065f4d0dd3695df4ce438 --- /dev/null +++ b/predictions/431.html @@ -0,0 +1,68 @@ +
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + - + + - + - - + + - + @@ -28,7 +29,7 @@ - + @@ -36,7 +37,7 @@ - + @@ -44,15 +45,15 @@ - + - + - + - + @@ -60,7 +61,7 @@ - + @@ -68,7 +69,7 @@ - + @@ -76,7 +77,7 @@ - + diff --git a/predictions/435.html b/predictions/435.html index f4e88ee4d320bb192af46580fd49fcb736c7ba9d..ffe5f3c4fe6e64addd133a5458589673aa03852d 100644 --- a/predictions/435.html +++ b/predictions/435.html @@ -1,51 +1,51 @@
Item No.Form 10-K
Report
Page
Caution Regarding Forward-Looking Statements1
PART I
1.Business2
1A.Risk Factors11
1B.Unresolved Staff Comments23
2.Properties23
3.Legal Proceedings23
PART II
5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities24
6.Selected Financial Data27
7.Management’s Discussion and Analysis of Financial Condition and Results of Operations29
7A.Quantitative and Qualitative Disclosures About Market Risk53
8.Financial Statements and Supplementary Data55
9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure \ No newline at end of file diff --git a/predictions/432.html b/predictions/432.html new file mode 100644 index 0000000000000000000000000000000000000000..a2e85ed1504b4a6b08c7f38011bca529f7f50a4b --- /dev/null +++ b/predictions/432.html @@ -0,0 +1,12 @@ +
+ + + + + + + + + + +
Exhibit No.Description
*23.1Consent of Deloitte & Touche LLP
*31.1Certification of Chief Executive Officer of Alliance Data Systems Corporation pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of
\ No newline at end of file diff --git a/predictions/433.html b/predictions/433.html index 3c269f89eee9dd4b35d62d7d9f3bf052be504908..0f399992e8dce0953112b9879dabac49fd1fb16a 100644 --- a/predictions/433.html +++ b/predictions/433.html @@ -1,21 +1,21 @@ - + - - - - + + + + - - + - + + @@ -26,61 +26,62 @@ - - - - + + + + - - - - + + + + - - - - + + + + - - - - + + + + - + + - - - - + + + + - - - - + + + + - - - - + + + + - - - - + + + +
December 31, 2018 December 31, 2017
Carrying AmountFair ValueCarrying AmountFair ValueCarrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
(In millions)(in millions)
Financial assetsFinancial assets
Credit card and loan receivables, net
Credit card and loan receivables held for sale$ 1,951.6$ 1,995.5$ 1,026.3$ 1,067.61,951.61,995.51,026.31,067.6
Redemption settlement assets, restricted$ 558.6$ 558.6$ 589.5$ 589.5558.6558.6589.5589.5
Other investments$ 291.3$ 291.3$ 254.9$ 254.9291.3291.3254.9254.9
Derivative instruments$ 3.8$ 3.8$ 16.0$ 16.03.83.816.016.0
Financial liabilitiesFinancial liabilities
Derivative instruments$ 0.3$ 0.3$ 0.3$ 0.30.30.33.83.8
Deposits$ 11,793.7$ 11,768.7$ 10,930.9$ 10,903.111,793.711,768.710,930.910,937.1
Non-recourse borrowings of consolidated securitization entities$ 7,651.7$ 7,626.9$ 8,807.3$ 8,805.37,651.77,626.98,807.38,805.3
Long-term and other debt$ 5,737.9$ 5,767.8$ 6,079.6$ 6,186.45,737.95,767.86,079.66,186.4
\ No newline at end of file diff --git a/predictions/434.html b/predictions/434.html index 75a17fa7916c492bbf9182a06fd936a1ca1881b4..88c5c7fd8ef507dcfbc64c2641151194636e10b6 100644 --- a/predictions/434.html +++ b/predictions/434.html @@ -9,18 +9,19 @@
(In thousands)(In thousands)
Certificates of deposit(1)Certificates of deposit(1) $450,923 $232,137 $34,528—$717,588$ —717,588
Senior notes(1)Senior notes(1) 272,225 272,385 —544,610
Convertible senior notes(1)Convertible senior notes(1) 14,088 28,175 827,305869,568
Credit facility(1)Credit facility(1) 5,500 11,031 366,345382,876
Operating leasesOperating leases 47,04468,10168,110 46,314 82,677244,136244,145
Capital leasesCapital leases 24,612 27,375 3752,024
Software licensesSoftware license 7,872 5,341 —13,213
FIN No. 48 obligations(2)FIN No. 48 obligations(2) 402 — —402
Purchase obligations(3)Purchase obligations(3) 53,428 55,158 27,964
- + + - - + - + - - + + - - + + - - + + - - + + - - + + - + - + diff --git a/predictions/436.html b/predictions/436.html new file mode 100644 index 0000000000000000000000000000000000000000..31a386590c395543777014a481d24b565c93736f --- /dev/null +++ b/predictions/436.html @@ -0,0 +1,69 @@ +
Year(In thousands)Operating
Leases		Capital
Leases
Operating LeasesCapital Leases(In thousands)
2010$48,530$ 48,530 $23,065
2011$41,018$3,92541,0183,925
2012$34,975$2234,97522
2013$28,160$1328,16013
2014$25,72225,722—
Thereafter$94,90194,901—
Total $273,306$27,02527,025
Less amount representing interest ($1,318)(1,318)
Total present value of minimum lease payments
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Age Since OriginationNumber of AccountsPercentage of Accounts Outstanding (in thousands)Principal Balances OutstandingPercentage of Balances Outstanding
PercentagePercentage
0-12 Months3,02722.1%$1,225,70223.1%
13-24 Months1,72212.5700,08613.2
25-36 Months1,41110.3562,24510.6
37-48 Months1,2439.0494,6129.3
49-60 Months9927.2385,8257.2
Over 60 Months5,33738.91,945,15236.6
Total13,732100.0%$5,313,622100.0%
\ No newline at end of file diff --git a/predictions/437.html b/predictions/437.html new file mode 100644 index 0000000000000000000000000000000000000000..d33cbc40a7c3b65b5da50ab0f7dc355652d0d144 --- /dev/null +++ b/predictions/437.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
201820172016
Net income . . .$ 963.1$ 788.7$ 517.6
Other comprehensive (loss) income, net of tax . . .29.6(46.1)6.6
Total comprehensive income, net of tax . . .$ 992.7$ 742.6$ 524.2
\ No newline at end of file diff --git a/predictions/438.html b/predictions/438.html index dc374bec720aca372c237d8cbfe7df74a3200ba3..a4161f0d03d44fd8b4656dfcafe7c7fd7de58fad 100644 --- a/predictions/438.html +++ b/predictions/438.html @@ -6,103 +6,103 @@ Lease Expiration Date - Plano, Texas + Plano, Texas. . . . . . . . . . . . . . . . . . . . . Corporate 107,698 June 30, 2026 - Columbus, Ohio + Columbus, Ohio. . . . . . . . . . . . . . . . . . . Corporate, Card Services 567,006 September 12, 2032 - Toronto, Ontario, Canada + Toronto, Ontario, Canada . . . . . . . . . . . . LoyaltyOne 199,539 March 31, 2033 - Mississauga, Ontario, Canada + Mississauga, Ontario, Canada . . . . . . . . . LoyaltyOne 50,908 November 30, 2019 - Den Bosch, Netherlands + Den Bosch, Netherlands . . . . . . . . . . . . . LoyaltyOne - 132,482 + 32,482 December 31, 2033 - Maasbree, Netherlands + Maasbree, Netherlands . . . . . . . . . . . . . . LoyaltyOne - 668,923 + 68,923 September 1, 2033 - Wakefield, Massachusetts + Wakefield, Massachusetts. . . . . . . . . . . . Epsilon 184,411 December 31, 2020 - Irving, Texas + Irving, Texas . . . . . . . . . . . . . . . . . . . . Epsilon 221,898 June 30, 2026 - Earth City, Missouri + Earth City, Missouri . . . . . . . . . . . . . . . . Epsilon 116,783 April 30, 2022 - West Chicago, Illinois + West Chicago, Illinois. . . . . . . . . . . . . . . Epsilon 155,412 October 31, 2025 - Bengaluru, India + Bengaluru, India . . . . . . . . . . . . . . . . . . Epsilon 308,807 October 10, 2028 - Draper, Utah + Draper, Utah . . . . . . . . . . . . . . . . . . . . . Card Services 134,903 May 31, 2031 - Columbus, Ohio + Columbus, Ohio . . . . . . . . . . . . . . . . . . Card Services 103,161 December 31, 2027 - Westminster, Colorado + Westminster, Colorado . . . . . . . . . . . . . . Card Services 120,132 June 30, 2028 - Coeur D'Alene, Idaho + Couer D’Alene, Idaho. . . . . . . . . . . . . . . Card Services 114,000 July 31, 2038 - Westerville, Ohio + Westerville, Ohio . . . . . . . . . . . . . . . . . . Card Services 100,800 July 31, 2024 - Wilmington, Delaware + Wilmington, Delaware . . . . . . . . . . . . . . . Card Services 5,198 November 30, 2020 diff --git a/predictions/439.html b/predictions/439.html index c457a4030526f6c3a6a961d3849c6540948e6e9e..8699252bf68fa12ec3e29dc6dd0d4cd3f2ab15d3 100644 --- a/predictions/439.html +++ b/predictions/439.html @@ -1,44 +1,40 @@ - - - - - - + + - + - + - + - + - + - + diff --git a/predictions/44.html b/predictions/44.html index d2aa7d7eab66b250ae2a44087874c73eff34d859..7089261a791678a0d0e3ad5daa129972612bbd50 100644 --- a/predictions/44.html +++ b/predictions/44.html @@ -1,12 +1,18 @@
December 31,
20102009December 31,
2010		December 31,
2009
(In thousands)
Principal receivables ..................................................Principal receivables $ 5,116,111 $ 5,332,777
Billed and accrued finance charges .................................Billed and accrued finance charges 214,643 155,729
Other receivables .....................................................Other receivables 25,669 21,016
Total credit card receivables ......................................Total credit card receivables 5,356,423 5,509,522
Less credit card receivables - restricted for securitization investorsLess credit card receivables – restricted for securitization investors 4,795,753 4,838,441
Other credit card receivables .....................................Other credit card receivables $ 560,670 $ 671,081
- + + + + + + + diff --git a/predictions/440.html b/predictions/440.html new file mode 100644 index 0000000000000000000000000000000000000000..efbd38c8b476bc23d7d2885e0f3911fd23ed2f22 --- /dev/null +++ b/predictions/440.html @@ -0,0 +1,30 @@ +
Millions of shares December 31
2015 2014
Millions of shares
Issued 1,071
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + +
ALLIANCE DATA SYSTEMS CORPORATION AND SUBSIDIARIESPage
Reports of Independent Registered Public Accounting FirmF-2
Consolidated Statements of Income for the years ended December 31, 2009, 2008 and 2007F-4
Consolidated Balance Sheets as of December 31, 2009 and 2008F-5
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2009, 2008 and 2007F-6
Consolidated Statements of Cash Flows for the years ended December 31, 2009, 2008 and 2007F-7
Notes to Consolidated Financial StatementsF-8
\ No newline at end of file diff --git a/predictions/441.html b/predictions/441.html new file mode 100644 index 0000000000000000000000000000000000000000..78198ac851fdc3614a8d23ab7a839862b3a373cd --- /dev/null +++ b/predictions/441.html @@ -0,0 +1,90 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
201520142013
Net income$605,428$516,140$496,170
Other comprehensive (loss) income:
    Unrealized loss on securities available-for-sale(2,870)(264)(7,592)
        Tax benefit (expense)149(171)1,460
    Unrealized loss on securities available-for-sale, net of tax(2,721)(1,535)(6,132)
    Unrealized (loss) gain on cash flow hedges(1,359)3,302
        Tax benefit (expense)358(952)
    Unrealized (loss) gain on cash flow hedges, net of tax(1,001)2,350
    Foreign currency translation adjustments(58,076)(58,041)9,766
Other comprehensive (loss) income, net of tax(61,798)(57,226)3,634
Total comprehensive income, net of tax$543,630$458,914$499,804
Less: Comprehensive income attributable to non-controlling interest9,63011,766
Comprehensive income attributable to common stockholders$534,000$447,148$499,804
\ No newline at end of file diff --git a/predictions/442.html b/predictions/442.html index 7e22b951c605050ea25b38b377f4436bd031c929..07bb7ce80149788f264664c82fb77543c5f0060f 100644 --- a/predictions/442.html +++ b/predictions/442.html @@ -1,29 +1,36 @@ - + + - + + - + + - + + - + + - + + + diff --git a/predictions/443.html b/predictions/443.html new file mode 100644 index 0000000000000000000000000000000000000000..dcd3387feb2496952aa77d7c9d607a50df12dba1 --- /dev/null +++ b/predictions/443.html @@ -0,0 +1,389 @@ +
2008$ 686,130$686,130
2009$ 261,652261,652
2010$ 11,26611,266
2011$ 250,457250,457
2012$ 121,000121,000
Thereafter—
$1,330,505
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,Change
20072006$%
Revenue:
Loyalty Services$ 628,792$ 541,227$ 87,56516.2%
Epsilon Marketing Services458,610302,007156,54051.8
Private Label Services370,832382,680(11,848)(3.1)
Private Label Credit827,952745,33682,61611.1
Corporate/Other33,36037,024(3,665)(9.8)
Eliminations(357,387)(357,789)402(0.1)
Total$1,962,159$1,650,549$311,61018.9%
Adjusted EBITDA:
Loyalty Services$ 132,136$ 103,652$ 28,48427.5%
Epsilon Marketing Services118,21974,15844,06159.4
Private Label Services99,084119,835(20,751)(17.3)
Private Label Credit350,039282,70567,33423.8
Corporate/Other(67,333)(81,754)14,421(17.6)
Total$ 632,185$ 498,596$133,58926.8%
Stock compensation expense:
Loyalty Services$ 7,353$ 7,492$ (139)(1.9)%
Epsilon Marketing Services11,3805,4895,891107.3
Private Label Services5,6135,4821312.4
Private Label Credit1,71486984597.2
Corporate/Other23,79116,4597,33244.6
Total$ 49,851$ 35,791$ 12,52035.0%
Depreciation and amortization:
Loyalty Services$ 24,601$ 22,795$ 1,8087.9%
Epsilon Marketing Services71,90134,47337,428108.6
Private Label Services11,82910,4251,40613.5
Private Label Credit84,231110,408(26,177)(23.7)
Corporate/Other10,84910,3265235.1
Total$ 123,011$ 89,425$ 37,58642.0%
(Adjusted operating expense):
Loyalty Services$ 496,656$ 437,575$ 59,08113.5%
Epsilon Marketing Services340,391227,912112,47949.4
Private Label Services271,748262,6318,9033.4
Private Label Credit477,873426,84551,02412.0
Corporate/Other100,693118,779(18,086)(15.2)
Eliminations(357,387)(357,789)402(0.1)
Total$1,329,974$1,115,953$178,02115.5%
Operating income (loss):
Loyalty Services$ 100,184$ 73,369$ 26,81536.5%
Epsilon Marketing Services34,93534,1967392.2
Private Label Services33,042103,927(70,885)(68.2)
Private Label Credit138,075270,428(67,647)(25.0)
Corporate/Other(137,011)(108,540)(28,471)26.2
Total$ 172,225$ 373,380$ (47,449)(12.8)%
Adjusted EBITDA margin2:
Loyalty Services21.0%19.2%1.8%
Epsilon Marketing Services25.824.51.3
Private Label Services26.731.3(4.6)
Private Label Credit42.337.94.4
Total32.2%30.2%2.0%
Segment operating data:
Private label statements generated135,261135,764(503)(0.4)%
Credit sales - used receivables$7,502,947$7,444,029$ 58,6490.8%
Average managed receivables$3,905,027$3,640,853$269,5767.4%
AIR MILES reward miles issued4,143,0003,741,834401,16610.8%
AIR MILES reward miles redeemed3,513,0003,201,000312,0009.7%
\ No newline at end of file diff --git a/predictions/444.html b/predictions/444.html new file mode 100644 index 0000000000000000000000000000000000000000..1a0700ba68d7dc48da0e68fae9758ae31b90117b --- /dev/null +++ b/predictions/444.html @@ -0,0 +1,75 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
DescriptionBalance at Beginning of PeriodCharged to Costs and ExpensesCharged to Other Accounts (net of amounts)Write-Offs Net of RecoveriesBalance at End of Period
Allowance for Doubtful Accounts—Trade receivables:
Year Ended December 31, 2007$ 5,325$ 5,027$ (64)$ (822)$ 9,466
Year Ended December 31, 20062,0793,550(208)(512)5,325
Year Ended December 31, 20051,45879940(218)2,079
Allowance for Doubtful Accounts—Seller’s interest and credit card receivables:
Year Ended December 31, 2007$45,919$35,812$ (1,798)$ (41,207)$38,726
Year Ended December 31, 200638,41533,7774,802(31,075)45,919
Year Ended December 31, 200511,67320,91621,698(15,872)38,415
\ No newline at end of file diff --git a/predictions/445.html b/predictions/445.html new file mode 100644 index 0000000000000000000000000000000000000000..de63c705c8a2978d0d16398de6436990fabf3f14 --- /dev/null +++ b/predictions/445.html @@ -0,0 +1,61 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31, 2015December 31, 2014
CostUnrealized GainsUnrealized LossesFair ValueCostUnrealized GainsUnrealized LossesFair Value
Cash and cash equivalents$270,324$$270,324$237,127$$237,127
Mutual funds25,215(321)24,894
Corporate bonds160,3561,029(39)161,346280,0533,160283,213
Total$455,895$1,029$(360)$456,564$517,180$3,160$$520,340
\ No newline at end of file diff --git a/predictions/446.html b/predictions/446.html new file mode 100644 index 0000000000000000000000000000000000000000..be9cc87573d026bb6d8a17a54901e04ca9b84c3f --- /dev/null +++ b/predictions/446.html @@ -0,0 +1,42 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
As of
February 1, 2007
(In thousands)
Current assets$ 22,863
Property, plant and equipment13,844
Capitalized software19,200
Identifiable intangible assets169,760
Goodwill222,935
Total assets acquired448,602
Current liabilities9,325
Total liabilities assumed9,325
Net assets acquired$439,277
\ No newline at end of file diff --git a/predictions/447.html b/predictions/447.html new file mode 100644 index 0000000000000000000000000000000000000000..c1cb6aa942a3f293934ff8f8109f46f82bd7a525 --- /dev/null +++ b/predictions/447.html @@ -0,0 +1,31 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Amortized
Cost		Estimated
Fair Value
Due in one year or less$138,515$138,208
Due after one year through five years179,883178,845
Due after five years through ten years
Due after ten years
Total$318,398$317,053
\ No newline at end of file diff --git a/predictions/448.html b/predictions/448.html index 27ac07da49bf36362d86d8694ee199ad90c524c3..8e3a89a6edc77d27a07037d46879d6110ec0d0bf 100644 --- a/predictions/448.html +++ b/predictions/448.html @@ -12,82 +12,73 @@ Fair Value - (In thousands) - - - Financial assets + Financial assets + + + + - Cash and cash equivalents . . . . . . . . . . . . . . . . + Cash and cash equivalents $ 265,839 $ 265,839 $ 180,075 $ 180,075 - Due from card associations . . . . . . . . . . . . . . . - $ 21,456 - $ 21,456 - $ 108,671 - $ 108,671 - - - Trade receivables, net . . . . . . . . . . . . . . . . . - $ 306,992 - $ 306,992 - $ 271,563 - $ 271,563 + Due from card associations + 21,456 + 21,456 + 108,671 + 108,671 - Seller’s interest and credit card receivables, net . . . - $ 652,434 - $ 652,434 - $ 569,389 - $ 569,389 + Trade receivables, net + 306,992 + 306,992 + 271,563 + 271,563 - Redemption settlement assets, restricted . . . . . . . . - $ 317,053 - $ 317,053 - $ 260,957 - $ 260,957 + Seller’s interest and credit card receivables, net + 652,434 + 652,434 + 569,389 + 569,389 - Due from securitizations . . . . . . . . . . . . . . . . - $ 379,268 - $ 379,268 - $ 325,457 - $ 325,457 + Redemption settlement assets, restricted + 317,053 + 317,053 + 260,957 + 260,957 - Financial liabilities + Due from securitizations + 379,268 + 379,268 + 325,457 + 325,457 - Accounts payable - $ 134,790 - $ 134,790 - $ 112,582 - $ 112,582 - - - Merchant settlement obligations - $ 216,560 - $ 216,560 - $ 188,336 - $ 188,336 - - - Debt . . . . . . . . . . . . . . . . . . . . . . . + Financial liabilities - - $ 1,330,505 - $ 1,323,218 - $ 1,210,301 - $ 1,203,218 + Accounts payable + 134,790 + 134,790 + 112,582 + 112,582 + + + Merchant settlement obligations + 216,560 + 216,560 + 188,336 + 188,336 \ No newline at end of file diff --git a/predictions/449.html b/predictions/449.html new file mode 100644 index 0000000000000000000000000000000000000000..ca47b7e6b3af9be2f7c2c416bdee5a085061564b --- /dev/null +++ b/predictions/449.html @@ -0,0 +1,82 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
BusinessMonth AcquiredConsiderationSegment
2007:
Abacus. . . . . . . . . . . . . . . . . . . . . . . . . . . . .February 2007Cash for Assets andCommon StockMarketing Services
2006:
iCOM Information &
Communications, Inc. . . . . . . . . . . . . . . .		February 2006Cash for Assets andCommon StockMarketing Services
DoubleClick Email Solutions . . . . . . . . . . . . . . . .April 2006Cash for Assets andCommon StockMarketing Services
Big Design, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .August 2006Cash for AssetsMarketing Services
CPC Associates, Inc. . . . . . . . . . . . . . . . . . . . . . . .October 2006Cash for Common StockMarketing Services
2005:
Atrana Solutions, Inc. . . . . . . . . . . . . . . . . . . . . . .May 2005Cash for Common StockTransaction Services
Bigfoot Interactive, Inc. . . . . . . . . . . . . . . . . . . . .September 2005Cash for EquityMarketing Services
\ No newline at end of file diff --git a/predictions/45.html b/predictions/45.html index 25da36e6feb46ba80ed3bf1e66f749d5768581b5..26e8ceb7f5e5f86f49f540df2feab025e1afc800 100644 --- a/predictions/45.html +++ b/predictions/45.html @@ -1,24 +1,27 @@ - - - + + + + - - + + - + + + @@ -26,6 +29,7 @@ + @@ -33,6 +37,7 @@ + @@ -40,14 +45,16 @@ - + + - + + diff --git a/predictions/450.html b/predictions/450.html new file mode 100644 index 0000000000000000000000000000000000000000..31e8f12e3d1d422e1d5beef42effd769890b9b19 --- /dev/null +++ b/predictions/450.html @@ -0,0 +1,72 @@ +
Stock OptionsNumber of Shares (in millions)Weighted AverageAggregate Intrinsic Value (in millions)Number
of Shares
(in millions)		Weighted
Average		Weighted
Average
Remaining
Contractual
Term (years)		Aggregate
Intrinsic
Value
(in millions)
Exercise Price per ShareRemaining Contractual Term (years)Exercise
Price
per Share
Outstanding at January 1, 2009 12.8$ 25.64$25.64
Granted 3.9 21.81
Exercised (1.0) 16.86
Forfeited/expired (0.5) 26.10
Outstanding at December 31, 2009 15.2$ 25.17$25.17 6.5 $ 119
Exercisable at December 31, 2009 9.2$ 23.51$23.51 4.9 $ 81
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Quarter Ended
March 31,
2006		June 30,
2006		September 30,
2006		December 31,
2006
(In thousands, except per share amounts)
Revenues$477,231$490,447$506,584$524,480
Operating expenses377,823407,265417,375449,012
Interest expense, net8,53710,05910,63911,763
Income before income taxes90,87173,12378,57063,705
Provision for income taxes34,45028,32829,79024,096
Net income$ 56,421$ 44,795$ 48,780$ 39,609
Net income per share—basic$ 0.70$ 0.56$ 0.61$ 0.50
Net income per share—diluted$ 0.69$ 0.55$ 0.60$ 0.48
\ No newline at end of file diff --git a/predictions/451.html b/predictions/451.html new file mode 100644 index 0000000000000000000000000000000000000000..56c938a6ab4910addd85e9c758dfd91608cd6e7c --- /dev/null +++ b/predictions/451.html @@ -0,0 +1,36 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200720062005
(In thousands, except percentages)(In thousands, except percentages)(In thousands, except percentages)
Average managed receivables$3,909,627$3,640,057$3,170,485
Net charge-offs227,393180,449207,397
Net charge-offs as a percentage of average managed receivables5.8%5.0%6.5%
\ No newline at end of file diff --git a/predictions/452.html b/predictions/452.html new file mode 100644 index 0000000000000000000000000000000000000000..8acf21f935a53192f7b998de3fb52b06531412ba --- /dev/null +++ b/predictions/452.html @@ -0,0 +1,380 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
200920082007
(In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$ 143,734206,402164,061
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization125,409143,810166,632
Deferred income taxes17,47521,104(27,729)
Provision for doubtful accounts97,65847,26942,145
Non-cash stock compensation53,70254,33356,243
Fair value gain on interest-only strip(5,340)(31,065)(39,958)
Amortization of discount on convertible senior notes52,67716,928
Impairment of long-lived assets21,22719,00439,961
Gain on acquisition of businesses(19,913)(20,564)16,045
Loss (gain) on sale of assets(2,442)
Change in operating assets and liabilities, net of acquisitions:
Change in trade accounts receivable(2,162)(17,014)(24,042)
Change in merchant settlement activity(18,907)(76,197)115,439
Change in other assets(31,631)(46,166)(28,821)
Change in accounts payable and accrued expenses(39,460)(52,909)66,646
Change in deferred revenue(5,053)376,27349,858
Change in other liabilities(9,405)28,403(9,566)
Data acquisition costs(21,185)(4,637)(8,207)
Purchase of credit card receivables(27,407)(206,529)(224,626)
Proceeds from sale of credit card receivable portfolios53,240102,986218,849
Excess tax benefits from stock-based compensation(9,040)(2,629)(1,163)
Other(21,377)(8,611)6,729
Net cash provided by operating activities358,414451,019571,521
CASH FLOWS FROM INVESTING ACTIVITIES:
Change in redemption settlement assets52,354(317,591)(9,477)
Payments for acquired businesses, net of cash acquired(138,011)(2,478)(438,183)
Proceeds from the sale of assets4,01314,098
Proceeds from sale of credit card receivable portfolios to the securitization trusts91,910
Investments in the stock of an investee(5,347)(8,000)
Change in due from securitization(205,869)(319,614)(117,115)
Net increase in seller’s interest and credit card receivables(429,540)(61,339)(117,691)
Capital expenditures(52,970)(43,562)(116,852)
Proceeds from the sale of businesses17,95612,347
Change in restricted cash(107,299)
Other7,354(5,910)(6,057)
Net cash used in investing activities(888,002)(625,181)(694,028)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under debt agreements3,124,0003,754,4162,309,000
Proceeds from issuance of convertible senior notes345,000305,000
Repayment of borrowings(3,094,939)(3,799,786)(2,113,000)
Certificates of deposit issuances1,579,0001,078,500494,100
Repayments of certificates of deposit(803,400)(710,000)(422,700)
Payment of capital lease obligations(21,840)(22,503)(14,481)
Payment of deferred financing costs(24,058)(34,861)
Proceeds from sale leaseback transactions34,22125,949
Excess tax benefits from stock-based compensation9,0402,6298,163
Proceeds from issuance of common stock28,86430,92020,892
Proceeds from issuance of warrants30,05094,185
Payment for convertible note hedges(80,765)(201,814)
Purchase of prepaid forward contracts(74,872)
Purchase of treasury shares(445,891)(1,000,853)(108,536)
Other(20,506)(2,312)
Net cash provided by used in financing activities570,189206,066197,075
Effect of exchange rate changes on cash and cash equivalents15,886(27,123)11,976
Change in cash and cash equivalents56,467105,29885,754
Cash and cash equivalents at beginning of year156,91151,61370,679
Cash and cash equivalents at end of year$ 213,378156,911256,833
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid$ 84,08268,79579,858
Income taxes paid, net of refunds$ 73,579113,987107,516
\ No newline at end of file diff --git a/predictions/453.html b/predictions/453.html new file mode 100644 index 0000000000000000000000000000000000000000..b8d3849787d6a5a6232c1b9103220bd22fda78d5 --- /dev/null +++ b/predictions/453.html @@ -0,0 +1,62 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Exhibit No.Description
+10.45Form of Canadian Agreement for 2007 Special Award under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (incorporated by reference to Exhibit No. 10.104 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.46Form of Canadian Time-based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (2008 grant) (incorporated by reference to Exhibit No. 99.3 to our Current Report on Form 8-K filed with the SEC on April 29, 2008, File No. 001-15749).
+10.47Form of Canadian Performance-Based Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (2008 grant) (incorporated by reference to Exhibit No. 99.4 to our Current Report on Form 8-K filed with the SEC on April 29, 2008, File No. 001-15749).
+10.48Form of Non-Employee Director Nonqualified Stock Option Agreement (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on June 13, 2005, File No. 001-15749).
+10.49Form of Non-Employee Director Share Award Letter (incorporated by reference to Exhibit No. 10.2 to our Current Report on Form 8-K filed with the SEC on June 13, 2005, File No. 001-15749).
+10.50Form of Non-Employee Director Restricted Stock Unit Award Agreement under the Alliance Data Systems Corporation 2005 Long Term Incentive Plan (2008 grant) (incorporated by reference to Exhibit No. 10.10 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
+10.51Alliance Data Systems Corporation Non-Employee Director Deferred Compensation Plan (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on June 9, 2006, File No. 001-15749).
+10.52Form of Alliance Data Systems Associate Confidentiality Agreement (incorporated by reference to Exhibit No. 10.24 to our Annual Report on Form 10-K filed with the SEC on March 12, 2003, File No. 001-15749).
+10.53Form of Alliance Data Systems Corporation Indemnification Agreement for Officers and Directors (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K filed with the SEC on February 1, 2005, File No. 001-15749).
+10.54Amended and Restated Alliance Data Systems 401(k) and Retirement Savings Plan, effective January 1, 1004 (incorporated by reference to Exhibit No. 10.18 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
+10.55First Amendment, dated June 2, 2005, to Amended and Restated Alliance Data Systems 401(k) and Retirement Savings Plan (incorporated by reference to Exhibit No. 10.19 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
+10.56Second Amendment, dated December 20, 2005, to Amended and Restated Alliance Data Systems 401(k) and Retirement Savings Plan (incorporated by reference to Exhibit No. 10.20 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
+10.57Third Amendment, dated April 20, 2006, to Amended and Restated Alliance Data Systems 401(k) and Retirement Savings Plan (incorporated by reference to Exhibit No. 10.21 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
+10.58Fourth Amendment, dated October 31, 2006, to Amended and Restated Alliance Data Systems 401(k) and Retirement Savings Plan (incorporated by reference to Exhibit No. 10.22 to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2008, File No. 001-15749).
\ No newline at end of file diff --git a/predictions/454.html b/predictions/454.html index 0817acb4e5f0ff67c2c751f41df4dba501e860ed..61343a725183807d5cd70050c65bd5a9f7ad4bd7 100644 --- a/predictions/454.html +++ b/predictions/454.html @@ -2,7 +2,7 @@ 2008 - December 31, 2007 + 2007 Carrying Amount @@ -11,10 +11,11 @@ Fair Value - (In thousands) - - - Financial assets + Financial assets + + + + Cash and cash equivalents @@ -25,47 +26,51 @@ Trade receivables, net - $ 219,362 - $ 219,362 - $ 228,582 - $ 228,582 + 219,362 + 219,362 + 228,582 + 228,582 - Seller's interest and credit card receivables, net - $ 639,573 - $ 639,573 - $ 652,434 - $ 652,434 + Seller’s interest and credit card receivables, net + 639,573 + 639,573 + 652,434 + 652,434 Redemption settlement assets, restricted - $ 531,594 - $ 531,594 - $ 317,053 - $ 317,053 + 531,594 + 531,594 + 317,053 + 317,053 - Due from securitizations - $ 701,347 - $ 701,347 - $ 379,268 - $ 379,268 + Other financial securitization assets + 701,347 + 701,347 + 379,268 + 379,268 - Financial liabilities + Financial liabilities + + + + Accounts payable - $ 108,369 - $ 108,369 - $ 133,857 - $ 133,857 + 108,369 + 108,369 + 133,857 + 133,857 Debt - $ 2,416,075 - $ 2,206,587 - $ 1,328,050 - $ 1,320,763 + 2,416,075 + 2,206,587 + 1,328,050 + 1,320,763 \ No newline at end of file diff --git a/predictions/455.html b/predictions/455.html index fb6df7d9fbb5d231dd5f05092372190f5a8c5ba6..ba9f2aadeafb691e5cdf16067360c884f6ffb528 100644 --- a/predictions/455.html +++ b/predictions/455.html @@ -1,10 +1,11 @@ - + + - + diff --git a/predictions/456.html b/predictions/456.html new file mode 100644 index 0000000000000000000000000000000000000000..0c31c0fc6f53a38cc94da8c7b3b80b1667d2b900 --- /dev/null +++ b/predictions/456.html @@ -0,0 +1,69 @@ +
As of February 1, 2007 (In thousands)As of February 1, 2007(In thousands)
Current assets$22,863$ 22,863
Property, plant and equipment
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Age of Accounts Since OriginationNumber of Active Accounts with BalancesPercentage of Active Accounts with BalancesPrincipal Receivables OutstandingPercentage of Principal Receivables Outstanding
Within 30 days, except percentagesOver 30 days
0-12 Months6,51428.2%$ 3,331,17325.3%
13-24 Months3,66315.92,201,96616.7
25-36 Months2,43810.61,501,89911.4
37-48 Months1,7747.71,070,3148.1
49-60 Months1,3235.7803,6786.1
Over 60 Months7,35131.94,281,39132.4
Total23,063100.0%$13,196,421100.0%
\ No newline at end of file diff --git a/predictions/457.html b/predictions/457.html new file mode 100644 index 0000000000000000000000000000000000000000..41332cca1d14a56d60b84126153647a6f2cf99f4 --- /dev/null +++ b/predictions/457.html @@ -0,0 +1,35 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20182017
(In millions)
Accrued payroll and benefits$   242.2$   247.2
Accrued taxes24.064.6
Accrued other liabilities154.8131.0
Accrued expenses$   421.0$   442.8
\ No newline at end of file diff --git a/predictions/458.html b/predictions/458.html index 746a668f9d1e9e8686959a2bce43649b1b35da90..025b997eb8f38d8b2363e409023437d6802c16bb 100644 --- a/predictions/458.html +++ b/predictions/458.html @@ -1,6 +1,6 @@ - + @@ -9,34 +9,37 @@ - - - - - + + - + - + + + + + + + - + - + diff --git a/predictions/459.html b/predictions/459.html index fb6b8dbba22b5e0ef2aeab0696f01a1b7216f244..8552424c701a3187b1b309f56344e00f140cb7ff 100644 --- a/predictions/459.html +++ b/predictions/459.html @@ -13,23 +13,23 @@ - + - + - + - + - + @@ -49,7 +49,7 @@ - + @@ -57,6 +57,6 @@ - +
Year Ended December 31,
2006
(In thousands)
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$217,393Net income$217,303 $164,061 $189,605
Unrealized (loss) gain on securities available-for-sale . . . . . . . . . .Unrealized (loss) gain on securities available-for-sale (45,349) 846 1,880
Reclassification adjustment for the foreign currency translation gain realized upon the sale of the utility services business—
(7,535) —
Foreign currency translation adjustments(1) . . . . . . . . . . . . . . . . .Foreign currency translation adjustments(1) (19,005) 13,946 (721)
Total comprehensive income, net of tax . . . . . . . . . . . . . . . . . .Total comprehensive income, net of tax $145,504 $178,853 $190,764
10.19Lease Agreement by and between ADS Place Phase I, LLC and ADS Alliance Data Systems, Inc. dated August 25, 2006 (incorporated by reference to Exhibit No. 10.20 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).Lease Agreement by and between ADS Place Phase I, LLC and ADS Alliance Data Systems, Inc., dated August 25, 2006 (incorporated by reference to Exhibit No. 10.20 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
10.20Agreement of Lease by and between 11 West 19th Associates LLC and Epsilon Data Management, LLC, dated March 15, 2007 (incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).Agreement of Lease by and between 11 West 19 Associates LLC and Epsilon Data Management LLC, dated March 15, 2007 (incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
10.21Office Lease by and between Location3 Limited and 3407276 Canada, Inc., dated as of July 20, 1999 (incorporated by reference to Exhibit 10.21 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).Office Lease by and between Location³ Limited and 3407276 Canada, Inc., dated as of July 20, 1999 (incorporated by reference to Exhibit 10.21 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
10.22Lease Agreement by and between DoubleClick, Inc. and Epsilon Data Management LLC, dated as of February 1, 2007, as amended June 2007 (incorporated by reference to Exhibit 10.22 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).Lease Agreement by and between DoubleClick Inc. and Epsilon Data Management LLC, dated as of February 1, 2007, as amended June 2007 (incorporated by reference to Exhibit 10.22 to our Annual Report on Form 10-K, filed with the SEC on February 28, 2008, File No. 001-15749).
*10.23Second Amendment to Lease Agreement by and between Google Inc. (as successor-in-interest to DoubleClick, Inc.) and Epsilon Data Management LLC, dated as of July 24, 2008.Second Amendment to Lease Agreement by and between Google Inc. (as successor-in-interest to Doubleclick Inc.) and Epsilon Data Management LLC, dated as of July 24, 2008.
10.24
+10.28Alliance Data Systems Corporation 2007 Incentive Compensation Plan (incorporated by reference to Exhibit No. 10.26 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).Alliance Data Systems Corporation 2007 Incentive Compensation Plan (incorporated by reference to Exhibit No. 10.26 to our Annual Report on Form 10-K filed with the SEC on February 26, 2007, File No. 001-15749).
+10.29
+10.30Form of Alliance Data Systems Corporation Incentive Stock Option Agreement under the Amended and Restated Alliance Data Systems Corporation and its Subsidiaries Stock Option and Restricted Stock Plan (incorporated by reference to Exhibit No. 10.35 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623).Form of Alliance Data Systems Corporation Incentive Stock Option Agreement under the Amended and Restated Alliance Data Systems Corporation and its Subsidiaries Stock Option and Restricted Stock Plan (incorporated by reference to Exhibit No. 10.35 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623)
\ No newline at end of file diff --git a/predictions/46.html b/predictions/46.html index 2af39462a640939c4567ca364d6cb5bc4bbe1ac9..7acd083f80972a73191c5b1912ab8ca4815bfd72 100644 --- a/predictions/46.html +++ b/predictions/46.html @@ -1,63 +1,60 @@ - + - + - + - + - + - + - + - + - + - + - - -
Millions of dollars Year Ended December 31
Millions of dollars 2014 2013 2012
Net incomeNet income $ 3,501 $ 2,135 $ 2,645
Other comprehensive income, net of income taxes:Other comprehensive income, net of income taxes:
Defined benefit and other postretirement plans adjustmentsDefined benefit and other postretirement plans adjustments (84) — (33)
OtherOther (7) 2 (3)
Other comprehensive income (loss), net of income taxesOther comprehensive income (loss), net of income taxes (91) 2 (36)
Comprehensive incomeComprehensive income $ 3,410 $ 2,137 $ 2,609
Comprehensive income attributable to noncontrolling interestComprehensive income attributable to noncontrolling interest (1) (10) (10)
Comprehensive income attributable to common shareholdersComprehensive income attributable to company shareholders $ 3,409 $ 2,127 $ 2,599
See notes to consolidated financial statements.
\ No newline at end of file diff --git a/predictions/460.html b/predictions/460.html new file mode 100644 index 0000000000000000000000000000000000000000..670241213770ee2ef61fe2297e6087d60c98e49b --- /dev/null +++ b/predictions/460.html @@ -0,0 +1,106 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
20082007200620052004
(In thousands, except per share amounts)
Adjusted EBITDA(2)$ 655,161$ 632,185$ 498,596$ 321,361$ 254,707
Other financial data
Cash flows from operating activities$ 451,019$ 571,521$ 397,910$ 109,081$ 348,629
Cash flows from investing activities$ (512,518)$ (694,808)$ (472,102)$ (330,951)$ (399,859)
Cash flows from financing activities$ (20,306)$ 197,075$ 112,270$ 278,579$ 66,369
Segment Operating data
Private label sales statements generated125,230135,261135,764124,836123,292
Credit cards$7,272,893$7,502,947$7,444,298$6,582,800$6,227,211
Average annual receivables$3,919,353$3,909,627$3,640,057$3,170,485$3,021,800
AIR MILES reward miles issued4,463,1914,243,0003,541,8343,246,5182,884,105
AIR MILES reward miles redeemed4,131,7892,733,5042,716,9322,023,2231,823,122
\ No newline at end of file diff --git a/predictions/461.html b/predictions/461.html new file mode 100644 index 0000000000000000000000000000000000000000..95400dd514c5ab4052d92df1054bde918ae0c70b --- /dev/null +++ b/predictions/461.html @@ -0,0 +1,126 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
20152014201320122011
Net income$ 605,428$ 516,140$ 496,170$ 422,256$ 315,286
Stock compensation expense91,38172,46259,18350,49743,486
Provision for income taxes326,248321,801297,242260,648198,809
Interest expense, net330,184260,526305,500291,460298,585
Depreciation and other amortization142,051109,65584,29173,80270,427
Amortization of purchased intangibles350,089203,427131,82893,07482,726
Regulatory settlement(1)64,563
Earn-out obligation(2)105,944
Business acquisition costs(3)7,301
Adjusted EBITDA$1,909,944$1,597,256$1,374,214$1,191,737$1,009,319
Less: Securitization funding costs97,10991,10395,32692,808126,711
Less: Interest expense on deposits53,63037,54329,11125,18123,078
Less: Adjusted EBITDA attributable to non-controlling interest30,93543,050
Adjusted EBITDA, net$1,728,270$1,425,560$1,249,777$1,073,748$859,530
\ No newline at end of file diff --git a/predictions/462.html b/predictions/462.html index d5220f809b0cf1e8b50e2248eae092c7e120bee4..b71874248a3cc439d8c39e006122660f02676185 100644 --- a/predictions/462.html +++ b/predictions/462.html @@ -1,16 +1,13 @@ - - - - - - + + + - - + + @@ -24,7 +21,7 @@ - - + +
December 31,
20072006December 31, 2007December 31, 2006
Total credit card receivables managed$4,157.3$4,171.3$ 4,157.3$ 4,171.3
Less credit card receivables securitized
Principal amount of managed credit card receivables 90 days or more past due101.988.1
\ No newline at end of file diff --git a/predictions/463.html b/predictions/463.html index 77cb72662640ffcb13edf01750a5be08fd11af8f..296871028baf1bc85f4a694f3b16564ececdaaef 100644 --- a/predictions/463.html +++ b/predictions/463.html @@ -1,21 +1,17 @@ - + - - - - - + @@ -43,7 +39,7 @@ - + @@ -71,7 +67,7 @@ - + @@ -99,7 +95,7 @@ - + diff --git a/predictions/464.html b/predictions/464.html index 5528f70ac4e34ce13142a51337a994c330e8dd0d..1dfae28af2030b6baa1aa03c9b77ccf2ed5f9fb1 100644 --- a/predictions/464.html +++ b/predictions/464.html @@ -1,38 +1,38 @@
Outstanding Exercisable
Options Weighted Average Exercise Price Options Weighted Average Exercise Price
(In thousands, except per share amounts)
Balance at January 1, 2005 . . . . . . . . . . . . . . . . .Balance at January 1, 2005 6,615 $21.33
Balance at December 31, 2005 . . . . . . . . . . . . . .Balance at December 31, 2005 6,680 $27.19 3,319
Balance at December 31, 2006 . . . . . . . . . . . . . .Balance at December 31, 2006 4,872 $30.98 2,697
Balance at December 31, 2007 . . . . . . . . . . . . . .Balance at December 31, 2007 4,606 $33.98 3,327
- - - - - + + + + + - + - + - + - - - - + + + +
Years Ended December 31,
(In thousands)Years Ended December 31,
2009 2008 2007
RevenueRevenue $(10,212) $173,754 $329,031
Loss before provision for income taxesLoss before provision for income taxes (52,131) (40,152) (77,092)
Benefit from income taxesBenefit from income taxes 19,146 14,002 26,712
Loss from discontinued operations(32,985)(26,150)(50,380)Loss from discontinued operations$(32,985)$(26,150)$(50,380)
\ No newline at end of file diff --git a/predictions/465.html b/predictions/465.html new file mode 100644 index 0000000000000000000000000000000000000000..39ce0c12e0b08c2e5acd0cde5f22082c6445395d --- /dev/null +++ b/predictions/465.html @@ -0,0 +1,126 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20092008
(In thousands)
Deferred tax assets
Deferred revenue$ 143,232$ 135,276
Allowance for doubtful accounts31,34815,499
Net operating loss carryforwards and other carryforwards195,273104,376
Depreciation8,05315,428
Stock-based compensation and other employee benefits17,21627,795
Fair value adjustments31,89521,822
Accrued expenses and other25,18828,911
Total deferred tax assets452,205349,107
Valuation allowance(116,132)(70,222)
Deferred tax assets, net of valuation allowance336,073278,885
Deferred tax liabilities
Deferred income$ 90,963$ 48,492
Convertible note hedges25,49816,737
Servicing rights72,51363,762
Intangible assets90,35670,861
Total deferred tax liabilities279,330199,852
Net deferred tax asset$ 56,743$ 79,033
Amounts recognized in the consolidated balance sheets:
Current assets$ 197,455$ 201,895
Non-current liabilities$ (140,712)$ (123,476)
Discontinued operations net deferred tax asset (included in assets of discontinued operations)$ —$ 614
\ No newline at end of file diff --git a/predictions/466.html b/predictions/466.html new file mode 100644 index 0000000000000000000000000000000000000000..1e6a1954b6064cea43d9a5c0e97c14f467ba9479 --- /dev/null +++ b/predictions/466.html @@ -0,0 +1,118 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200820072006
In thousands, except per share amounts
Numerator
Income from continuing operations$243,399$214,441$206,397
Loss from discontinued operations(26,060)(50,380)(16,792)
Net income$217,339$164,061$189,605
Denominator
Weighted average shares, basic71,50278,40379,735
Weighted average effect of dilutive securities:
    Net effect of dilutive stock options and unvested restricted stock2,1382,4081,951
Weighted average shares, diluted calculation73,64080,81181,686
Basic (per share):
Income from continuing operations$  3.40$  2.742.59
Loss from discontinued operations$  (0.36)$  (0.65)$  (0.21)
Net income$  3.04$  2.092.38
Diluted (per share):
Income from continuing operations$  3.31$  2.652.53
Loss from discontinued operations$  (0.36)$  (0.62)$  (0.21)
Net income$  2.952.032.32
\ No newline at end of file diff --git a/predictions/467.html b/predictions/467.html new file mode 100644 index 0000000000000000000000000000000000000000..b3a246362b041beebc978bbc62aa72a2c7998f05 --- /dev/null +++ b/predictions/467.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200920082007
(In thousands, except percentages)
Average managed receivables$4,359,625$3,915,658$3,909,627
Net charge-offs404,382286,987227,393
Net charge-offs as a percentage of average managed receivables9.3%7.3%5.8%
\ No newline at end of file diff --git a/predictions/468.html b/predictions/468.html index 44a7082d0b446127068fa7cd745e8c1c1b8ef9ed..fb846eb6a38ea1ec16f24de52cc30bb07fc7f010 100644 --- a/predictions/468.html +++ b/predictions/468.html @@ -4,44 +4,44 @@ Description - +*10.61 + *10.61 Form of Performance-Based Restricted Stock Unit Award Agreement under the 2005 Long Term Incentive Plan (2010 grant). - +10.62 + *10.62 Form of Canadian Performance-Based Restricted Stock Unit Award Agreement under the 2005 Long Term Incentive Plan (2010 grant). - +10.63 + *10.63 Letter employment agreement with J. Michael Parks, dated February 19, 1997 (incorporated by reference to Exhibit 10.39 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623). - +10.64 + *10.64 Change in Control Agreement, dated as of September 25, 2003, by and between ADS Alliance Data Systems, Inc. and J. Michael Parks (incorporated by reference to Exhibit No. 10.2 to our Registration Statement on Form S-3 filed with the SEC on October 15, 2003, File No. 333-109713). - +10.65 - Transition Agreement, dated as of March 27, 2009, by and between J. Michael Parks and ADS Alliance Data Systems, Inc. (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K, filed with the SEC on March 30, 2009, File No. 000-15749). + *10.65 + Transition Agreement, dated as of March 27, 2009, by and between J. Michael Parks and ADS Alliance Data Systems, Inc. (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K, filed with the SEC on March 30, 2009, File No. 001-15749). - +10.66 - Letter employment agreement with Ivan Szefelt, dated May 4, 1998 (incorporated by reference to Exhibit 10.40 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623). + *10.66 + Letter employment agreement with Ivan Szeftel, dated May 4, 1998 (incorporated by reference to Exhibit 10.40 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623). - +10.67 - Form of Change in Control Agreement, dated as of September 25, 2003 by and between ADS Alliance Data Systems, Inc. and each of Edward J. Heffernan, Ivan M. Szefelt and Alan M. Utay (incorporated by reference to Exhibit No. 10.1 to our Registration Statement on Form S-3 filed with the SEC on October 15, 2003, File No. 333-109713). + *10.67 + Form of Change in Control Agreement, dated as of September 25, 2003, by and between ADS Alliance Data Systems, Inc. and each of Edward J. Heffernan, Ivan M. Szeftel and Alan M. Utay (incorporated by reference to Exhibit No. 10.3 to our Registration Statement on Form S-3 filed with the SEC on October 15, 2003, File No. 333-109713). - +10.68 - Separation Agreement and General Release of Claims, dated as of March 24, 2009, by and among John W. Scullion, LoyaltyOne, Inc. and Alliance Data Systems Corporation (incorporated by reference to Exhibit No. 10.2 to our Current Report on Form 8-K, filed with the SEC on March 30, 2009, File No. 000-15749). + *10.68 + Separation Agreement and General Release of Claims, dated as of March 24, 2009, by and among John W. Scullion, LoyaltyOne, Inc. and Alliance Data Systems Corporation (incorporated by reference to Exhibit No. 10.2 to our Current Report on Form 8-K, filed with the SEC on March 30, 2009, File No. 001-15749). - +10.69 - Separation Agreement and General Release of Claims by and between Dwayne Tucker and ADS Alliance Data Systems, Inc. (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K, filed with the SEC on August 18, 2009, File No. 000-15749). + *10.69 + Separation Agreement and General Release of Claims by and between Dwayne Tucker and ADS Alliance Data Systems, Inc. (incorporated by reference to Exhibit No. 10.1 to our Current Report on Form 8-K, filed with the SEC on August 18, 2009, File No. 001-15749). 10.70 - Amended and Restated License to Use the Air Miles Scheme in Canada, dated as of July 24, 1998, by and between Air Miles International Holdings N.V. and Loyalty Management Group Canada Inc. (incorporated by reference to Exhibit No. 10.43 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623) (assigned by Air Miles International Holdings N.V. to Air Miles International Trading B.V. by a novation agreement dated as of July 18, 2001). + Amended and Restated License to Use the Air Miles Trade Marks in Canada, dated as of July 24, 1998, by and between Air Miles International Holdings N.V. and Loyalty Management Group Canada Inc. (incorporated by reference to Exhibit No. 10.43 to our Registration Statement on Form S-1 filed with the SEC on January 13, 2000, File No. 333-94623) (assigned by Air Miles International Holdings N.V. to Air Miles International Trading B.V. by a novation agreement dated as of July 18, 2001). 10.71 @@ -53,6 +53,6 @@ 10.73 - Second Amended and Restated Pooling and Servicing Agreement, dated as of January 17, 1996 as amended and restated as of September 17, 1999 and August 1, 2001, by and among WFN Credit Company, LLC, World Financial Network National Bank, and BNY Midwest Trust Company (incorporated by reference to Exhibit No. 4.6 to the Registration Statement on Form S-3 of World Financial Network Credit Card Master Trust filed with the SEC on July 5, 2011, File No. 333-60418). + Second Amended and Restated Pooling and Servicing Agreement, dated as of January 17, 1996 as amended and restated as of September 17, 1999 and August 1, 2001, by and among WFNC Credit Company, LLC, World Financial Network National Bank, and BNY Midwest Trust Company (incorporated by reference to Exhibit No. 4.6 to the Registration Statement on Form S-3 of world financial network credit card master trust filed with the SEC on July 5, 2001, File No. 333-60418). \ No newline at end of file diff --git a/predictions/469.html b/predictions/469.html new file mode 100644 index 0000000000000000000000000000000000000000..4a2b5a79feafdfab77086e50b29d41d255f65d2b --- /dev/null +++ b/predictions/469.html @@ -0,0 +1,30 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
201020092008
Average credit card receivables$ 5,025,915$ 4,359,625$ 3,915,658
Net charge-offs of principal receivables448,587404,382286,987
Net charge-offs as a percentage of average credit card receivables8.9%9.3%7.3%
\ No newline at end of file diff --git a/predictions/47.html b/predictions/47.html index d647601afe5e9ca2f9d309608abf4c988572420a..3fbee3e185bcf6f6df16b34cfa7db300431b2fa3 100644 --- a/predictions/47.html +++ b/predictions/47.html @@ -1,13 +1,16 @@ - - - - + + + + + + + @@ -15,19 +18,19 @@ - + - + - + @@ -39,91 +42,91 @@ - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + - + @@ -135,19 +138,19 @@ - + - + - + @@ -159,31 +162,31 @@ - + - + - + - + - + diff --git a/predictions/470.html b/predictions/470.html new file mode 100644 index 0000000000000000000000000000000000000000..0b13e66770eb67313a730e331d87e03649e328de --- /dev/null +++ b/predictions/470.html @@ -0,0 +1,88 @@ +
Millions of dollars and shares except per share dataYear Ended December 31
Year Ended December 31 2008 2007 2006
Millions of dollars and shares except per share data
Revenue:
ServicesServices $ 13,391 $ 11,256 $ 9,643
Product salesProduct sales 4,888 4,008 3,312
Total revenueTotal revenue 18,279 15,264 12,955
Cost of servicesCost of services 10,0798,1678,162 6,751
Cost of salesCost of sales 3,970 3,358 2,675
General and administrativeGeneral and administrative 282 293 342
Gain on sale of business assets, netGain on sale of business assets, net (62) (52) (58)
Total operating costs and expensesTotal operating costs and expenses 14,269 11,766 9,710
Operating incomeOperating income 4,010 3,498 3,245
Interest expenseInterest expense (160)(103)(154) (165)
Interest incomeInterest income 39 124 129
Other, netOther, net (726) (8) (10)
Income from continuing operations before income taxes and minority interestIncome from continuing operations before income taxes and minority interest 3,163 3,460 3,199
Provision for income taxesProvision for income taxes (1,211) (907) (1,003)
Minority interest in net income of subsidiariesMinority interest in net income of subsidiaries 9 (29) (19)
Income from continuing operationsIncome from continuing operations 1,961 2,524 2,177
Income (loss) from discontinued operations, net of income tax (provision) benefit of $3, $(15), and $(183)Income (loss) from discontinued operations, net of income tax (provision) benefit of $3, $(15), and $(183) (423) 975 171
Net incomeNet income $ 1,538 $ 3,499 $ 2,348
Income from continuing operationsIncome from continuing operations $ 2.24 $ 2.76 $ 2.15
Income (loss) from discontinued operations, netIncome (loss) from discontinued operations, net (0.49) 1.07 0.16
Net income per shareNet income per share $ 1.75 $ 3.83 $ 2.31
Income from continuing operationsIncome from continuing operations $ 2.17 $ 2.66 $ 2.07
Income (loss) from discontinued operations, netIncome (loss) from discontinued operations, net (0.47) 1.02 0.16
Net income per shareNet income per share $ 1.70 $ 3.68 $ 2.23
Basic weighted average common shares outstandingBasic weighted average common shares outstanding 877 913 1,014
Diluted weighted average common shares outstandingDiluted weighted average common shares outstanding 904 950 1,054
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
United StatesCanadaEurope, Middle East and Africa
(in millions)		Asia PacificOtherTotal
Revenues
Year Ended December 31, 2018 . . .$6,657.1$427.3$ 526.7$ 131.3$ 48.8$ 7,791.2
Year Ended December 31, 2017 . . .$6,336.1$742.8$ 485.1$ 140.4$ 15.0$ 7,719.4
Year Ended December 31, 2016 . . .$5,730.3$706.5$ 537.4$ 154.5$ 9.4$ 7,138.1
Long Lived Assets
December 31, 2018 . . .$4,693.1$261.0$ 698.6$ 22.5$ 0.8$ 5,676.0
December 31, 2017 . . .$4,910.5$297.0$ 750.2$ 20.5$ 1.0$ 5,979.2
\ No newline at end of file diff --git a/predictions/471.html b/predictions/471.html new file mode 100644 index 0000000000000000000000000000000000000000..077d124148beeacd223e0ce87415b90c541ef20f --- /dev/null +++ b/predictions/471.html @@ -0,0 +1,8 @@ +
+ + + + + + +
Exhibit No.Description
10.70Third Amendment to the Transfer and Servicing Agreement, dated as of May 19, 2004, among WFN Credit Company, LLC, World Financial Network National Bank and World Financial Network Credit Card Master Note Trust (
\ No newline at end of file diff --git a/predictions/472.html b/predictions/472.html index bb16fa1885e346eaa2894c05bdf4cb44b1cb3e4b..b537602a872f6463a03e6ca233f41882f07c1cc5 100644 --- a/predictions/472.html +++ b/predictions/472.html @@ -1,107 +1,107 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Performance-BasedService-BasedTotalWeighted Average Fair Value
Balance at January 1, 2013 . . .773,841315,1511,088,992$ 93.33
Shares granted . . .409,57592,206501,781155.31
Shares vested . . .(448,868)(122,931)(571,799)88.15
Shares cancelled . . .(49,544)(14,915)(64,459)115.83
Balance at December 31, 2013 . . .685,004269,511954,515$121.86
Shares granted(1) . . .271,616246,867518,483282.34
Shares vested . . .(405,655)(99,037)(504,692)116.07
Shares cancelled . . .(32,898)(16,074)(48,972)177.14
Balance at December 31, 2014 . . .518,067401,267919,334$198.85
Shares granted . . .281,49182,811364,302284.22
Shares vested . . .(315,330)(178,691)(494,021)174.93
Shares cancelled . . .(37,862)(29,849)(67,711)239.35
Balance at December 31, 2015 . . .446,366275,538721,904$238.37
Outstanding and Expected to Vest666,504225,635892,139$235.23
Performance-BasedService-BasedTotalWeighted Average Fair Value
Balance at January 1, 2013773,841315,1511,088,992$ 93.33
Shares granted409,57592,206501,781155.31
Shares vested(448,868)(122,931)(571,799)88.15
Shares cancelled(49,544)(14,915)(64,459)115.83
Balance at December 31, 2013685,004269,511954,515$121.86
Shares granted(1)271,616246,867518,483282.34
Shares vested(405,655)(99,037)(504,692)116.07
Shares cancelled(32,989)(16,074)(48,972)177.14
Balance at December 31, 2014518,067401,267919,334$198.85
Shares granted281,49182,811364,302284.22
Shares vested(315,330)(178,691)(494,021)174.93
Shares cancelled(37,862)(29,849)(67,711)239.35
Balance at December 31, 2015446,366275,538721,904$238.37
Outstanding and Expected to Vest665,204$235.23
\ No newline at end of file diff --git a/predictions/473.html b/predictions/473.html new file mode 100644 index 0000000000000000000000000000000000000000..92939d0c406d4e6015a0bc2efcad0c5524a7dde8 --- /dev/null +++ b/predictions/473.html @@ -0,0 +1,108 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Quarter Ended
March 31,
2007		June 30,
2007		September 30,
2007		December 31,
2007
(In thousands, except per share amounts)
Revenues$466,347$481,820$492,026$521,966
Operating expenses345,776379,599376,454439,105
Operating income120,571102,221115,57282,861
Interest expense, net15,80018,93417,77116,876
Income from continuing operations before income taxes104,77183,28797,80165,985
Provision for income taxes40,05631,75236,53529,060
Income from continuing operations64,71551,53561,26636,925
Loss from discontinued operations(7,855)(7,446)(32,093)(2,986)
Net income$56,860$44,089$29,173$33,939
Income from continuing operations per share—basic$0.82$0.66$0.78$0.47
Income from continuing operations per share—diluted$0.80$0.64$0.76$0.46
Net income per share—basic$0.72$0.56$0.37$0.43
Net income per share—diluted$0.70$0.55$0.36$0.42
\ No newline at end of file diff --git a/predictions/474.html b/predictions/474.html index 33540c82dd0d951b5d6e608b04dc9a85f601f68e..b3b5821bfc7425d2d0c60b30c0948e60f126543e 100644 --- a/predictions/474.html +++ b/predictions/474.html @@ -1,13 +1,18 @@ - - + + + + + + + @@ -16,15 +21,15 @@ - - - + + + - - - + + + @@ -35,7 +40,7 @@ - + @@ -76,8 +81,8 @@ - - - + + +
Years Ended December 31,
(In thousands)		Years Ended December 31,
2009 2008 2007
(In thousands)
Interest from loans to subsidiaries $ 15,428
Dividends from subsidiaries$1,101,641$350,800$202,2501,101,641350,800202,250
Total revenue$1,117,069$375,114$237,2981,117,069375,114237,298
Loss on sale of long-lived assets
Interest expense, net 120,36376,45446,454 64,289
Net income143,734206,402164,061$ 143,734$ 206,402$ 164,061
\ No newline at end of file diff --git a/predictions/475.html b/predictions/475.html index 157f9722753ad4289a3fa4383e849361eddc890f..081dad318fcd26253ff442ca69ac99b7eb038ca1 100644 --- a/predictions/475.html +++ b/predictions/475.html @@ -1,14 +1,22 @@ - + + + + + + + - + + + @@ -17,88 +25,92 @@ - - + + - - + + - - + + - - + + - - + + - - - + + + - - - + + + - - - + + + - + + + - - + + - - + + - - + + - - - + + + - + - + - + + + - - + + - - + + - - + +
December 31,December 31,
2007 2006
(In thousands)
Deferred tax assetsDeferred tax assets
Deferred revenue
Allowance for doubtful accounts$17,008$16,10517,00816,105
Net operating loss carryforwards and other carryforwards$84,754$53,59284,75453,592
Depreciation$12,863$9,2672,8639,267
Stock-based compensation and other employee benefits$34,730$16,68434,73016,684
Accrued expenses and other$27,913$15,59727,91315,597
Total deferred tax assets$315,912$223,792Total deferred tax assets315,912223,792
Valuation allowance$(53,312)$(32,070)Valuation allowance(53,312)(32,070)
Deferred tax assets, net of valuation allowance$262,600$191,722Deferred tax assets, net of valuation allowance262,600191,722
Deferred tax liabilitiesDeferred tax liabilities
Deferred income$36,372$35,948$ 36,372$ 35,948
Servicing rights$56,907$38,78856,90738,788
Intangible assets$40,269$72,49840,26972,498
Total deferred tax liabilities$133,548$147,234Total deferred tax liabilities133,548147,234
Net deferred tax assetNet deferred tax asset $129,052$44,488$ 44,488
Amounts recognized in the consolidated balance sheet:Amounts recognized in the consolidated balance sheet:
Current assets$95,950$88,722$ 95,950$ 88,722
Non-current assets$33,102—33,102
Non-current liabilities—$44,234$ —$ 44,234
\ No newline at end of file diff --git a/predictions/476.html b/predictions/476.html new file mode 100644 index 0000000000000000000000000000000000000000..df1d39250e24136309bd85f5bc7944d0f9f907d6 --- /dev/null +++ b/predictions/476.html @@ -0,0 +1,84 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Less than 12 monthsDecember 31, 2008
12 Months or Greater		Total
Fair ValueUnrealized LossesFair Value
(In thousands)		Unrealized LossesFair ValueUnrealized Losses
Government bonds . . . . . . . . . . . . . . . . . . . . .$$$
Corporate bonds . . . . . . . . . . . . . . . . . . . . . .176,845$(8,170)26,704$(415)203,549$(8,585)
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . .$176,845$(8,170)$ 26,704$(415)$203,549$(8,585)
Less than 12 monthsDecember 31, 2007
12 Months or Greater		Total
Fair ValueUnrealized LossesFair Value
(In thousands)		Unrealized LossesFair ValueUnrealized Losses
Government bonds . . . . . . . . . . . . . . . . . . . . .$ 19,884$(92)$ 23,717$(79)$ 43,601$(169)
Corporate bonds . . . . . . . . . . . . . . . . . . . . . .62,360$(881)100,398$(790)162,758$(1,671)
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 82,244$(973)$124,115$(867)$206,359$(1,840)
\ No newline at end of file diff --git a/predictions/477.html b/predictions/477.html new file mode 100644 index 0000000000000000000000000000000000000000..6157c1240fb85ac380107a2938c336c68184d3e6 --- /dev/null +++ b/predictions/477.html @@ -0,0 +1,184 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200720062005
(In thousands, except per share amounts)
Revenues
Transaction$ 675,388$ 660,305$ 616,589
Redemption420,966352,801275,840
Securitization income and finance charges, net655,712579,742405,868
Database marketing fees and direct marketing services452,136319,704194,775
Other revenue86,98786,19059,365
Total revenue2,291,1891,998,7421,552,437
Operating expenses
Cost of operations (exclusive of depreciation and amortization disclosed separately below)1,631,0291,434,6201,124,590
General and administrative80,89891,81591,532
Depreciation and other amortization84,33865,44358,565
Amortization of purchased intangibles82,29459,59741,142
Impairment on long-lived assets39,961——
Loss on the sale of assets16,045——
Merger costs12,349——
Total operating expenses1,946,9141,651,4751,315,829
Operating income344,275347,267236,608
Interest income(10,691)(6,595)(4,017)
Interest expense80,21447,59318,499
Income before income taxes274,752306,269222,126
Provision for income taxes110,691116,66483,381
Net income$ 164,061$ 189,605$ 138,745
Net income per share:
Basic$ 2.09$ 2.38$ 1.69
Diluted$ 2.03$ 2.32$ 1.64
Weighted average shares:
Basic78,40379,73582,208
Diluted80,81181,68684,637
\ No newline at end of file diff --git a/predictions/478.html b/predictions/478.html index 58b64ade4be26f320c9df7925ccc91d5340ee61b..396759a66bdf3a5141541a9e421ce71c423bf33f 100644 --- a/predictions/478.html +++ b/predictions/478.html @@ -5,4 +5,4 @@ 10.89 - Series 2008-A Indenture Supplement, dated as of September 12, 2008 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the SEC by WFN Credit Company, LLC \ No newline at end of file + Series 2008-A Indenture Supplement, dated as of September 12, 2008 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the SEC by WFN Credit Company, LLC, World \ No newline at end of file diff --git a/predictions/479.html b/predictions/479.html index 6dce2771a8f4f2b7572cd29ad7da05436066ff95..f898badb7a18319abc2b3f0a2b40348e3e75ad0e 100644 --- a/predictions/479.html +++ b/predictions/479.html @@ -1,85 +1,83 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Quarter Ended
(In millions, except per share amounts)
March 31, 2018June 30, 2018September 30, 2018December 31, 2018
Revenues . . . . . . . . . . . . . . . . . . . . . . .$ 1,884.2$ 1,903.9$ 1,947.2$ 2,055.9
Operating expenses . . . . . . . . . . . . . . . . . .$ 1,506.4$ 1,483.6$ 1,425.2$ 1,481.7
Operating income . . . . . . . . . . . . . . . . . . .$ 377.8$ 420.3$ 522.0$ 574.2
Interest expense . . . . . . . . . . . . . . . . . . .$ 159.2$ 165.7$ 168.9$ 176.8
Income before income taxes . . . . . . . . . . . . .$ 218.6$ 254.6$ 353.1$ 397.4
Provision for income taxes . . . . . . . . . . . . .$ 54.7$ 36.8$ 56.6$ 112.5
Net income . . . . . . . . . . . . . . . . . . . . . .$ 163.9$ 217.8$ 296.5$ 284.9
Net income attributable to common stockholders per share:
Basic . . . . . . . . . . . . . . . . . . . . . . . . .$ 2.96$ 3.94$ 5.41$ 5.28
Diluted . . . . . . . . . . . . . . . . . . . . . . . .$ 2.93$ 3.93$ 5.39$ 5.25
March 31, 2018Quarter Ended June 30, 2018September 30, 2018December 31, 2018
Revenues$ 1,884.2$ 1,903.9$ 1,947.2$ 2,055.9
Operating expenses1,506.41,483.61,425.21,481.7
Operating income377.8420.3522.0574.2
Interest expense, net159.2165.7168.9176.8
Income before income taxes218.6254.6353.1397.4
Provision for income taxes54.736.856.6112.5
Net income$ 163.9$ 217.8$ 296.5$ 284.9
Net income attributable to common stockholders per share:
Basic$ 2.96$ 3.94$ 5.41$ 5.28
Diluted$ 2.95$ 3.93$ 5.39$ 5.27
\ No newline at end of file diff --git a/predictions/48.html b/predictions/48.html index d6fae666fc8e61328f3c584697b774bf57e700b3..6c2e9cb08259536d93acc1abe6ed539d8f7197e2 100644 --- a/predictions/48.html +++ b/predictions/48.html @@ -1,6 +1,6 @@ - + @@ -9,32 +9,32 @@ - - + + - - + + - - + + - - + + - - + + - - + +
Millions of dollars December 31
Land$ 248$ 228$ 248$ 228
Buildings and property improvements$ 3,460$ 3,3993,4603,399
Machinery, equipment and other$ 17,062$ 16,10317,06216,103
Total$ 20,770$ 19,73020,77019,730
Less accumulated depreciation$ 12,249$ 11,19812,24911,198
Net property, plant and equipment$ 8,521$ 8,532$ 8,521$ 8,532
\ No newline at end of file diff --git a/predictions/480.html b/predictions/480.html index 08bb740726feb09f30502937caac49a92c021fda..86ed8a8aeadd7ba370424daa7264e354b964cf68 100644 --- a/predictions/480.html +++ b/predictions/480.html @@ -1,83 +1,18 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + +
Quarter Ended
(In millions, except per share amounts)
March 31, 2017June 30, 2017September 30, 2017December 31, 2017
Revenues$ 1,879.0$ 1,821.8$ 1,912.4$ 2,106.2
Operating expenses1,526.61,470.41,433.51,643.4
Operating income352.4351.4478.9462.8
Interest expense, net125.2137.5145.3156.4
Income before income taxes227.2213.9333.6306.4
Provision for income taxes80.876.2100.435.0
Net income$ 146.4$ 137.7$ 233.2$ 271.4
Net income attributable to common stockholders per share:
Basic$ 2.60$ 2.48$ 4.21$ 4.91
Diluted$ 2.58$ 2.47$ 4.19$ 4.88
Quarter Ended
March 31,
2017		June 30,
2017		September 30,
2017		December 31,
2017
Revenues . . . . . . . . . . . . . . . . . . . . . . .$ 1,879.0$ 1,821.8$ 1,912.4$ 2,106.2
Operating expenses . . . . . . . . . . . . . . . . . .1,526.61,470.41,433.51,643.4
Operating income . . . . . . . . . . . . . . . . . . .352.4351.4478.9462.8
Interest expense, net . . . . . . . . . . . . . . . .125.2137.5145.3156.4
Income before income taxes . . . . . . . . . . . . . .227.2213.9333.6306.4
Provision for income taxes . . . . . . . . . . . . . .80.876.2100.435.0
Net income . . . . . . . . . . . . . . . . . . . . . . .$ 146.4$ 137.7$ 233.2$ 271.4
Net income attributable to common stockholders per share:
Basic. . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 2.60$ 2.48$ 4.21$ 4.91
Diluted. . . . . . . . . . . . . . . . . . . . . . . . . . .$ 2.46$ 2.34$ 3.99$ 4.63
\ No newline at end of file diff --git a/predictions/481.html b/predictions/481.html index 6a877c3ee3e10da984d7e106065814f5bbd2d16e..7c1a295ad7fef28ab648469897e961751d9d7c9e 100644 --- a/predictions/481.html +++ b/predictions/481.html @@ -1,27 +1,30 @@ - - + + + + + + - - + - + - + diff --git a/predictions/482.html b/predictions/482.html new file mode 100644 index 0000000000000000000000000000000000000000..42e7043547becc1e6ec0c85224f57435c718a710 --- /dev/null +++ b/predictions/482.html @@ -0,0 +1,105 @@ +
Years Ended December 31, (In thousands)Years Ended December 31,
2009 2008 20072006
Cost of operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Cost of operations $29,256 $29,843 $27,593
General and administrative . . . . . . . . . . . . . . . . . . . . . . . . . .General and administrative 24,356 18,891 20,718
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Total $53,612 $48,734 $48,311
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
LocationSegmentApproximate Square FootageLease Expiration Date
Plano, TexasCorporate108,269June 29, 2021
Columbus, OhioCorporate, Card Services272,602February 28, 2018
Toronto, Ontario, CanadaLoyaltyOne194,018September 30, 2017
Mississauga, Ontario, CanadaLoyaltyOne50,908November 30, 2019
Den Bosch, NetherlandsLoyaltyOne132,482December 31, 2028
Maasbree, NetherlandsLoyaltyOne488,681September 1, 2028
Wakefield, MassachusettsEpsilon184,411December 31, 2020
Irving, TexasEpsilon221,898June 30, 2026
Earth City, MissouriEpsilon116,783December 31, 2016
West Chicago, IllinoisEpsilon155,412October 31, 2025
Columbus, OhioCard Services103,161January 31, 2019
Westminster, ColoradoCard Services119,207November 30, 2027
Couer D’Alene, IdahoCard Services114,000March 31, 2027
Westerville, OhioCard Services100,800July 31, 2024
Wilmington, DelawareCard Services5,198November 30, 2020
Salt Lake City, UtahCard Services6,488January 18, 2018
\ No newline at end of file diff --git a/predictions/483.html b/predictions/483.html new file mode 100644 index 0000000000000000000000000000000000000000..e629eed1e68d733b85ea46d055afb982871226d3 --- /dev/null +++ b/predictions/483.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20102009
(In thousands)
Accrued payroll and benefits$    92,283$    66,501
Accrued taxes22,5512,656
Accrued other liabilities53,74458,855
Accrued expenses$  168,578$  128,012
\ No newline at end of file diff --git a/predictions/484.html b/predictions/484.html new file mode 100644 index 0000000000000000000000000000000000000000..de57009e19ca39b66f03703bd1be65cea32dbc17 --- /dev/null +++ b/predictions/484.html @@ -0,0 +1,84 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20182017
(In millions)
Assets:
Cash and cash equivalents$ 0.1$ 0.1
Investment in subsidiaries8,606.08,203.9
Other assets20.195.3
Total assets$ 8,626.2$ 8,299.3
Liabilities:
Current debt$ 114.4$ 76.2
Long-term debt5,427.75,797.5
Intercompany liabilities395.9177.8
Other liabilities356.1392.5
Total liabilities6,294.16,444.0
Stockholders’ equity2,332.11,855.3
Total liabilities and stockholders’ equity$ 8,626.2$ 8,299.3
\ No newline at end of file diff --git a/predictions/485.html b/predictions/485.html new file mode 100644 index 0000000000000000000000000000000000000000..a99ed9cd520dc4f1702dff81de952f557134dc37 --- /dev/null +++ b/predictions/485.html @@ -0,0 +1,56 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
YearOperating LeasesCapital Leases
(In thousands)
2009$ 47,044$24,612
201038,27223,312
201129,8384,063
201225,10323
201321,21114
Thereafter82,677—
Total$244,14552,024
Less amount representing interest(4,170)
Total present value of minimum lease payments$47,854
\ No newline at end of file diff --git a/predictions/486.html b/predictions/486.html new file mode 100644 index 0000000000000000000000000000000000000000..bd932255d8cdf977d298b113705d97dda005198c --- /dev/null +++ b/predictions/486.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
201820172016 (in millions)20152014
Years Ended December 31,
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 963.1$ 788.7$ 517.6$ 605.4$ 516.1
Stock compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80.875.176.591.372.5
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .260.6292.4319.4326.2321.8
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .670.6564.4428.5330.7260.5
Depreciation and other amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . .196.1183.1167.1142.1109.7
Amortization of purchased intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . .291.2314.5345.0350.1203.4
Impact of expiry* . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .——241.7——
Regulatory settlement (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .———64.6—
Earn-out obligation (3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .————105.9
Business acquisition costs (4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .————7.3
Strategic transaction costs (5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3.3————
Adjusted EBITDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 2,465.7$ 2,218.2$ 2,095.8$ 1,909.9$ 1,597.2
Less: securitization funding costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .220.2156.6125.697.391.2
Less: Interest expense on deposits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .165.7125.184.753.637.5
Less: Adjusted EBITDA attributable to non-controlling interest . . . . . . . . . . . . .——5.530.943.1
Adjusted EBITDA, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$ 2,079.8$ 1,936.5$ 1,880.0$ 1,728.3$ 1,425.5
\ No newline at end of file diff --git a/predictions/487.html b/predictions/487.html index 535910cedc827e8819701403ba250d369ffe88f2..a055960a69ec726812492b41489e697263887c08 100644 --- a/predictions/487.html +++ b/predictions/487.html @@ -1,17 +1,21 @@ - - + + + + - - - - - - + + + + + + + + @@ -20,30 +24,30 @@ - + - + - + - + - + - + - + - + - +
Years Ended December 31,Years Ended December 31,
201520142013
(In thousands)201520142013
Income Statement Location Gain (Loss) on Derivative Instruments Income Statement LocationGain (Loss) on Derivative Instruments
Interest rate derivatives . . . . . . .Interest rate derivatives . . Interest expense on long-term and other debt, net$ 213$        213 Interest expense on long-term and other debt, net$ 297$        297 Securitization funding costs $8,511
Foreign currency exchange forward contracts . . . . . . .Foreign currency exchange forward contracts . . . . . . . . . . . . General and administrative $(15,032) General and administrative $(16,990) General and administrative$ —$        —
Foreign currency exchange hedges . . . . . . .Foreign currency exchange hedges . . . . . . . . . . . . . . . . . Cost of operations$ 321$        321 Cost of operations$ 257$        257 Cost of operations$ —$        —
\ No newline at end of file diff --git a/predictions/488.html b/predictions/488.html new file mode 100644 index 0000000000000000000000000000000000000000..f34b0e6a5ed1d85a7cc439b569a8e387b52fb250 --- /dev/null +++ b/predictions/488.html @@ -0,0 +1,21 @@ + + + + + + + + + + + + + + + + + + + + +
December 31, 2010December 31, 2009
(in thousands)
Total credit card receivables — restricted for securitization investors$ 4,795,753$ 4,838,441
Principal amount of credit card receivables — restricted for securitization investors, 90 days or more past due$ 117,594$ 148,215
\ No newline at end of file diff --git a/predictions/489.html b/predictions/489.html new file mode 100644 index 0000000000000000000000000000000000000000..b2317c95735bf64cd813d98775a61a2a3e7ef96c --- /dev/null +++ b/predictions/489.html @@ -0,0 +1,55 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31,
20072006
(In thousands)
Certificates of deposit$ 370,400$ 299,000
Senior notes500,000500,000
Bridge loan300,000
Credit facility121,000225,000
Capital lease obligations39,10520,377
1,330,5051,044,377
Less: current portion(686,130)(302,702)
Long-term portion$ 644,375$ 741,675
\ No newline at end of file diff --git a/predictions/49.html b/predictions/49.html index 0b405aacc99fdd63608c635051e150e2214e9513..396bdbfce6560039ed6f29427b780f2c9c8340f3 100644 --- a/predictions/49.html +++ b/predictions/49.html @@ -1,102 +1,105 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
20092008
United StatesInternationalUnited StatesInternational
Plan assets
Fair value of plan assets at beginning of period$ 66$ 430$ 107$ 724
Actual return on plan assets14107(33)(111)
Employer contributions1485151
Settlements/curtailments(8)(3)—(42)
Divestitures———(1)
Business combinations———1
Plan participants' contributions———5
Currency fluctuations—48—(181)
Benefits paid(6)(27)(9)(28)
Retained earnings adjustment — Adoption of accounting standard———12
Fair value of plan assets at end of period$ 80$ 642$ 66$ 430
Funded status at end of period$ (30)$ (191)$ (42)$ (260)
20092008
Millions of dollarsUnited StatesInternationalUnited StatesInternational
Plan assets
Fair value of plan assets at beginning of period$    66$    430$    107$    724
Actual return on plan assets14107(33)(111)
Employer contributions1485151
Settlements/curtailments(8)(3)–(42)
Divestitures–––(1)
Business combinations–––1
Plan participants’ contributions–2–5
Currency fluctuations–48–(181)
Benefits paid(6)(27)(9)(28)
Retained earnings adjustment – Adoption of accounting standard–––12
Fair value of plan assets at end of period$    80$    642$    66$    430
Funded status at end of period(30)(191)(42)(260)
\ No newline at end of file diff --git a/predictions/490.html b/predictions/490.html new file mode 100644 index 0000000000000000000000000000000000000000..7f7fe6e4ad7736f6589b903721f4e179e1fa0f16 --- /dev/null +++ b/predictions/490.html @@ -0,0 +1,22 @@ + + + + + + + + + + + + + + + + + + + + + +
Amortized CostEstimated Fair Value
Due in one year or less$ 88,201$ 88,260
Due after one year through five years97,37097,980
Total$185,571$186,240
\ No newline at end of file diff --git a/predictions/491.html b/predictions/491.html index c2bfd35b97f1d62fe8d7308e6822c477d0f4ba3b..b4b88e0b746fd85f7d0e1bbc14b3d0f121f4cb1c 100644 --- a/predictions/491.html +++ b/predictions/491.html @@ -1,37 +1,34 @@ - + + - - - - - + - + - + - + - + - + - +
ALLIANCE DATA SYSTEMS CORPORATION AND SUBSIDIARIESALLIANCE DATA SYSTEMS CORPORATION AND SUBSIDIARIESPage
Page
Reports of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . .Reports of Independent Registered Public Accounting Firm F-2
Consolidated Balance Sheets as of December 31, 2015 and 2014 . . . . . . . . . . . . . . . . . . . . . . . .Consolidated Balance Sheets as of December 31, 2015 and 2014 F-4
Consolidated Statements of Income for the years ended December 31, 2015, 2014 and 2013 . . . . . . . . . . . .Consolidated Statements of Income for the years ended December 31, 2015, 2014 and 2013 F-5
Consolidated Statements of Comprehensive Income for the years ended December 31, 2015, 2014 and 2013 . . . . .Consolidated Statements of Comprehensive Income for the years ended December 31, 2015, 2014 and 2013 F-6
Consolidated Statements of Stockholders' Equity for the years ended December 31, 2015, 2014 and 2013 . . . . . .Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2015, 2014 and 2013 F-7
Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014 and 2013 . . . . . . . . . . .Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014 and 2013 F-8
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Notes to Consolidated Financial Statements F-9
\ No newline at end of file diff --git a/predictions/492.html b/predictions/492.html new file mode 100644 index 0000000000000000000000000000000000000000..9d2cde41b26e675485e8eb19b83e001e0fc21060 --- /dev/null +++ b/predictions/492.html @@ -0,0 +1,11 @@ + + + + + + + + + + +
As of December 31, 2007
Fixed rateVariable rateTotal
Off-balance sheet . . . . . . . . . . . . . . . . . . . . . .$2,050.0$1,438.4$3,488.4
On-balance sheet . . . . . . . . . . . . . . . . . . . . . .909.5421.01,330.5
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$2,959.5$1,859.4$4,818.9
\ No newline at end of file diff --git a/predictions/493.html b/predictions/493.html new file mode 100644 index 0000000000000000000000000000000000000000..325ce958061ada557ee7b094456e60ac8e5fdb70 --- /dev/null +++ b/predictions/493.html @@ -0,0 +1,16 @@ + + + + + + + + + + + + + + + +
Years Ended December 31,
200920082007
Net managed charge-offs$404,382$286,987$227,393
\ No newline at end of file diff --git a/predictions/494.html b/predictions/494.html new file mode 100644 index 0000000000000000000000000000000000000000..8369ce8305447a5dcc1181f7de6e385818124b82 --- /dev/null +++ b/predictions/494.html @@ -0,0 +1,41 @@ + + + + + + + + + + + + + + + + + +
SegmentProducts and Services
LoyaltyOne + • AIR MILES REWARD Program
+ • Loyalty Services
+ —Loyalty consulting
+ —Customer analytics
+ —Creative services +
Epsilon + • Marketing Services
+ —Marketing database services
+ —Analytical services
+ —Strategic consulting and creative services
+ —Proprietary data services
+ —Digital communications +
Private Label Services and Credit + • Processing Services
+ —New account processing
+ —Bill processing
+ —Remittance processing
+ —Customer care
+
+ • Private Label Receivables Financing
+ —Underwriting and risk management
+ —Receivables funding +
\ No newline at end of file diff --git a/predictions/495.html b/predictions/495.html new file mode 100644 index 0000000000000000000000000000000000000000..132f5aae59276e0e95a023d68316dfcd035b134d --- /dev/null +++ b/predictions/495.html @@ -0,0 +1,84 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,
200720062005
Interest from loans to subsidiaries$ 35,048$ 33,996$ 27,235
Dividends from subsidiaries202,250102,500100,000
Total revenue237,298136,496127,235
Loss on sale of long-lived assets16,045
Interest expense, net64,28934,06111,665
Other expenses, net(289)184140
Total expenses80,04534,24511,805
Income before income taxes and equity in undistributed net income of subsidiaries157,253102,251115,430
(Benefit) provision for income taxes(19,645)1,39910,192
Income before equity in undistributed net income of subsidiaries176,898100,852105,238
Equity in undistributed net (loss) income of subsidiaries(12,837)88,75333,507
Net income$164,061$189,605$138,745
\ No newline at end of file diff --git a/predictions/496.html b/predictions/496.html index de243d2a1454c7222582085f17b933c18488501b..0c87ece2a9a8a765af71fa42f980215763ff030c 100644 --- a/predictions/496.html +++ b/predictions/496.html @@ -1,37 +1,46 @@ - + + - + + + + + + + - + + + diff --git a/predictions/497.html b/predictions/497.html index 3e54a2f95e22d800896b3407f25ae14e9a634a82..27a6b0224ff83239c51088161b907c6778ab7ba2 100644 --- a/predictions/497.html +++ b/predictions/497.html @@ -1,12 +1,9 @@
2010$ 824,463$824,463
2011642,077624,077
2012 776,372
2013(1) 856,213
2014(2) 447,300
Thereafter —
Total maturities 3,546,425
Unamortized discount on convertible senior notes(299,808)(299,073)
$3,247,352
- - - - + - - + + @@ -15,7 +12,7 @@ - + @@ -28,7 +25,7 @@ - + @@ -45,7 +42,7 @@ - + @@ -58,7 +55,7 @@ - + @@ -74,19 +71,4 @@ - - - - - - - - - - - - - - -
Deferred Revenue
ServiceRedemptionTotal (In thousands)Deferred Revenue
Redemption
(in thousands)		Total
December 31, 2013$ 1,137,186
Cash proceedsNew proceeds 219,124 437,383 656,507
Other— 85 85
1,013,177
Cash proceedsNew proceeds 200,193 381,153 581,346
Other— 685 685
$ 552,595 $ 844,907
Amounts recognized in the consolidated balance sheets:
Current liabilities$ 146,402$ 552,595$ 698,997
Non-current liabilities$ 145,910$ 145,910
\ No newline at end of file diff --git a/predictions/498.html b/predictions/498.html new file mode 100644 index 0000000000000000000000000000000000000000..a32c4bfebd631275cde31ea150a1df7dd34b1366 --- /dev/null +++ b/predictions/498.html @@ -0,0 +1,459 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year Ended December 31,Change
20082007$%
Revenue:
Loyalty Services . . . . . . . .$ 755,546$ 628,792$ 126,75420.2%
Epsilon Marketing Services . . .490,998458,61032,3887.1
Private Label Services . . . . . .382,650370,83211,8183.2
Private Label Credit . . . . . . .750,365827,952(77,587)(9.4)
Corporate/Other . . . . . . . . . .17,33733,360(16,023)(48.0)
Eliminations . . . . . . . . . . . .(14,242)
Total . . . . . . . . . . . . . . .$2,023,267$1,957,189$ 66,0783.4%
Adjusted EBITDA:
Loyalty Services . . . . . . . .$ 204,895$ 132,136$ 72,75955.1%
Epsilon Marketing Services . . .126,558118,2198,3397.1
Private Label Services . . . . . .115,93999,08416,85517.0
Private Label Credit . . . . . . .254,176350,079(95,903)(27.4)
Corporate/Other . . . . . . . . . .(46,407)(67,333)20,926(31.1)
Total . . . . . . . . . . . . . . .$ 655,161$ 632,185$ 22,9763.6%
Stock compensation expense:
Loyalty Services . . . . . . . .$ 12,611$ 7,353$ 5,25871.5%
Epsilon Marketing Services . . .8,45313,880(5,427)(39.1)
Private Label Services . . . . . .6,5815,61396817.2
Private Label Credit . . . . . . .1,7981,51328518.8
Corporate/Other . . . . . . . . . .18,89123,191(4,300)(18.5)
Total . . . . . . . . . . . . . . .$ 48,734$ 48,311$ 4230.9%
Depreciation and amortization:
Loyalty Services . . . . . . . .$ 29,796$ 24,601$ 5,19521.1%
Epsilon Marketing Services . . .75,48171,9013,5805.0
Private Label Services . . . . . .8,8548,4294255.0
Private Label Credit . . . . . . .11,48611,843(357)(3.0)
Corporate/Other . . . . . . . . . .10,20110,829(628)(5.8)
Total . . . . . . . . . . . . . . .$ 135,818$ 127,011$ 8,8076.9%
Adjusted operating expense(1):
Loyalty Services . . . . . . . .$ 550,651$ 496,656$ 53,99510.9%
Epsilon Marketing Services . . .364,440340,39124,0497.1
Private Label Services . . . . . .266,711271,748(5,037)(1.9)
Private Label Credit . . . . . . .496,189477,87318,3163.8
Corporate/Other . . . . . . . . . .63,744100,693(36,949)(36.7)
Eliminations . . . . . . . . . . . .(371,629)(357,387)(14,242)4.0
Total . . . . . . . . . . . . . . .$1,370,106$1,329,974$ 40,1323.0%
Operating income (loss):
Loyalty Services . . . . . . . .$ 162,488$ 100,184$ 62,30462.2%
Epsilon Marketing Services . . .39,59134,9354,65613.3
Private Label Services . . . . . .99,05985,04214,01716.5
Private Label Credit . . . . . . .240,092338,025(97,933)(29.0)
Corporate/Other . . . . . . . . . .(81,539)(137,011)55,472(40.5)
Total . . . . . . . . . . . . . . .$ 460,691$ 421,225$ 39,2769.3%
Adjusted EBITDA margin(2):
Loyalty Services . . . . . . . .27.1%21.0%6.1%
Epsilon Marketing Services . . .25.825.80.0
Private Label Services . . . . . .30.326.73.6
Private Label Credit . . . . . . .33.942.3(8.4)
Total . . . . . . . . . . . . . . .32.3%32.2%0.1%
Segment operating data:
Private label statements generated . . .125,230135,261(10,031)(7.4)%
Credit sales . . . . . . . . . . . . .$7,272,893$7,502,947$(230,054)(3.1)%
Average manage receivables . . . . . .$4,993,353$4,909,027$ 84,3261.7%
AIR MILES reward miles issued . . . .4,461,1813,443,6071,017,57429.6%
AIR MILES reward miles redeemed . . .3,121,7992,723,524398,27514.6%
\ No newline at end of file diff --git a/predictions/499.html b/predictions/499.html new file mode 100644 index 0000000000000000000000000000000000000000..bf100396540955b87e38a7ca5a5f541dd03fe7e0 --- /dev/null +++ b/predictions/499.html @@ -0,0 +1,124 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years Ended December 31,
200920082007
In thousands, except per share amounts
Numerator
Income from continuing operations$176,719$232,552$214,441
Loss from discontinued operations(32,985)(26,150)(50,380)
Net income$143,734$206,402$164,061
Denominator
Weighted average shares, basic55,76571,50278,403
Weighted average effect of dilutive securities:
    Shares from assumed conversion of convertible senior notes612
    Net effect of dilutive stock options and unvested restricted stock1,3292,1382,408
Weighted average shares for diluted calculation57,70673,64080,811
Basic (per share):
Income from continuing operations$ 3.17$ 3.25$ 2.74
Loss from discontinued operations$ (0.59)$ (0.37)$ (0.65)
Net income$ 2.58$ 2.88$ 2.09
Diluted (per share):
Income from continuing operations$ 3.06$ 3.16$ 2.65
Loss from discontinued operations$ (0.57)$ (0.36)$ (0.62)
Net income$ 2.49$ 2.80$ 2.03
\ No newline at end of file diff --git a/predictions/5.html b/predictions/5.html index bcba6c21d17978f2c04c7d55a5036965567aa9bd..aa55c994d2f141075ed019919d64352bf78fe651 100644 --- a/predictions/5.html +++ b/predictions/5.html @@ -1,34 +1,47 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - +
Millions of dollarsEffect on
Pretax Pension Expense in 2009Pension Benefit Obligation at December 31, 2009
25-basis-point decrease in discount rate$ 1$ 35
25-basis-point increase in discount rate$ (1)$ (33)
25-basis-point decrease in expected long-term rate of return$ 1NA
25-basis-point increase in expected long-term rate of return$ (1)NA
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Effect onEffect on
Pretax Pension Expense in 2009Pension Benefit Obligation at December 31, 2009
Millions of dollars$$
25-basis-point decrease in discount rate$1$35
25-basis-point increase in discount rate$(1)$(33)
25-basis-point decrease in expected long-term rate of return$1NA
25-basis-point increase in expected long-term rate of return$(1)NA
\ No newline at end of file diff --git a/predictions/50.html b/predictions/50.html index 1f2f5fec59116c7e8d5631da864db7cdb463693b..6eee1e4150373e11f129b4f8f7bef998dbb873aa 100644 --- a/predictions/50.html +++ b/predictions/50.html @@ -1,20 +1,46 @@ - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Page No.
Management’s Report on Internal Control Over Financial Reporting40
Reports of Independent Registered Public Accounting Firm41
Consolidated Statements of Operations for the years ended December 31, 2014, 2013, and 201243
Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013, and 201244
Consolidated Balance Sheets at December 31, 2014 and 201345
Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013, and 201246
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2014, 2013, and 201247
Notes to Consolidated Financial Statements48
Selected Financial Data (Unaudited)73
Quarterly Data and Market Price Information (Unaudited)75
Page No.
Management’s Report on Internal Control Over Financial Reporting40
Reports of Independent Registered Public Accounting Firm41
Consolidated Statements of Operations for the years ended December 31, 2014, 2013, and 201243
Consolidated Statements of Comprehensive Income for the years ended December 31, 2014, 2013, and 201244
Consolidated Balance Sheets at December 31, 2014 and 201345
Consolidated Statements of Cash Flows for the years ended December 31, 2014, 2013, and 201246
Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2014, 2013, and 201247
Notes to Consolidated Financial Statements48
Selected Financial Data (Unaudited)73
Quarterly Data and Market Price Information (Unaudited)75
\ No newline at end of file diff --git a/predictions/51.html b/predictions/51.html index de701e3bc3b888e6b4ea2e0250df404313617713..670f52d3c88b1a167c39ceaccdf76bc483d9fca5 100644 --- a/predictions/51.html +++ b/predictions/51.html @@ -1,54 +1,54 @@ - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + + - - + +
4.6Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton's Form 10-K for the year ended December 31, 1998, File No. 001-03492).4.6Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.7Resolutions of Halliburton's Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton's Form 10-K for the year ended December 31, 1996, File No. 001-03492).4.7Resolutions of Halliburton’s Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton’s Form 10-K for the year ended December 31, 1996, File No. 001-03492).
4.8Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton's Form 8-K dated as of February 11, 1997, File No. 001-03492).4.8Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 8-K dated as of February 11, 1997, File No. 001-03492).
4.9Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request.4.9Copies of instruments that define the rights of holders of miscellaneous long-term notes of Halliburton Company and its subsidiaries have not been filed with the Commission. Halliburton Company agrees to furnish copies of these instruments upon request.
4.10Form of debt security of 7.53% Notes due May 12, 2017 (incorporated by reference to Exhibit 4.4 to Halliburton's Form 10-Q for the quarter ended March 31, 1997, File No. 001-03492).4.10Form of debt security of 7.53% Notes due May 12, 2017 (incorporated by reference to Exhibit 4.4 to Halliburton’s Form 10-Q for the quarter ended March 31, 1997, File No. 001-03492).
4.11Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser's Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser's Form 8-K filed on August 9, 1996, File No. 1-4003).4.11Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser’s Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser’s Form 8-K filed on August 9, 1996, File No. 1-4003).
4.12Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).4.12Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.13Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996, (incorporated by reference to Exhibit 4.16 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).4.13Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996, (incorporated by reference to Exhibit 4.16 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.14Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.10 to Halliburton's Form 10-Q for the quarter ended September 30, 2003, File No. 001-03492).4.14Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 10-Q for the quarter ended September 30, 2003, File No. 001-03492).
4.15Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).4.15Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.16Form of note of 7.60% debentures due 2096 (included as Exhibit A to Exhibit 4.15 above).4.16Form of note of 7.6% debentures due 2096 (included as Exhibit A to Exhibit 4.15 above).
4.17Fourth Supplemental Indenture, dated as of September 12, 2008, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor to JPMorgan Chase Bank, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton's Form 8-K filed September 12, 2008, File No. 001-03492).4.17Fourth Supplemental Indenture, dated as of September 12, 2008, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed September 12, 2008, File No. 001-03492).
4.18Form of Global Note for Halliburton's 5.90% Senior Notes due 2018 (included as part of Exhibit 4.17).4.18Form of Global Note for Halliburton’s 5.90% Senior Notes due 2018 (included as part of Exhibit 4.17).
\ No newline at end of file diff --git a/predictions/52.html b/predictions/52.html index 647d35f3916d500b366672736f8955b338f2f459..b4cb42c2baa256d00cc0d7773d76b7d7910fe4ea 100644 --- a/predictions/52.html +++ b/predictions/52.html @@ -1,10 +1,9 @@ - +
- - + + - @@ -24,20 +23,20 @@ - + - + - + @@ -48,7 +47,7 @@ - + @@ -61,12 +60,12 @@ - + - + diff --git a/predictions/53.html b/predictions/53.html new file mode 100644 index 0000000000000000000000000000000000000000..dc2063b51ebf7835715c19e16839e1a7d51ed810 --- /dev/null +++ b/predictions/53.html @@ -0,0 +1,80 @@ +
Millions of dollarsYear Ended December 31Millions of dollarsYear Ended December 31
2007 2006 2005
Foreign (449)(289)(122) (116)
State (38) (11)(1)
Total current (1,047) (289)(95)$ 95
Deferred income taxes:
Federal 129600(600) 291
State 4 (19)(57)57
Total deferred 140486(714) 220
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Years ended December 31
Millions of dollars200420032002
Current income taxes:
Federal$ (38)$ (167)$ 71
Foreign(156)(181)(173)
State(6)1(4)
Total current(200)(347)(106)
Deferred income taxes:
Federal380(1)
Foreign62511
State-818
Total deferred911328
Provision for income taxes$ (241)$ (234)$ (80)
\ No newline at end of file diff --git a/predictions/54.html b/predictions/54.html index c010e804c8506dbe98c4df77a4042068bd59bdaa..50bdbd890e356fbf19209ed77a39e5ae201b3f2c 100644 --- a/predictions/54.html +++ b/predictions/54.html @@ -1,46 +1,40 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars
December 31
20142013
Total assets:
Completion and Production$ 16,033$ 14,203
Drilling and Evaluation$ 11,237$ 10,010
Shared assets$ 1,930$ 1,351
Corporate and other$ 3,040$ 3,659
Total$ 32,240$ 29,223
Millions of dollarsDecember 31
20142013
Total assets:
Completion and Production$ 16,033$ 14,203
Drilling and Evaluation11,23710,010
Shared assets1,9301,351
Corporate and other3,0403,659
Total$ 32,240$ 29,223
\ No newline at end of file diff --git a/predictions/55.html b/predictions/55.html index 94336bd5f6a4f61166a68517d2624cf6db873a4c..0add1624bb521e6cfd4d3503c89ebf2f4a023b1c 100644 --- a/predictions/55.html +++ b/predictions/55.html @@ -1,25 +1,38 @@ - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Average Oil Prices (dollars per barrel)
200920082007
West Texas Intermediate$ 61.65$ 99.37$ 71.91
United Kingdom Brent$ 61.49$ 96.86$ 72.21
200920082007
Average Oil Prices (dollars per barrel)
West Texas Intermediate$ 61.65$ 99.37$ 71.91
United Kingdom Brent$ 61.49$ 96.86$ 72.21
Average United States Gas Prices (dollars per thousand cubic feet, or mcf)
Henry Hub$ 4.06$ 9.13$ 7.18
\ No newline at end of file diff --git a/predictions/56.html b/predictions/56.html index 654dd9e783026616880566750afb27c9d9bbf603..fd76fefadf43f89f2c672ddb0cb57a3ea7cca37a 100644 --- a/predictions/56.html +++ b/predictions/56.html @@ -1,24 +1,24 @@ - + - - + + - - - + + + - - - + + + - + diff --git a/predictions/57.html b/predictions/57.html index a5f0a40b4dcbc916abc5def78796e5599c9f3704..626c7e8f107b70090c506d8b08c4508f3c2447ee 100644 --- a/predictions/57.html +++ b/predictions/57.html @@ -1,6 +1,5 @@
Millions of dollarsPension benefitsPension Benefits
2004200520242023
Projected benefit obligation$1,241$2,632Projected benefit obligation$1,942$2,050
Accumulated benefit obligation$1,829$2,362Accumulated benefit obligation$1,642$2,327
Fair value of plan assetsFair value of plan assets $1,503 $2,087
- diff --git a/predictions/58.html b/predictions/58.html index 3193f70906ede135876a65e4ae9e055e9c7136d6..c8d494e68c4462e890e5ebb64910b2625ce9ed46 100644 --- a/predictions/58.html +++ b/predictions/58.html @@ -5,10 +5,14 @@ - + + + - + + + @@ -31,7 +35,9 @@ - + + + @@ -54,7 +60,9 @@ - + + + @@ -69,7 +77,7 @@ - + @@ -82,7 +90,9 @@ - + + + diff --git a/predictions/59.html b/predictions/59.html index 901fda542f3e29bbbf54835b2eb21b4275c800ba..32e1cf54d29f6c781e538035bc5cd9891596aea5 100644 --- a/predictions/59.html +++ b/predictions/59.html @@ -1,8 +1,12 @@
Page No.
Description
Operations:Operations:
Completion and Production segment:Completion and Production segment:
Johor, MalaysiaResearch and development laboratory
Drilling and Evaluation segment:Drilling and Evaluation segment:
Alvarado, TexasManufacturing facility
Shared facilities:Shared facilities:
Carrollton, Texas
Houston, Texas OwnedCampus facilitiesCampus facility
Houston, TexasTechnology facility
Corporate:Corporate:
Houston, Texas
- - - + + + + + + + diff --git a/predictions/6.html b/predictions/6.html index 8052ddd31ef0808c8dbaf17132c54264e56e58d2..dea9d6b0161ee85ca82faf2bbaa3b8edc1afc88a 100644 --- a/predictions/6.html +++ b/predictions/6.html @@ -1,5 +1,26 @@ -| | 2015 | 2014 | 2013 | -|---|---:|---:|---:| -| Oil price - WTI (1) | $ 48.69 | $ 93.37 | $ 97.99 | -| Oil price - Brent (1) | 52.36 | 99.04 | 108.71 | -| Natural gas price - Henry Hub (2) | 2.63 | 4.39 | 3.73 | \ No newline at end of file +
Restricted StockNumber of Shares (in millions)Weighted Average Grant-Date Fair Value per ShareRestricted StockNumber of Shares
(in millions)		Weighted Average
Grant-Date Fair
Value per Share
Nonvested shares at January 1, 2008
+ + + + + + + + + + + + + + + + + + + + + + + + +
201520142013
Oil price - WTI (1)$ 48.69$ 93.37$ 97.99
Oil price - Brent (1)52.3699.04108.71
Natural gas price - Henry Hub (2)2.634.393.73
\ No newline at end of file diff --git a/predictions/60.html b/predictions/60.html index 762386a51efd11033f53fa4c8db269481e6ed47b..88a9dd1658309c0619c1d1a95a7a800c1c5fbf22 100644 --- a/predictions/60.html +++ b/predictions/60.html @@ -1,6 +1,6 @@ - + @@ -22,9 +22,9 @@ - - - + + + diff --git a/predictions/61.html b/predictions/61.html index 72364513d8c79e4f405fa0f9877cf78fcb80c393..1f5d5560312c1d1a4f4a9170aeefbf1a474d4cd3 100644 --- a/predictions/61.html +++ b/predictions/61.html @@ -1,25 +1,36 @@
Millions of dollars Year Ended December 31
Other countries$ 10,504$ 8,591$ 7,08610,5048,5917,086
Total
- + - - + + + + + + + + + + - - - + + + - + + + + @@ -46,7 +57,10 @@ - + + + + @@ -63,14 +77,14 @@ - + - + - + @@ -79,13 +93,16 @@ - - - - + + + + - + + + + @@ -124,25 +141,28 @@ - - - - + + + + - + + + + - + - + - + @@ -163,10 +183,10 @@ - - - - + + + + @@ -175,25 +195,28 @@ - + - + - - - - + + + + - + + + + @@ -203,17 +226,14 @@ - - - + + + - - - - - - + + +
Millions of dollars Year Ended December 31
2014 2013 2012
Cash flows from operating activities:Millions of dollars
Cash flows from operating activities:
Net income$ 3,501$ 2,135$ 2,645$ 3,501$ 2,135$ 2,645
Adjustments to reconcile net income to net cash flows from operating activities:Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation, depletion, and amortization217
Other changes:Other changes:
Receivables
Inventories (247)(107)(611) (611)
Payment of Barracuda-Caratinga obligation—— (219)——
Other(208)
Total cash flows from operating activities4,0624,4473,654Total cash flows from operating activities4,0624,4473,654
Cash flows from investing activities:Cash flows from investing activities:
Capital expenditures(55)
Total cash flows from investing activities(3,138)(2,870)(3,688)Total cash flows from investing activities(3,138)(2,870)(3,688)
Cash flows from financing activities:Cash flows from financing activities:
Payments to reacquire common stock— (800) (4,356)—
Proceeds from long-term borrowings, net of offering costs—— 2,968——
Dividends to shareholders54
Total cash flows from financing activities(1,030)(1,754)(172)Total cash flows from financing activities(1,030)(1,754)(172)
Effect of exchange rate changes on cash(8)
Decrease in cash and equivalentsDecrease in cash and cash equivalents (65) (128) (214)
Cash and equivalents at beginning of yearCash and cash equivalents at beginning of year 2,356 2,484 2,698
Cash and equivalents at end of year$ 2,291$ 2,356$ 2,484Cash and cash equivalents at end of year$ 2,291$ 2,356$ 2,484
Supplemental disclosure of cash flow information:Supplemental disclosure of cash flow information:
Cash payments during the year for:
Interest$ 384$ 293$ 294$ 384$ 293$ 294
Income taxes$ 1,269$ 913$ 1,098
See notes to consolidated financial statements.$ 1,269$ 913$ 1,098
\ No newline at end of file diff --git a/predictions/62.html b/predictions/62.html index 01104547e4067d91b6db9cc16ddb90a6a5bb7aa9..31d033b67025aee5b34c8a30b758b12296097852 100644 --- a/predictions/62.html +++ b/predictions/62.html @@ -1,26 +1,28 @@ - - + + + + - - + + - + - + @@ -34,7 +36,7 @@ - + @@ -49,12 +51,12 @@ - + - - + +
Millions of dollarsDecember 31December 31
2008 2007
6.7% senior notes due September 2038$ 800$ —$    800$    —
5.5% senior notes due October 2010$ 749749 749
5.9% senior notes due September 2018 400402—
7.6% senior debentures due August 2096
3.125% convertible senior notes due July 20231,200— 1,200
Less current portion26— 159
Noncurrent portion of long-term debt$ 2,586$ 2,627$    2,586$    2,627
\ No newline at end of file diff --git a/predictions/63.html b/predictions/63.html index ba41b782af96aba1852b8eda5dbe85a18b912f51..aefe5473b2edeaf4d7f099d0a555c6504c6b3ae2 100644 --- a/predictions/63.html +++ b/predictions/63.html @@ -1,25 +1,27 @@ - - - - + + + + + + - - + + - - + + - - + +
Millions of dollarsPension Benefits
2005 2004
Pension Benefits
Projected benefit obligation2,1701,942$2,170$1,942
Accumulated benefit obligation1,9521,629$1,952$1,629
Fair value of plan assets1,7561,503$1,756$1,503
\ No newline at end of file diff --git a/predictions/64.html b/predictions/64.html new file mode 100644 index 0000000000000000000000000000000000000000..1a547e7ddc12a6f9bc3ab4de2cb8a7643c7baf16 --- /dev/null +++ b/predictions/64.html @@ -0,0 +1,130 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollarsDecember 31
20162015
5.0% senior notes due November 2045$      2,000$      2,000
3.8% senior notes due November 20252,0002,000
3.5% senior notes due August 20231,1001,100
4.85% senior notes due November 20351,0001,000
6.15% senior notes due September 20191,0001,000
7.45% senior notes due September 20391,0001,000
4.75% senior notes due August 2043900900
6.7% senior notes due September 2038800800
3.25% senior notes due November 2021500500
4.5% senior notes due November 2041500500
2.0% senior notes due August 2018400400
5.9% senior notes due September 2018400400
7.6% senior debentures due August 2096300300
8.75% senior debentures due February 2021185185
6.75% notes due February 2027104104
7.53% notes due May 20174545
3.375% senior notes due November 2022—1,250
2.7% senior notes due November 2020—1,250
1.0% senior notes due August 2016—600
Other253144
Unamortized debt issuance costs and discounts(110)(132)
Total12,37715,346
Current maturities(163)(659)
Total long-term debt$  12,214$  14,687
\ No newline at end of file diff --git a/predictions/65.html b/predictions/65.html index a19575d7fc9ce7ec2dd25f11a57816d6db197bf8..257920838e7345ed7c023a80798056e60ec95338 100644 --- a/predictions/65.html +++ b/predictions/65.html @@ -1,30 +1,32 @@ - - + + + + - + - + - + - - - + + +
Millions of dollarsDecember 31December 31
Millions of dollars 2004 2003
Finished products and partsFinished products and parts $534 $503
Raw materials and suppliesRaw materials and supplies 156 159
Work in processWork in process 33 33
Total inventories723695$723$695
\ No newline at end of file diff --git a/predictions/66.html b/predictions/66.html index 125279d0574dd4d97787459ad8ecf8c72ca0122a..15fb4ae2161227b3bfeb248961d8574f99b4552d 100644 --- a/predictions/66.html +++ b/predictions/66.html @@ -1,9 +1,10 @@ - + + @@ -13,12 +14,12 @@ - - - - - - + + + + + + @@ -30,7 +31,7 @@ - + diff --git a/predictions/67.html b/predictions/67.html index efaf7bf84594f0d99f2704e08a93a0ed4e1fe1ff..e6812f689a9a1ed202f31a89c3ab607a8fd78ffd 100644 --- a/predictions/67.html +++ b/predictions/67.html @@ -1,27 +1,28 @@
December 31
2010 2011 2012
Halliburton$ 100.0085.3186.73128.36100.6388.69$        100.00$        85.31$        86.73$        128.36$        100.63$        88.69
Philadelphia Oil Service Index (OSX)71.30
Standard & Poor's 500 ® IndexStandard & Poor’s 500 ® Index 100.00 102.11 118.45
- + + - + - - - - + + + + - + diff --git a/predictions/68.html b/predictions/68.html index 956af3a355f591707beb4d800d2b1dc878664206..a5b7a3ed5025d49b22df631b0514b9083b285705 100644 --- a/predictions/68.html +++ b/predictions/68.html @@ -5,7 +5,9 @@ - + + + @@ -33,7 +35,9 @@ - + + + @@ -56,7 +60,9 @@ - + + + diff --git a/predictions/69.html b/predictions/69.html new file mode 100644 index 0000000000000000000000000000000000000000..eba25985707c854b2223c24c8b4f5e6fef81726e --- /dev/null +++ b/predictions/69.html @@ -0,0 +1,98 @@ +
Millions of dollars Year Ended December 31
Millions of dollars 2007 2006 2005
United StatesUnited States $ 2,219 $ 2,280 $ 1,399
Foreign$ 1,241$ 919$ 598Foreign1,241919598
TotalTotal $ 3,460 $ 3,199 $ 1,997Description
Completion and Production segment:Completion and Production segment:
Arbroath, United KingdomResearch and development laboratory
Drilling and Evaluation segment:Drilling and Evaluation segment:
Alvarado, TexasManufacturing facility
Shared/corporate facilities:Shared/corporate facilities:
Carrollton, Texas
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Land vs. Offshore200520042003
United States:
Land1,2871,093924
Offshore9397108
Total1,3801,1901,032
Canada:
Land454365368
Offshore444
Total458369372
International (excluding Canada):
Land643594544
Offshore265242226
Total908836770
Worldwide total2,7462,3952,174
Land total2,3842,0521,836
Offshore total362343338
\ No newline at end of file diff --git a/predictions/7.html b/predictions/7.html index bbf9e2634c0677c0decb52334b666e41dd97c873..3418f21b0457335dc2d0c2bb572702c171b7f504 100644 --- a/predictions/7.html +++ b/predictions/7.html @@ -1,52 +1,40 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars
$December 31
20152014
Land232217
Buildings and property improvements3,3593,311
Machinery, equipment, and other17,10919,954
Total20,70023,482
Less accumulated depreciation9,78911,007
Net property, plant, and equipment10,91112,475
Millions of dollarsDecember 31
20152014
Land$ 232$ 217
Buildings and property improvements3,3593,311
Machinery, equipment, and other17,10919,954
Total20,70023,482
Less accumulated depreciation9,78911,007
Net property, plant, and equipment$ 10,911$ 12,475
\ No newline at end of file diff --git a/predictions/70.html b/predictions/70.html index 317a8d0157bbd4bf4dc88c9164d80d6b7a01716d..00b4cc8bcc2cdb8983ad8d51daf304d1fd38c69f 100644 --- a/predictions/70.html +++ b/predictions/70.html @@ -6,21 +6,21 @@ 2005 - Health care cost trend rate assumed for next year + Health care cost trend rate assumed for next year 9.0% 10.0% - 11.0% + 10.0% - Rate to which the cost trend rate is assumed to decline
(the ultimate trend rate) + Rate to which the cost trend rate is assumed to decline
(the ultimate trend rate) 5.0% 5.0% 5.0% - Year that the rate reaches the ultimate trend rate - - - + Year that the rate reaches the ultimate trend rate + 2012 + 2012 + 2012 \ No newline at end of file diff --git a/predictions/71.html b/predictions/71.html index bb65229dafa848a04ca73585338f698d8c57eef6..70e9868dd7a682136fcd4138ca56e68ec66b8ca0 100644 --- a/predictions/71.html +++ b/predictions/71.html @@ -2,19 +2,22 @@ $ - $ - $ + + + North America + 272 1,426 (1,154) - (81) + (81)% Latin America + 172 214 (42) @@ -22,6 +25,7 @@ Europe/Africa/CIS + 315 360 (45) @@ -29,6 +33,7 @@ Middle East/Asia + 257 304 (47) @@ -36,25 +41,23 @@ Total + 1,016 2,304 (1,288) (56) - - - - - - - - - - + + + + + + + @@ -62,6 +65,7 @@ + @@ -69,6 +73,7 @@ + @@ -76,6 +81,7 @@ + @@ -83,25 +89,23 @@ + -
Drilling and Evaluation:
$$$Drilling and Evaluation:
North America 178 679 (501)
Latin America 187 307 (120)
Europe/Africa/CIS 380 497 (117)
Middle East/Asia 438 487 (49)
Total 1,183 1,970 (787) (40)
- - - - - - - - - + + + + + + + @@ -109,6 +113,7 @@ + @@ -116,6 +121,7 @@ + @@ -123,6 +129,7 @@ + diff --git a/predictions/72.html b/predictions/72.html index d7072f07a382adc6bc2c9bc5e68add8dcb89fe59..6c0852e7ffb80ecf860507742f1c7f06f9e1ef78 100644 --- a/predictions/72.html +++ b/predictions/72.html @@ -29,7 +29,7 @@ - + @@ -39,7 +39,7 @@ - - + +
Total operating income by region (excluding Corporate and other):
$$$Total operating income by region (excluding Corporate and other):
North America 450 2,105 (1,655)
Latin America 359 521 (162)
Europe/Africa/CIS 695 857 (162)
Middle East/Asia 695 791 (96)
Corporate and other353,015 3,047
Total$13,13516,860$ 13,135$ 16,860
\ No newline at end of file diff --git a/predictions/73.html b/predictions/73.html index 0c25c61656cdcd1efbaaa39cff17d03508596520..bc4e00e456f864f02ad8e098a3d2b3b0a13a2e44 100644 --- a/predictions/73.html +++ b/predictions/73.html @@ -1,14 +1,22 @@ - + + + + + - - + + - + + + + +
1. Financial Statements:1.Financial Statements:
The reports of the Independent Registered Public Accounting Firm and the financial statements of Halliburton Company as required by Part II, Item 8, are included on pages 41 and 42 and pages 43 through 73 of this annual report. See index on page (i).
2. Financial Statement Schedules:The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.2.Financial Statement Schedules:
3. Exhibits: The schedules listed in Rule 5-04 of Regulation S-X (17 CFR 210.5-04) have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.
3.Exhibits:
\ No newline at end of file diff --git a/predictions/74.html b/predictions/74.html index 2352d97e074ab6cc92910dd3b9f61088f3711fdb..d3c2fd8df66f5b1bac0bf57e0a2a343089141570 100644 --- a/predictions/74.html +++ b/predictions/74.html @@ -1,22 +1,24 @@ - + + + - + - + @@ -28,14 +30,14 @@ - - - - - + + + + + - + @@ -43,20 +45,20 @@ - - - - - - + + + + + + - - - - - - + + + + + + @@ -80,13 +82,15 @@ - + + - + + - + @@ -94,50 +98,55 @@ - + - + + - + + - - - - - - + + + + + + - - - - - - + + + + + + + - - - - - + + + + + - + - - + + + - + + @@ -149,46 +158,46 @@ - - - - - + + + + + - - - - - + + + + + - - - - - + + + + + - - - - - - + + + + + + - - - - - + + + + + - + @@ -196,15 +205,17 @@ - + + - + + @@ -216,27 +227,27 @@ - - - - - + + + + + - - - - - - + + + + + + - - - - - + + + + + diff --git a/predictions/75.html b/predictions/75.html index 72470ff6d526d704e4a97b395fc4d74559e03e6a..ac62bd63432bb28f83f27396636a8d358095a07f 100644 --- a/predictions/75.html +++ b/predictions/75.html @@ -1,19 +1,15 @@
Millions of dollars and shares
except per share and employee data		 Year Ended December 31
2007 2006 2005 2004 2003
Total revenue $ 15,264$ 12,955$ 12,945 $ 10,100 $ 7,998$ 6,995$ 6,699
Total operating income
Nonoperating expense, net$ (38)$ (46)$ (167)$ (189)$ (117)(38)(46)(167)(189)(117)
Income from continuing operations before
income taxes and minority interest		Income from continuing operations before income taxes and minority interest $ 3,460 $ 3,199 $ 1,997$ 639
(Provision) benefit for income taxes$ (907)$ (1,003)$ 125$ (322)$ (200)Provision (benefit) for income taxes(907)(1,003)125(322)(200)
Minority interest in net (income) loss of
consolidated subsidiaries		$ (29)$ (19)$ (15)$ 3$ (14)Minority interest in net (income) loss of consolidated subsidiaries(29)(19)(15)3(14)
Income from continuing operations$ 2,348 $ 2,358 $ (979)$ (812)$ (820)
Basic income (loss) per share:Basic income (loss) per share:
Continuing operations    Continuing operations $ 2.76 $ 2.15 $ 2.09$ 0.49
Net income (loss)    Net income (loss) $ 3.83 $ 2.31 $ 2.34 $ (1.12)$ (0.95)$ (0.94)
Diluted income (loss) per share:Diluted income (loss) per share:
Continuing operations$ 2.66$ 2.07$ 2.03$ 0.76$ 0.49    Continuing operations2.662.072.030.760.49
Net income (loss)$ 3.68$ 2.23$ 2.27$ (1.11)$ (0.94)    Net income (loss)3.682.232.27(1.11)(0.94)
Cash dividends per share$ 0.35$ 0.30$ 0.25$ 0.25$ 0.250.350.300.250.250.25
Return on average shareholders' equityReturn on average shareholders’ equity 49.14% 34.16% 45.76%(30.22%)(26.86%)(30.22)%(26.86)%
Financial position:Financial position:
Net working capital
Total assets$ 13,135$ 16,860$ 15,073$ 15,883$ 15,55613,13516,86015,07315,88315,556
Property, plant, and equipment, net$ 3,630$ 2,557$ 2,203$ 2,075$ 2,0853,6302,5572,2032,0752,085
Long-term debt (including current maturities)$ 2,786$ 2,809$ 3,139$ 3,879$ 3,3612,7862,8093,1393,8793,361
Shareholders' equity$ 8,666$ 7,376$ 6,372$ 3,932$ 2,547Shareholders’ equity6,8667,3766,3723,9372,547
Total capitalization$ 9,663$ 10,187$ 9,525$ 7,818$ 5,9229,66310,1879,5257,8185,922
Basic weighted average common shares
outstanding		Basic weighted average common shares outstanding 913 1,014 1,010868
Diluted weighted average common shares
outstanding		Diluted weighted average common shares outstanding 950 1,054 1,038 882 874
Other financial data:Other financial data:
Capital expenditures
Long-term borrowings (repayments), net$ (7)$ (254)$ (779)$ 493$ 1,960(7)(324)(779)4931,960
Depreciation, depletion, and
amortization expense		$ 583$ 480$ 448$ 456$ 468Depreciation, depletion, and amortization expense583480448456468
Payroll and employee benefits$ 4,585$ 3,853$ 3,211$ 2,823$ 2,5614,5853,8533,2112,8232,561
Number of employees
- - - - - + - + - + @@ -21,38 +17,38 @@ - + - + - + - + - + - + - + - + - +
ItemDescription
4.6Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton's Form 10-K for the year ended December 31, 1998, File No. 001-03492).Fourth Supplemental Indenture dated as of September 29, 1998 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.8 to Halliburton’s Form 10-K for the year ended December 31, 1998, File No. 001-03492).
4.7Resolutions of Halliburton's Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton's Form 10-K for the year ended December 31, 1996, File No. 001-03492).Resolutions of Halliburton’s Board of Directors adopted by unanimous consent dated December 5, 1996 (incorporated by reference to Exhibit 4(g) of Halliburton’s Form 10-K for the year ended December 31, 1996, File No. 001-03492).
4.8Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton's Form 8-K dated as of February 11, 1997, File No. 001-03492).Form of debt security of 6.75% Notes due February 1, 2027 (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 8-K dated as of February 11, 1997, File No. 001-03492).
4.9
4.10Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser's Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser's Form 8-K filed on August 9, 1996, File No. 1-4003).Form of Indenture dated as of April 18, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4 to Dresser’s Registration Statement on Form S-3/A filed on April 19, 1996, Registration No. 333-01303), as supplemented and amended by Form of First Supplemental Indenture dated as of August 6, 1996 between Dresser and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), Trustee, for 7.60% Debentures due 2096 (incorporated by reference to Exhibit 4.1 to Dresser’s Form 8-K filed on August 9, 1996, File No. 1-4003).
4.11Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank, N.A.), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Second Supplemental Indenture dated as of October 27, 2003 between DII Industries, LLC and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.15 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.12Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.16 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Third Supplemental Indenture dated as of December 12, 2003 among DII Industries, LLC, Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Indenture dated as of April 18, 1996 (incorporated by reference to Exhibit 4.16 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.13Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton's Form 10-K for the quarter ended September 30, 2003, File No. 001-03492).Indenture dated as of October 17, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee (incorporated by reference to Exhibit 4.1 to Halliburton’s Form 10-Q for the quarter ended September 30, 2003, File No. 001-03492).
4.14Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton's Form 10-K for the year ended December 31, 2003, File No. 001-03492).Second Supplemental Indenture dated as of December 15, 2003 between Halliburton Company and The Bank of New York Trust Company, N.A. (as successor to JPMorgan Chase Bank), as Trustee, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.27 to Halliburton’s Form 10-K for the year ended December 31, 2003, File No. 001-03492).
4.15Form of note for 7.6% debentures due 2096 (included as Exhibit A to Exhibit 4.14 above).Form of note of 7.6% debentures due 2096 (included as Exhibit A to Exhibit 4.14 above).
4.16Fourth Supplemental Indenture, dated as of September 12, 2008, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, as to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton's Form 8-K filed September 12, 2008, File No. 001-03492).Fourth Supplemental Indenture, dated as of September 12, 2008, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed September 12, 2008, File No. 001-03492).
4.17Form of Global Note for Halliburton's 6.70% Senior Notes due 2038 (included as part of Exhibit 4.16).Form of Global Note for Halliburton’s 6.70% Senior Notes due 2038 (included as part of Exhibit 4.16).
4.18Fifth Supplemental Indenture, dated as of March 13, 2009, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton's Form 8-K filed March 13, 2009, File No. 001-03492).Fifth Supplemental Indenture, dated as of March 13, 2009, between Halliburton Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee to JPMorgan Chase Bank, to the Senior Indenture dated as of October 17, 2003 (incorporated by reference to Exhibit 4.2 to Halliburton’s Form 8-K filed March 13, 2009, File No. 001-03492).
\ No newline at end of file diff --git a/predictions/76.html b/predictions/76.html index eb208bc8a9dfce27e198a95f6d1c187f59157742..1223a7807532f5fa7031d1394c445c8323089ca4 100644 --- a/predictions/76.html +++ b/predictions/76.html @@ -1,7 +1,4 @@ - - - @@ -12,12 +9,14 @@ - + + + - - + + @@ -36,7 +35,7 @@ - - + +
Millions of dollars
December 312016
Total assets:Total assets:
Completion and Production$ 12,276$ 10,349$  12,276$  10,349
Drilling and Evaluation
Total$ 25,085$ 27,000$  25,085$  27,000
\ No newline at end of file diff --git a/predictions/77.html b/predictions/77.html index ceefc65edfb718fd9b0e708c31f706e022ac89c9..d1426a4c7a164306efc3ed67d199a5acee6c5fa0 100644 --- a/predictions/77.html +++ b/predictions/77.html @@ -1,9 +1,10 @@ - + + @@ -17,8 +18,8 @@ - - + + @@ -70,8 +71,8 @@ - - - + + +
Millions of dollars Year Ended December 31
Millions of dollars 2015 2014 2013
Federal $ 635$(959)$(245)$(959)$(245)
Foreign
Income tax benefit (provision)$ 274$(1,275)$(648)$ 274 $(1,275)$(648)
\ No newline at end of file diff --git a/predictions/78.html b/predictions/78.html index 8c09c36ab3ebde95a2897c38c4028544dda20b03..aeb3f97b6f7e1ed3a0fee00f42fb465f6ca18f4e 100644 --- a/predictions/78.html +++ b/predictions/78.html @@ -1,35 +1,27 @@ - - - - - - + + + - - - - - - + - + - + - + - +
DueRateAmount
(in millions)DueRateAmount
(in millions)
08/2006 6.00% $275
01/20075.63%$250
12/20087.50%6.25% $150
05/201705/2011 7.53%$85$ 50
05/201902/2027 6.75%$125$ 50
\ No newline at end of file diff --git a/predictions/79.html b/predictions/79.html new file mode 100644 index 0000000000000000000000000000000000000000..3eb84592384402241cdb73d8e9151738acdc4d95 --- /dev/null +++ b/predictions/79.html @@ -0,0 +1,71 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200920082007
Millions of dollarsUnited StatesInternationalUnited StatesInternationalUnited StatesInternational
Service cost$$ 21$$ 29$$ 26
Interest cost544650745
Expected return on plan assets(7)(38)(7)(44)(7)(40)
Settlements/curtailments4252
Recognized actuarial loss233669
Net periodic benefit cost$$ 32$$ 46$$ 40
\ No newline at end of file diff --git a/predictions/8.html b/predictions/8.html index ac27c0446324d4b1ffe1c8b24f133dcdf9e999ff..156c3ca28098258359b20145023f0f5c4248d81b 100644 --- a/predictions/8.html +++ b/predictions/8.html @@ -1,26 +1,26 @@ - - - - - - - - - - - - - - - - - - - - - - - - + + + + + + + + + + + + + + + + + + + + + + + +
20042003
1 - 5 years26%30%
6 - 10 years63%62%
11 - 25 years11%8%
Machinery, Equipment, and Other
20042003
1 – 5 years28%30%
6 – 10 years63%62%
Over 10 years9%8%
\ No newline at end of file diff --git a/predictions/80.html b/predictions/80.html index e667dad5852443e3b29399308e210cfff4523135..63a1ec12e4968c462be3cf72de624ebf7277b675 100644 --- a/predictions/80.html +++ b/predictions/80.html @@ -9,16 +9,10 @@ Health care cost trend rate assumed for next year 9.0% 9.0% - 9.0% - - - Rate to which this cost trend rate is assumed to decline - - - + 10.0% - - ultimate trend rate + Rate to which the cost trend rate is assumed to decline
(the ultimate trend rate) 5.0% 5.0% 5.0% diff --git a/predictions/81.html b/predictions/81.html index afe48ec492205d8ef5883eb9329e662dce9c5cc3..2286df6ddd53ca802e5dd465da9c7fb2384cd360 100644 --- a/predictions/81.html +++ b/predictions/81.html @@ -1,9 +1,11 @@ - - + + + + diff --git a/predictions/82.html b/predictions/82.html new file mode 100644 index 0000000000000000000000000000000000000000..bbd0db2fda19e8190d9b879b570127cc139e6653 --- /dev/null +++ b/predictions/82.html @@ -0,0 +1,50 @@ +
Millions of dollarsDecember 31December 31
Millions of dollars 2008 2007
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200820072006
Millions of shares
Basic weighted average common shares outstanding8779131,014
Dilutive effect of:
    Convertible senior notes premium222929
    Stock options469
    Restricted stock122
Diluted weighted average common shares outstanding9049501,054
\ No newline at end of file diff --git a/predictions/83.html b/predictions/83.html new file mode 100644 index 0000000000000000000000000000000000000000..df77734162b2693c97ae73d8d88f7f513c8f91f0 --- /dev/null +++ b/predictions/83.html @@ -0,0 +1,104 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
200820072006
Land vs. Offshore
United States:
Land1,8121,6941,558
Offshore (incl. Gulf of Mexico)128144176
Total1,9401,8381,734
Canada:
Land378341467
Offshore133
Total379344470
International (excluding Canada):
Land784719656
Offshore295287269
Total1,0791,006925
Worldwide total3,3983,1883,129
Land total2,9742,7542,681
Offshore total424434448
\ No newline at end of file diff --git a/predictions/84.html b/predictions/84.html new file mode 100644 index 0000000000000000000000000000000000000000..0def7da54516ecafb8705a476c100fcab23f7c1b --- /dev/null +++ b/predictions/84.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
the plan of reorganization$2,345
One-year non-interest-bearing note for the benefit of
absent claimants31
Cash payments related to insurance participation agreement16
in October 2004 – first of three installments16
First installment payment for the silica note15
Payments related to RHI Refractories agreement15
Total$2,418
\ No newline at end of file diff --git a/predictions/85.html b/predictions/85.html index 16e887b9ad13ef6944e87afb2ff5bea51f8e2fc5..d91a8b5ae142760fa65ba9bc6798cba0f275cd06 100644 --- a/predictions/85.html +++ b/predictions/85.html @@ -6,19 +6,19 @@ 2014 - Oil price - WTI (1) - $ 43.14 - $ 48.69 - 49.37 + Oil price - WTI (1) + $ 43.14 $ + 48.69 $ + 93.37 - Oil price - Brent (1) + Oil price - Brent (1) 43.55 52.36 99.04 - Natural gas price - Henry Hub (2) + Natural gas price - Henry Hub (2) 2.52 2.63 4.39 diff --git a/predictions/86.html b/predictions/86.html index 628136f7fed3d904990187803f5baa6b47660976..3898515490972b9d292c163502b7ecdf638ce4a3 100644 --- a/predictions/86.html +++ b/predictions/86.html @@ -1,7 +1,6 @@ - - + @@ -10,23 +9,28 @@ - + - - + + + + + + + - + - + - + diff --git a/predictions/87.html b/predictions/87.html index 0e7bd952a071aa56217ae7282471a33aa668a92a..c55b2f4e70dbe6c9f0874c710e9b67c4df97f420 100644 --- a/predictions/87.html +++ b/predictions/87.html @@ -1,7 +1,7 @@
Millions of shares
Millions of shares 2007 2006 2005Basic weighted average common shares outstanding 913 1,0141,0051,010
Dilutive effect of:
Convertible senior notes premiumDilutive effect of:
    Convertible senior notes premium 29 29 16
Stock options    Stock options 63 910
Restricted stock    Restricted stock 2 2 2
- - + + @@ -12,11 +12,11 @@ - + - + @@ -24,55 +24,55 @@ - + - + -
(Millions of dollars except per share dataYear ended December 31, 2005Year ended
December 31, 2005
Net income, as reported
Stock-based compensation expense included in continuing operations, net of related tax effects    Stock-based compensation expense included in
    continuing operations, net of related tax effects		 23
Stock-based compensation expense included in discontinued operations, net of related tax effects    Stock-based compensation expense included in
    discontinued operations, net of related tax effects		 8
Stock-based compensation expense for continuing operations determined under fair-value-based method for all awards, net of related tax effects    Stock-based compensation expense for continuing
    operations determined under fair-value-based
    method for all awards, net of related tax effects		 (46)
Stock-based compensation expense for discontinued operations determined under fair-value-based method for all awards, net of related tax effects    Stock-based compensation expense for discontinued
    operations determined under fair-value-based
    method for all awards, net of related tax effects		 (15)
Net income, pro forma $ 2,328
- - - - + + + + + - + - - + - + - - - + + + + + - + - - + - +
Basic income per share:Continuing operationsAs reportedBasic income per share:
    Continuing operations
        As reported		 $ 2.09
Pro forma        Pro forma $ 2.07
Discontinued operationsAs reported    Discontinued operations
        As reported		 $ 0.25
Pro forma        Pro forma $ 0.24
Diluted income per share:Continuing operationsAs reportedDiluted income per share:
    Continuing operations
        As reported		 $ 2.03
Pro forma        Pro forma $ 2.01
Discontinued operationsAs reported    Discontinued operations
        As reported		 $ 0.24
Pro forma        Pro forma $ 0.24
\ No newline at end of file diff --git a/predictions/88.html b/predictions/88.html new file mode 100644 index 0000000000000000000000000000000000000000..0ea229c6175bbe2cc1e29646ad0895ec78992ae5 --- /dev/null +++ b/predictions/88.html @@ -0,0 +1,34 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
NumberExhibits
3.1Restated Certificate of Incorporation of Halliburton Company filed with the Secretary of State of Delaware on May 30, 2006 (incorporated by reference to Exhibit 3.1 to Halliburton’s Form 8-K filed June 5, 2006, File No. 001-03492).
3.2By-laws of Halliburton Company revised effective December 7, 2017 (incorporated by reference to Exhibit 3.1 to Halliburton’s Form 8-K filed December 12, 2017, File No. 001-03492).
4.1Form of debt security of 8.75% Debentures due February 12, 2021 (incorporated by reference to Exhibit 4(a) to the Form 8-K of Halliburton Company, now known as Halliburton Energy Services, Inc. (the Predecessor), dated as of February 20, 1991, File No. 001-03492).
4.2Senior Indenture dated as of January 2, 1991 between the Predecessor and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee (incorporated by reference to Exhibit 4(b) to the Predecessor’s Registration Statement on Form S-3 (Registration No. 33-38394) originally filed with the Securities and Exchange Commission on December 21, 1990), as supplemented and amended by the First Supplemental Indenture dated as of December 12, 1996 among the Predecessor, Halliburton and the Trustee (incorporated by reference to Exhibit 4.1 of Halliburton’s Registration Statement on Form S-8 dated December 12, 1996, File No. 001-03492).
4.3Resolutions of the Predecessor’s Board of Directors adopted at a meeting held on February 11, 1991 and of the special pricing committee of the Board of Directors of the Predecessor adopted at a meeting held on February 11, 1991 and the special pricing committee’s consent in lieu of meeting dated February 12, 1991 (incorporated by reference to Exhibit 4(c) to the Predecessor’s Form 8-K dated as of February 20, 1991, File No. 001-03492).
4.4Second Senior Indenture dated as of December 1, 1996 between the Predecessor and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, as supplemented and amended by the First Supplemental Indenture dated as of December 5, 1996 between the Predecessor and the Trustee and the Second Supplemental Indenture dated as of December 12, 1996 among the Predecessor, Halliburton and the Trustee (incorporated by reference to Exhibit 4.2 of Halliburton’s Registration Statement on Form 8-B dated December 12, 1996, File No. 001-03492).
4.5Third Supplemental Indenture dated as of August 1, 1997 between Halliburton and The Bank of New York Trust Company, N.A. (as successor to Texas Commerce Bank National Association), as Trustee, to the Second Senior Indenture dated as of December 1, 1996 (incorporated by reference to Exhibit 4.7 to Halliburton’s Form 10-K for the year ended December 31, 1997, File No. 001-03492).
\ No newline at end of file diff --git a/predictions/89.html b/predictions/89.html new file mode 100644 index 0000000000000000000000000000000000000000..965212498b4f6ed14ddf258e6da92edf03703903 --- /dev/null +++ b/predictions/89.html @@ -0,0 +1,36 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
December 31
Millions of dollars200920082007
Long-lived assets:
United States$ 4,274$ 3,571$ 2,733
Other countries3,4013,0272,263
Total$ 7,675$ 6,598$ 4,996
\ No newline at end of file diff --git a/predictions/9.html b/predictions/9.html index 189e75df4b8cb5a67f781c64978e498226e1e355..16dd38e0b7bfa2565fbf6b4851609b1149f76137 100644 --- a/predictions/9.html +++ b/predictions/9.html @@ -1,9 +1,10 @@ - + + @@ -22,9 +23,9 @@ - - - + + + @@ -35,13 +36,13 @@ - + - + diff --git a/predictions/90.html b/predictions/90.html new file mode 100644 index 0000000000000000000000000000000000000000..9578b548326a505759a27cdf66b7a5085ba18b70 --- /dev/null +++ b/predictions/90.html @@ -0,0 +1,104 @@ +
Millions of dollars December 31
2008 2007 2006
Drilling and Evaluation$ 6,096$ 4,606$ 3,5666,0964,6063,566
Shared assets
Corporate and other 1,5963,0151,015 3,047
Discontinued operations — 5,395
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Millions of dollars200820072006
Balance at January 1$ 6,866$ 7,376$ 6,372
Dividends and other transactions with shareholders(558)(1,499)(1,324)
Sale of stock by a subsidiary––117
Adoption of Financial Accounting Standards Board–––
    Interpretation No. 48 and Statement of Financial
Accounting Standard No. 158(10)(30)(218)
Shares exchanged in KBR, Inc. exchange offer–(2,809)–
Other–(4)34
Comprehensive income:
    Net income1,5383,4992,348
    Net cumulative translation adjustments1(23)34
    Defined benefit and other postretirement plans adjustments(106)3552
    Net unrealized gains (losses) on investments
    and derivatives(6)111
Total comprehensive income1,4273,8322,395
Balance at December 31$ 7,725$ 6,866$ 7,376
\ No newline at end of file diff --git a/predictions/91.html b/predictions/91.html index 83d6ae3c1a6ce03f2fa9224e864ac799f28c7606..a5df6c1de5a389c0f0dd5276d13fc2c48b7cb0e9 100644 --- a/predictions/91.html +++ b/predictions/91.html @@ -1,12 +1,17 @@ - + + + + + + diff --git a/predictions/92.html b/predictions/92.html index 1ff5b53913eab186291c6cb7be79f1ee979ea504..7a3e55899dbd63acc3c23c7e687fa82f1e3ce8ff 100644 --- a/predictions/92.html +++ b/predictions/92.html @@ -1,13 +1,10 @@
Millions of shares December 31
2017 2016
Millions of shares
Issued 1,069
- - - - + - + diff --git a/predictions/93.html b/predictions/93.html index bf8fd56b33b08789c4f8c35dde1d21c46ca32be4..a0c9722a050872f27ff0cd49b99cacc20f8a0f9b 100644 --- a/predictions/93.html +++ b/predictions/93.html @@ -1,10 +1,10 @@
Shares of common stock
Millions of shares December 31
Shares of common stock
Millions of shares		 2009 2008 2007
- + - + diff --git a/predictions/94.html b/predictions/94.html new file mode 100644 index 0000000000000000000000000000000000000000..e207191f125e4b054b9605a6900d31607ee83209 --- /dev/null +++ b/predictions/94.html @@ -0,0 +1,42 @@ +
Millions of dollars December 31
Millions of dollars 2017 2016
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Offering period January 1 through June 30
200920082007
Expected term (in years)0.50.50.5
Expected volatility70.91%24.69%34.91%
Expected dividend yield1.85%0.93%1.00%
Risk-free interest rate1.27%3.40%5.09%
Weighted average grant-date fair value per share$  6.69$  8.64$  7.20
\ No newline at end of file diff --git a/predictions/95.html b/predictions/95.html new file mode 100644 index 0000000000000000000000000000000000000000..8d4fe53e7962a6f7a0d14b09ca060ffb80520d92 --- /dev/null +++ b/predictions/95.html @@ -0,0 +1,102 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Year ended December 31
Millions of dollars except per share20152014201320122011
Revenue$ 23,633$ 32,870$ 29,402$ 28,503$ 24,829
Operating income (loss)(165)5,0973,1384,1594,737
Income (loss) from continuing operations(662)3,4372,1162,5873,010
Basic income (loss) per share from continuing operations(0.78)4.052.352.783.27
Diluted income (loss) per share from continuing operations(0.78)4.032.332.783.26
Cash dividends per share0.720.630.5250.360.36
Net working capital16,2508,7818,6788,3347,456
Total assets36,94232,16529,22327,41023,677
Long-term debt (including current maturities)15,3467,7797,8164,8204,820
Total shareholders’ equity15,49516,29813,61515,79013,216
Capital expenditures2,1841,6251,3941,5351,295
\ No newline at end of file diff --git a/predictions/96.html b/predictions/96.html index 1eae4166839c17e2736a3d485e8ceaf184570391..9ac8048d6b7919b7e2c3cffd85c8ddc4cb492ab4 100644 --- a/predictions/96.html +++ b/predictions/96.html @@ -1,9 +1,10 @@ - + + diff --git a/predictions/97.html b/predictions/97.html index 7b8e99d1f0cf57437045c11f95b513b9e503165e..5711db265fb6ab0098e3cae5f77f6800adc7e954 100644 --- a/predictions/97.html +++ b/predictions/97.html @@ -31,7 +31,7 @@ - +
Millions of shares December 31
Millions of shares 2016 2015
Total 299,692 $52.60—
\ No newline at end of file diff --git a/predictions/98.html b/predictions/98.html new file mode 100644 index 0000000000000000000000000000000000000000..b9b5012e4ac5308f20fe14c05d8b199a6d5b2e5b --- /dev/null +++ b/predictions/98.html @@ -0,0 +1,26 @@ + + + + + + + + + + + + + + + + + + + + + + + + + +
201420132012
Oil price - WTI (1)$ 93.37$ 97.99$ 94.15
Oil price - Brent (1)99.04108.71111.60
Natural gas price - Henry Hub (2)4.393.732.81
\ No newline at end of file diff --git a/predictions/99.html b/predictions/99.html new file mode 100644 index 0000000000000000000000000000000000000000..490c333790bd5542003b4be7c00f46e8017aea03 --- /dev/null +++ b/predictions/99.html @@ -0,0 +1,32 @@ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Average Oil Prices (dollars per barrel)200520042003
West Texas Intermediate55.3041.3131.14
United Kingdom Brent55.4538.1428.78
Average United States Gas Prices (dollars per million cubic feet)
Henry Hub5.795.855.63
\ No newline at end of file diff --git a/results.json b/results.json index 63f40e0633b3c0a29d75657f8f014a42241dfb9f..7cdceb724275198adabef3d4184e0e0b1f4797c0 100644 --- a/results.json +++ b/results.json @@ -1,25 +1,25 @@ { - "totalSamples": 1000, - "scoredSamples": 451, - "errorSamples": 549, - "meanAccuracy": 0.8218011560956067, - "medianAccuracy": 0.8230978260869566, - "p25Accuracy": 0.7216239677177178, - "p75Accuracy": 0.9679623349774884, - "minAccuracy": 0.4142857142857143, + "totalSamples": 500, + "scoredSamples": 500, + "errorSamples": 0, + "meanAccuracy": 0.820616501995053, + "medianAccuracy": 0.8322549019607843, + "p25Accuracy": 0.7326361985472154, + "p75Accuracy": 0.974283141772304, + "minAccuracy": 0.22677322677322678, "maxAccuracy": 1, "results": [ { "id": "0", - "score": 0.9861111111111112, - "predictedRows": 16, + "score": 0.9427609427609428, + "predictedRows": 33, "predictedCols": 4, "groundTruthRows": 32, "groundTruthCols": 4 }, { "id": "1", - "score": 0.8240740740740741, + "score": 0.8611111111111112, "predictedRows": 8, "predictedCols": 4, "groundTruthRows": 8, @@ -35,7 +35,7 @@ }, { "id": "3", - "score": 0.9116666666666667, + "score": 0.9176587301587302, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -43,7 +43,7 @@ }, { "id": "4", - "score": 0.7882326007326008, + "score": 0.8525641025641026, "predictedRows": 8, "predictedCols": 8, "groundTruthRows": 8, @@ -51,40 +51,39 @@ }, { "id": "5", - "score": 0.8333333333333334, - "predictedRows": 6, - "predictedCols": 3, + "score": 0.625, + "predictedRows": 7, + "predictedCols": 5, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "6", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 1, + "predictedRows": 4, + "predictedCols": 4, "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "7", - "score": 0.7220982142857143, + "score": 0.84375, "predictedRows": 8, - "predictedCols": 4, + "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "8", - "score": 0.6500000000000001, - "predictedRows": 4, + "score": 0.8109217171717171, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "9", - "score": 0.8065843621399178, + "score": 0.7962962962962963, "predictedRows": 9, "predictedCols": 4, "groundTruthRows": 9, @@ -92,41 +91,39 @@ }, { "id": "10", - "score": 0.7357285258601048, - "predictedRows": 32, + "score": 0.8468461427548759, + "predictedRows": 31, "predictedCols": 6, "groundTruthRows": 31, "groundTruthCols": 6 }, { "id": "11", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7889863547758285, + "predictedRows": 17, + "predictedCols": 6, "groundTruthRows": 17, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "12", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7753404439900424, + "predictedRows": 47, + "predictedCols": 4, "groundTruthRows": 53, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "13", - "score": 0.6635802469135803, - "predictedRows": 5, + "score": 0.8088888888888889, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "14", - "score": 0.8035714285714286, + "score": 0.9642857142857143, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -134,40 +131,39 @@ }, { "id": "15", - "score": 0.8383512544802868, - "predictedRows": 8, + "score": 0.9435200905489529, + "predictedRows": 9, "predictedCols": 5, "groundTruthRows": 9, "groundTruthCols": 5 }, { "id": "16", - "score": 0.5407407407407407, - "predictedRows": 4, + "score": 0.7703703703703705, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "17", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8741258741258742, + "predictedRows": 13, + "predictedCols": 6, "groundTruthRows": 13, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "18", - "score": 0.9338235294117647, - "predictedRows": 17, + "score": 0.8819444444444444, + "predictedRows": 18, "predictedCols": 3, "groundTruthRows": 17, "groundTruthCols": 3 }, { "id": "19", - "score": 1, + "score": 0.890030264979555, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -175,7 +171,7 @@ }, { "id": "20", - "score": 0.8125, + "score": 0.8541666666666666, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -183,7 +179,7 @@ }, { "id": "21", - "score": 0.7491666666666668, + "score": 0.7625, "predictedRows": 8, "predictedCols": 5, "groundTruthRows": 8, @@ -191,34 +187,32 @@ }, { "id": "22", - "score": 0.6574680335097001, - "predictedRows": 32, + "score": 0.8403439153439154, + "predictedRows": 28, "predictedCols": 4, "groundTruthRows": 28, "groundTruthCols": 4 }, { "id": "23", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.9427609427609428, + "predictedRows": 33, + "predictedCols": 4, "groundTruthRows": 32, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "24", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8157101758179924, + "predictedRows": 42, + "predictedCols": 6, "groundTruthRows": 42, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "25", - "score": 0.6904761904761905, - "predictedRows": 3, + "score": 0.44642857142857145, + "predictedRows": 4, "predictedCols": 9, "groundTruthRows": 3, "groundTruthCols": 9 @@ -233,7 +227,7 @@ }, { "id": "27", - "score": 0.811965811965812, + "score": 0.8712434518886132, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -249,15 +243,15 @@ }, { "id": "29", - "score": 0.8194444444444445, - "predictedRows": 8, + "score": 0.7283950617283951, + "predictedRows": 9, "predictedCols": 4, "groundTruthRows": 8, "groundTruthCols": 4 }, { "id": "30", - "score": 0.7537037037037037, + "score": 0.8222222222222222, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -265,7 +259,7 @@ }, { "id": "31", - "score": 0.8222222222222222, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -273,24 +267,23 @@ }, { "id": "32", - "score": 0.7211497211497212, - "predictedRows": 7, + "score": 0.7142142142142142, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "33", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.836877943193439, + "predictedRows": 42, + "predictedCols": 6, "groundTruthRows": 42, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "34", - "score": 0.7777777777777778, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -298,33 +291,31 @@ }, { "id": "35", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8771929824561403, + "predictedRows": 38, + "predictedCols": 4, "groundTruthRows": 39, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "36", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8260659033313497, + "predictedRows": 40, + "predictedCols": 6, "groundTruthRows": 40, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "37", - "score": 0.869281045751634, - "predictedRows": 17, + "score": 0.9427609427609428, + "predictedRows": 33, "predictedCols": 4, "groundTruthRows": 32, "groundTruthCols": 4 }, { "id": "38", - "score": 0.8262496519075467, + "score": 0.8472222222222222, "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 9, @@ -332,15 +323,15 @@ }, { "id": "39", - "score": 0.6922398589065255, - "predictedRows": 5, + "score": 0.6785714285714286, + "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "40", - "score": 0.49218261413383363, + "score": 0.5947467166979363, "predictedRows": 7, "predictedCols": 8, "groundTruthRows": 11, @@ -348,7 +339,7 @@ }, { "id": "41", - "score": 0.8222222222222222, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -356,7 +347,7 @@ }, { "id": "42", - "score": 0.765625, + "score": 0.828125, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -364,7 +355,7 @@ }, { "id": "43", - "score": 0.9945725801112502, + "score": 0.9996772004171562, "predictedRows": 12, "predictedCols": 2, "groundTruthRows": 12, @@ -372,31 +363,31 @@ }, { "id": "44", - "score": 0.825, - "predictedRows": 5, + "score": 0.6666666666666666, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "45", - "score": 0.8564311594202898, + "score": 0.7770833333333333, "predictedRows": 8, - "predictedCols": 5, + "predictedCols": 6, "groundTruthRows": 7, "groundTruthCols": 5 }, { "id": "46", - "score": 0.8069153069153069, - "predictedRows": 11, + "score": 0.8666666666666667, + "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 11, "groundTruthCols": 4 }, { "id": "47", - "score": 0.7620925106639393, + "score": 0.7533292104720677, "predictedRows": 32, "predictedCols": 4, "groundTruthRows": 35, @@ -404,7 +395,7 @@ }, { "id": "48", - "score": 0.8251488095238095, + "score": 0.7885416666666667, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -412,7 +403,7 @@ }, { "id": "49", - "score": 0.6, + "score": 0.5975694444444445, "predictedRows": 15, "predictedCols": 5, "groundTruthRows": 16, @@ -428,7 +419,7 @@ }, { "id": "51", - "score": 0.9977857800030616, + "score": 1, "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 13, @@ -436,7 +427,7 @@ }, { "id": "52", - "score": 0.811965811965812, + "score": 0.8632478632478633, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -444,16 +435,15 @@ }, { "id": "53", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8660968660968662, + "predictedRows": 13, + "predictedCols": 4, "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "54", - "score": 0.8132440476190476, + "score": 0.84375, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -461,15 +451,15 @@ }, { "id": "55", - "score": 0.9259259259259259, - "predictedRows": 3, + "score": 0.7101704879482656, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "56", - "score": 0.8, + "score": 0.7875, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -477,7 +467,7 @@ }, { "id": "57", - "score": 1, + "score": 0.987012987012987, "predictedRows": 11, "predictedCols": 2, "groundTruthRows": 11, @@ -485,7 +475,7 @@ }, { "id": "58", - "score": 0.9382440476190477, + "score": 1, "predictedRows": 21, "predictedCols": 3, "groundTruthRows": 21, @@ -493,15 +483,15 @@ }, { "id": "59", - "score": 1, - "predictedRows": 6, + "score": 0.8035714285714286, + "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "60", - "score": 0.8218694885361552, + "score": 0.8148148148148148, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -509,7 +499,7 @@ }, { "id": "61", - "score": 0.8138888888888889, + "score": 0.8063956876456876, "predictedRows": 40, "predictedCols": 4, "groundTruthRows": 40, @@ -517,7 +507,7 @@ }, { "id": "62", - "score": 0.828125, + "score": 0.7657076719576721, "predictedRows": 12, "predictedCols": 3, "groundTruthRows": 12, @@ -533,16 +523,15 @@ }, { "id": "64", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8259049773755656, + "predictedRows": 26, + "predictedCols": 3, "groundTruthRows": 26, - "groundTruthCols": 3, - "error": "No prediction found" + "groundTruthCols": 3 }, { "id": "65", - "score": 0.7942708333333334, + "score": 0.8125, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -550,7 +539,7 @@ }, { "id": "66", - "score": 0.8115079365079365, + "score": 0.7333333333333333, "predictedRows": 5, "predictedCols": 7, "groundTruthRows": 5, @@ -558,7 +547,7 @@ }, { "id": "67", - "score": 0.8037037037037038, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -566,7 +555,7 @@ }, { "id": "68", - "score": 0.8937074829931972, + "score": 0.9294217687074829, "predictedRows": 20, "predictedCols": 3, "groundTruthRows": 21, @@ -574,16 +563,15 @@ }, { "id": "69", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 1, + "predictedRows": 16, + "predictedCols": 4, "groundTruthRows": 27, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "70", - "score": 0.7666666666666667, + "score": 0.6579799415620311, "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 5, @@ -591,15 +579,15 @@ }, { "id": "71", - "score": 0.8027192982456139, - "predictedRows": 19, - "predictedCols": 5, + "score": 0.7889863547758285, + "predictedRows": 17, + "predictedCols": 6, "groundTruthRows": 17, "groundTruthCols": 5 }, { "id": "72", - "score": 0.8027777777777777, + "score": 0.8194444444444444, "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 9, @@ -607,15 +595,15 @@ }, { "id": "73", - "score": 0.6023809523809524, - "predictedRows": 3, + "score": 1, + "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 5, "groundTruthCols": 2 }, { "id": "74", - "score": 0.621767148878113, + "score": 0.7152371907414412, "predictedRows": 34, "predictedCols": 6, "groundTruthRows": 39, @@ -623,23 +611,23 @@ }, { "id": "75", - "score": 0.9262401699447886, - "predictedRows": 14, + "score": 0.9999297826773866, + "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 13, "groundTruthCols": 2 }, { "id": "76", - "score": 0.7083333333333334, - "predictedRows": 9, + "score": 0.7840073529411764, + "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "77", - "score": 0.8632478632478633, + "score": 0.8717948717948718, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -647,32 +635,31 @@ }, { "id": "78", - "score": 0.6908730158730158, - "predictedRows": 7, + "score": 0.9053571428571429, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "79", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6145833333333334, + "predictedRows": 8, + "predictedCols": 7, "groundTruthRows": 8, - "groundTruthCols": 7, - "error": "No prediction found" + "groundTruthCols": 7 }, { "id": "80", - "score": 0.9627360562143171, - "predictedRows": 4, + "score": 0.8518518518518519, + "predictedRows": 3, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "81", - "score": 0.8333333333333334, + "score": 0.8541666666666666, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -680,7 +667,7 @@ }, { "id": "82", - "score": 0.8138888888888889, + "score": 0.7712532924797075, "predictedRows": 8, "predictedCols": 4, "groundTruthRows": 7, @@ -688,23 +675,23 @@ }, { "id": "83", - "score": 0.8507625272331156, - "predictedRows": 34, + "score": 0.9150326797385621, + "predictedRows": 17, "predictedCols": 4, "groundTruthRows": 32, "groundTruthCols": 4 }, { "id": "84", - "score": 0.6223316912972086, - "predictedRows": 6, + "score": 0.934984520123839, + "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 8, "groundTruthCols": 2 }, { "id": "85", - "score": 0.9814814814814815, + "score": 1, "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 4, @@ -712,23 +699,23 @@ }, { "id": "86", - "score": 0.7666666666666667, - "predictedRows": 8, + "score": 0.9449243977545864, + "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, "groundTruthCols": 4 }, { "id": "87", - "score": 0.4532915360501567, - "predictedRows": 17, - "predictedCols": 4, + "score": 0.678726035868893, + "predictedRows": 19, + "predictedCols": 2, "groundTruthRows": 29, "groundTruthCols": 2 }, { "id": "88", - "score": 0.9988649230103557, + "score": 0.9997636829889188, "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 8, @@ -736,7 +723,7 @@ }, { "id": "89", - "score": 0.8209876543209877, + "score": 0.8518518518518519, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -744,31 +731,31 @@ }, { "id": "90", - "score": 0.6867628062596616, - "predictedRows": 16, + "score": 0.936914907791751, + "predictedRows": 17, "predictedCols": 4, "groundTruthRows": 17, "groundTruthCols": 4 }, { "id": "91", - "score": 0.825, - "predictedRows": 5, + "score": 0.6666666666666666, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "92", - "score": 0.6481481481481481, - "predictedRows": 6, + "score": 0.8203174603174602, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "93", - "score": 0.7916666666666666, + "score": 0.8541666666666666, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -776,7 +763,7 @@ }, { "id": "94", - "score": 0.8504983388704319, + "score": 0.8015873015873016, "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, @@ -784,15 +771,15 @@ }, { "id": "95", - "score": 0.7837995337995338, - "predictedRows": 12, + "score": 0.8461538461538461, + "predictedRows": 13, "predictedCols": 6, "groundTruthRows": 13, "groundTruthCols": 6 }, { "id": "96", - "score": 0.825, + "score": 0.85, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -800,7 +787,7 @@ }, { "id": "97", - "score": 0.96, + "score": 1, "predictedRows": 5, "predictedCols": 5, "groundTruthRows": 5, @@ -808,7 +795,7 @@ }, { "id": "98", - "score": 0.9642857142857143, + "score": 1, "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 4, @@ -816,23 +803,23 @@ }, { "id": "99", - "score": 0.5238095238095238, - "predictedRows": 7, + "score": 0.9711111111111111, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "100", - "score": 0.6031154337531691, - "predictedRows": 35, + "score": 0.7136222117121968, + "predictedRows": 34, "predictedCols": 6, "groundTruthRows": 39, "groundTruthCols": 6 }, { "id": "101", - "score": 0.8898809523809524, + "score": 0.8928571428571429, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -840,7 +827,7 @@ }, { "id": "102", - "score": 0.8083333333333333, + "score": 0.8333333333333334, "predictedRows": 5, "predictedCols": 7, "groundTruthRows": 5, @@ -848,23 +835,23 @@ }, { "id": "103", - "score": 0.4671223513328776, - "predictedRows": 3, - "predictedCols": 1, + "score": 1, + "predictedRows": 5, + "predictedCols": 2, "groundTruthRows": 5, "groundTruthCols": 2 }, { "id": "104", - "score": 0.7222222222222223, - "predictedRows": 7, - "predictedCols": 5, + "score": 0.8125, + "predictedRows": 6, + "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "105", - "score": 0.8359375, + "score": 0.828125, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -872,41 +859,39 @@ }, { "id": "106", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.9333333333333333, + "predictedRows": 3, + "predictedCols": 5, "groundTruthRows": 4, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "107", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.5313788914623091, + "predictedRows": 35, + "predictedCols": 9, "groundTruthRows": 40, - "groundTruthCols": 8, - "error": "No prediction found" + "groundTruthCols": 8 }, { "id": "108", - "score": 0.7609649122807018, - "predictedRows": 19, - "predictedCols": 5, + "score": 0.825, + "predictedRows": 16, + "predictedCols": 7, "groundTruthRows": 16, "groundTruthCols": 5 }, { "id": "109", - "score": 0.7222886762360446, - "predictedRows": 11, + "score": 0.8361842105263158, + "predictedRows": 10, "predictedCols": 3, "groundTruthRows": 10, "groundTruthCols": 3 }, { "id": "110", - "score": 0.8296130952380952, + "score": 0.84375, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -914,7 +899,7 @@ }, { "id": "111", - "score": 0.798095238095238, + "score": 0.8666666666666667, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -930,7 +915,7 @@ }, { "id": "113", - "score": 0.6666666666666666, + "score": 0.7142857142857143, "predictedRows": 3, "predictedCols": 9, "groundTruthRows": 3, @@ -938,41 +923,39 @@ }, { "id": "114", - "score": 0.9629629629629629, - "predictedRows": 6, + "score": 0.7588813303099018, + "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "115", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.437914010791017, + "predictedRows": 22, + "predictedCols": 10, "groundTruthRows": 29, - "groundTruthCols": 8, - "error": "No prediction found" + "groundTruthCols": 8 }, { "id": "116", - "score": 0.78125, - "predictedRows": 8, + "score": 0.7361111111111112, + "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "117", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8129643528605376, + "predictedRows": 18, + "predictedCols": 4, "groundTruthRows": 18, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "118", - "score": 0.7822222222222223, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -980,15 +963,15 @@ }, { "id": "119", - "score": 0.7555555555555555, - "predictedRows": 8, + "score": 0.8518518518518519, + "predictedRows": 9, "predictedCols": 4, "groundTruthRows": 9, "groundTruthCols": 4 }, { "id": "120", - "score": 0.9861111111111112, + "score": 0.9722222222222222, "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 4, @@ -996,7 +979,7 @@ }, { "id": "121", - "score": 0.8459569341347551, + "score": 0.8473723370287184, "predictedRows": 39, "predictedCols": 3, "groundTruthRows": 39, @@ -1004,7 +987,7 @@ }, { "id": "122", - "score": 0.828125, + "score": 0.6777644230769232, "predictedRows": 16, "predictedCols": 3, "groundTruthRows": 16, @@ -1012,33 +995,32 @@ }, { "id": "123", - "score": 0.9183006535947712, - "predictedRows": 34, + "score": 1, + "predictedRows": 16, "predictedCols": 4, "groundTruthRows": 32, "groundTruthCols": 4 }, { "id": "124", - "score": 0.7777777777777778, - "predictedRows": 5, + "score": 0.6481481481481481, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "125", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8626543209876543, + "predictedRows": 36, + "predictedCols": 4, "groundTruthRows": 36, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "126", - "score": 0.8263888888888888, - "predictedRows": 18, + "score": 0.711265882621455, + "predictedRows": 19, "predictedCols": 3, "groundTruthRows": 18, "groundTruthCols": 3 @@ -1053,7 +1035,7 @@ }, { "id": "128", - "score": 0.896825396825397, + "score": 0.8650793650793651, "predictedRows": 6, "predictedCols": 2, "groundTruthRows": 6, @@ -1069,40 +1051,39 @@ }, { "id": "130", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7998090817611966, + "predictedRows": 42, + "predictedCols": 4, "groundTruthRows": 49, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "131", - "score": 0.8092147435897437, - "predictedRows": 5, + "score": 0.7333333333333333, + "predictedRows": 4, "predictedCols": 7, "groundTruthRows": 5, "groundTruthCols": 7 }, { "id": "132", - "score": 0.826675061050061, - "predictedRows": 5, + "score": 0.7333333333333333, + "predictedRows": 4, "predictedCols": 7, "groundTruthRows": 5, "groundTruthCols": 7 }, { "id": "133", - "score": 0.9444444444444444, + "score": 0.4722222222222222, "predictedRows": 3, - "predictedCols": 7, + "predictedCols": 13, "groundTruthRows": 3, "groundTruthCols": 7 }, { "id": "134", - "score": 0.6953703703703704, + "score": 0.7449074074074074, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -1110,23 +1091,23 @@ }, { "id": "135", - "score": 0.7627683147777711, - "predictedRows": 26, + "score": 0.7875717662951706, + "predictedRows": 27, "predictedCols": 4, "groundTruthRows": 27, "groundTruthCols": 4 }, { "id": "136", - "score": 0.8125, - "predictedRows": 4, + "score": 0.625, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 4, "groundTruthCols": 3 }, { "id": "137", - "score": 0.8431818181818183, + "score": 0.8264462809917354, "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 11, @@ -1134,16 +1115,16 @@ }, { "id": "138", - "score": 0.7037037037037037, - "predictedRows": 6, + "score": 0.7962059620596206, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "139", - "score": 0.8333333333333334, - "predictedRows": 7, + "score": 0.8541666666666666, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 @@ -1158,15 +1139,15 @@ }, { "id": "141", - "score": 0.7333333333333333, - "predictedRows": 5, + "score": 1, + "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 4, "groundTruthCols": 4 }, { "id": "142", - "score": 0.825, + "score": 0.8, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -1174,24 +1155,23 @@ }, { "id": "143", - "score": 0.8230978260869566, - "predictedRows": 8, + "score": 0.9624060150375939, + "predictedRows": 7, "predictedCols": 5, "groundTruthRows": 7, "groundTruthCols": 5 }, { "id": "144", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6487179487179487, + "predictedRows": 10, + "predictedCols": 8, "groundTruthRows": 10, - "groundTruthCols": 8, - "error": "No prediction found" + "groundTruthCols": 8 }, { "id": "145", - "score": 0.811965811965812, + "score": 0.8717948717948718, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -1207,7 +1187,7 @@ }, { "id": "147", - "score": 0.9998154300479882, + "score": 0.9993585637226383, "predictedRows": 18, "predictedCols": 2, "groundTruthRows": 18, @@ -1215,23 +1195,23 @@ }, { "id": "148", - "score": 0.7948717948717948, + "score": 0.8461538461538461, "predictedRows": 13, - "predictedCols": 4, + "predictedCols": 5, "groundTruthRows": 13, "groundTruthCols": 4 }, { "id": "149", - "score": 0.4857142857142857, - "predictedRows": 3, + "score": 0.9991875423155042, + "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 5, "groundTruthCols": 2 }, { "id": "150", - "score": 0.9444444444444444, + "score": 1, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -1239,12 +1219,11 @@ }, { "id": "151", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.9999239312338355, + "predictedRows": 12, + "predictedCols": 2, "groundTruthRows": 12, - "groundTruthCols": 2, - "error": "No prediction found" + "groundTruthCols": 2 }, { "id": "152", @@ -1256,7 +1235,7 @@ }, { "id": "153", - "score": 0.9270833333333334, + "score": 1, "predictedRows": 32, "predictedCols": 4, "groundTruthRows": 32, @@ -1264,7 +1243,7 @@ }, { "id": "154", - "score": 0.8567784256559766, + "score": 0.7931003027578808, "predictedRows": 14, "predictedCols": 3, "groundTruthRows": 14, @@ -1272,15 +1251,15 @@ }, { "id": "155", - "score": 0.84375, - "predictedRows": 8, + "score": 0.7361111111111112, + "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "156", - "score": 0.8222222222222222, + "score": 0.8, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -1288,15 +1267,15 @@ }, { "id": "157", - "score": 0.835978835978836, - "predictedRows": 7, + "score": 0.6554232804232805, + "predictedRows": 8, "predictedCols": 4, "groundTruthRows": 7, "groundTruthCols": 4 }, { "id": "158", - "score": 0.8481481481481482, + "score": 0.8663817663817664, "predictedRows": 20, "predictedCols": 4, "groundTruthRows": 20, @@ -1312,24 +1291,23 @@ }, { "id": "160", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8139863437997409, + "predictedRows": 40, + "predictedCols": 6, "groundTruthRows": 40, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "161", - "score": 0.8416666666666667, - "predictedRows": 15, + "score": 0.7122239155272376, + "predictedRows": 16, "predictedCols": 3, "groundTruthRows": 15, "groundTruthCols": 3 }, { "id": "162", - "score": 0.9996767937944409, + "score": 1, "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 8, @@ -1337,7 +1315,7 @@ }, { "id": "163", - "score": 0.7924875239606055, + "score": 0.7770459880495091, "predictedRows": 39, "predictedCols": 3, "groundTruthRows": 41, @@ -1345,25 +1323,25 @@ }, { "id": "164", - "score": 0.4857142857142857, - "predictedRows": 3, + "score": 1, + "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 5, "groundTruthCols": 2 }, { "id": "165", - "score": 1, - "predictedRows": 6, + "score": 0.8379120879120878, + "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "166", - "score": 0.7887125220458554, - "predictedRows": 5, - "predictedCols": 4, + "score": 0.6296296296296297, + "predictedRows": 6, + "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 4 }, @@ -1377,7 +1355,7 @@ }, { "id": "168", - "score": 0.8461538461538461, + "score": 0.8632478632478633, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -1385,7 +1363,7 @@ }, { "id": "169", - "score": 0.8027290448343081, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -1393,9 +1371,9 @@ }, { "id": "170", - "score": 0.5625, - "predictedRows": 4, - "predictedCols": 4, + "score": 1, + "predictedRows": 6, + "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, @@ -1409,7 +1387,7 @@ }, { "id": "172", - "score": 0.829556530214425, + "score": 0.8235380116959066, "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 9, @@ -1417,15 +1395,15 @@ }, { "id": "173", - "score": 0.8333333333333334, - "predictedRows": 7, + "score": 0.8541666666666666, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "174", - "score": 0.7654320987654322, + "score": 0.8333333333333334, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -1433,15 +1411,15 @@ }, { "id": "175", - "score": 0.8333333333333334, - "predictedRows": 24, + "score": 0.7205294954012398, + "predictedRows": 25, "predictedCols": 3, "groundTruthRows": 24, "groundTruthCols": 3 }, { "id": "176", - "score": 0.6547619047619049, + "score": 0.6964285714285714, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 6, @@ -1449,24 +1427,23 @@ }, { "id": "177", - "score": 0.7599283775754364, - "predictedRows": 32, + "score": 0.7248545573827377, + "predictedRows": 34, "predictedCols": 4, "groundTruthRows": 34, "groundTruthCols": 4 }, { "id": "178", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8461538461538461, + "predictedRows": 13, + "predictedCols": 4, "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "179", - "score": 0.9166666666666667, + "score": 0.9375, "predictedRows": 4, "predictedCols": 3, "groundTruthRows": 4, @@ -1474,31 +1451,31 @@ }, { "id": "180", - "score": 0.8194444444444444, - "predictedRows": 8, + "score": 0.7283950617283951, + "predictedRows": 9, "predictedCols": 4, "groundTruthRows": 8, "groundTruthCols": 4 }, { "id": "181", - "score": 0.49230769230769234, - "predictedRows": 8, + "score": 0.5594405594405595, + "predictedRows": 10, "predictedCols": 8, "groundTruthRows": 11, "groundTruthCols": 8 }, { "id": "182", - "score": 0.797979797979798, - "predictedRows": 11, + "score": 0.7962962962962963, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 11, "groundTruthCols": 4 }, { "id": "183", - "score": 0.8546296296296296, + "score": 0.8055555555555556, "predictedRows": 20, "predictedCols": 4, "groundTruthRows": 20, @@ -1506,23 +1483,23 @@ }, { "id": "184", - "score": 0.9236111111111112, - "predictedRows": 32, + "score": 1, + "predictedRows": 16, "predictedCols": 4, "groundTruthRows": 32, "groundTruthCols": 4 }, { "id": "185", - "score": 1, - "predictedRows": 7, - "predictedCols": 3, + "score": 0.5872141720813447, + "predictedRows": 9, + "predictedCols": 4, "groundTruthRows": 7, "groundTruthCols": 3 }, { "id": "186", - "score": 0.9444444444444444, + "score": 1, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -1530,31 +1507,31 @@ }, { "id": "187", - "score": 0.8185563624160115, - "predictedRows": 39, + "score": 0.8765316067947647, + "predictedRows": 38, "predictedCols": 4, "groundTruthRows": 39, "groundTruthCols": 4 }, { "id": "188", - "score": 0.6923076923076924, + "score": 0.5576923076923077, "predictedRows": 8, - "predictedCols": 8, + "predictedCols": 15, "groundTruthRows": 8, "groundTruthCols": 8 }, { "id": "189", - "score": 0.7491666666666668, - "predictedRows": 8, + "score": 0.6666666666666666, + "predictedRows": 9, "predictedCols": 5, "groundTruthRows": 8, "groundTruthCols": 5 }, { "id": "190", - "score": 0.8027290448343081, + "score": 0.8444444444444444, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -1562,7 +1539,7 @@ }, { "id": "191", - "score": 0.8384387351778656, + "score": 0.9352173913043478, "predictedRows": 22, "predictedCols": 3, "groundTruthRows": 23, @@ -1570,23 +1547,23 @@ }, { "id": "192", - "score": 0.722718253968254, - "predictedRows": 11, + "score": 0.7022317650659897, + "predictedRows": 10, "predictedCols": 3, "groundTruthRows": 12, "groundTruthCols": 3 }, { "id": "193", - "score": 0.905982905982906, - "predictedRows": 13, + "score": 0.9759344104071888, + "predictedRows": 12, "predictedCols": 4, "groundTruthRows": 12, "groundTruthCols": 4 }, { "id": "194", - "score": 0.7079752710632773, + "score": 0.7545572386564026, "predictedRows": 37, "predictedCols": 4, "groundTruthRows": 41, @@ -1594,7 +1571,7 @@ }, { "id": "195", - "score": 0.8247222222222222, + "score": 0.8125, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -1602,7 +1579,7 @@ }, { "id": "196", - "score": 0.9992422917759516, + "score": 1, "predictedRows": 11, "predictedCols": 2, "groundTruthRows": 11, @@ -1610,15 +1587,15 @@ }, { "id": "197", - "score": 0.5623456790123457, - "predictedRows": 6, + "score": 0.7666666666666667, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "198", - "score": 0.8514285714285715, + "score": 0.8444444444444444, "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 10, @@ -1626,31 +1603,31 @@ }, { "id": "199", - "score": 0.6606800336188634, - "predictedRows": 26, + "score": 0.7617900765507147, + "predictedRows": 25, "predictedCols": 3, "groundTruthRows": 27, "groundTruthCols": 3 }, { "id": "200", - "score": 0.7083333333333334, - "predictedRows": 9, + "score": 0.859375, + "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "201", - "score": 0.5262626262626262, - "predictedRows": 4, + "score": 0.7777777777777778, + "predictedRows": 3, "predictedCols": 4, "groundTruthRows": 5, "groundTruthCols": 4 }, { "id": "202", - "score": 0.84375, + "score": 0.828125, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -1658,7 +1635,7 @@ }, { "id": "203", - "score": 0.9183673469387754, + "score": 0.9489795918367347, "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 7, @@ -1666,47 +1643,47 @@ }, { "id": "204", - "score": 0.5739348370927319, - "predictedRows": 15, + "score": 0.8088888888888889, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 11, "groundTruthCols": 4 }, { "id": "205", - "score": 0.6785714285714286, - "predictedRows": 7, + "score": 0.7847222222222223, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, "groundTruthCols": 3 }, { "id": "206", - "score": 0.865, - "predictedRows": 25, + "score": 0.7245816177592407, + "predictedRows": 26, "predictedCols": 3, "groundTruthRows": 25, "groundTruthCols": 3 }, { "id": "207", - "score": 0.8173363095238095, - "predictedRows": 8, + "score": 0.7361111111111112, + "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "208", - "score": 0.55, - "predictedRows": 13, + "score": 0.7029268292682926, + "predictedRows": 15, "predictedCols": 5, "groundTruthRows": 15, "groundTruthCols": 5 }, { "id": "209", - "score": 0.8490028490028491, + "score": 0.8717948717948718, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -1714,7 +1691,7 @@ }, { "id": "210", - "score": 0.84375, + "score": 0.7582656495285305, "predictedRows": 16, "predictedCols": 3, "groundTruthRows": 16, @@ -1722,15 +1699,15 @@ }, { "id": "211", - "score": 0.8259259259259258, - "predictedRows": 9, + "score": 0.57, + "predictedRows": 10, "predictedCols": 5, "groundTruthRows": 9, "groundTruthCols": 5 }, { "id": "212", - "score": 1, + "score": 0.890030264979555, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -1746,15 +1723,15 @@ }, { "id": "214", - "score": 0.8, - "predictedRows": 5, + "score": 0.6666666666666666, + "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "215", - "score": 0.8509485094850948, + "score": 0.8095238095238095, "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, @@ -1762,50 +1739,47 @@ }, { "id": "216", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8292234081707766, + "predictedRows": 13, + "predictedCols": 6, "groundTruthRows": 13, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "217", - "score": 0.5987654320987654, - "predictedRows": 5, - "predictedCols": 5, + "score": 0.6349206349206349, + "predictedRows": 7, + "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "218", - "score": 0.6643771043771044, - "predictedRows": 16, + "score": 0.711764705882353, + "predictedRows": 17, "predictedCols": 5, "groundTruthRows": 18, "groundTruthCols": 5 }, { "id": "219", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.8333333333333334, + "predictedRows": 26, + "predictedCols": 4, "groundTruthRows": 25, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "220", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.4126862881066306, + "predictedRows": 38, + "predictedCols": 9, "groundTruthRows": 60, - "groundTruthCols": 8, - "error": "No prediction found" + "groundTruthCols": 8 }, { "id": "221", - "score": 0.9858890272588903, + "score": 0.9801194239550404, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -1813,7 +1787,7 @@ }, { "id": "222", - "score": 0.9375, + "score": 1, "predictedRows": 20, "predictedCols": 3, "groundTruthRows": 20, @@ -1821,15 +1795,15 @@ }, { "id": "223", - "score": 0.7485119047619047, - "predictedRows": 12, + "score": 0.6916666666666667, + "predictedRows": 13, "predictedCols": 3, "groundTruthRows": 15, "groundTruthCols": 3 }, { "id": "224", - "score": 0.8333333333333334, + "score": 0.8541666666666666, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -1837,15 +1811,15 @@ }, { "id": "225", - "score": 0.9988282394297432, - "predictedRows": 4, + "score": 0.22677322677322678, + "predictedRows": 16, "predictedCols": 2, "groundTruthRows": 4, "groundTruthCols": 2 }, { "id": "226", - "score": 0.9352678571428572, + "score": 1, "predictedRows": 12, "predictedCols": 3, "groundTruthRows": 12, @@ -1869,7 +1843,7 @@ }, { "id": "229", - "score": 0.9992237973891742, + "score": 0.9989207221350078, "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 13, @@ -1877,7 +1851,7 @@ }, { "id": "230", - "score": 0.9731495623565081, + "score": 0.9920761641891436, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -1885,7 +1859,7 @@ }, { "id": "231", - "score": 0.5364779874213836, + "score": 0.43333333333333335, "predictedRows": 2, "predictedCols": 5, "groundTruthRows": 3, @@ -1893,15 +1867,15 @@ }, { "id": "232", - "score": 1, - "predictedRows": 3, + "score": 0.3706100560461272, + "predictedRows": 11, "predictedCols": 2, "groundTruthRows": 3, "groundTruthCols": 2 }, { "id": "233", - "score": 1, + "score": 0.8888888888888888, "predictedRows": 2, "predictedCols": 4, "groundTruthRows": 2, @@ -1909,23 +1883,23 @@ }, { "id": "234", - "score": 1, - "predictedRows": 4, + "score": 0.6940728353771832, + "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 4, "groundTruthCols": 4 }, { "id": "235", - "score": 0.6534090909090909, - "predictedRows": 15, + "score": 0.6928977272727272, + "predictedRows": 16, "predictedCols": 6, "groundTruthRows": 15, "groundTruthCols": 6 }, { "id": "236", - "score": 0.8857142857142857, + "score": 0.7571428571428571, "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 10, @@ -1933,7 +1907,7 @@ }, { "id": "237", - "score": 0.997978436657682, + "score": 0.8214285714285714, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -1941,8 +1915,8 @@ }, { "id": "238", - "score": 0.7946428571428571, - "predictedRows": 6, + "score": 0.9961538461538462, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 @@ -1965,15 +1939,15 @@ }, { "id": "241", - "score": 0.7868480725623583, + "score": 0.8469387755102041, "predictedRows": 7, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 7, "groundTruthCols": 2 }, { "id": "242", - "score": 0.9997598956534758, + "score": 0.9998785228377065, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -1981,7 +1955,7 @@ }, { "id": "243", - "score": 0.9418803418803419, + "score": 0.9971509971509972, "predictedRows": 13, "predictedCols": 4, "groundTruthRows": 13, @@ -1989,7 +1963,7 @@ }, { "id": "244", - "score": 0.8697888721387517, + "score": 0.9455555555555556, "predictedRows": 25, "predictedCols": 4, "groundTruthRows": 25, @@ -1997,15 +1971,15 @@ }, { "id": "245", - "score": 1, - "predictedRows": 6, + "score": 0.7879465153750385, + "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 6, "groundTruthCols": 2 }, { "id": "246", - "score": 0.9506172839506173, + "score": 1, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -2013,7 +1987,7 @@ }, { "id": "247", - "score": 0.7118055555555557, + "score": 0.6960857332009268, "predictedRows": 8, "predictedCols": 7, "groundTruthRows": 8, @@ -2021,23 +1995,23 @@ }, { "id": "248", - "score": 0.6791383219954648, + "score": 0.6666666666666666, "predictedRows": 7, - "predictedCols": 7, + "predictedCols": 9, "groundTruthRows": 7, "groundTruthCols": 7 }, { "id": "249", - "score": 0.7131313131313131, - "predictedRows": 9, - "predictedCols": 6, + "score": 0.6022727272727273, + "predictedRows": 8, + "predictedCols": 11, "groundTruthRows": 8, "groundTruthCols": 6 }, { "id": "250", - "score": 0.9761904761904762, + "score": 0.9937622424856468, "predictedRows": 21, "predictedCols": 3, "groundTruthRows": 38, @@ -2045,15 +2019,15 @@ }, { "id": "251", - "score": 0.7959183673469388, - "predictedRows": 7, + "score": 1, + "predictedRows": 6, "predictedCols": 2, "groundTruthRows": 6, "groundTruthCols": 2 }, { "id": "252", - "score": 0.8640522875816994, + "score": 1, "predictedRows": 2, "predictedCols": 4, "groundTruthRows": 2, @@ -2061,7 +2035,7 @@ }, { "id": "253", - "score": 0.993866940806978, + "score": 0.9985865131887334, "predictedRows": 4, "predictedCols": 2, "groundTruthRows": 4, @@ -2069,7 +2043,7 @@ }, { "id": "254", - "score": 0.9964249964249964, + "score": 0.985985985985986, "predictedRows": 27, "predictedCols": 2, "groundTruthRows": 27, @@ -2077,15 +2051,15 @@ }, { "id": "255", - "score": 0.999781730874168, - "predictedRows": 11, + "score": 1, + "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 11, "groundTruthCols": 2 }, { "id": "256", - "score": 0.9792429792429791, + "score": 0.9408465823205383, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -2093,8 +2067,8 @@ }, { "id": "257", - "score": 0.7878787878787878, - "predictedRows": 21, + "score": 0.7161711566670245, + "predictedRows": 22, "predictedCols": 6, "groundTruthRows": 21, "groundTruthCols": 6 @@ -2103,13 +2077,13 @@ "id": "258", "score": 0.9904761904761904, "predictedRows": 10, - "predictedCols": 3, + "predictedCols": 2, "groundTruthRows": 10, "groundTruthCols": 2 }, { "id": "259", - "score": 0.9999196529005303, + "score": 0.9996592447214884, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -2117,9 +2091,9 @@ }, { "id": "260", - "score": 0.8181818181818182, - "predictedRows": 3, - "predictedCols": 6, + "score": 0.5789312039312039, + "predictedRows": 8, + "predictedCols": 11, "groundTruthRows": 8, "groundTruthCols": 6 }, @@ -2133,7 +2107,7 @@ }, { "id": "262", - "score": 0.9523809523809523, + "score": 0.9656084656084657, "predictedRows": 14, "predictedCols": 4, "groundTruthRows": 14, @@ -2141,7 +2115,7 @@ }, { "id": "263", - "score": 0.8672229808590103, + "score": 0.8679812834224598, "predictedRows": 10, "predictedCols": 3, "groundTruthRows": 10, @@ -2149,7 +2123,7 @@ }, { "id": "264", - "score": 0.9118305118305118, + "score": 1, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 5, @@ -2157,15 +2131,15 @@ }, { "id": "265", - "score": 0.7401703453805539, + "score": 0.8408163265306123, "predictedRows": 7, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 7, "groundTruthCols": 2 }, { "id": "266", - "score": 0.9996846420687481, + "score": 1, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -2173,24 +2147,23 @@ }, { "id": "267", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7727272727272727, + "predictedRows": 16, + "predictedCols": 6, "groundTruthRows": 16, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "268", - "score": 0.9058441558441559, - "predictedRows": 11, - "predictedCols": 2, + "score": 0.8571428571428571, + "predictedRows": 10, + "predictedCols": 3, "groundTruthRows": 10, "groundTruthCols": 2 }, { "id": "269", - "score": 0.996790670534107, + "score": 0.997145286686103, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -2198,7 +2171,7 @@ }, { "id": "270", - "score": 0.8703703703703703, + "score": 0.8618233618233618, "predictedRows": 12, "predictedCols": 4, "groundTruthRows": 12, @@ -2206,8 +2179,8 @@ }, { "id": "271", - "score": 1, - "predictedRows": 3, + "score": 0.46811921891058583, + "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 3, "groundTruthCols": 2 @@ -2222,15 +2195,15 @@ }, { "id": "273", - "score": 0.4142857142857143, + "score": 0.4040431266846361, "predictedRows": 4, - "predictedCols": 6, + "predictedCols": 5, "groundTruthRows": 7, "groundTruthCols": 5 }, { "id": "274", - "score": 0.6039015976761074, + "score": 0.589612601106854, "predictedRows": 9, "predictedCols": 7, "groundTruthRows": 9, @@ -2238,16 +2211,15 @@ }, { "id": "275", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.9907518325609083, + "predictedRows": 15, + "predictedCols": 2, "groundTruthRows": 15, - "groundTruthCols": 2, - "error": "No prediction found" + "groundTruthCols": 2 }, { "id": "276", - "score": 0.9629230466431747, + "score": 0.9987879605728759, "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 13, @@ -2263,15 +2235,15 @@ }, { "id": "278", - "score": 0.9796834812472012, - "predictedRows": 4, + "score": 0.7466707021791767, + "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 4, "groundTruthCols": 2 }, { "id": "279", - "score": 0.8822853072853073, + "score": 1, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -2279,7 +2251,7 @@ }, { "id": "280", - "score": 0.9949329734132493, + "score": 0.9479831945315628, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -2295,7 +2267,7 @@ }, { "id": "282", - "score": 0.999644665048227, + "score": 1, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -2303,7 +2275,7 @@ }, { "id": "283", - "score": 0.9927594545346294, + "score": 0.9988163137151856, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -2311,7 +2283,7 @@ }, { "id": "284", - "score": 0.8711477015048443, + "score": 0.8693255440704419, "predictedRows": 4, "predictedCols": 2, "groundTruthRows": 4, @@ -2319,9 +2291,9 @@ }, { "id": "285", - "score": 0.525, + "score": 0.5288461538461539, "predictedRows": 8, - "predictedCols": 6, + "predictedCols": 7, "groundTruthRows": 8, "groundTruthCols": 8 }, @@ -2335,16 +2307,15 @@ }, { "id": "287", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6363636363636364, + "predictedRows": 17, + "predictedCols": 6, "groundTruthRows": 15, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "288", - "score": 0.9928831913821596, + "score": 0.989037758965329, "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 5, @@ -2360,8 +2331,8 @@ }, { "id": "290", - "score": 0.6762820512820512, - "predictedRows": 15, + "score": 0.7727272727272727, + "predictedRows": 16, "predictedCols": 6, "groundTruthRows": 16, "groundTruthCols": 6 @@ -2384,7 +2355,7 @@ }, { "id": "293", - "score": 0.9947840240442755, + "score": 0.9927270757835541, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 3, @@ -2392,7 +2363,7 @@ }, { "id": "294", - "score": 1, + "score": 0.9663865546218487, "predictedRows": 17, "predictedCols": 2, "groundTruthRows": 17, @@ -2400,7 +2371,7 @@ }, { "id": "295", - "score": 1, + "score": 0.9925925925925926, "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 10, @@ -2408,7 +2379,7 @@ }, { "id": "296", - "score": 0.8364197530864198, + "score": 0.7469135802469137, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -2416,15 +2387,15 @@ }, { "id": "297", - "score": 0.9675309753673396, - "predictedRows": 13, + "score": 0.8562958889763509, + "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 13, "groundTruthCols": 2 }, { "id": "298", - "score": 0.995476049009152, + "score": 0.9578084472557487, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -2440,7 +2411,7 @@ }, { "id": "300", - "score": 0.9708333333333334, + "score": 1, "predictedRows": 8, "predictedCols": 5, "groundTruthRows": 8, @@ -2456,7 +2427,7 @@ }, { "id": "302", - "score": 1, + "score": 0.9961538461538462, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -2464,23 +2435,23 @@ }, { "id": "303", - "score": 0.7671957671957672, - "predictedRows": 7, + "score": 1, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "304", - "score": 0.553168044077135, - "predictedRows": 17, - "predictedCols": 16, + "score": 0.7727272727272727, + "predictedRows": 16, + "predictedCols": 6, "groundTruthRows": 16, "groundTruthCols": 6 }, { "id": "305", - "score": 0.9998792416374834, + "score": 0.9997584748184988, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -2488,8 +2459,8 @@ }, { "id": "306", - "score": 0.9894781056527415, - "predictedRows": 4, + "score": 0.25065026010404157, + "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 4, "groundTruthCols": 2 @@ -2504,7 +2475,7 @@ }, { "id": "308", - "score": 0.8462099125364432, + "score": 0.8571428571428571, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -2512,7 +2483,7 @@ }, { "id": "309", - "score": 0.8371923789326456, + "score": 1, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -2520,17 +2491,17 @@ }, { "id": "310", - "score": 1, - "predictedRows": 3, + "score": 0.25217608180571144, + "predictedRows": 11, "predictedCols": 2, "groundTruthRows": 3, "groundTruthCols": 2 }, { "id": "311", - "score": 0.6785714285714287, + "score": 0.6785714285714286, "predictedRows": 7, - "predictedCols": 7, + "predictedCols": 9, "groundTruthRows": 7, "groundTruthCols": 7 }, @@ -2544,15 +2515,15 @@ }, { "id": "313", - "score": 0.9352678571428571, - "predictedRows": 16, + "score": 0.9908496732026143, + "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 15, "groundTruthCols": 2 }, { "id": "314", - "score": 0.9805921685251868, + "score": 0.9767906443632086, "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 5, @@ -2560,15 +2531,15 @@ }, { "id": "315", - "score": 0.8068181818181818, + "score": 0.6022727272727273, "predictedRows": 8, - "predictedCols": 6, + "predictedCols": 11, "groundTruthRows": 8, "groundTruthCols": 6 }, { "id": "316", - "score": 1, + "score": 0.9983333333333334, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 6, @@ -2592,23 +2563,23 @@ }, { "id": "319", - "score": 0.6714285714285715, + "score": 0.677689594356261, "predictedRows": 7, - "predictedCols": 7, + "predictedCols": 9, "groundTruthRows": 7, "groundTruthCols": 7 }, { "id": "320", - "score": 0.7936507936507936, - "predictedRows": 7, + "score": 1, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "321", - "score": 1, + "score": 0.8645420164399047, "predictedRows": 11, "predictedCols": 4, "groundTruthRows": 11, @@ -2616,16 +2587,16 @@ }, { "id": "322", - "score": 0.8677248677248678, + "score": 0.8333333333333334, "predictedRows": 9, - "predictedCols": 5, + "predictedCols": 6, "groundTruthRows": 8, "groundTruthCols": 5 }, { "id": "323", - "score": 0.9170164519708593, - "predictedRows": 15, + "score": 0.9999131567520625, + "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, "groundTruthCols": 2 @@ -2633,46 +2604,46 @@ { "id": "324", "score": 1, - "predictedRows": 8, + "predictedRows": 5, "predictedCols": 2, "groundTruthRows": 8, "groundTruthCols": 2 }, { "id": "325", - "score": 0.7575757575757576, - "predictedRows": 9, - "predictedCols": 6, + "score": 0.6016584766584766, + "predictedRows": 8, + "predictedCols": 11, "groundTruthRows": 8, "groundTruthCols": 6 }, { "id": "326", - "score": 0.7160493827160493, - "predictedRows": 18, - "predictedCols": 4, + "score": 0.7407407407407407, + "predictedRows": 15, + "predictedCols": 7, "groundTruthRows": 15, "groundTruthCols": 4 }, { "id": "327", - "score": 0.9281537176274018, - "predictedRows": 19, + "score": 1, + "predictedRows": 18, "predictedCols": 4, "groundTruthRows": 18, "groundTruthCols": 4 }, { "id": "328", - "score": 0.9842479674796747, - "predictedRows": 3, + "score": 0.4701298701298701, + "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 3, "groundTruthCols": 2 }, { "id": "329", - "score": 0.9842985842985843, + "score": 1, "predictedRows": 37, "predictedCols": 2, "groundTruthRows": 37, @@ -2680,23 +2651,23 @@ }, { "id": "330", - "score": 0.9683936945876372, - "predictedRows": 5, + "score": 0.28943977131610393, + "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 5, "groundTruthCols": 2 }, { "id": "331", - "score": 0.84375, - "predictedRows": 20, + "score": 0.902158295863875, + "predictedRows": 38, "predictedCols": 3, "groundTruthRows": 37, "groundTruthCols": 3 }, { "id": "332", - "score": 0.9555555555555555, + "score": 0.7777777777777778, "predictedRows": 2, "predictedCols": 4, "groundTruthRows": 2, @@ -2704,7 +2675,7 @@ }, { "id": "333", - "score": 1, + "score": 0.9993355481727574, "predictedRows": 10, "predictedCols": 2, "groundTruthRows": 10, @@ -2712,7 +2683,7 @@ }, { "id": "334", - "score": 0.9196985778750433, + "score": 0.8222222222222222, "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 10, @@ -2720,7 +2691,7 @@ }, { "id": "335", - "score": 0.9695386323494473, + "score": 0.9701556368879454, "predictedRows": 12, "predictedCols": 2, "groundTruthRows": 12, @@ -2736,7 +2707,7 @@ }, { "id": "337", - "score": 0.6761363636363636, + "score": 0.6988636363636364, "predictedRows": 16, "predictedCols": 6, "groundTruthRows": 15, @@ -2744,7 +2715,7 @@ }, { "id": "338", - "score": 1, + "score": 0.9797979797979798, "predictedRows": 4, "predictedCols": 4, "groundTruthRows": 4, @@ -2752,7 +2723,7 @@ }, { "id": "339", - "score": 0.89755172273829, + "score": 1, "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 8, @@ -2760,7 +2731,7 @@ }, { "id": "340", - "score": 1, + "score": 0.9285557645172678, "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 7, @@ -2776,31 +2747,31 @@ }, { "id": "342", - "score": 0.7946428571428571, - "predictedRows": 6, + "score": 1, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "343", - "score": 0.9990132078336116, - "predictedRows": 4, + "score": 0.7508916876824566, + "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 4, "groundTruthCols": 2 }, { "id": "344", - "score": 0.9941689054848992, - "predictedRows": 3, + "score": 0.668542199488491, + "predictedRows": 4, "predictedCols": 2, "groundTruthRows": 3, "groundTruthCols": 2 }, { "id": "345", - "score": 0.7691728991966962, + "score": 1, "predictedRows": 9, "predictedCols": 2, "groundTruthRows": 9, @@ -2808,10 +2779,10 @@ }, { "id": "346", - "score": 0.7160493827160493, - "predictedRows": 7, - "predictedCols": 5, - "groundTruthRows": 9, + "score": 1, + "predictedRows": 9, + "predictedCols": 4, + "groundTruthRows": 9, "groundTruthCols": 4 }, { @@ -2824,47 +2795,47 @@ }, { "id": "348", - "score": 0.980952380952381, - "predictedRows": 10, - "predictedCols": 2, + "score": 0.7476190476190476, + "predictedRows": 9, + "predictedCols": 3, "groundTruthRows": 10, "groundTruthCols": 2 }, { "id": "349", - "score": 0.6303030303030303, - "predictedRows": 14, - "predictedCols": 6, + "score": 0.6017429193899783, + "predictedRows": 16, + "predictedCols": 11, "groundTruthRows": 15, "groundTruthCols": 6 }, { "id": "350", - "score": 0.5676169678916932, - "predictedRows": 6, + "score": 0.59635196534235, + "predictedRows": 8, "predictedCols": 8, "groundTruthRows": 7, "groundTruthCols": 8 }, { "id": "351", - "score": 0.8059235886069397, + "score": 0.9332977092656013, "predictedRows": 37, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 37, "groundTruthCols": 3 }, { "id": "352", - "score": 1, - "predictedRows": 4, + "score": 0.6878999958710104, + "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 4, "groundTruthCols": 4 }, { "id": "353", - "score": 0.9708483477041173, + "score": 0.9665201835909449, "predictedRows": 9, "predictedCols": 2, "groundTruthRows": 9, @@ -2872,33 +2843,31 @@ }, { "id": "354", - "score": 0.7238365800865801, - "predictedRows": 21, + "score": 0.7747485357779476, + "predictedRows": 22, "predictedCols": 3, "groundTruthRows": 22, "groundTruthCols": 3 }, { "id": "355", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6776776467106944, + "predictedRows": 32, + "predictedCols": 8, "groundTruthRows": 35, - "groundTruthCols": 8, - "error": "No prediction found" + "groundTruthCols": 8 }, { "id": "356", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 1, + "predictedRows": 12, + "predictedCols": 2, "groundTruthRows": 16, - "groundTruthCols": 2, - "error": "No prediction found" + "groundTruthCols": 2 }, { "id": "357", - "score": 0.8095238095238095, + "score": 1, "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 11, @@ -2906,55 +2875,55 @@ }, { "id": "358", - "score": 0.5334881920247774, - "predictedRows": 5, + "score": 0.7619047619047619, + "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, "groundTruthCols": 4 }, { "id": "359", - "score": 0.6818181818181818, - "predictedRows": 2, + "score": 0.45454545454545453, + "predictedRows": 1, "predictedCols": 6, "groundTruthRows": 2, "groundTruthCols": 6 }, { "id": "360", - "score": 0.7589098532494759, - "predictedRows": 11, + "score": 0.6868686868686869, + "predictedRows": 10, "predictedCols": 4, "groundTruthRows": 11, "groundTruthCols": 4 }, { "id": "361", - "score": 0.7370798319327732, - "predictedRows": 24, + "score": 0.8211764705882354, + "predictedRows": 25, "predictedCols": 3, "groundTruthRows": 25, "groundTruthCols": 3 }, { "id": "362", - "score": 0.6834676434676434, - "predictedRows": 15, + "score": 1, + "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, "groundTruthCols": 2 }, { "id": "363", - "score": 0.7395833333333334, - "predictedRows": 12, + "score": 0.6979166666666666, + "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 12, "groundTruthCols": 3 }, { "id": "364", - "score": 0.793574481074481, + "score": 0.7970467032967032, "predictedRows": 16, "predictedCols": 3, "groundTruthRows": 16, @@ -2962,7 +2931,7 @@ }, { "id": "365", - "score": 0.8201612903225806, + "score": 0.8683333333333334, "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, @@ -2970,16 +2939,15 @@ }, { "id": "366", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7115384615384616, + "predictedRows": 13, + "predictedCols": 6, "groundTruthRows": 14, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "367", - "score": 0.6904761904761905, + "score": 0.6766513056835637, "predictedRows": 14, "predictedCols": 4, "groundTruthRows": 14, @@ -2987,23 +2955,23 @@ }, { "id": "368", - "score": 0.55, - "predictedRows": 4, + "score": 0.775, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 5, "groundTruthCols": 3 }, { "id": "369", - "score": 0.9857142857142858, - "predictedRows": 10, + "score": 0.8095238095238095, + "predictedRows": 12, "predictedCols": 2, "groundTruthRows": 10, "groundTruthCols": 2 }, { "id": "370", - "score": 0.9988662131519275, + "score": 1, "predictedRows": 14, "predictedCols": 4, "groundTruthRows": 14, @@ -3011,40 +2979,39 @@ }, { "id": "371", - "score": 0.8323858318894944, + "score": 0.8559861191440139, "predictedRows": 13, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 13, "groundTruthCols": 2 }, { "id": "372", - "score": 0.6444444444444445, - "predictedRows": 5, + "score": 0.6228070175438597, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "373", - "score": 0.745764652014652, - "predictedRows": 12, + "score": 0.7884615384615384, + "predictedRows": 13, "predictedCols": 3, "groundTruthRows": 13, "groundTruthCols": 3 }, { "id": "374", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.666345092551271, + "predictedRows": 65, + "predictedCols": 4, "groundTruthRows": 69, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "375", - "score": 0.6391554500041448, + "score": 0.7321428571428571, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 7, @@ -3052,15 +3019,15 @@ }, { "id": "376", - "score": 0.6666666666666666, - "predictedRows": 4, + "score": 0.5833333333333334, + "predictedRows": 3, "predictedCols": 4, "groundTruthRows": 4, "groundTruthCols": 4 }, { "id": "377", - "score": 0.6551100288600289, + "score": 0.6446944359987838, "predictedRows": 44, "predictedCols": 5, "groundTruthRows": 44, @@ -3068,7 +3035,7 @@ }, { "id": "378", - "score": 0.7148148148148148, + "score": 0.7592592592592593, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -3076,7 +3043,7 @@ }, { "id": "379", - "score": 0.9714285714285714, + "score": 1, "predictedRows": 1, "predictedCols": 2, "groundTruthRows": 12, @@ -3084,7 +3051,7 @@ }, { "id": "380", - "score": 1, + "score": 0.9994597583883297, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -3092,15 +3059,15 @@ }, { "id": "381", - "score": 0.7528061224489796, - "predictedRows": 16, + "score": 1, + "predictedRows": 13, "predictedCols": 2, "groundTruthRows": 13, "groundTruthCols": 2 }, { "id": "382", - "score": 0.631578947368421, + "score": 0.6783625730994152, "predictedRows": 18, "predictedCols": 4, "groundTruthRows": 19, @@ -3108,23 +3075,23 @@ }, { "id": "383", - "score": 0.6472865072865073, - "predictedRows": 8, + "score": 0.7625, + "predictedRows": 7, "predictedCols": 5, "groundTruthRows": 8, "groundTruthCols": 5 }, { "id": "384", - "score": 0.7680596047942986, + "score": 0.8571428571428571, "predictedRows": 7, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 7, "groundTruthCols": 2 }, { "id": "385", - "score": 0.9999149659863946, + "score": 0.9991663238818203, "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 15, @@ -3132,15 +3099,15 @@ }, { "id": "386", - "score": 0.7309027777777778, - "predictedRows": 12, + "score": 0.6354166666666666, + "predictedRows": 10, "predictedCols": 3, "groundTruthRows": 12, "groundTruthCols": 3 }, { "id": "387", - "score": 0.7583774250440917, + "score": 0.7777777777777778, "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, @@ -3148,15 +3115,15 @@ }, { "id": "388", - "score": 0.6183396464646465, - "predictedRows": 7, + "score": 0.765625, + "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "389", - "score": 0.7618650344753286, + "score": 0.8333854166666667, "predictedRows": 8, "predictedCols": 5, "groundTruthRows": 8, @@ -3164,15 +3131,15 @@ }, { "id": "390", - "score": 0.6231267806267806, - "predictedRows": 6, + "score": 0.6111111111111112, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "391", - "score": 0.9914183481946723, + "score": 0.9820819029225978, "predictedRows": 16, "predictedCols": 2, "groundTruthRows": 16, @@ -3188,24 +3155,23 @@ }, { "id": "393", - "score": 0.6547007774022384, - "predictedRows": 15, + "score": 0.7782907196969697, + "predictedRows": 16, "predictedCols": 5, "groundTruthRows": 16, "groundTruthCols": 5 }, { "id": "394", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.765, + "predictedRows": 19, + "predictedCols": 5, "groundTruthRows": 20, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "395", - "score": 0.6836099069379102, + "score": 0.7813176406926406, "predictedRows": 16, "predictedCols": 6, "groundTruthRows": 16, @@ -3213,15 +3179,15 @@ }, { "id": "396", - "score": 0.7849999999999999, - "predictedRows": 8, + "score": 0.7625, + "predictedRows": 7, "predictedCols": 5, "groundTruthRows": 8, "groundTruthCols": 5 }, { "id": "397", - "score": 0.8388704318936877, + "score": 0.8392857142857143, "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 8, @@ -3229,7 +3195,7 @@ }, { "id": "398", - "score": 0.6698039215686274, + "score": 0.6679738562091503, "predictedRows": 16, "predictedCols": 5, "groundTruthRows": 17, @@ -3237,32 +3203,31 @@ }, { "id": "399", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7567567567567568, + "predictedRows": 36, + "predictedCols": 4, "groundTruthRows": 37, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "400", - "score": 0.7201957183838115, - "predictedRows": 9, + "score": 0.7666666666666667, + "predictedRows": 8, "predictedCols": 5, "groundTruthRows": 9, "groundTruthCols": 5 }, { "id": "401", - "score": 0.8042207792207793, - "predictedRows": 4, + "score": 0.8152380952380953, + "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 23, "groundTruthCols": 2 }, { "id": "402", - "score": 0.6674244799404603, + "score": 0.7458112874779542, "predictedRows": 12, "predictedCols": 4, "groundTruthRows": 12, @@ -3270,7 +3235,7 @@ }, { "id": "403", - "score": 0.6587639131498779, + "score": 0.7251461988304093, "predictedRows": 18, "predictedCols": 4, "groundTruthRows": 19, @@ -3278,7 +3243,7 @@ }, { "id": "404", - "score": 0.6661880381219601, + "score": 0.6387542883848966, "predictedRows": 16, "predictedCols": 6, "groundTruthRows": 16, @@ -3286,7 +3251,7 @@ }, { "id": "405", - "score": 0.6804050189576505, + "score": 0.9, "predictedRows": 9, "predictedCols": 5, "groundTruthRows": 9, @@ -3294,7 +3259,7 @@ }, { "id": "406", - "score": 0.9989648033126295, + "score": 0.9994795732500651, "predictedRows": 3, "predictedCols": 2, "groundTruthRows": 15, @@ -3302,7 +3267,7 @@ }, { "id": "407", - "score": 0.7690434479657537, + "score": 0.873015873015873, "predictedRows": 7, "predictedCols": 4, "groundTruthRows": 7, @@ -3310,15 +3275,15 @@ }, { "id": "408", - "score": 0.6555699035812672, - "predictedRows": 16, + "score": 0.6088042866003393, + "predictedRows": 15, "predictedCols": 6, "groundTruthRows": 16, "groundTruthCols": 6 }, { "id": "409", - "score": 0.8267124821218119, + "score": 1, "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 7, @@ -3326,7 +3291,7 @@ }, { "id": "410", - "score": 0.7649405061169767, + "score": 0.8395089285714286, "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, @@ -3334,43 +3299,39 @@ }, { "id": "411", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 1, + "predictedRows": 2, + "predictedCols": 2, "groundTruthRows": 9, - "groundTruthCols": 2, - "error": "No prediction found" + "groundTruthCols": 2 }, { "id": "412", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7507507507507507, + "predictedRows": 36, + "predictedCols": 4, "groundTruthRows": 37, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "413", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7876838235294118, + "predictedRows": 23, + "predictedCols": 3, "groundTruthRows": 24, - "groundTruthCols": 3, - "error": "No prediction found" + "groundTruthCols": 3 }, { "id": "414", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.5010521885521886, + "predictedRows": 10, + "predictedCols": 7, "groundTruthRows": 12, - "groundTruthCols": 7, - "error": "No prediction found" + "groundTruthCols": 7 }, { "id": "415", - "score": 0.7331349206349206, + "score": 0.7604166666666666, "predictedRows": 12, "predictedCols": 3, "groundTruthRows": 12, @@ -3386,18 +3347,17 @@ }, { "id": "417", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6529787234042552, + "predictedRows": 46, + "predictedCols": 6, "groundTruthRows": 47, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "418", - "score": 0.9067661323788775, - "predictedRows": 6, - "predictedCols": 5, + "score": 0.818011988011988, + "predictedRows": 7, + "predictedCols": 6, "groundTruthRows": 6, "groundTruthCols": 5 }, @@ -3411,7 +3371,7 @@ }, { "id": "420", - "score": 0.8490250471047257, + "score": 0.9910714285714286, "predictedRows": 16, "predictedCols": 2, "groundTruthRows": 16, @@ -3419,23 +3379,23 @@ }, { "id": "421", - "score": 0.6363636363636364, + "score": 0.6236717827626919, "predictedRows": 11, - "predictedCols": 6, + "predictedCols": 7, "groundTruthRows": 12, "groundTruthCols": 6 }, { "id": "422", - "score": 0.640625, - "predictedRows": 7, + "score": 0.765625, + "predictedRows": 8, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "423", - "score": 0.894545551913973, + "score": 0.8732364110141888, "predictedRows": 15, "predictedCols": 4, "groundTruthRows": 15, @@ -3443,7 +3403,7 @@ }, { "id": "424", - "score": 0.8728957528957527, + "score": 0.95, "predictedRows": 10, "predictedCols": 2, "groundTruthRows": 10, @@ -3451,15 +3411,15 @@ }, { "id": "425", - "score": 0.6405128205128205, - "predictedRows": 13, + "score": 0.6538461538461539, + "predictedRows": 11, "predictedCols": 5, "groundTruthRows": 13, "groundTruthCols": 5 }, { "id": "426", - "score": 0.7205800415376278, + "score": 0.7405372405372407, "predictedRows": 14, "predictedCols": 4, "groundTruthRows": 14, @@ -3467,42 +3427,39 @@ }, { "id": "427", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7428040560062719, + "predictedRows": 61, + "predictedCols": 4, "groundTruthRows": 61, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "428", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6973856209150328, + "predictedRows": 50, + "predictedCols": 5, "groundTruthRows": 51, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "429", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7123722431414738, + "predictedRows": 25, + "predictedCols": 6, "groundTruthRows": 26, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "430", - "score": 0.8114533682186609, - "predictedRows": 8, + "score": 0.7495039682539683, + "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 8, "groundTruthCols": 3 }, { "id": "431", - "score": 0.8461604336883147, + "score": 0.9107142857142857, "predictedRows": 14, "predictedCols": 3, "groundTruthRows": 25, @@ -3518,7 +3475,7 @@ }, { "id": "433", - "score": 0.6454365079365079, + "score": 0.7061904761904763, "predictedRows": 14, "predictedCols": 5, "groundTruthRows": 14, @@ -3526,7 +3483,7 @@ }, { "id": "434", - "score": 0.8254438553640681, + "score": 0.834760839878649, "predictedRows": 12, "predictedCols": 6, "groundTruthRows": 12, @@ -3534,7 +3491,7 @@ }, { "id": "435", - "score": 0.8133116883116884, + "score": 0.8636363636363636, "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 11, @@ -3542,23 +3499,23 @@ }, { "id": "436", - "score": 0.755, - "predictedRows": 7, - "predictedCols": 5, + "score": 0.8545454545454545, + "predictedRows": 9, + "predictedCols": 6, "groundTruthRows": 9, "groundTruthCols": 5 }, { "id": "437", - "score": 0.651563340952392, - "predictedRows": 6, + "score": 0.5961199294532628, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "438", - "score": 0.9400584795321637, + "score": 0.842763512172031, "predictedRows": 18, "predictedCols": 4, "groundTruthRows": 19, @@ -3566,23 +3523,23 @@ }, { "id": "439", - "score": 0.7629629629629631, - "predictedRows": 10, + "score": 0.875, + "predictedRows": 9, "predictedCols": 3, "groundTruthRows": 9, "groundTruthCols": 3 }, { "id": "440", - "score": 0.9012304601666664, - "predictedRows": 8, + "score": 0.8392857142857143, + "predictedRows": 7, "predictedCols": 2, "groundTruthRows": 8, "groundTruthCols": 2 }, { "id": "441", - "score": 0.6597222222222222, + "score": 0.6700313764661219, "predictedRows": 15, "predictedCols": 4, "groundTruthRows": 16, @@ -3590,24 +3547,23 @@ }, { "id": "442", - "score": 0.978862973760933, + "score": 0.8571428571428571, "predictedRows": 7, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 7, "groundTruthCols": 2 }, { "id": "443", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7328006456820015, + "predictedRows": 58, + "predictedCols": 5, "groundTruthRows": 59, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "444", - "score": 0.6662109804995181, + "score": 0.8656565656565657, "predictedRows": 10, "predictedCols": 6, "groundTruthRows": 10, @@ -3615,16 +3571,15 @@ }, { "id": "445", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.5204081632653061, + "predictedRows": 6, + "predictedCols": 9, "groundTruthRows": 7, - "groundTruthCols": 9, - "error": "No prediction found" + "groundTruthCols": 9 }, { "id": "446", - "score": 0.9704081632653061, + "score": 1, "predictedRows": 10, "predictedCols": 2, "groundTruthRows": 10, @@ -3632,7 +3587,7 @@ }, { "id": "447", - "score": 0.7276785714285714, + "score": 0.6607142857142857, "predictedRows": 6, "predictedCols": 3, "groundTruthRows": 7, @@ -3640,23 +3595,23 @@ }, { "id": "448", - "score": 0.6146349206349206, - "predictedRows": 15, + "score": 0.6866666666666666, + "predictedRows": 12, "predictedCols": 5, "groundTruthRows": 15, "groundTruthCols": 5 }, { "id": "449", - "score": 0.9416449520587898, - "predictedRows": 11, - "predictedCols": 4, + "score": 0.7330528645356589, + "predictedRows": 12, + "predictedCols": 5, "groundTruthRows": 11, "groundTruthCols": 4 }, { "id": "450", - "score": 0.7043595620066209, + "score": 0.7593319559228651, "predictedRows": 11, "predictedCols": 5, "groundTruthRows": 11, @@ -3664,7 +3619,7 @@ }, { "id": "451", - "score": 0.6665081029305168, + "score": 0.7592592592592593, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -3672,16 +3627,15 @@ }, { "id": "452", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.7444733915322151, + "predictedRows": 65, + "predictedCols": 4, "groundTruthRows": 65, - "groundTruthCols": 4, - "error": "No prediction found" + "groundTruthCols": 4 }, { "id": "453", - "score": 0.9994961421048378, + "score": 1, "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 15, @@ -3689,15 +3643,15 @@ }, { "id": "454", - "score": 0.5828205128205128, - "predictedRows": 12, + "score": 0.6538461538461539, + "predictedRows": 11, "predictedCols": 5, "groundTruthRows": 13, "groundTruthCols": 5 }, { "id": "455", - "score": 0.9857142857142858, + "score": 0.9737327188940091, "predictedRows": 10, "predictedCols": 2, "groundTruthRows": 10, @@ -3705,15 +3659,15 @@ }, { "id": "456", - "score": 0.738, - "predictedRows": 10, - "predictedCols": 5, + "score": 0.7, + "predictedRows": 9, + "predictedCols": 6, "groundTruthRows": 10, "groundTruthCols": 5 }, { "id": "457", - "score": 0.7321428571428571, + "score": 0.7678571428571429, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -3721,7 +3675,7 @@ }, { "id": "458", - "score": 0.7027441311941864, + "score": 0.6561930783242258, "predictedRows": 8, "predictedCols": 4, "groundTruthRows": 8, @@ -3729,7 +3683,7 @@ }, { "id": "459", - "score": 0.9956309313382898, + "score": 0.995689935034627, "predictedRows": 15, "predictedCols": 2, "groundTruthRows": 15, @@ -3737,56 +3691,55 @@ }, { "id": "460", - "score": 0.6433274881572095, - "predictedRows": 15, + "score": 0.689613887795706, + "predictedRows": 14, "predictedCols": 6, "groundTruthRows": 15, "groundTruthCols": 6 }, { "id": "461", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6684491978609626, + "predictedRows": 16, + "predictedCols": 6, "groundTruthRows": 17, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "462", - "score": 0.6428571428571429, - "predictedRows": 6, + "score": 0.5357142857142857, + "predictedRows": 5, "predictedCols": 3, "groundTruthRows": 7, "groundTruthCols": 3 }, { "id": "463", - "score": 0.711764705882353, - "predictedRows": 16, + "score": 0.6823529411764706, + "predictedRows": 15, "predictedCols": 5, "groundTruthRows": 17, "groundTruthCols": 5 }, { "id": "464", - "score": 0.7107583774250441, - "predictedRows": 7, + "score": 0.6349206349206349, + "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 7, "groundTruthCols": 4 }, { "id": "465", - "score": 0.7269607843137255, - "predictedRows": 23, + "score": 0.8311764705882354, + "predictedRows": 25, "predictedCols": 3, "groundTruthRows": 25, "groundTruthCols": 3 }, { "id": "466", - "score": 0.7209876543209877, + "score": 0.7057818930041152, "predictedRows": 20, "predictedCols": 4, "groundTruthRows": 20, @@ -3794,7 +3747,7 @@ }, { "id": "467", - "score": 0.6990934202501935, + "score": 0.7592592592592593, "predictedRows": 6, "predictedCols": 4, "groundTruthRows": 6, @@ -3802,7 +3755,7 @@ }, { "id": "468", - "score": 0.9954761392662705, + "score": 0.9702318090073192, "predictedRows": 14, "predictedCols": 2, "groundTruthRows": 14, @@ -3810,17 +3763,17 @@ }, { "id": "469", - "score": 0.7292393095671784, - "predictedRows": 6, + "score": 0.6111111111111112, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "470", - "score": 0.46894586894586904, - "predictedRows": 7, - "predictedCols": 8, + "score": 0.6033388314090069, + "predictedRows": 8, + "predictedCols": 9, "groundTruthRows": 9, "groundTruthCols": 8 }, @@ -3834,7 +3787,7 @@ }, { "id": "472", - "score": 0.9330923076923078, + "score": 0.9863783783783784, "predictedRows": 15, "predictedCols": 5, "groundTruthRows": 15, @@ -3842,7 +3795,7 @@ }, { "id": "473", - "score": 0.753125, + "score": 0.7782907196969697, "predictedRows": 16, "predictedCols": 5, "groundTruthRows": 16, @@ -3850,23 +3803,23 @@ }, { "id": "474", - "score": 0.6858169934640523, - "predictedRows": 14, + "score": 0.7555555555555555, + "predictedRows": 15, "predictedCols": 4, "groundTruthRows": 15, "groundTruthCols": 4 }, { "id": "475", - "score": 0.7123193480290667, - "predictedRows": 22, + "score": 0.8156162464985995, + "predictedRows": 23, "predictedCols": 3, "groundTruthRows": 23, "groundTruthCols": 3 }, { "id": "476", - "score": 0.5029761904761905, + "score": 0.4665377735690236, "predictedRows": 10, "predictedCols": 7, "groundTruthRows": 12, @@ -3874,7 +3827,7 @@ }, { "id": "477", - "score": 0.7244239631336405, + "score": 0.773928049913713, "predictedRows": 31, "predictedCols": 4, "groundTruthRows": 31, @@ -3890,23 +3843,23 @@ }, { "id": "479", - "score": 0.634410849534189, - "predictedRows": 13, + "score": 0.6615384615384615, + "predictedRows": 11, "predictedCols": 5, "groundTruthRows": 13, "groundTruthCols": 5 }, { "id": "480", - "score": 0.7230769230769231, - "predictedRows": 13, + "score": 0.6139049355391859, + "predictedRows": 12, "predictedCols": 5, "groundTruthRows": 13, "groundTruthCols": 5 }, { "id": "481", - "score": 0.5205835784606241, + "score": 0.6111111111111112, "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 6, @@ -3914,15 +3867,15 @@ }, { "id": "482", - "score": 0.9947052221562025, - "predictedRows": 17, + "score": 0.943758573388203, + "predictedRows": 18, "predictedCols": 4, "groundTruthRows": 17, "groundTruthCols": 4 }, { "id": "483", - "score": 0.7021428571428572, + "score": 0.7678571428571429, "predictedRows": 7, "predictedCols": 3, "groundTruthRows": 7, @@ -3930,15 +3883,15 @@ }, { "id": "484", - "score": 0.7138020833333333, - "predictedRows": 17, + "score": 0.7981770833333334, + "predictedRows": 16, "predictedCols": 3, "groundTruthRows": 16, "groundTruthCols": 3 }, { "id": "485", - "score": 0.8636363636363636, + "score": 0.875, "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 11, @@ -3946,24 +3899,23 @@ }, { "id": "486", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6672532269725623, + "predictedRows": 18, + "predictedCols": 6, "groundTruthRows": 19, - "groundTruthCols": 6, - "error": "No prediction found" + "groundTruthCols": 6 }, { "id": "487", - "score": 0.5476190476190477, - "predictedRows": 7, + "score": 0.5194081110705151, + "predictedRows": 6, "predictedCols": 7, "groundTruthRows": 7, "groundTruthCols": 7 }, { "id": "488", - "score": 0.7432993162038956, + "score": 0.8650167084377611, "predictedRows": 4, "predictedCols": 3, "groundTruthRows": 4, @@ -3971,15 +3923,15 @@ }, { "id": "489", - "score": 0.6569264069264069, - "predictedRows": 10, + "score": 0.7613636363636364, + "predictedRows": 11, "predictedCols": 3, "groundTruthRows": 11, "groundTruthCols": 3 }, { "id": "490", - "score": 0.7265625, + "score": 0.675, "predictedRows": 4, "predictedCols": 3, "groundTruthRows": 5, @@ -3987,24 +3939,24 @@ }, { "id": "491", - "score": 0.9043386903491305, - "predictedRows": 9, + "score": 0.8567737172388334, + "predictedRows": 8, "predictedCols": 2, "groundTruthRows": 9, "groundTruthCols": 2 }, { "id": "492", - "score": 0.6749639249639251, - "predictedRows": 6, + "score": 0.6444444444444445, + "predictedRows": 5, "predictedCols": 4, "groundTruthRows": 6, "groundTruthCols": 4 }, { "id": "493", - "score": 0.6666666666666666, - "predictedRows": 4, + "score": 0.5833333333333334, + "predictedRows": 3, "predictedCols": 4, "groundTruthRows": 4, "groundTruthCols": 4 @@ -4019,4545 +3971,44 @@ }, { "id": "495", - "score": 0.6843488649940264, - "predictedRows": 15, + "score": 0.7111111111111111, + "predictedRows": 14, "predictedCols": 4, "groundTruthRows": 15, "groundTruthCols": 4 }, { "id": "496", - "score": 0.9089947089947091, + "score": 0.8306878306878307, "predictedRows": 9, - "predictedCols": 2, + "predictedCols": 3, "groundTruthRows": 9, "groundTruthCols": 2 }, { "id": "497", - "score": 0.7058823529411765, - "predictedRows": 16, + "score": 0.6074074074074074, + "predictedRows": 12, "predictedCols": 4, "groundTruthRows": 17, "groundTruthCols": 4 }, { "id": "498", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, + "score": 0.6070935960591134, + "predictedRows": 65, + "predictedCols": 5, "groundTruthRows": 59, - "groundTruthCols": 5, - "error": "No prediction found" + "groundTruthCols": 5 }, { "id": "499", - "score": 0.6296296296296297, - "predictedRows": 20, + "score": 0.7648162145516644, + "predictedRows": 21, "predictedCols": 4, "groundTruthRows": 21, "groundTruthCols": 4 - }, - { - "id": "500", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "501", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "502", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 47, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "503", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "504", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "505", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "506", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "507", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "508", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "509", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "510", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "511", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "512", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "513", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 24, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "514", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "515", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "516", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "517", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "518", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "519", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 19, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "520", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "521", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "522", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "523", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "524", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "525", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "526", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "527", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "528", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 36, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "529", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "530", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "531", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "532", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "533", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "534", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 46, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "535", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "536", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "537", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 19, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "538", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "539", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "540", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "541", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "542", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "543", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 56, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "544", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "545", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "546", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "547", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "548", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "549", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 29, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "550", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "551", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 22, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "552", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "553", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "554", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "555", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "556", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "557", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "558", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "559", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "560", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "561", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "562", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "563", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "564", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "565", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 22, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "566", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "567", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "568", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "569", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "570", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "571", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "572", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "573", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "574", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "575", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "576", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "577", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "578", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "579", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "580", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "581", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "582", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "583", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "584", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "585", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 32, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "586", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "587", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "588", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "589", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "590", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "591", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "592", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "593", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "594", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "595", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "596", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "597", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 29, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "598", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "599", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "600", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "601", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "602", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "603", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "604", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "605", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "606", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "607", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 37, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "608", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "609", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "610", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "611", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "612", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "613", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "614", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "615", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "616", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "617", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "618", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "619", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "620", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 31, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "621", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "622", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "623", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "624", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "625", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "626", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "627", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "628", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "629", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "630", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "631", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "632", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "633", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "634", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "635", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "636", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 28, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "637", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "638", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "639", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "640", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "641", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "642", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "643", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "644", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "645", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "646", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "647", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "648", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "649", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "650", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "651", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "652", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "653", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "654", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "655", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "656", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "657", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "658", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "659", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "660", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "661", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "662", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "663", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 29, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "664", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "665", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "666", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "667", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "668", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "669", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "670", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "671", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 35, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "672", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "673", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 28, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "674", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "675", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 25, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "676", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "677", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "678", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "679", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "680", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "681", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "682", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "683", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 28, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "684", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "685", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "686", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "687", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "688", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "689", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "690", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 23, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "691", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "692", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "693", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "694", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "695", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "696", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "697", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "698", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "699", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "700", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "701", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "702", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "703", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "704", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "705", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "706", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "707", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "708", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "709", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "710", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "711", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "712", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "713", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "714", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "715", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "716", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 36, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "717", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "718", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "719", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "720", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "721", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "722", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "723", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "724", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "725", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "726", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "727", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "728", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "729", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "730", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "731", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "732", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "733", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "734", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "735", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "736", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 23, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "737", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "738", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "739", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "740", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "741", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "742", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "743", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "744", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "745", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "746", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "747", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 25, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "748", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "749", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "750", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "751", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "752", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "753", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "754", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 23, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "755", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 28, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "756", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "757", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 35, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "758", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "759", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "760", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "761", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "762", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "763", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "764", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "765", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "766", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "767", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "768", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 29, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "769", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "770", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "771", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "772", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "773", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "774", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "775", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "776", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "777", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "778", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "779", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "780", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "781", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "782", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "783", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "784", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "785", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "786", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "787", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "788", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "789", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "790", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "791", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "792", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "793", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "794", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "795", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "796", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "797", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "798", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "799", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "800", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "801", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "802", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "803", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "804", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "805", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 29, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "806", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 32, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "807", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "808", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "809", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "810", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "811", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "812", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "813", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "814", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "815", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "816", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "817", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "818", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 25, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "819", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "820", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "821", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "822", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "823", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 36, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "824", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "825", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 8, - "error": "No prediction found" - }, - { - "id": "826", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "827", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "828", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "829", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "830", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "831", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "832", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "833", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "834", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "835", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "836", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "837", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "838", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 14, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "839", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 10, - "error": "No prediction found" - }, - { - "id": "840", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "841", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "842", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "843", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "844", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "845", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "846", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "847", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 32, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "848", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "849", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "850", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 19, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "851", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 20, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "852", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "853", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "854", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 35, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "855", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "856", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 24, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "857", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "858", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "859", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 24, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "860", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "861", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "862", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "863", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "864", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "865", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "866", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "867", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "868", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "869", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "870", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "871", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "872", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "873", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "874", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "875", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "876", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "877", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "878", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 32, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "879", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "880", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "881", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "882", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "883", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "884", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 9, - "error": "No prediction found" - }, - { - "id": "885", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "886", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "887", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "888", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "889", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 22, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "890", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "891", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "892", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "893", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "894", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "895", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "896", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "897", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "898", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "899", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "900", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "901", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "902", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "903", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "904", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "905", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "906", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 18, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "907", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "908", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "909", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "910", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "911", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "912", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "913", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "914", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "915", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 19, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "916", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "917", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "918", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "919", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "920", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "921", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "922", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "923", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "924", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "925", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 10, - "error": "No prediction found" - }, - { - "id": "926", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "927", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "928", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "929", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "930", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "931", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "932", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "933", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "934", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "935", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 42, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "936", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 17, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "937", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "938", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "939", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "940", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 46, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "941", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 20, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "942", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 23, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "943", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 23, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "944", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "945", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "946", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "947", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "948", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 45, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "949", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "950", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 42, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "951", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "952", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 21, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "953", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 24, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "954", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "955", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "956", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "957", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "958", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "959", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 9, - "error": "No prediction found" - }, - { - "id": "960", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "961", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "962", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "963", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 16, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "964", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "965", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "966", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "967", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "968", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "969", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "970", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "971", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 24, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "972", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "973", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "974", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "975", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "976", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 15, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "977", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "978", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 3, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "979", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "980", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 8, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "981", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "982", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "983", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 13, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "984", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "985", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 10, - "error": "No prediction found" - }, - { - "id": "986", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "987", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 26, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "988", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 12, - "groundTruthCols": 6, - "error": "No prediction found" - }, - { - "id": "989", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "990", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 11, - "groundTruthCols": 7, - "error": "No prediction found" - }, - { - "id": "991", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 5, - "error": "No prediction found" - }, - { - "id": "992", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 5, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "993", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 39, - "groundTruthCols": 2, - "error": "No prediction found" - }, - { - "id": "994", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 6, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "995", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 4, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "996", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "997", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 10, - "groundTruthCols": 4, - "error": "No prediction found" - }, - { - "id": "998", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 7, - "groundTruthCols": 3, - "error": "No prediction found" - }, - { - "id": "999", - "score": 0, - "predictedRows": 0, - "predictedCols": 0, - "groundTruthRows": 9, - "groundTruthCols": 3, - "error": "No prediction found" } ], - "elapsedSeconds": 3.4 + "elapsedSeconds": 2 } \ No newline at end of file